Advanced Search
MyIDEAS: Login

Research classified by Journal of Economic Literature (JEL) codes


Top JEL
/ I: Health, Education, and Welfare
/ / I1: Health
/ / / I10: General
/ / / I11: Analysis of Health Care Markets
/ / / I12: Health Production
/ / / I13: Health Insurance, Public and Private
/ / / I14: Health and Inequality
/ / / I15: Health and Economic Development
/ / / I18: Government Policy; Regulation; Public Health
/ / / I19: Other

This JEL code is mentioned in the follow RePEc Biblio entries:
  1. > Economic Development Technological Change, and Growth > Technological Change: Choices and Consequences > Technology Assessment > Health Technology Assessment

This topic is covered by the following reading lists:
  1. SOEP based publications

Most recent items first, undated at the end.
  • 2014 The Effect of Dental Insurance on the Use of Dental Care For Older Adults: A Partial Identification Analysis
    by Kreider, Brent & Manski, Richard & Moeller, John & Pepper, John V.
  • 2014 A synthesis of the Grossman and Becker-Murphy models of health and addiction: theoretical and empirical implications
    by Jones, A. M.; & Laporte, A.; & Rice, N.; & Zucchelli, E.;
  • 2014 Do occupational demands explain the educational gradient in health?
    by Meyer S.C. & Künn-Nelen A.C.
  • 2014 Analysis of Cigarette Tax Structure as a Requirement for an Effective Tax Policy: Evaluation and Simulation for Argentina
    by Frank Chaloupka & Martin Gonzalez-Rozada & German Rodriguez Iglesias & Veronica Schoj
  • 2014 A New Formulation for Latent Class Models
    by Sarah Brown & William Greene & Mark N. Harris
  • 2014 The Science of Making Better Decisions about Health: Cost-Effectiveness and Cost-Benefit Analysis
    by Louise Russell
  • 2014 Health Insurance Generosity and Conditional Coverage: Evidence from Medicaid Managed Care in Kentucky
    by Marton, James & Yelowitz, Aaron
  • 2014 Health care and social care: complements, substitutes and attributes
    by Wildman, John & McMeekin, Peter
  • 2014 High fluoride and low pH level have been detected in popular flavoured beverages in Malaysia
    by Rahim, Zubaidah HA & Bakri, Marina M & Zakir, HM & Ahmed, IA & Zulkifli, NA
  • 2014 La Spesa sanitaria Ssn in Italia e nella Regione Basilicata Ricostruzione e benchmarking con la metodologia Ecofin-Ocse
    by SALERNO, Nicola Carmine
  • 2014 La Spesa sanitaria Ssn in Italia e nella Regione Emilia Romagna - Ricostruzione e benchmarking con la metodologia Ecofin-Ocse
    by SALERNO, Nicola Carmine
  • 2014 A Zero Inflated Regression Model for Grouped Data
    by Sarah Brown & Alan S Duncan & Mark N Harris & Jennifer Roberts & Karl Taylor
  • 2014 Mental Health Analysis Profiles (MhAPs): Scotland
    by Alessia Forti
  • 2014 Mental Health Analysis Profiles (MhAPs): Netherlands
    by Alessia Forti & Chris Nas & Alex van Geldrop & Gedrien Franx & Ionela Petrea & Ype van Strien & Patrick Jeurissen
  • 2014 Mental Health Analysis Profiles (MhAPs): Finland
    by Pauliina Patana
  • 2014 Mental Health Analysis Profiles (MhAPs): Italy
    by Alessia Forti
  • 2014 Pricing and competition in Specialist Medical Services: An Overview for South Africa
    by Ankit Kumar & Grégoire de Lagasnerie & Frederica Maiorano & Alessia Forti
  • 2014 Fairly Sharing the Social Impact of the Crisis in Greece
    by Vassiliki Koutsogeorgopoulou & Manos Matsaganis & Chrysa Leventi & Jan-David Schneider
  • 2014 Dividing the Pie in Brazil: Income Distribution, Social Policies and the New Middle Class
    by Jens Arnold & João Jalles
  • 2014 Will Divestment from Employment-Based Health Insurance Save Employers Money? The Case of State and Local Governments
    by Jeremy D. Goldhaber-Fiebert & David M. Studdert & Monica S. Farid & Jay Bhattacharya
  • 2014 Pharmaceutical Profits and the Social Value of Innovation
    by David Dranove & Craig Garthwaite & Manuel Hermosilla
  • 2014 Medicaid: A Review of the Literature
    by Marianne P. Bitler & Madeline Zavodny
  • 2014 Health, Disability Insurance and Retirement in Denmark
    by Paul Bingley & Nabanita Datta Gupta & Michael Jorgensen & Peder Pedersen
  • 2014 Effects of Maternal Depression on Family Food Insecurity
    by Kelly Noonan & Hope Corman & Nancy E. Reichman
  • 2014 Is Smoking Inferior? Evidence from Variation in the Earned Income Tax Credit
    by Donald S. Kenkel & Maximilian D. Schmeiser & Carly J. Urban
  • 2014 The Market for High-Quality Medicine
    by Daniel Bennett & Wesley Yin
  • 2014 Health Care in a Multipayer System: The Effects of Health Care Service Demand among Adults under 65 on Utilization and Outcomes in Medicare
    by Sherry A. Glied
  • 2014 How Much Favorable Selection Is Left in Medicare Advantage?
    by Joseph P. Newhouse & Mary Price & J. Michael McWilliams & John Hsu & Thomas McGuire
  • 2014 Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market
    by Eric Helland & Darius N. Lakdawalla & Anup Malani & Seth A. Seabury
  • 2014 Does grief transfer across generations? In-utero deaths and child outcomes
    by Sandra Black & Paul J. Devereux & Kjell Salvanes
  • 2014 Adjusting Body Mass for Measurement Error with Invalid Validation Data
    by Charles Courtemanche & Joshua C. Pinkston & Jay Stewart
  • 2014 Relaxing Occupational Licensing Requirements: Analyzing Wages and Prices for a Medical Service
    by Morris M. Kleiner & Allison Marier & Kyoung Won Park & Coady Wing
  • 2014 The Role of Health in Retirement
    by Alan L. Gustman & Thomas L. Steinmeier
  • 2014 Short-run Effects of Job Loss on Health Conditions, Health Insurance, and Health Care Utilization
    by Jessamyn Schaller & Ann Huff Stevens
  • 2014 Equilibrium Health Spending and Population Aging in a Model of Endogenous Growth - Will the GDP Share of Health Spending Keep Rising?
    by Isaac Ehrlich & Yong Yin
  • 2014 Could a Website Really Have Doomed the Health Exchanges? Multiple Equilibria, Initial Conditions and the Construction of the Fine
    by Florian Scheuer & Kent Smetters
  • 2014 Econometric Modelling of Price Response by Alcohol Types to Inform Alcohol Tax Policies
    by Preety Srivastava & Keith R. McLaren & Michael Wohlgenant & Xueyan Zhao
  • 2014 Revisiting an important Canadian natural experiment with new methods: an evaluation of the impact of the 1994 tax decrease on smoking
    by Philip Merrigan & François Gardes
  • 2014 Infant Feeding Practices and Food Consumption Patterns of Children Participating in WIC
    by Denise M. Deming & Ronette R. Briefel & Kathleen C. Reidy
  • 2014 Reaching the Underserved Elderly and Working Poor in SNAP: Evaluation Findings from the Fiscal Year 2009 Pilots
    by Jacqueline Kauff & Lisa Dragoset & Elizabeth Clary & Elizabeth Laird & Libby Makowsky & Emily Samaa-Miller
  • 2014 SNAP Participation and Urban and Rural Food Security
    by James Mabli
  • 2014 SNAP Participation, Food Security, and Geographic Access to Food
    by James Mabli
  • 2014 Supplemental Nutrition Assistance Program Food Security Survey: Impacts of Urbanicity and Food Access on Food Security
    by James Mabli
  • 2014 Supplemental Nutrition Assistance Program Participation and Child Food Security
    by James Mabli & Julie Worthington
  • 2014 Programs Conferring Categorical Eligibility for SNAP: State Policies and the Number and Characteristics of Households Affected
    by Elizabeth Laird & Carole Trippe
  • 2014 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2012
    by Kelsey Farson Gray & Esa Eslami
  • 2014 Supplemental Nutrition Assistance Program Participation Rates: Fiscal Years 2010 and 2011
    by Esa Eslami & Karen Cunnyngham
  • 2014 Reaching Those in Need: State Supplemental Nutrition Assistance Program Participation Rates in 2011
    by Karen E. Cunnyngham
  • 2014 Rationalizable Suicides: Evidence from Changes in Inmates' Expected Length of Sentence
    by Campaniello, Nadia & Diasakos, Theodoros & Mastrobuoni, Giovanni
  • 2014 A New Formulation for Latent Class Models
    by Brown, Sarah & Greene, William H. & Harris, Mark N.
  • 2014 The Power of the Little Blue Pill: Innovations and Implications of Life Style Drugs in an Aging Population
    by LaRiviere, Jacob & Wolff, Hendrik
  • 2014 Does Grief Transfer across Generations? In-Utero Deaths and Child Outcomes
    by Black, Sandra E. & Devereux, Paul J. & Salvanes, Kjell G.
  • 2014 Do Occupational Demands Explain the Educational Gradient in Health?
    by Meyer, Sophie-Charlotte & Künn-Nelen, Annemarie
  • 2014 Adjusting Body Mass for Measurement Error with Invalid Validation Data
    by Courtemanche, Charles & Pinkston, Joshua C. & Stewart, Jay
  • 2014 The Miracle Drugs: Hormone Replacement Therapy and Labor Market Behavior of Middle-Aged Women
    by Daysal, N. Meltem & Orsini, Chiara
  • 2014 Economic Status, Air Quality, and Child Health: Evidence from Inversion Episodes
    by Jans, Jenny & Johansson, Per & Nilsson, Peter
  • 2014 Equilibrium Health Spending and Population Aging in a Model of Endogenous Growth: Will the GDP Share of Health Spending Keep Rising?
    by Ehrlich, Isaac & Yin, Yong
  • 2014 Atypical Employment and Health: A Meta-Analysis
    by Alice Sanwald & Engelbert Theurl
  • 2014 What drives out-of pocket health expenditures of private households? - Empirical evidence from the Austrian household budget survey
    by Alice sanwald & Engelbert Theurl
  • 2014 Business As Usual: New Jersey Employers’ Experiences with Family Leave Insurance
    by Sharon Lerner & Eileen Appelbaum
  • 2014 Documenting the Need for a National Paid Family and Medical Leave Program: Evidence from the 2012 FMLA Survey
    by Helene Jorgensen & Eileen Appelbaum
  • 2014 Expanding Family and Medical Leave to Small Firms
    by Helene Jorgensen & Eileen Appelbaum
  • 2014 Expanding Federal Family and Medical Leave Coverage: Who Benefits from Changes in Eligibility Requirements?
    by Helene Jorgensen & Eileen Appelbaum
  • 2014 Giving and promising gifts: experimental evidence on reciprocity from the field
    by J. Michelle Brock & Andreas Lange & Kenneth L. Leonard
  • 2014 Natural resources and the spread of HIV/AIDS: curse or blessing?
    by Olivier C. Sterck
  • 2014 How Will The Affordable Care Act Change Employers’ Incentives To Offer Insurance?
    by Jean M. Abraham, Ph.D. & Roger Feldman, Ph.D. & Peter Graven, M.S.
  • 2014 Estimação dos parâmetros de valorização dos estados de saúde em minas gerais a partir do EQ-5D
    by Mônica Viegas Andrade & Kenya Noronha
  • 2014 A Synthesis of the Grossman and Becker-Murphy Models of Health and Addiction: Theoretical and Empirical Implications
    by Andrew Jones & Audrey Laporte & Nigel Rice & Eugenio Zucchelli
  • 2014 Which attitudes will make us individually and socially happier and healthier? A cross-culture and cross-development analytical model
    by F. Zagonari
  • 2014 Are bad health and pain making us grumpy? An empirical evaluation of reporting heterogeneity in rating health system responsiveness
    by G. Fiorentini & G. Ragazzi & S. Robone
  • 2014 Drinking Water Supply Management through Innovative Methods and Finance in Municipal Councils of Mumbai Metropolitan Region
    by Sanjay RODE
  • 2014 Experiencia comparada europea y el reto de la descentralización sanitaria/Comparative European Experience and the Decentralization Health Challenge
    by BLÁZQUEZ-FERNÁNDEZ, CARLA & CANTARERO-PRIETO, DAVID & PASCUAL-SÁEZ, MARTA
  • 2014 The Praxis of Social Enterprise and Human Security: An Applied Research Agenda
    by Malcolm David Brown
  • 2014 Fragile States, Infectious Disease and Health Security: The Case for Timor-Leste
    by John M. Quinn & Nelson Martins & Mateus Cunha & Michiyo Higuchi & Dan Murphy & Vladimir Bencko
  • 2014 Human Security in World Affairs: A Pedagogical, Multi-disciplinary Approach
    by John Janzekovic
  • 2014 Editorial for Journal of Human Security Volume 10
    by Sabina Lautensach
  • 2014 Does substance use affect educational outcomes?
    by Daniel I. Rees
  • 2014 The effect of entry regulation in the health care sector: The case of home health
    by Polsky, Daniel & David, Guy & Yang, Jianing & Kinosian, Bruce & Werner, Rachel M.
  • 2014 The effect of relationship status on health with dynamic health and persistent relationships
    by Kohn, Jennifer L. & Averett, Susan L.
  • 2014 The causal effect of family income on child health in the UK
    by Kuehnle, Daniel
  • 2014 Health information exchange, system size and information silos
    by Miller, Amalia R. & Tucker, Catherine
  • 2014 Social learning and health insurance enrollment: Evidence from China's New Cooperative Medical Scheme
    by Liu, Hong & Sun, Qi & Zhao, Zhong
  • 2014 Religion and risky health behaviors among U.S. adolescents and adults
    by Fletcher, Jason & Kumar, Sanjeev
  • 2014 Education policies and health inequalities: Evidence from changes in the distribution of Body Mass Index in France, 1981–2003
    by Etile, Fabrice
  • 2014 Interactive effects of in utero nutrition and genetic inheritance on cognition: New evidence using sibling comparisons
    by Cook, C. Justin & Fletcher, Jason M.
  • 2014 Violating the Monotonicity condition for instrumental variable—Dimorphic patterns of gene–behavior association
    by Fang, Muriel Zheng
  • 2014 Armed conflict, household victimization, and child health in Côte d'Ivoire
    by Minoiu, Camelia & Shemyakina, Olga N.
  • 2014 Catastrophic out-of-pocket payment for healthcare and implications for household coping strategies: evidence from West Bengal, India
    by Swadhin Mondal & Henry Lucas & David Peters & Barun Kanjilal
  • 2014 Gesundheitsforschung am DIW Berlin
    by Tomaso Duso & Peter Haan & Gert G. Wagner
  • 2013 Surcharge et engorgement des urgences : la réponse durable du modèle des Pass
    by Rochefort, Jeanine & Mechali, Denis & Tapié de Celeyran, Florence & Pierru, Frédéric & Georges-Tarragano, Claire
  • 2013 On the Fuzzy Boundaries between Public and Private in Health-Care Organization and Funding Systems
    by Alessandro Petretto
  • 2013 Economic Evaluation of Human Losses from Disasters
    by B. Porfiriev.
  • 2013 The Dow is Killing Me: Risky Health Behaviors and the Stock Market
    by Chad Cotti & Richard A. Dunn & Nathan Tefft
  • 2013 The causal effect of family income on child health: A re-examination using an instrumental variables approach
    by Kuehnle, Daniel
  • 2013 The Parental Co-Immunization Hypothesis
    by Miguel Portela & Paul Schweinzer
  • 2013 The Causal Effect of Retirement on Mortality: Evidence from Targeted Incentives to Retire Early
    by Bloemen, H.; & Hochguertel, S.; & Zweering, J.;
  • 2013 Weather shocks and nutritional status of disadvantaged children in Vietnam
    by Edoka, I.;
  • 2013 Moving up and sliding down: An empirical assessment of the effect of social mobility on subjective wellbeing
    by Dolan, P.; & Lordan, G.;
  • 2013 The Demand for Cigarettes as Derived from the Demand for Weight Control
    by Cawley, J.; & Von Hinke Kessler Scholder, S.;
  • 2013 Typological analysis of factors reducing rural mortality in Russian regions
    by Tatiana Blinova & Svetlana Bylina
  • 2013 Substituting Leisure for Health Expenditure: A General Equilibrium-Based Empirical Investigation
    by Kevin x.d. Huang & Hui He & Sheng-ti Hung
  • 2013 The Equilibrium Dynamics of Economic Epidemiology
    by David Aadland & David Finnoff & Kevin x.d. Huang
  • 2013 The impact of investment in education on economic development: Spain in comparative perspective (1860-2000)
    by Enriqueta Camps
  • 2013 Do parents drink their children's welfare? A joint analysis of intra-household allocation of time
    by Gianna Claudia Giannelli & Lucia Mangiavacchi & Luca Piccoli
  • 2013 Are You Happy While You Work?
    by Alex Bryson & George MacKerron
  • 2013 An Econometric Approach of Computing Competitiveness Index in Human Capital
    by Salahodjaev, Raufhon & Nazarov, Zafar
  • 2013 The financial burden from non-communicable diseases in low- and middle-income countries: a literature review
    by Kankeu Tchewonpi, Hyacinthe & Saksena, Priyanka & Xu, Ke & Evans, David B
  • 2013 Preventive health and active ageing: the elderly are not a burden
    by Aisa, Rosa & Larramona, Gemma & Pueyo, Fernando
  • 2013 Dietary quality and tree cover in Africa
    by Ickowitz, Amy & Powell, Bronwen & Salim, Mohammad & Sunderland, Terry
  • 2013 Bang for Your Buck: STI Risk and Pregnancy Risk as Sources of the Price Premium for Unprotected Sex
    by Manda, Constantine
  • 2013 La demografia dell’Italia e delle Regioni italiane. Uno sguardo alle proiezioni a medio-lungo termine
    by SALERNO, Nicola Carmine
  • 2013 Quality and health care performance in the Italian regions
    by De Nicola, Arianna & Mancuso, Paolo & Valdmanis, Vivian
  • 2013 Un Test sulle Ipotesi delle Proiezioni a medio-lungo termine della Spesa Sanitaria
    by Salerno, Nicola Carmine
  • 2013 Causal Inference and the Millennium Development Goals (MDGs): Assessing Whether There Was an Acceleration in MDG Development Indicators Following the MDG Declaration
    by Friedman, Howard Steven
  • 2013 Association between obesity and selected morbidities: A study of BRICS
    by Ankita, Ankita Shukla & Kaushal, Kaushalendra Kumar & Abhishek, Abhishek Singh
  • 2013 Relative Deprivation in China
    by Chen, Xi
  • 2013 Rising Mortality Rate in Andhra Pradesh: Towards a demystification
    by Motkuri, Venkatanarayana & Mishra, Uday Shankar
  • 2013 Dynamics of obesity in Finland
    by Halicioglu, Ferda
  • 2013 Research and Science Today No. 1(5)/2013
    by ADAM, Elena & TRIȘCAȘ, Floarea Elena & NICOARĂ, Raluca-Maria & IVAN, Ruben Ioan & DUȚĂ, Paul & PANAIT, Ion & MANOLACHE, Viorella & ANDRONACHE, Alin & TRANDAFIR, Andreea & TAROPA-IACOB, Anda & DUȚĂ, Andreea Emilia & IORDAN, Costel & ALEXA, Oana Alexandra & CIOREI, Mihaela Andreea & MARCAU, Flavius-Cristian & SIMA, Isabella Cristiana & MATEIU, Mihaela & NISIPEANU, Elena & CĂLIN, Alexandra & HARANGUS, Katalin & EDU, Filip Vladimir & MARIN, Aurelia Camelia & AŞER, Nica & BOGDAN, Laura & MOGA, Monika & VULPAȘU, Dana & COSTESCU, Elena-Alis & CIUNTUC, Cristina-Elena & NECHIFOR, Caleb Otniel Traian & CRISTESCU, Cosmina & PIPOŞ, Cristina
  • 2013 Endogenous fertility, endogenous lifetime and economic growth: the role of child policies
    by Fanti, Luciano & Gori, Luca
  • 2013 The Determinants of Rising Inequality in Health Insurance and Wages: An Equilibrium Model of Workers' Compensation and Health Care Policies
    by Rong Hai
  • 2013 Econometric Modelling of Social Bads
    by William H Greene & Mark N Harris & Preety Srivastava & Xueyan Zhao
  • 2013 Modelling Illegal Drug Participation in Australia
    by Sarah Brown & Mark N Harris & Preety Srivastava
  • 2013 The Parental Co-Immunization Hypothesis
    by Miguel Portela & Paul Schweinzer
  • 2013 How Obamacare Will Re-Shape the Practice of Medicine
    by Scott Gottlieb
  • 2013 The Effect of U.S. Health Insurance Expansions on Medical Innovation
    by Jeffrey Clemens
  • 2013 Employer Contribution and Premium Growth in Health Insurance
    by Yiyan Liu & Ginger Zhe Jin
  • 2013 The Roles of Assimilation and Ethnic Enclave Residence in Immigrant Smoking
    by Johanna Catherine Maclean & Douglas Webber & Jody L. Sindelar
  • 2013 The Effect of Patient Cost Sharing on Utilization, Health, and Risk Protection
    by Hitoshi Shigeoka
  • 2013 Calculating Disease-Based Medical Care Expenditure Indexes for Medicare Beneficiaries: A Comparison of Method and Data Choices
    by Anne E. Hall & Tina Highfill
  • 2013 Going into the Affordable Care Act: Measuring the Size, Structure and Performance of the Individual and Small Group Markets for Health Insurance
    by Pinar Karaca-Mandic & Jean M. Abraham & Kosali Simon & Roger Feldman
  • 2013 Is This Time Different? The Slowdown in Healthcare Spending
    by Amitabh Chandra & Jonathan Holmes & Jonathan Skinner
  • 2013 Health and the Economy in the United States, from 1750 to the Present
    by Dora Costa
  • 2013 Women’s Education: Harbinger of Another Spring? Evidence from a Natural Experiment in Turkey
    by Mehmet Alper Dinçer & Neeraj Kaushal & Michael Grossman
  • 2013 What Do We Know About Short and Long Term Effects of Early Life Exposure to Pollution?
    by Janet Currie & Joshua S. Graff Zivin & Jamie Mullins & Matthew J. Neidell
  • 2013 The Role of Retiree Health Insurance in the Early Retirement of Public Sector Employees
    by John B. Shoven & Sita Slavov
  • 2013 Conforming and Non-conforming Peer Effects in Vaccination Decisions
    by Elizabeth Bodine-Baron & Sarah Nowak & Raffaello Varadavas & Neeraj Sood
  • 2013 Childhood Health and Sibling Outcomes: The Shared Burden and Benefit of the 1918 Influenza Pandemic
    by John Parman
  • 2013 Who Is in Control? The Determinants of Patient Adherence with Medication Therapy
    by Sergei Koulayev & Niels Skipper & Emilia Simeonova
  • 2013 Identifying the Health Production Function: The Case of Hospitals
    by John A. Romley & Neeraj Sood
  • 2013 The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity
    by Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro
  • 2013 The Changing Role of Government in Financing Health Care: An International Perspective
    by Mark Stabile & Sarah Thomson
  • 2013 The Role of Agents and Brokers in the Market for Health Insurance
    by Pinar Karaca-Mandic & Roger Feldman & Peter Graven
  • 2013 Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
    by David Cutler & Jonathan Skinner & Ariel Dora Stern & David Wennberg
  • 2013 If My Blood Pressure Is High, Do I Take It To Heart? Behavioral Impacts of Biomarker Collection in the Health and Retirement Study
    by Ryan D. Edwards
  • 2013 Do Firms Use Coupons and In-store Discounts to Strategically Market Experience Goods Over the Consumption Life-Cycle? The Case of Cigarettes
    by Andrew Sfekas & Dean R. Lillard
  • 2013 The Inter-generational and Social Transmission of Cultural Traits: Theory and Evidence from Smoking Behavior
    by Rebekka Christopoulou & Ahmed Jaber & Dean R. Lillard
  • 2013 Recessions, Healthy No More?
    by Christopher J. Ruhm
  • 2013 International Health Economics
    by Mark Egan & Tomas J. Philipson
  • 2013 Evidence for Significant Compression of Morbidity In the Elderly U.S. Population
    by David M. Cutler & Kaushik Ghosh & Mary Beth Landrum
  • 2013 Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy
    by Mireille Jacobson & Tom Y. Chang & Joseph P. Newhouse & Craig C. Earle, M.D.
  • 2013 Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician
    by Mariana Carrera & Dana Goldman & Geoffrey Joyce
  • 2013 Food Prices and Body Fatness among Youths
    by Michael Grossman & Erdal Tekin & Roy Wada
  • 2013 Informal Care and Caregiver's Health
    by Young Kyung Do & Edward C. Norton & Sally Stearns & Courtney H. Van Houtven
  • 2013 Economic Downturns and Substance Abuse Treatment: Evidence from Admissions Data
    by Johanna Catherine Maclean & Jonathan H. Cantor & Rosalie Liccardo Pacula
  • 2013 The Effect of Medicare Advantage on Hospital Admissions and Mortality
    by Christopher C. Afendulis & Michael E. Chernew & Daniel P. Kessler
  • 2013 The Spillover Effects of Medicare Managed Care: Medicare Advantage and Hospital Utilization
    by Katherine Baicker & Michael Chernew & Jacob Robbins
  • 2013 Adjusting National Accounting for Health: Is the Business Cycle Countercyclical?
    by Mark L. Egan & Casey B. Mulligan & Tomas J. Philipson
  • 2013 Unobservable Selection and Coefficient Stability: Theory and Validation
    by Emily Oster
  • 2013 Social Impact Bonds in Nonprofit Health Care: New Product or New Package?
    by Mark Pauly & Ashley Swanson
  • 2013 An Equilibrium Model of the African HIV/AIDS Epidemic
    by Jeremy Greenwood & Philipp Kircher & Cezar Santos & Michèle Tertilt
  • 2013 How Do Hospitals Respond to Market Entry? Evidence from A Deregulated Market for Cardiac Revascularization
    by Suhui Li & Avi Dor
  • 2013 The Effect of Deceptive Advertising on Consumption of the Advertised Good and its Substitutes: The Case of Over-the-Counter Weight Loss Products
    by John Cawley & Rosemary Avery & Matthew Eisenberg
  • 2013 Physical Activity and Health
    by Gregory J. Colman & Dhaval M. Dave
  • 2013 How do Hospitals Respond to Negative Financial Shocks? The Impact of the 2008 Stock Market Crash
    by David Dranove & Craig Garthwaite & Christopher Ody
  • 2013 The Demand for Cigarettes as Derived from the Demand for Weight Control
    by John Cawley & Stephanie von Hinke Kessler Scholder
  • 2013 Effectiveness and Spillovers of Online Sex Education: Evidence from a Randomized Evaluation in Colombian Public Schools
    by Alberto Chong & Marco Gonzalez-Navarro & Dean Karlan & Martin Valdivia
  • 2013 Alcohol Consumption, Deterrence and Crime in New York City
    by Hope Corman & Naci H. Mocan
  • 2013 Learning from Customers: Individual and Organizational Effects in Outsourced Radiological Services
    by Jonathan R. Clark & Robert S. Huckman & Bradley R. Staats
  • 2013 The Effects of Childhood ADHD on Adult Labor Market Outcomes
    by Jason Fletcher
  • 2013 Measuring the Effect of Supplemental Nutrition Assistance Program (SNAP) Participation on Food Security
    by James Mabli & Jim Ohls & Lisa Dragoset & Laura Canstner & Betsy Santos
  • 2013 New Data on the Nutritional Quality of School Lunches
    by Mary Kay Fox
  • 2013 Direct Certification in the National School Lunch Program State Implementation Progress, School Year 2012-2013
    by Quinn Moore & Kevin Conway & Brandon Kyler & Andrew Gothro
  • 2013 Direct Certification in the National School Lunch Program: State Implementation Progress, School Year 2012-2013
    by Quinn Moore & Kevin Conway & Brandon Kyler & Andrew Gothro
  • 2013 Impact of the Summer Electronic Benefits Transfer for Children (SEBTC) Demonstration on Children's Nutritional Status
    by Ronette Briefel & Ann Collins & Anne Wolf
  • 2013 The Effects of Proposed Changes to the Supplemental Nutrition Assistance Program on Eligibility, Participation, and Benefits
    by Joshua Leftin & Karen Cunnyngham
  • 2013 Summary of Summer Electronic Benefits Transfer for Children: Evaluation Findings for the Full Implementation Year 2012
    by Ann M. Collins & Ronette Briefel & Jacob Alex Klerman & Gretchen Rowe & Anne Wolf & Christopher W. Logan & Anne Gordon & Carrie Wolfson & Ayesha Enver & Cheryl Owens & Charlotte Cabili & Stephen Bell
  • 2013 Summer Electronic Benefits Transfer for Children (SEBTC) Demonstration: 2012. Technical Appendices
    by Ann M. Collins & Ronette Briefel & Jacob Alex Klerman & Gretchen Rowe & Anne Wolf & Christopher W. Logan & Anne Gordon & Carrie Wolfson & Ayesha Enver & Cheryl Owens & Charlotte Cabili & Stephen Bell
  • 2013 Summer Electronic Benefits Transfer for Children (SEBTC) Demonstration: 2012
    by Ann M. Collins & Ronette Briefel & Jacob Alex Klerman & Gretchen Rowe & Anne Wolf & Christopher W. Logan & Anne Gordon & Carrie Wolfson & Ayesha Enver & Cheryl Owens & Charlotte Cabili & Stephen Bell
  • 2013 Children's Consuption of Fruits and Vegetables: Do School Environment and Policies Affect Choices at School and Away from School?
    by Ariun Ishdorj & Mary Kay Crepinsek & Helen H. Jensen
  • 2013 White Paper on the Emergency Food Assistance Program (TEFAP)
    by Charlotte Cabili & Esa Eslami & Ronette Briefel
  • 2013 Using the SAS® Output Delivery System Report Writing Interface to Produce Codebooks for Survey Data
    by Nancy Cole & Cassandra Baxter
  • 2013 Analysis of Proposed Changes to SNAP Eligibility and Benefit Determination in the 2013 Farm Bill and Comparison of Cardiometabolic Health Status for SNAP Participants and Low-Income Nonparticipants
    by Joshua Leftin & Allison Dodd & Kai Filion & Rebecca Wang & rew Gothro & Karen Cunnyngham
  • 2013 Evaluating Obesity Prevention Efforts: A Plan for Measuring Progress
    by Committee on Evaluating Progress of Obesity Prevention Effort & Food & Nutrition Board & Institute of Medicine & of which Ronette Briefel is a member
  • 2013 Measuring the Effect of Supplemental Nutrition Assistance Program (SNAP) Participation on Food Security
    by James Mabli & Jim Ohls & Lisa Dragoset & Laura Castner & Betsy Santos
  • 2013 Measuring the Effect of Supplemental Nutrition Assistance Program (SNAP) Participation on Food Security
    by James Mabli & Jim Ohls & Lisa Dragoset & Laura Castner & Betsy Santos
  • 2013 The Healthy Weight Collaborative: Using Learning Collaboratives to Enhance Community-Based Prevention Initiatives Addressing Childhood Obesity
    by Margaret B. Hargreaves & Todd Honeycutt & Cara Orfield & Michaela Vine & Charlotte Cabili & Michaella Morzuch & Sylvia K. Fisher & Ronette Briefel
  • 2013 Expanding the Role of Primary Care in the Prevention and Treatment of Childhood Obesity: A Review of Clinic- and Community-Based Recommendations and Interventions
    by Michaela Vine & Margaret B. Hargreaves & Ronette R. Briefel & Cara Orfield
  • 2013 Disparities in Consumption of Sugar-Sweetened and Other Beverages by Race/Ethnicity and Obesity Status Among United States Schoolchildren
    by Allison Hedley Dodd & Ronette Briefel & Charlotte Cabili & er Wilson & Mary Kay Crepinsek
  • 2013 Reducing Calories and Added Sugars by Improving Children's Beverage Choices
    by Ronette R. Briefel & er Wilson & Charlotte Cabili & Allison Hedley Dodd
  • 2013 The Evolution of SNAP Modernization Initiatives in Five States
    by Lara Hulsey & Kevin Conway & rew Gothro & Rebecca Kleinman & Megan Reilly & Scott Cody & Emily Sama-Miller
  • 2013 Current State of School Meals & Snacks: School Nutrition Dietary Assessment Study IV
    by Tracy Fox & Jay Hirschman & Mary Kay Fox & Mary Kay Crepinsek
  • 2013 Accounting for the Rise of Health Spending and Longevity
    by Raquel Fonseca & Pierre-Carl Michaud & Arie Kapteyn & Titus Galama
  • 2013 The Effect of Education on Health: Cross-Country Evidence
    by Raquel Fonseca & Yuhui Zheng
  • 2013 Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from Eortic QLQ Data in Myeloma for Use in Cost effectiveness Analysis
    by Samer A Kharroubi & Richard Edlin & David Meads & Chantelle Browne & Julia Brown & Christopher McCabe
  • 2013 Nannying, nudging, rewarding? A discussion on the constraints and the degree of control over health status
    by Christine le Clainche & Sandy Tubeuf
  • 2013 Assignment errors and the valuation of EQ-5D health states-do responses mean what we think they mean?
    by Richard Edlin & Christopher McCabe & David Meads
  • 2013 Old Boys’ Network in General Practitioner’s Referral Behavior
    by Franz Hackl & Michael Hummer & Gerald Pruckner
  • 2013 Old Boys’ Network in General Practitioner’s Referral Behavior
    by Franz Hackl & Michael Hummer & Gerald Pruckner
  • 2013 Does High Home-Ownership Impair the Labor Market?
    by Blanchflower, David G. & Oswald, Andrew J.
  • 2013 The Causal Effect of Retirement on Mortality: Evidence from Targeted Incentives to Retire Early
    by Bloemen, Hans & Hochguertel, Stefan & Zweerink, Jochem
  • 2013 Defensive Investments and the Demand for Air Quality: Evidence from the NOx Budget Program and Ozone Reductions
    by Deschenes, Olivier & Greenstone, Michael & Shapiro, Joseph S.
  • 2013 Migration and Young Child Nutrition: Evidence from Rural China
    by Mu, Ren & de Brauw, Alan
  • 2013 Food Prices and Body Fatness among Youths
    by Grossman, Michael & Tekin, Erdal & Wada, Roy
  • 2013 The Earned Income Tax Credit, Health, and Happiness
    by Boyd-Swan, Casey & Herbst, Chris M. & Ifcher, John & Zarghamee, Homa
  • 2013 Social Learning and Health Insurance Enrollment: Evidence from China's New Cooperative Medical Scheme
    by Liu, Hong & Sun, Qi & Zhao, Zhong
  • 2013 The Effect of Deceptive Advertising on Consumption of the Advertised Good and its Substitutes: The Case of Over-the-Counter Weight Loss Products
    by Cawley, John & Avery, Rosemary & Eisenberg, Matthew
  • 2013 Do Parents Drink Their Children's Welfare? A Joint Analysis of Intra-Household Allocation of Time
    by Giannelli, Gianna Claudia & Mangiavacchi, Lucia & Piccoli, Luca
  • 2013 The Demand for Cigarettes as Derived from the Demand for Weight Control
    by Cawley, John & von Hinke Kessler Scholder, Stephanie
  • 2013 Financial Distress and Use of Mental Health Care: Evidence from Antidepressant Prescription Claims
    by Haizhen Lin & Jonathan D. Ketcham & James N. Rosenquest & Kosali Simon
  • 2013 Stochastic Dominance and Demographic Policy Evaluation: A Critique
    by Cordoba, Juan Carlos & Liu, Xiying
  • 2013 Does High Home-Ownership Impair the Labor Market?
    by David G. Blanchflower & Andrew J. Oswald
  • 2013 The Value of Risk Reduction: New Tools for an Old Problem
    by David Crainich & Louis Eeckhoudt & James K. Hammitt
  • 2013 The Casual Effect of Family Income on Child Health: A Re-examination Using an Instrumental Variables Approach
    by Daniel Kuehnle
  • 2013 Estimating the relationship between rate of time preferences and healthy lifestyle in Russia
    by Tatiana Kossova & Elena Kossova & Maria Sheluntcova
  • 2013 Behind-the-counter, but Over-the-border? The Assessment of the Geographical Spillover Effect of Increased Access to Emergency Contraception
    by Inna Cintina
  • 2013 Behind-the-counter, but Over-the-border? The Assessment of the Spillover Effect of Increased Availability of Emergency Contraception in Washington on Neighboring States
    by Inna Cintina
  • 2013 Behind-the-counter, but Over-the-border? The Assessment of the Geographical Spillover Effect of Increased Access to Emergency Contraception
    by Inna Cintina
  • 2013 Disability Prevalence among Adults: Estimates for 54 Countries and Progress towards a Global Estimate
    by Sophie Mitra & Usha Sambamoorthi
  • 2013 Women's Work and Family Profiles over the Lifecourse and their Subsequent Health Outcomes. Evidence for Europe
    by Thomas Leoni & Rainer Eppel
  • 2013 The Affordable Care Act: A Hidden Jobs Killer?
    by Helene Jorgensen & Dean Baker
  • 2013 State Savings with an Efficient Medicare Prescription Drug Benefit
    by Nicole Woo & Dean Baker
  • 2013 Ecuador’s Economy Since 2007
    by Mark Weisbrot & Jake Johnston & Stephan Lefebvre
  • 2013 Reducing Waste With an Efficient Medicare Prescription Drug Benefit
    by Dean Baker
  • 2013 Measuring income-related inequalities in health in multi-country analysis
    by Cristina Hernández-Quevedo & Cristina Masseria
  • 2013 Winning big but feeling no better? The effect of lottery prizes on physical and mental health
    by Bénédicte Apouey & Andrew E. Clark
  • 2013 Are you happy while you work?
    by Alex Bryson & George MacKerron
  • 2013 Building community capital in social care: is there an economic case?
    by Martin Knapp & Annette Bauer & Margaret Perkins & Tom Snell
  • 2013 Capturing the time-varying drivers of an epidemic using stochastic dynamical systems
    by Joseph Dureau & Konstantinos Kalogeropoulos & Marc Baguelin
  • 2013 Payment Systems in the Healthcare Industry: An Experimental Study Of Physician Incentives
    by Ellen P. Green
  • 2013 Selectivity Processes in and Weights for the Berlin Aging Study II (BASE-II)
    by Denise Saßenroth & Martin Kroh & Gert G. Wagner
  • 2013 The Causal Effect of Retirement on Mortality - Evidence from Targeted Incentives to retire early
    by Hans Bloemen & Stefan Hochguertel & Jochem Zweerink
  • 2013 This Is Only a Test? Long-Run Impacts of Prenatal Exposure to Radioactive Fallout
    by Black, Sandra & Bütikofer, Aline & Devereux, Paul J. & Salvanes, Kjell G
  • 2013 An Equilibrium Model of the African HIV/AIDS Epidemic
    by Greenwood, Jeremy & Kircher, Philipp & Santos, Cezar & Tertilt, Michèle
  • 2013 Losing Heart? The Effect of Job Displacement on Health
    by Black, Sandra & Devereux, Paul J. & Salvanes, Kjell G
  • 2013 Capital humano y crecimiento económico: herramientas de política en un entorno de desigualdad y expectativa de vida endógena
    by Oscar Iván Ávila Montealegre
  • 2013 Compulsory Schooling, Education And Mental Health: New Evidence From Sharelife
    by Laura Crespo & Borja López-Nodal & Pedro Mira
  • 2013 Does a hospitals quality depend on the quality of other hospitals? A spatial econometrics approach to investigating hospital quality competition
    by Hugh Gravelle & Rita Santos & Luigi Siciliani
  • 2013 Winning Big But Feeling No Better? The Effect of Lottery Prizes on Physical and Mental Health
    by Bénédicte Apouey & Andrew E. Clark
  • 2013 Moving Up and Sliding Down: An Empirical Assessment of the Effect of Social Mobility on Subjective Wellbeing
    by Paul Dolan & Grace Lordan
  • 2013 Are You Happy While You Work?
    by Alex Bryson & George MacKerron
  • 2013 Are you happy while you work?
    by Alex Bryson & George MacKerron
  • 2013 Two-Period Comparison of Healthcare Demand with Income Growth and Population Aging in Rural China: Implications for Adjustment of the Healthcare Supply and Development
    by Jacky MATHONNAT & Yong HE & Martine AUDIBERT
  • 2013 Multinomial and Mixed Logit Modeling in the Presence of Heterogeneity: A Two-Period Comparison of Healthcare Provider Choice in Rural China
    by Jacky MATHONNAT & Yong HE & Martine AUDIBERT
  • 2013 The causal effect of family income on child health: A re-examination using an instrumental variables approach
    by Daniel Kuehnle
  • 2013 Crisis agraria y desigualdad nutricional en Extremadura: una primera aproximación antropométrica a los efectos de la guerra y la posguerra
    by Antonio M. Linares Luján & Francisco M. Parejo
  • 2013 Construction des inégalités des chances en santé à travers les modes de vie
    by Bricard, Damien
  • 2013 Who Pays Cigarette Taxes? The Impact of Consumer Price Search
    by Philip DeCicca & Donald Kenkel & Feng Liu
  • 2013 The E-Health Systems In Poland
    by Ma³gorzata WALCZAK & Zdzis³aw PÓLKOWSKI
  • 2013 Characteristics of Health-Care Systems
    by Clipici Emilia & Frant Florin
  • 2013 Pharmaceutical Expenditure as a Determinant of Health Outcomes in EU Countries/El gasto farmacéutico como determinante de los resultados en salud en países de la UE
    by BLÁZQUEZ-FERNÁNDEZ, CARLA & GONZÁLEZ-PRIETO, NOELIA & MORENO-MENCÍA, PATRICIA
  • 2013 The Radicalisation of Prison Inmates: A Review of the Literature on Recruitment, Religion and Prisoner Vulnerability
    by Elizabeth Mulcahy & Shannon Merrington & Peter James Bell
  • 2013 Doing Justice to Human Security: A Textbook in Tune with its Time
    by Deane Edward Neubauer
  • 2013 A Review of "Human Security in World Affairs: Problems and Opportunities"
    by Arthur L. Fredeen
  • 2013 The United States and the Arab Spring
    by Timo Kivimäki
  • 2013 Editorial
    by Sabina Lautensach
  • 2013 'Out of Pocket Expenditure’ of Health Care Services in India: Factors, Consequences and Solution
    by Shatabdi Bagchi & Priyanka Bakhshi
  • 2013 The System Of Contributions For Health Insurance Scheme In Albania - Performance And Main Challenges
    by Enkelejda AVDI
  • 2013 Where to snuff the puff? Relative effectiveness of U.S. smoking control policies
    by Goel, Rajeev K.
  • 2013 Social conformity and suicide
    by Bussu, Anna & Detotto, Claudio & Sterzi, Valerio
  • 2013 The impact of consumer health information on the demand for health services
    by Dwyer, Debra Sabatini & Liu, Hong
  • 2013 Does retiree health insurance encourage early retirement?
    by Nyce, Steven & Schieber, Sylvester J. & Shoven, John B. & Slavov, Sita Nataraj & Wise, David A.
  • 2013 Digesting the doughnut hole
    by Joyce, Geoffrey F. & Zissimopoulos, Julie & Goldman, Dana P.
  • 2013 The impact of the partnership long-term care insurance program on private coverage
    by Lin, Haizhen & Prince, Jeffrey
  • 2013 Effects of breast and colorectal cancer on labour market outcomes—Average effects and educational gradients
    by Heinesen, Eskil & Kolodziejczyk, Christophe
  • 2013 The health effects of leaving school in a bad economy
    by Maclean, Johanna Catherine
  • 2013 Consumers’ misunderstanding of health insurance
    by Loewenstein, George & Friedman, Joelle Y. & McGill, Barbara & Ahmad, Sarah & Linck, Suzanne & Sinkula, Stacey & Beshears, John & Choi, James J. & Kolstad, Jonathan & Laibson, David & Madrian, Brigitte C. & List, John A. & Volpp, Kevin G.
  • 2013 Abortion before & after Roe
    by Joyce, Ted & Tan, Ruoding & Zhang, Yuxiu
  • 2013 A case study of a workplace wellness program that offers financial incentives for weight loss
    by Cawley, John & Price, Joshua A.
  • 2013 Family income and child health in the UK
    by Apouey, Bénédicte & Geoffard, Pierre-Yves
  • 2013 Sick but satisfied: The impact of life and health satisfaction on choice between health scenarios
    by Dolan, Paul & Kavetsos, Georgios & Tsuchiya, Aki
  • 2013 Demand for smokeless tobacco: Role of advertising
    by Dave, Dhaval & Saffer, Henry
  • 2013 Malaria: An early indicator of later disease and work level
    by Hong, Sok Chul
  • 2013 School meal crowd out in the 1980s
    by von Hinke Kessler Scholder, Stephanie
  • 2013 Weathering the storm: Hurricanes and birth outcomes
    by Currie, Janet & Rossin-Slater, Maya
  • 2013 Economic considerations for social distancing and behavioral based policies during an epidemic
    by Fenichel, Eli P.
  • 2013 Modeling the relationship between health and health care expenditures using a latent Markov model
    by Wouterse, Bram & Huisman, Martijn & Meijboom, Bert R. & Deeg, Dorly J.H. & Polder, Johan J.
  • 2013 Does hospital competition harm equity? Evidence from the English National Health Service
    by Cookson, Richard & Laudicella, Mauro & Donni, Paolo Li
  • 2013 Reducing underage alcohol and tobacco use: Evidence from the introduction of vertical identification cards
    by Bellou, Andriana & Bhatt, Rachana
  • 2013 Health expenditure growth: Looking beyond the average through decomposition of the full distribution
    by de Meijer, Claudine & O’Donnell, Owen & Koopmanschap, Marc & van Doorslaer, Eddy
  • 2013 The psychological costs of war: Military combat and mental health
    by Cesur, Resul & Sabia, Joseph J. & Tekin, Erdal
  • 2013 Marriage, bereavement and mortality: The role of health care utilization
    by Simeonova, Emilia
  • 2013 Endogenous cost-effectiveness analysis and health care technology adoption
    by Jena, Anupam B. & Philipson, Tomas J.
  • 2013 Smoking initiation and the iron law of demand
    by Lillard, Dean R. & Molloy, Eamon & Sfekas, Andrew
  • 2013 Does legal heritage affect obesity? The channel of motor vehicle dependence
    by Carlin, Paul S. & Kidd, Michael P. & Ulubaşoğlu, Mehmet A.
  • 2013 An investigation into the effect of type I and type II diabetes duration on employment and wages
    by Minor, Travis
  • 2013 How survey design affects self-assessed health responses in the Survey of Health, Ageing, and Retirement in Europe (SHARE)
    by Lumsdaine, Robin L. & Exterkate, Anneke
  • 2013 Child height, health and human capital: Evidence using genetic markers
    by von Hinke Kessler Scholder, Stephanie & Davey Smith, George & Lawlor, Debbie A. & Propper, Carol & Windmeijer, Frank
  • 2013 Can you trust survey responses? Evidence using objective health measures
    by Suziedelyte, Agne & Johar, Meliyanni
  • 2013 Risk attitudes and Medicare Part D enrollment decisions
    by Vetter, Stefan & Heiss, Florian & McFadden, Daniel & Winter, Joachim
  • 2013 Public smoking bans and self-assessed health: Evidence from Great Britain
    by Wildman, John & Hollingsworth, Bruce
  • 2013 On the relationship between GDP and health care expenditure: A new look
    by Lago-Peñas, Santiago & Cantarero-Prieto, David & Blázquez-Fernández, Carla
  • 2013 Health insurance reform and efficiency of township hospitals in rural China: An analysis from survey data
    by Audibert, Martine & Mathonnat, Jacky & Pelissier, Aurore & Huang, Xiao Xian & Ma, Anning
  • 2013 Mapping religious health assets: Are faith-inspired facilities located in poor areas in Ghana?
    by Harold Coulombe & Quentin Wodon
  • 2013 Are better vaccines really better? The case of a simple stochastic epidemic SIR model
    by Nicolas Houy
  • 2013 Labour market, obesity and public policy considerations
    by Konstantinos Eleftheriou & George Athanasiou & Periklis Kougoulis
  • 2013 Duration of Sick Leave, Income and Health Insurance: Evidence from French French linked employer-employee data
    by Ben Halima Mohamed Ali & Regaert Camille
  • 2013 User satisfaction among the three public health insurance schemes in Thailand: A casof Phayao province
    by Warunya Somrith & Nalitra Thaiprasert
  • 2013,2nd quarter update design and impact of physician payment incentives: theory and evidence
    by Douglas A. Conrad
  • 2012 L’effet de la Couverture maladie universelle complémentaire (CMU-C) sur le nombre de visites chez le médecin : une analyse par régression sur discontinuités
    by Guthmuller, Sophie & Wittwer, Jérôme
  • 2012 Student Solutions Manual to Accompany Health Economics
    by Sloan, Frank A. & Hsieh, Chee-Ruey
  • 2012 Chaos and Organization in Health Care
    by Lee, Thomas H., M.D. & Mongan, James J., M.D.
  • 2012 Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care
    by Parthasarathy, Shobita
  • 2012 Health Care Turning Point: Why Single Payer Won't Work
    by Battistella, Roger M.
  • 2012 Health Economics
    by Sloan, Frank A. & Hsieh, Chee-Ruey
  • 2012 How bulimia nervosa relates to addictive behavior
    by Daniela Iorio & Michelle Sovinsky
  • 2012 Race, social class, and bulimia nervosa
    by Michelle S. Goeree & John C. Ham & Daniela Iorio
  • 2012 Hospital market concentration and discrimination of patients
    by Dewenter, Ralf & Jaschinski, Thomas & Kuchinke, Björn A.
  • 2012 Temporary versus permanent employment: Does health matter?
    by Gail Pacheco & Dominic Page & Don Webber
  • 2012 Mental and physical health: reconceptualising the relationship with employment propensity
    by Gail Pacheco & Dom Page & Don Webber
  • 2012 A Short Note on Economic Development and Socioeconomic Inequality in Female Body Weight
    by Deuchert, Eva & Cabus, Sofie J. & Tafreschi, Darjusch
  • 2012 Paying informally for public health care in Albania: scarce resources or governance failure?
    by Tomini, Sonila & Groot, Wim
  • 2012 Smoking, Expectations, and Health: A Dynamic Stochastic Model of Lifetime Smoking Behavior
    by Michael Darden
  • 2012 Risk attitudes and Medicare Part D enrollment decisions
    by Vetter, Stefan & Heiss, Florian & McFadden, Daniel & Winter, Joachim
  • 2012 To love or to pay: Savings and health care in older age
    by Loretti I. Dobrescu
  • 2012 Wealth Effects or Economic Barometer: Why Do House Prices Matter for Psychological Health?
    by Anita Ratcliffe
  • 2012 Why does child labour persist with declining poverty?
    by Jayanta Sarkar & Dipanwita Sarkar
  • 2012 Health Aid and Health Improvement in Sub Saharan Africa
    by Yogo, Urbain Thierry & Mallaye, Douzounet
  • 2012 Economic Growth and Public Healthcare Expenditure in Kenya (1982 - 2012)
    by Nyamwange, Mathew
  • 2012 Research and Science Today No. 4
    by Mărcău, Flavius-Cristian & Ciorei, Mihaela
  • 2012 Cost-containment policies in public pharmaceutical spending in the EU
    by Carone, Giuseppe & Schwierz, Christoph & Xavier, Ana
  • 2012 Rural Health Infrastructures in the North-East India
    by Saikia, Dilip & Das, Kalyani Kangkana
  • 2012 Factors influencing quality of life in patients with active tuberculosis in Pakistan
    by Masood, Sarwar Awan & Muhammad, Waqas & Muhammad, Amir Aslam
  • 2012 Automation of e-health systems through mobile devices and semantic technology
    by Abdullai, Besim
  • 2012 Challenges in implementation of the maternity leave in Kosovo
    by Ramosaj, Argjiro
  • 2012 Comparative, dynamic efficiency of national healthcare systems
    by Waśniewski, Krzysztof
  • 2012 Carbon incentive for physical activity
    by Srinivasan, Raghavendra Guru
  • 2012 Management Evaluation of Public Hospital -Approach from Factor Analysis-
    by Takako Nakajima & Kiheiji Nishida & Masashi Manabe
  • 2012 Influence of Parentsf Unemployment on the Health of Newborn Babies
    by Miki Kohara & Fumio Ohtake
  • 2012 Improving the Health-Care System in Poland
    by Hervé Boulhol & Agnieszka Sowa & Stanislawa Golinowska & Patrizio Sicari
  • 2012 Increasing Our Understanding of the Health-Income Gradient in Children
    by Jason Fletcher & Barbara L. Wolfe
  • 2012 Incentives, Commitments and Habit Formation in Exercise: Evidence from a Field Experiment with Workers at a Fortune-500 Company
    by Heather Royer & Mark F. Stehr & Justin R. Sydnor
  • 2012 Public Liabilities and Health Care Policy
    by Kristopher J. Hult & Tomas J. Philipson
  • 2012 Words in Patents: Research Inputs and the Value of Innovativeness in Invention
    by Mikko Packalen & Jay Bhattacharya
  • 2012 Is Psychological Well-being Linked to the Consumption of Fruit and Vegetables?
    by David G. Blanchflower & Andrew J. Oswald & Sarah Stewart-Brown
  • 2012 Projecting the Effect of Changes in Smoking and Obesity on Future Life Expectancy in the United States
    by Samuel H. Preston & Andrew Stokes & Neil K. Mehta & Bochen Cao
  • 2012 Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange
    by Keith M. Marzilli Ericson
  • 2012 Temperature, Human Health, and Adaptation: A Review of the Empirical Literature
    by Olivier Deschenes
  • 2012 Defensive Investments and the Demand for Air Quality: Evidence from the NOx Budget Program and Ozone Reductions
    by Olivier Deschenes & Michael Greenstone & Joseph S. Shapiro
  • 2012 Are Recessions Good for Your Health Behaviors? Impacts of the Economic Crisis in Iceland
    by Tinna Laufey Ásgeirsdóttir & Hope Corman & Kelly Noonan & Þórhildur Ólafsdóttir & Nancy E. Reichman
  • 2012 Overseas Deployment, Combat Exposure, and Well-Being in the 2010 National Survey of Veterans
    by Ryan D. Edwards
  • 2012 Adolescent Depression and Adult Labor Market Outcomes
    by Jason M. Fletcher
  • 2012 Stand Your Ground Laws, Homicides, and Injuries
    by Chandler B. McClellan & Erdal Tekin
  • 2012 Demand for Smokeless Tobacco: Role of Magazine Advertising
    by Dhaval M. Dave & Henry Saffer
  • 2012 Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems
    by Peter J. Huckfeldt & Neeraj Sood & José J Escarce & David C. Grabowski & Joseph P. Newhouse
  • 2012 Demand and Reimbursement Effects of Healthcare Reform: Health Care Utilization and Infant Mortality in Thailand
    by Jonathan Gruber & Nathaniel Hendren & Robert Townsend
  • 2012 Education and Health: Insights from International Comparisons
    by David M. Cutler & Adriana Lleras-Muney
  • 2012 Reaching Those in Need: State Supplemental Nutrition Assistance Program Participation Rates in 2010
    by Karen E. Cunnyngham
  • 2012 Using American Community Survey Data to Expand Access to the School Meal Programs
    by Various Authors
  • 2012 School Food Purchase Study-III: Nutritional Characteristics of School Food Acquisition
    by Mary Kay Crepinsek & Elizabeth Condon & Mary Kay Fox
  • 2012 School Food Purchase Study-III: Nutritional Characteristics of School Food Acquisitions
    by Mary Kay Crepinsek & Elizabeth Condon & Mary Kay Fox
  • 2012 Direct Certification in the National School Lunch Program: State Implementation Progress School Year 2011-2012
    by Quinn Moore & Kevin Conway & Brandon Kyler
  • 2012 Direct Certification in the National School Lunch Program State Implementation Progress, School Year 2011-2012
    by Quinn Moore & Kevin Conway & Brandon Kyler
  • 2012 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2011
    by Mark Strayer & Esa Eslami & Joshua Leftin
  • 2012 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2011
    by Mark Strayer & Joshua Leftin & Esa Eslami
  • 2012 Summer Electronic Benefits Transfer for Children (SEBTC) Demonstration: Evaluation Findings for the Proof-of-Concept Year
    by Ann M. Collins & Ronette Briefel & Jacob Alex Klerman & Stephen Bell & Jeanne Bellotti & Christopher W. Logan & Anne Gordon & Anne Wolf & Gretchen Rowe & Steven M. McLaughlin & Ayesha Enver & Meena Fernandes & Carrie Wolfson & Marina Komarovsky & Charlotte Cabili
  • 2012 Summary of the Summer Electronic Benefits Transfer for Children (SEBTC): Evaluation Findings for Proof-of-Concept Year
    by Ann M. Collins & Ronette Briefel & Jacob Alex Klerman & Stephen Bell & Jeanne Bellotti & Christopher W. Logan & Anne Gordon & Anne Wolf & Gretchen Rowe & Steven M. McLaughlin & Ayesha enver & Meena Fernandes & Carrie Wolfson & Marina Komarovsky & Charlotte Cabili
  • 2012 Modeling of High-Risk Indicators of Certification Error in the National School Lunch Program
    by Quinn Moore & Nancy Cole & Elizabeth Potamites
  • 2012 Modeling of High Risk Indicators of Certification Error in the National School Lunch Program
    by Quinn Moore & Nancy Cole & Elizabeth Potamites
  • 2012 School Nutrition Dietary Assessment Study IV: Sampling and Data Collection Methods
    by John Hall & Eric Zeidman & Mary Kay Crepinsek & Elizabeth Condon
  • 2012 School Nutrition Dietary Assessment Study IV: School Foodservice Operations, School Environments, and Meals Offered and Served
    by Mary Kay Fox & Elizabeth Condon & Mary Kay Crepinsek & Katherine Niland & Denise Mercury & Sarah Forrestal & Charlotte Cabili & Vanessa Oddo & Anne Gordon & Nathan Wozny & Alexandra Killewald
  • 2012 School Nutrition Dietary Assessment Study-IV: Summary of Findings
    by Mary Kay Fox & Elizabeth Condon
  • 2012 School Nutrition Dietary Assessment Study IV
    by Mary Kay Fox & John Hall
  • 2012 Supplemental Nutrition Assistance Program Participation Rates: Fiscal Year 2010
    by Esa Eslami & Joshua Leftin & Mark Strayer
  • 2012 Supplemental Nutrition Assistance Program Participation Rates: Fiscal Year 2010
    by Esa Eslami & Joshua Leftin & Mark Strayer
  • 2012 Performance Measurement for Supplemental Nutrition Assistance Program Modernization Initiatives: Individual State Findings
    by Kathleen Keefe & Emily Sama-Miller & Laura Castner & Maura Bardos & Elizabeth Clary & Sarah Wissell & Larry Vittoriano
  • 2012 Performance Measurement for Supplemental Nutrition Assistance Program Modernization Initiatives: Integrated Report
    by Laura Castner & Amy Wodarek O'Reilly & Kevin Conway & Maura Bardos & Emily Sama-Miller
  • 2012 Performance Measurement for Supplemental Nutrition Assistance Program Modernization Initiatives
    by Laura Castner & Amy Wodarek O'Reilly & Kevin Conway & Maura Bardos & Emily Sama-Miller
  • 2012 National Data to Inform Childhood Obesity Prevention Strategies: Beverage, Dietary, and Activity Practices at Home and School
    by Ronette Briefel
  • 2012 The Feeding Infants and Toddlers Study 2008: Dramatic Changes in the Amount and Quality of Vegetables in the Diet Occur After the First Year of Life
    by Denise Deming & Kathleen Reidy & Ronette Briefel & Mary Kay Fox & Elizabeth Condon
  • 2012 Technical Working Paper: Creation of the 2012 Baseline of the 2009 MATH SIPP+ Microsimulation Model and Database
    by Joel Smith & Becca Wang
  • 2012 Predictors of Maternal and Child Double Burden of Malnutrition in Rural Indonesia and Bangladesh
    by Vanessa M. Oddo & Jee H. Rah & Richard D. Semba & Kai Sun & Nasima Akhter & Mayang Sari & Saskia de Pee & Regina Moench-Pfanner & Martin Bloem & Klaus Kraemer
  • 2012 Characteristics and Dietary Patterns of Healthy and Less-Healthy Eaters in the Low-Income Population
    by Yonatan Ben-Shalom & Mary Kay Fox & P.K. Newby
  • 2012 Characteristics and Dietary Patterns of Healthy and Less Healthy Eaters in the Low-Income Population
    by Yonatan Ben-Shalom & Mary Kay Fox & P.K. Newby
  • 2012 Effects of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC): A Review of Recent Research
    by Silvie Colman & Ira P. Nichols-Barrer & Julie E. Redline & Barbara L. Devaney & Sara V. Ansell & Ted Joyce
  • 2012 Effects of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC): A Review of Recent Research
    by Silvie Colman & Ira P. Nichols-Barrer & Julie E. Redline & Barbara L. Devaney & Sara V. Ansell & Ted Joyce
  • 2012 Addressing Child Hunger and Obesity in Indian Country: Report to Congress
    by Anne Gordon & Vanessa Oddo
  • 2012 Publishing Nutrition Research: A Review of Multivariate Techniques Part 2: Analysis of Variance
    by Jeffrey E. Harris & Patricia M. Sheean & Philip M. Gleason & Barbara Bruemmer & Carol Boushey
  • 2012 Public-Private Mix of Health Expenditure: A Political Economy Approach and A Quantitative Exercise
    by Shuyun May Li & Solmaz Moslehi & Siew Ling Yew
  • 2012 Public-Private Mix of Health Expenditure: A Political Economy Approach and A Quantitative Exercise
    by Shuyun May Li, Solmaz Moslehi, Siew Ling Yew
  • 2012 Limited Liability, Moral Hazard and Risk Taking A Safety Net Game Experiment
    by Tibor Neugebauer, & Sascha Fullbrunn
  • 2012 Limited Liability, Moral Hazard and Risk Taking ? A Safety Net Game Experiment
    by Tibor Neugebauer, & Sascha Fllbrunn
  • 2012 Risk attitudes and Medicare Part D enrollment decisions
    by Vetter, Stefan & Heiss, Florian & McFadden, Daniel & Winter, Joachim
  • 2012 Health Expenditures And Life Expectancy Around The World: A Quantile Regression Approach
    by Maksym Obrizan & George L. Wehby
  • 2012 The Influence of (Im)perfect Data Privacy on the Acquisition of Personal Health Data
    by Simeon Schudy & Verena Utikal
  • 2012 Reducing Underage Alcohol and Tobacco Use: Evidence from the Introduction of Vertical Identification Cards
    by Bellou, Andriana & Bhatt, Rachana
  • 2012 The Effects of Pharmacological Treatment of ADHD on Children's Health
    by Dalsgaard, Søren & Nielsen, Helena Skyt & Simonsen, Marianne
  • 2012 Stand Your Ground Laws and Homicides
    by McClellan, Chandler & Tekin, Erdal
  • 2012 Medical Marijuana Laws and Teen Marijuana Use
    by Anderson, D. Mark & Hansen, Benjamin & Rees, Daniel I.
  • 2012 Medical Marijuana Laws and Teen Marijuana Use
    by Anderson, D. Mark & Hansen, Benjamin & Rees, Daniel I.
  • 2012 Care or Cash? The Effect of Child Care Subsidies on Student Performance
    by Black, Sandra E. & Devereux, Paul J. & Loken, Katrine Vellesen & Salvanes, Kjell G.
  • 2012 Care or Cash? The Effect of Child Care Subsidies on Student Performance
    by Black, Sandra E. & Devereux, Paul J. & Loken, Katrine V. & Salvanes, Kjell G.
  • 2012 Mental Health and Education Decisions
    by Cornaglia, Francesca & Crivellaro, Elena & McNally, Sandra
  • 2012 Mental Health and Education Decisions
    by Cornaglia, Francesca & Crivellaro, Elena & McNally, Sandra
  • 2012 Combat Exposure and Migraine Headache: Evidence from Exogenous Deployment Assignment
    by Cesur, Resul & Sabia, Joseph J. & Tekin, Erdal
  • 2012 Combat Exposure and Migraine Headache: Evidence from Exogenous Deployment Assignment
    by Cesur, Resul & Sabia, Joseph J. & Tekin, Erdal
  • 2012 The Impact of the Partnership Long-term Care Insurance Program on Private Coverage and Medicaid Expenditures
    by Haizhen Lin & Jeffrey T. Prince
  • 2012 The training and job decisions of nurses: the first year of a longitudinal study investigating nurse recruitment and retention. CHERE Working Paper 2012/02
    by Patricia Kenny & Denise Doiron & Jane Hall & Deborah J Street & Kathleen Milton-Wildey & Glenda Parmenter
  • 2012 Deriving utility weights for the EQ-5D-5L using a discrete choice experiment. CHERE Working Paper 2012/01
    by Richard Norman & Paula Cronin & Rosalie Viney
  • 2012 The information content of the WTP-WTA gap: An empirical analysis among severely ill patients
    by Nathalie Havet & Magali Morelle & Alexis Penot & Raphaël Remonnay
  • 2012 Changements organisationnels dans les entreprises, outils de gestion et risques psychosociaux : une analyse sur données françaises
    by Azza Aziza-Chebil & Eric Delattre & Marc-Arthur Diaye
  • 2012 Venezuela's Economic Recovery: Is It Sustainable?
    by Jake Johnston & Mark Weisbrot
  • 2012 The Mexican Economy and the 2012 Elections
    by Rebecca Ray & Mark Weisbrot
  • 2012 Ecuador’s Economy Since 2007
    by Rebecca Ray & Sara Kozameh
  • 2012 Health-insurance Coverage for Low-wage Workers, 1979-2010 and Beyond
    by John Schmitt
  • 2012 Familiarising the unfamiliar: cognitive polyphasia, emotions and the creation of social representations
    by Ama de-Graft Aikins
  • 2012 Establishing and sustaining research partnerships in Africa: a case study of the UK-Africa Academic Partnership on Chronic Disease
    by Ama de-Graft Aikins & Daniel Arhinful & Emma Pitchforth & Gbenga Ogedegbe & Pascale Allotey & Charles Agyemang
  • 2012 When to Quit Under Uncertainty? A real options approach to smoking cessation
    by Yu-Fu Chen & Dennis Petrie
  • 2012 The Miracle Drug: Hormone Replacement Therapy and Labor Market Behavior of Middle-Aged Women
    by Daysal, N. Meltem & Orsini, C.
  • 2012 Does Family Planning Reduce Infant Mortality? Evidence from Surveillance Data in Matlab, Bangladesh
    by Soest, A.H.O. van & Saha, U.R.
  • 2012 Path-breaking innovations for lung cancer: a revolution in clinical practice
    by Mario Coccia
  • 2012 Limited Liability, Moral Hazard and Risk Taking A Safety Net Game Experiment
    by Tibor Neugebauer, & Sascha Fullbrunn
  • 2012 Germs, Social Networks and Growth
    by Fogli, Alessandra & Veldkamp, Laura
  • 2012 Pertinencia de incentivar la competencia en el mercado de medicamentos biotecnológicos en Colombia y su impacto sobre las finanzas del sector de la sa
    by Juan Gonzalo Zapata & Roberto Steiner & Sergio Bernal & Jairo Castillo
  • 2012 Los subsidios de oferta y el régimen subsidiado de salud en Colombia
    by Karelys Katina Guzmán Finol
  • 2012 Innovative Financing in Early Recovery: The Liberia Health Sector Pool Fund - Working Paper 288
    by Jacob Hughes, Amanda Glassman, and Walter Gwenigale
  • 2012 Mental Health and Education Decisions
    by Francesca Cornaglia & Elena Crivellaro & Sandra McNally
  • 2012 The Effect of a Hospital Nurse Staffing Mandate on Patient Health Outcomes: Evidence from California’s Minimum Staffing Regulation Abstract: We evaluate the impact of California Assembly Bill 394, which mandated maximum levels of patients per nurse in the hospital setting. When the law was passed, some hospitals already met the requirements, while others did not. Thus changes in staffing ratios from the pre- to post-mandate periods are driven in part by the legislation. We find persuasive evidence that AB394 had the intended effect of decreasing patient/nurse ratios in hospitals that previously did not meet mandated standards. However, these improvements in staffing ratios do not appear to be associated with relative improvements in measured patient safety in affected hospitals
    by Andrew Cook & Martin Gaynor & Melvin Stephens, Jr. & Lowell Taylor
  • 2012 Smoking and Obesity Revisited: Evidence from Belarus
    by Aliaksandr Amialchuk & Kateryna Bornukova & Mir M. Ali
  • 2012 Working Conditions, Lifestyles and Health
    by Elena Cottini & Paolo Ghinetti
  • 2012 Disability and Social Exclusion
    by Peter J. Sloane & Melanie K. Jones
  • 2012 A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines
    by Josie Messina & David. L. Grainger
  • 2012 Estimating Preference-Based EQ-5D Health State Utilities or Item Responses from Neuropathic Pain Scores
    by Ning Yan. Gu & Chris Bell & Marc F. Botteman & Xiang Ji & John A. Carter & Ben van Hout
  • 2012 Patients' Perceptions of the Interpersonal Sensitivity of Their Healthcare Providers: The Potential Role of Patient-Provider Racial/Ethnic Concordance
    by Karon L. Phillips & David A. Chiriboga & Yuri Jang
  • 2012 Psychometric Evaluation of an Inpatient Consumer Survey Measuring Satisfaction with Psychiatric Care
    by Glorimar Ortiz & Lucille Schacht
  • 2012 Comparison of Expected Outcomes between Patients and Neurologists Using Kano's Methodology in Symptomatic Migraine Treatment
    by J. Matas-Guiu & M.T. Caloto & G. Nocea
  • 2012 Practicing Patient-Centered Care: The Questions Clinically Excellent Physicians Use to Get to Know their Patients as Individuals
    by Laura A. Hanyok & David B. Hellmann & Cynthia Rand & Roy C. Ziegelstein
  • 2012 Cognitive Testing and Readability of an Item Bank for Measuring the Impact of Headache on Health-Related Quality of Life
    by Diane M. Turner-Bowker & Renee N. Saris-Baglama & Michael A. DeRosa & Christine A. Paulsen
  • 2012 Patient and Public Involvement in Patient-Reported Outcome Measures: Evolution Not Revolution
    by Sophie Staniszewska & Kirstie L. Haywood & Jo Brett & Liz Tutton
  • 2012 Patient and Public Involvement in Developing Patient-Reported Outcome Measures: Indispensable, Desirable, Challenging
    by Oliver Groene
  • 2012 Seeking What Matters: Patients as Research Partners
    by Musa Mayer
  • 2012 Assessing Stakeholder Opinion on Relations between Cancer Patient Groups and Pharmaceutical Companies in Europe
    by Susanna Leto di Priolo & Andras Fehervary & Phil Riggins & Kathy Redmond
  • 2012 Content Validity of Visual Analog Scales to Assess Symptom Severity of Acute Angioedema Attacks in Adults with Hereditary Angioedema: An Interview Study
    by Carolyn Vivienne. McMillan & Jane Speight & Anurag Relan & Luca Bellizzi & Gerald Haase & Marco Cicardi
  • 2012 Designing Family-Centered Male Circumcision Services: A Conjoint Analysis Approach
    by John F.P. Bridges & Sarah C. Searle & Frederic W. Selck & Neil A. Martinson
  • 2012 Burden of a Multiple Sclerosis Relapse: The Patient's Perspective
    by MerriKay Oleen-Burkey & Jane Castelli-Haley & Maureen J. Lage & Kenneth P. Johnson
  • 2012 A Comparison of Analytic Hierarchy Process and Conjoint Analysis Methods in Assessing Treatment Alternatives for Stroke Rehabilitation
    by Maarten J. IJzerman & Janine A. van Til & John F.P. Bridges
  • 2012 Patient Preferences for First-Line Oral Treatment for Mild-to-Moderate Ulcerative Colitis: A Discrete-Choice Experiment
    by Paul Hodgkins & Paul Swinburn & Dory Solomon & Linnette Yen & Sarah Dewilde & Andrew Lloyd
  • 2012 Re-Engineering the Post-Discharge Appointment Process for General Medicine Patients
    by Robert Chang & David Spahlinger & Christopher S. Kim
  • 2012 Test-Retest Reliability of an Interactive Voice Response Version of the EQ-5D in a Sample of Cancer Survivors
    by J. Jason. Lundy & Stephen Joel. Coons
  • 2012 Patients' Perceptions of Sharing in Decisions: A Systematic Review of Interventions to Enhance Shared Decision Making in Routine Clinical Practice
    by France Lgar & Stphane Turcotte & Dawn Stacey & Stphane Ratt & Jennifer Kryworuchko & Ian D. Graham
  • 2012 The Authors' Reply
    by Hareth Al-Janabi & Terry N. Flynn & Joanna Coast
  • 2012 Caregivers' Quality of Life and Economic Evaluations
    by Afschin Gandjour
  • 2012 Dabigatran Etexilate: A Pharmacoeconomic Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    by Kate McKeage
  • 2012 A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease
    by Petra Menn & Reiner Leidl & Rolf Holle
  • 2012 Costs Associated with Febrile Neutropenia in the US
    by Shannon L. Michels & Rich L. Barron & Matthew W. Reynolds & Karen Smoyer Tomic & Jingbo Yu & Gary H. Lyman
  • 2012 Lost Productivity in Four European Countries among Patients with Rheumatic Disorders: Are Absenteeism and Presenteeism Transferable?
    by Saskia Knies & Math J.J.M. Candel & Annelies Boonen & Silvia M.A.A. Evers & Andre J.H.A. Ament & Johan L. Severens
  • 2012 Reimbursement Decisions of the All Wales Medicines Strategy Group: Influence of Policy and Clinical and Economic Factors
    by Warren G. Linley & Dyfrig A. Hughes
  • 2012 Cost of Illness of Cystic Fibrosis in Germany: Results from a Large Cystic Fibrosis Centre
    by Mareike Heimeshoff & Helge Hollmeyer & Jonas Schreygg & Oliver Tiemann & Doris Staab
  • 2012 Assessing the Quality of Pharmacoeconomic Studies in India: A Systematic Review
    by Pooja R. Desai & Hitesh S. Chandwani & Karen L. Rascati
  • 2012 Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    by Vanja Sikirica & M. Haim Erder & Jipan Xie & Dendy Macaulay & Melissa Diener & Paul Hodgkins & Eric Q. Wu
  • 2012 Valuation of the Child Health Utility 9D Index
    by Katherine Stevens
  • 2012 Developing Adolescent-Specific Health State Values for Economic Evaluation: An Application of Profile Case Best-Worst Scaling to the Child Health Utility 9D
    by Julie Ratcliffe & Terry Flynn & Frances Terlich & Katherine Stevens & John Brazier & Michael Sawyer
  • 2012 A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma
    by Wendy J. Ungar & Katherine Boydell & Sharon Dell & Brian M. Feldman & Deborah Marshall & Andrew Willan & James G. Wright
  • 2012 The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt: A Government Perspective Analysis
    by Mark P. Connolly & Oleksandr Topachevskyi & Baudouin Standaert & Omayra Ortega & Maarten Postma
  • 2012 Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments
    by J. Mick. Tilford & Nalin Payakachat & Erica Kovacs & Jeffrey M. Pyne & Werner Brouwer & Todd G. Nick & Jayne Bellando & Karen A. Kuhlthau
  • 2012 Economic Evaluations of Childhood Influenza Vaccination: A Critical Review
    by Anthony T. Newall & Mark Jit & Philippe Beutels
  • 2012 Comparative Effectiveness and Child Health
    by Lisa A. Prosser
  • 2012 Valuing Children's Health: Whose Quality of Life Matters?
    by Eve Wittenberg
  • 2012 Quetiapine: A Pharmacoeconomic Review of its Use in Bipolar Disorder
    by Greg L. Plosker
  • 2012 Duloxetine Use in Chronic Low Back Pain: Treatment Patterns and Costs
    by Jasmina I. Ivanova & Howard G. Birnbaum & Evan Kantor & Matt Schiller & Ralph W. Swindle
  • 2012 Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis: An Application of Bayesian Methods for Evidence Synthesis in a Markov Model
    by Christine M. Nguyen & Mark Bounthavong & Margaret A.S. Mendes & Melissa L.D. Christopher & Josephine N. Tran & Rashid Kazerooni & Anthony P. Morreale
  • 2012 Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures
    by A. Degrassat-Thas & M. Bensadon & C. Rieu & M. Angalakuditi & C. Le Pen & P. Paubel
  • 2012 Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models
    by Kristian Bolin
  • 2012 Cost Effectiveness of Rituximab for Non-Hodgkin's Lymphoma: A Systematic Review
    by Philipp W.P. Auweiler & Dirk Mller & Stephanie Stock & Andreas Gerber
  • 2012 Corrigendum
    by Adis International Limited
  • 2012 The Authors' Reply
    by A. George. Awad & Lakshmi N.P. Voruganti
  • 2012 The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility?
    by Laurent Boyer & Pascal Auquier
  • 2012 Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode
    by Mattias Ekman & Peter Lindgren & Carolin Miltenburger & Genevieve Meier & Julie C. Locklear & Mary Lou. Chatterton
  • 2012 Pharmacoeconomics of the Myeloid Growth Factors: A Critical and Systematic Review
    by Bradford R. Hirsch & Gary H. Lyman
  • 2012 Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal
    by Dwayne Boyers & Xueli Jia & David Jenkinson & Graham Mowatt
  • 2012 A Critical Review of Model-Based Economic Studies of Depression: Modelling Techniques, Model Structure and Data Sources
    by Hossein Haji Ali Afzali & Jonathan Karnon & Jodi Gray
  • 2012 Value of Information and Pricing New Healthcare Interventions
    by Andrew R. Willan & Simon Eckermann
  • 2012 The Authors' Reply
    by Livio Garattini & Katelijne van de Vooren & Alessandro Curto
  • 2012 Human Papillomavirus Vaccination Is Not Exclusively a Matter of Price
    by Alessandro Capone & Giampiero Favato
  • 2012 The Impact of Co-Morbidity Burden on Preference-Based Health-Related Quality of Life in the United States
    by Patrick W. Sullivan & Vahram H. Ghushchyan & Elizabeth A. Bayliss
  • 2012 Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma
    by Joshua Pink & Steven Lane & Dyfrig A. Hughes
  • 2012 Anti-Inflammatory Medication Adherence, Healthcare Utilization and Expenditures among Medicaid and Children's Health Insurance Program Enrollees with Asthma
    by Jill Boylston. Herndon & Soeren Mattke & Alison Evans Cuellar & Seo Yeon. Hong & Elizabeth A. Shenkman
  • 2012 Changes in Antipsychotic Medication Use after Implementation of a Medicaid Mental Health Carve-Out in the US
    by John Robst
  • 2012 Pharmacoeconomics of Bisphosphonates for Skeletal-Related Event Prevention in Metastatic Non-Breast Solid Tumours
    by John A. Carter & Avani D. Joshi & Satyin Kaura & Marc F. Botteman
  • 2012 Issues in the Economic Evaluation of Influenza Vaccination by Injection of Healthy Working Adults in the US: A Review and Decision Analysis of Ten Published Studies
    by Thomas J. Hogan
  • 2012 Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program
    by Nadia Demarteau & Thomas Breuer & Baudouin Standaert
  • 2012 Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006
    by Howard G. Birnbaum & Crystal Pike & Ritesh Banerjee & Tracy Waldman & Mary Cifaldi
  • 2012 Cost Effectiveness of Anticoagulation in Acute Coronary Syndromes
    by Jaime Latour-Prez & Eva de-Miguel-Balsa
  • 2012 Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease: A Review of the Evidence and Methodological Issues
    by Maureen P.M.H. Rutten-van Mlken & Lucas M.A. Goossens
  • 2012 Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal
    by Huiqin Yang & Dawn Craig & David Epstein & Laura Bojke & Kate Light & Ian N. Bruce & Mark Sculpher & Nerys Woolacott
  • 2012 Rufinamide: A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome
    by Paul L. McCormack
  • 2012 Common Drug Review Recommendations: An Evidence Base for Expectations?
    by Angela Rocchi & Elizabeth Miller & Robert B. Hopkins & Ron Goeree
  • 2012 Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands
    by Ties Hoomans & Johan L. Severens & Nicole van der Roer & Gepke O. Delwel
  • 2012 Pricing Human Papillomavirus Vaccines: Lessons from Italy
    by Livio Garattini & Katelijne van de Vooren & Alessandro Curto
  • 2012 Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7
    by Frank R. Lichtenberg
  • 2012 Measuring Quality of Life in Patients with Schizophrenia: An Update
    by A. George. Awad & Lakshmi N.P. Voruganti
  • 2012 Population- versus Cohort-Based Modelling Approaches
    by Olivier Ethgen & Baudouin Standaert
  • 2012 Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective
    by Aurea Duran & Nishan Sengupta & Alexander Diamantopoulos & Fiona Forster & Louis Kwong & Michael Lees
  • 2012 Health Utility Elicitation: Is There Still a Role for Direct Methods?
    by Lisa A. Prosser & Scott D. Grosse & Eve Wittenberg
  • 2012 Osteoporotic Fractures: A Systematic Review of US Healthcare Costs and Resource Utilization
    by Sangeeta Budhia & Yeshi Mikyas & Michael Tang & Enkhe Badamgarav
  • 2012 Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal
    by Michael Holmes & Christopher Carroll & Diana Papaioannou
  • 2012 Real Economics Needs to Reflect Real Decisions: A Response to Johnson
    by Mark Sculpher & Karl Claxton
  • 2012 Why Not Real Economics?
    by F. Reed. Johnson
  • 2012 Incorporating Calibrated Model Parameters into Sensitivity Analyses: Deterministic and Probabilistic Approaches
    by Douglas C.A. Taylor & Vivek Pawar & Denise T. Kruzikas & Kristen E. Gilmore & Myrlene Sanon & Milton C. Weinstein
  • 2012 Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer
    by Robert I. Griffiths & Richard L. Barron & Michelle L. Gleeson & Mark D. Danese & Anthony OHagan & Victoria M. Chia & Jason C. Legg & Gary H. Lyman
  • 2012 Erratum
    by Adis International Limited
  • 2012 A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
    by Christopher Fitzpatrick & Katherine Floyd
  • 2012 Does the EQ-5D Reflect Lost Earnings?
    by Carl Tilling & Marieke Krol & Aki Tsuchiya & John Brazier & Job van Exel & Werner Brouwer
  • 2012 Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal
    by Claire McKenna & Emma Maund & Muhammad Sarowar & David Fox & Matt Stevenson & Chris Pepper & Nerys Woolacott & Stephen Palmer
  • 2012 Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
    by Mathilda L. Bongers & Veerle M.H. Coup & Elise P. Jansma & Egbert F. Smit & Carin A. Uyl-de Groot
  • 2012 Economic and Humanistic Burden of External Genital Warts
    by Adam J.N. Raymakers & Mohsen Sadatsafavi & Fawziah Marra & Carlo A. Marra
  • 2012 Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
    by Liv Ariane Augestad & Kim Rand-Hendriksen & Ivar Snb Kristiansen & Knut Stavem
  • 2012 What's Good and Bad About Contraceptive Products?: A Best-Worst Attribute Experiment Comparing the Values of Women Consumers and GPs
    by Stephanie A. Knox & Rosalie C. Viney & Deborah J. Street & Marion R. Haas & Denzil G. Fiebig & Edith Weisberg & Deborah Bateson
  • 2012 Chemotherapy Administration: Modelling the Costs of Alternative Protocols
    by Philip Haywood & Johan de Raad & Kees van Gool & Marion Haas & Gisselle Gallego & Sallie-Anne Pearson & Margaret Faedo & Robyn Ward
  • 2012 Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex) for Spasticity in Multiple Sclerosis
    by Lanting Lu & Hilary Pearce & Chris Roome & James Shearer & Iain A. Lang & Ken Stein
  • 2012 Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic Review
    by Ccile Gaujoux-Viala & Bruno Fautrel
  • 2012 A Systematic Review and Critical Assessment of Health State Utilities: Weight Change and Type 2 Diabetes Mellitus
    by Scott Doyle & Andrew Lloyd & Lee Moore & Joshua Ray & Alastair Gray
  • 2012 Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal
    by Sophie Whyte & Abdullah Pandor & Matt Stevenson
  • 2012 Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
    by Marta O. Soares & Lusa Canto e Castro
  • 2012 Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal
    by Jane Burch & Susan Griffin & Claire McKenna & Simon Walker & James Paton & Kath Wright & Nerys Woolacott
  • 2012 Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis: A Case for Excluding Dialysis Costs
    by Daniel T. Grima & Lisa M. Bernard & Elizabeth S. Dunn & Philip A. McFarlane & David C. Mendelssohn
  • 2012 Erratum
    by Adis International Limited
  • 2012 The General Public's Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer's Disease Medication
    by Mark Oremus & Jean-Eric Tarride & Parminder Raina & Lehana Thabane & Gary Foster & Charlie H. Goldsmith & Natasha Clayton
  • 2012 The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes: A New Zealand Evaluation
    by Laura Panattoni & Paul M. Brown & Braden Te Ao & Mark Webster & Patrick Gladding
  • 2012 A 3-Dimensional View of Access to Licensed and Subsidized Medicines under Single-Payer Systems in the US, the UK, Australia and New Zealand
    by Rajan Ragupathy & Katri Aaltonen & June Tordoff & Pauline Norris & David Reith
  • 2012 Losing Sight of the Wood for the Trees: Some Issues in Describing and Valuing Health, and Another Possible Approach
    by Paul Dolan & Henry Lee & Tessa Peasgood
  • 2012 Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups: A Systematic Review
    by Ava John-Baptiste & Man Wah Yeung & Victoria Leung & Gabrielle van der Velde & Murray Krahn
  • 2012 The Burden of Moderate to Severe Psoriasis: An Overview
    by Giovanna Raho & Daniela Mihajlova Koleva & Livio Garattini & Luigi Naldi
  • 2012 The Authors' Reply
    by Ties Hoomans & Johan L. Severens & Nicole van der Roer & Gepke O. Delwel
  • 2012 Is There a Role for Pharmacoeconomics in Decision Making?
    by Johan C.F. van Luijn
  • 2012 Validity of Cost and Utility Results?
    by Alex Diamantopoulos & Laura Sawyer & Sarika Ogale & Fred Dejonckheere
  • 2012 The Authors' Reply
    by Mark Bounthavong & Christine M. Nguyen & Margaret A.S. Mendes & Melissa L.D. Christopher & Josephine N. Tran & Rashid Kazerooni & Anthony P. Morreale
  • 2012 Patient Preferences for Community Pharmacy Asthma Services: A Discrete Choice Experiment
    by Pradnya Naik-Panvelkar & Carol Armour & John M. Rose & Bandana Saini
  • 2012 Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting
    by Laura McCullagh & Cathal Walsh & Michael Barry
  • 2012 The State of Health Economic Research in South Africa: A Systematic Review
    by Paul Gavaza & Karen L. Rascati & Abiola O. Oladapo & Star Khoza
  • 2012 The Cost Effectiveness of Newer Epilepsy Treatments: A Review of the Literature on Partial-Onset Seizures
    by Kristian Bolin & Lars Forsgren
  • 2012 Counting the Cost of Not Costing HIV Health Facilities Accurately: Pay Now, or Pay More Later
    by Eduard J. Beck & Carlos Avila & Sofia Gerbase & Guy Harling & Paul De Lay
  • 2012 New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
    by Douglas W. Mapel & Melissa H. Roberts
  • 2012 Private Manufacturers' Thresholds to Invest in Comparative Effectiveness Trials
    by Anirban Basu & David Meltzer
  • 2012 Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?
    by Jaume Puig-Junoy
  • 2012 Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
    by Tatiana Dilla & Amparo Valladares & Claudia Nicolay & Javier Salvador & Jess Reviriego & Mara Costi
  • 2012 What Explains Willingness to Pay for Smoking-Cessation Treatments - Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
    by Jan Abel. Olsen & Ole J. Rgeberg & Knut Stavem
  • 2012 Insensitivity to Scope in Contingent Valuation Studies: Reason for Dismissal of Valuations?
    by Rikke Sgaard & Jes Lindholt & Dorte Gyrd-Hansen
  • 2012 Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison
    by M. Haim Erder & Jipan Xie & James E. Signorovitch & Kristina S. Chen & Paul Hodgkins & Mei Lu & Eric Q. Wu & Vanja Sikirica
  • 2012 Inclusion of Compliance and Persistence in Economic Models: Past, Present and Future
    by Ananth Kadambi & Robert J. Leipold & Anuraag R. Kansal & Sonja Sorensen & Denis Getsios
  • 2012 Insensitivity to Scope in Contingent Valuation Studies: New Direction for an Old Problem
    by Jennifer A. Whitty
  • 2012 Acknowledgement
    by Adis International Limited
  • 2012 Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
    by Christine Carron & Pierre Voirol & Philippe Eggimann & Andr Pannatier & Ren Chiolro & Jean-Blaise Wasserfallen
  • 2012 Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis: Results from a 1-Year, Multicentre, Open-Label, Single-Arm Study in a Clinical Setting
    by Ronald Vender & Charles Lynde & Vincent Ho & Dina Chau & Melanie Poulin-Costello
  • 2012 Clopidogrel versus Aspirin in Patients with Atherothrombosis: A CAPRIE-Based Cost-Effectiveness Model for Greece
    by Georgia Kourlaba & Vassilis Fragoulakis & Nikos Maniadakis
  • 2012 Estimating Incremental Costs with Skew: A Cautionary Note
    by Linnea A. Polgreen & John M. Brooks
  • 2012 Lifetime Productivity Losses Associated with Obesity Status in Early Adulthood: A Population-Based Study of Swedish Men
    by Kristian Neovius & Clas Rehnberg & Finn Rasmussen & Martin Neovius
  • 2012 PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites: A NICE Medical Technology Guidance
    by Judith White & Grace Carolan-Rees
  • 2012 NICE Medical Technologies Guidance: A Novel and Rigorous Methodology to Address a New Health Technology Assessment Challenge
    by Bruce Campbell & Mark Campbell
  • 2012 Is More Expensive Medical Technology Better?: The Use of Analytics in the Evaluation of Clinical Outcomes for Different Material Compositions of Total Knee Implants
    by Jeffrey Voigt & Michael Mosier
  • 2012 Alcohol Reform in Viet Nam: Confronting Rising Consumption, Injury and Harm
    by Nguyen Minh. Tam & Christopher M. Doran & Peter S. Hill & Michael P. Dunne
  • 2012 Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures
    by Avram A. Edidin & Kevin L. Ong & Edmund Lau & Jordana K. Schmier & Jason E. Kemner & Steven M. Kurtz
  • 2012 Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis
    by Georgia Kourlaba & Vassilis Fragoulakis & Nikos Maniadakis
  • 2012 Resource Utilization and Outcomes in Patients with Atrial Fibrillation: A Case Control Study
    by Rachael Boggon & Gregory Y.H. Lip & Arlene M. Gallagher & Tjeerd P. van Staa
  • 2012 Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach
    by Michael Bumler & Tom Stargardt & Jonas Schreygg & Reinhard Busse
  • 2012 Economic Consequences of the Demography of MRSA Patients and the Impact of Broad-Spectrum Antimicrobials
    by K. Kaier & S. Moog
  • 2012 A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
    by Ulf Persson & Johanna Svensson & Billie Pettersson
  • 2012 Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
    by John Slof
  • 2012 National Health Insurance Reform in South Africa: Estimating the Implications for Demand for Private Health Insurance
    by Okore Apia Okorafor
  • 2012 Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
    by Antonio Roman & Joan A. Barber & Pilar Escribano & Maria L. Sala & Laia Febrer & Itziar Oyagez & Eliazar Sabater & Miguel . Casado
  • 2012 Direct Healthcare Costs of Osteoporosis-Related Fractures in Managed Care Patients Receiving Pharmacological Osteoporosis Therapy
    by Hema N. Viswanathan & Jeffrey R. Curtis & Jingbo Yu & Jeffrey White & Bradley S. Stolshek & Claire Merinar & Akhila Balasubramanian & Joel D. Kallich & John L. Adams & Sally W. Wade
  • 2012 Economic Evaluations of Adult Weight Management Interventions: A Systematic Literature Review Focusing on Methods Used for Determining Health Impacts
    by Ulla K. Griffiths & Benedict Anigbogu & Kiran Nanchahal
  • 2012 Understanding Consumer Preferences in the Context of Managed Competition: Evidence from a Choice Experiment in Colombia
    by Antonio J. Trujillo & Fernando Ruiz & John F.P. Bridges & Jeannette L. Amaya & Christine Buttorff & Anglica M. Quiroga
  • 2012 Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel: Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer
    by Oren Shavit & Raanan Raz & Michal Stein & Gabriel Chodick & Eduardo Schejter & Yehuda Ben-David & Raanan Cohen & Daphna Arbel & Varda Shalev
  • 2012 Using the Economics of Certification to Improve the Safety and Quality of Male Circumcision in Developing Countries: Three Models of Implementation
    by Michael R. Richards
  • 2012 The Need for Measurement of Efficiency in Greek Primary Healthcare: The Case for Rural Southern and Western Greece
    by Nikolaos Oikonomou & Yannis Tountas & John Kyriopoulos
  • 2012 Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain
    by Juan Pasquau & Joana Gostkorzewicz & Francisco Ledesma & Anne Anceau & Andrew Hill & Christiane Moecklinghoff
  • 2012 A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries
    by Sergio Iannazzo & Michela Carsi & Silvia Chiroli
  • 2012 Insights from Triangulation of Two Purchase Choice Elicitation Methods to Predict Social Decision Making in Healthcare
    by Jennifer A. Whitty & Sharyn R. Rundle-Thiele & Paul A. Scuffham
  • 2012 Alcohol Policy and Taxation in South Africa: An Examination of the Economic Burden of Alcohol Tax
    by John Ele-Ojo. Ataguba
  • 2012 Tackling Alcohol Misuse: Purchasing Patterns Affected by Minimum Pricing for Alcohol
    by Anne Ludbrook & Dennis Petrie & Lynda McKenzie & Shelley Farrar
  • 2012 The Efficiency of a Volumetric Alcohol Tax in Australia
    by Joshua Byrnes & Dennis J. Petrie & Christopher M. Doran & Anthony Shakeshaft
  • 2012 The Role of Health Economics in Alcohol Policy
    by Christopher M. Doran & Joshua Byrnes
  • 2012 Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones: Cost-Utility and Value-of-Information Analysis
    by Kurinchi Gurusamy & Edward Wilson & Andrew K. Burroughs & Brian R. Davidson
  • 2012 Triangulating Health Expenditure Estimates from Different Data Sources in Developing Countries: The Case of Pakistan's Private Health Expenditure
    by Christian Lorenz
  • 2012 Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
    by Michael Eaddy & Brian Seal & Krishna Tangirala & Elizabeth Hackney. Davies & Ken ODay
  • 2012 Health Satellite Accounts and Indicators for Ageing Populations in EU and Romania Statistics
    by Carmen Luiza Costuleanu & Maria (Grosu) Berheci
  • 2012 State Dependence in Self-Assessed Health in Spain
    by Sara Ayllón & Cristina Blanco-Perez
  • 2012 Sabotaging public engagement with science: Missing scientific principles in newspaper stories about the Wakefield MMR-Autism controversy
    by Judith MCINTOSH WHITE
  • 2012 Income based price subsidies and parallel imports
    by Acharyya, Rajat & García-Alonso, María D.C.
  • 2012 Democracy, dictatorship, and disease: Political regimes and HIV/AIDS
    by Justesen, Mogens K.
  • 2012 Pain at the pump: Gasoline prices and subjective well-being
    by Boyd-Swan, Casey & Herbst, Chris M.
  • 2012 Primary prevention and health outcomes: Treatment of residential lead-based paint hazards and the prevalence of childhood lead poisoning
    by Jones, David J.
  • 2012 The impact of direct-to-consumer television and magazine advertising on antidepressant use
    by Avery, Rosemary J. & Eisenberg, Matthew D. & Simon, Kosali I.
  • 2012 When does weight matter most?
    by Chen, Alice J.
  • 2012 The medical care costs of obesity: An instrumental variables approach
    by Cawley, John & Meyerhoefer, Chad
  • 2012 Inequality decomposition by population subgroups for ordinal data
    by Kobus, Martyna & Miłoś, Piotr
  • 2012 Valuing mother and child health: The intrauterine environment
    by Nastis, Stefanos A. & Crocker, Thomas D.
  • 2012 Weight and earnings among childbearing women in Metropolitan Cebu, Philippines (1983–2002)
    by Colchero, M. Arantxa & Bishai, David
  • 2012 The intergenerational transmission of health in early childhood—Evidence from the German Socio-Economic Panel Study
    by Coneus, Katja & Spiess, C. Katharina
  • 2012 Cash transfers and anemia among women of reproductive age
    by Schady, Norbert
  • 2012 Do doctors charge high income patients more?
    by Johar, Meliyanni
  • 2012 Sources of advantageous selection: Evidence using actual health expenditure risk
    by Johar, Meliyanni & Savage, Elizabeth
  • 2012 Adolescent drug use and the deterrent effect of school-imposed penalties
    by Waddell, G.R.
  • 2012 The social economic impact of AIDS: Accounting for intergenerational transmission, productivity and fertility
    by Vasilakis, Chrysovalantis
  • 2012 Mainstreaming health insurance for people with disabilities
    by Palmer, Michael G. & Nguyen, Thi Minh Thuy
  • 2012 An alternative perspective on health inequality
    by Benjamin Ho & Sita N. Slavov
  • 2012 A developed theoretical model of paid and unpaid work in healthcare supply
    by Yan Feng
  • 2012 A City-Level Analysis of Mortality and the Business Cycle across Racial and Ethnic Groups
    by Fidel Gonzalez & Troy Quast & Matias Fontenla
  • 2012 Eating Behavior and the Utilization of Outpatient Services - The Case of Taiwan
    by Yen-ju Lin & Chun-chih Chen
  • 2012 A note on the decomposition technique of economic indices
    by Kota Mori & Joe Chen & Yun Jeong Choi & Yasuyuki Sawada & Saki Sugano
  • 2012 Demographic and Socio-economic Determinants of Smoking Behavior: Evidence from Vietnam
    by Cuong Viet Nguyen
  • 2012 Labour and leisure costs of informal caregivers
    by Miriam Marcén
  • 2012 HIV/AIDS-GDP Nexus? Evidence from panel-data for African countries
    by Arshia Amiri & Ulf-g Gerdtham & Bruno Ventelou
  • 2012 Healthcare Information and the Utilization of Pap-smear Testing amongst Taiwanese Women
    by Yen-ju Lin & Tsai-ching Liu & Chin-shyan Chen
  • 2012 El SISBEN como mecanismo de focalización individual del régimen subsidiado en salud en Colombia: ventajas y limitaciones
    by Martha Bottia & Lina Cardona-Sosa & Carlos Medina
  • 2012 Risk adjustment and prevention
    by Karen Eggleston & Randall P. Ellis & Mingshan Lu
  • 2012 Better Value for Money in Healthcare: European Lessons for Canada
    by Ake Blomqvist & Colin Busby
  • 2012 Better Value for Money in Healthcare: European Lessons for Canada
    by Ake Blomqvist & Colin Busby
  • 2012 Saving Money or Just Saving Lives? Improving the Productivity of US Health Care Spending
    by Katherine Baicker & Amitabh Chandra & Jonathan S. Skinner
  • 2012 A quantile approach to the demographic, residential, and socioeconomic effects on 19th-century African-American body mass index values
    by Scott Alan Carson
  • 2012,1st quarter update health econometrics
    by Andrew M. Jones
  • 2011 The effect of competition on process and outcome quality within hospital care in The Netherlands
    by Bijlsma, M. & Koning, P.W.C. & Shestalova, V.
  • 2011 The Effect of Children's Medicaid Enrollment on School Days Missed: A Propensity Score Matching Approach
    by ShiShu Zhang
  • 2011 The Double African Paradox: What does selective mortality tell us?
    by Rouanet, Léa
  • 2011 HIV/AIDS as a Fiscal Liability
    by Haacker, Markus
  • 2011 Inequality decomposition by population subgroups for ordinal data
    by Martyna Kobus & Piotr Miłoś
  • 2011 Determinantes macroeconómicos de la mortalidad infantil en Uruguay
    by Ivone Perazzo
  • 2011 Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety
    by Andersson, Henrik & Hammitt, James & Lindberg, Gunnar & Sundström, Kristian
  • 2011 Assessing Development Strategies to Achieve the MDGs in Asia. Macroeconomic Strategies of MDG Achievement in the Kyrgyz Republic
    by Roman Mogilevsky & Anara Omorova
  • 2011 Use of Anthropometric Measures to Analyze How Sources of Water and Sanitation Affect Chidren’s Health in Nigeria
    by Adewara, Sunday Olabisi & Visser, Martine
  • 2011 Public-Place Smoking Laws and Exposure to Environmental Tobacco Smoke (ETS)
    by Christopher Carpenter & Sabina Postolek & Casey Warman
  • 2011 The Impact of Education on Total Fertility Rate in Pakistan (1981-2008)
    by Naeem Ur Rehman, Khattak & Khan, Jangraiz & Tariq, Muhammad & Naeem, Muhammad & Tasleem, Sajjad
  • 2011 Double burden of nutritional disorder among Indian women: an assessment of differentials and determinants
    by Singh, Deepti & Goli, Srinivas & T.V., Sekher
  • 2011 Economic Crises, Maternal and Infant Mortality, Low Birth Weight and Enrollment Rates: Evidence from Argentina’s Downturns
    by Cruces, Guillermo & Gluzmann, Pablo & Lopez-Calva, Luis Felipe
  • 2011 Sağlıkta Dönüşümün Ampirik Analizi
    by Celikay, Ferdi & Gumus, Erdal
  • 2011 A two-stage DEA model to evaluate the efficiency of the Italian health system
    by De Nicola, Arianna & Gitto, Simone & Mancuso, Paolo
  • 2011 Análisis del mercado de órganos para trasplante: evaluación de la introducción de incentivos en la Argentina
    by Calabria, Alejandro A.
  • 2011 Effect of universal health coverage on marriage, cohabitation and labor force participation
    by Azuara, Oliver
  • 2011 Modeling healthcare quality: life expectancy SURS in the G7 countries and Korea
    by Firl, Daniel J.
  • 2011 Structural social capital and health in Italy
    by Fiorillo, Damiano & Sabatini, Fabio
  • 2011 Status of Health related Quality of life between HBV and HCV Patients of Pakistan
    by Awan, Masood Sarwar & Waqas, Muhammad & Ali, Mumtaz & Aslam, Muhammad Amir
  • 2011 Empirical Analysis of Field Data on HIV/AIDS Epidemic in Khartoum State, Sudan
    by Mohamed, Issam A.W.
  • 2011 The Dynamics of Economic Epidemiology Equilibria
    by Aadland, David & Finnoff, David & Huang, Kevin X.D.
  • 2011 Evaluating Hospital Efficiency Adjusting for Quality Indicators: an Application to Portuguese NHS Hospitals
    by : Álvaro Almeida & José Pedro Fique
  • 2011 Airports, Air Pollution, and Contemporaneous Health
    by Wolfram Schlenker & W. Reed Walker
  • 2011 Utilization of Infertility Treatments: The Effects of Insurance Mandates
    by Marianne P. Bitler & Lucie Schmidt
  • 2011 The Best of Times, the Worst of Times: Understanding Pro-cyclical Mortality
    by Ann Huff Stevens & Douglas L. Miller & Marianne E. Page & Mateusz Filipski
  • 2011 Marginal Effects in Multivariate Probit and Kindred Discrete and Count Outcome Models, with Applications in Health Economics
    by John Mullahy
  • 2011 The Socio-Economic Causes of Obesity
    by Charles L. Baum & Shin-Yi Chou
  • 2011 Exercise, Physical Activity, and Exertion over the Business Cycle
    by Gregory J. Colman & Dhaval M. Dave
  • 2011 Do Religious Proscriptions Matter? Evidence from a Theory-Based Test
    by Daniel M. Hungerman
  • 2011 Was What Ail'd Ya' What Kill'd Ya'?
    by Robert W. Fogel & Louis Cain & Joseph Burton & Brian Bettenhausen
  • 2011 Vertical Integration and Optimal Reimbursement Policy
    by Christopher Afendulis & Daniel Kessler
  • 2011 How Survey Design Affects Inference Regarding Health Perceptions and Outcomes
    by Anneke Exterkate & Robin L. Lumsdaine
  • 2011 Gauging the Generosity of Employer-Sponsored Insurance: Differences Between Households With and Without a Chronic Condition
    by Jean M. Abraham & Anne Beeson Royalty & Thomas DeLeire
  • 2011 Early Maternal Employment and Family Wellbeing
    by Pinka Chatterji & Sara Markowitz & Jeanne Brooks-Gunn
  • 2011 The Empirical Content of Models with Multiple Equilibria in Economies with Social Interactions
    by Alberto Bisin & Andrea Moro & Giorgio Topa
  • 2011 The Oregon Health Insurance Experiment: Evidence from the First Year
    by Amy Finkelstein & Sarah Taubman & Bill Wright & Mira Bernstein & Jonathan Gruber & Joseph P. Newhouse & Heidi Allen & Katherine Baicker & The Oregon Health Study Group
  • 2011 Smoking Policies and Birth Outcomes: Estimates From a New Era
    by Sara Markowitz & E. Kathleen Adams & Patricia M. Dietz & Viji Kannan & Van Tong
  • 2011 Dimensions of Health in the Elderly Population
    by David M. Cutler & Mary Beth Landrum
  • 2011 The Economics of Risky Health Behaviors
    by John Cawley & Christopher Ruhm
  • 2011 The Doctor Might See You Now: The Supply Side Effects of Public Health Insurance Expansions
    by Craig L. Garthwaite
  • 2011 Isolating the Effect of Major Depression on Obesity: Role of Selection Bias
    by Dhaval M. Dave & Jennifer Tennant & Gregory J. Colman
  • 2011 Disability, Health and Retirement in the United Kingdom
    by James Banks & Richard Blundell & Antoine Bozio & Carl Emmerson
  • 2011 Socioeconomic Status in Childhood and Health After Age 70: A New Longitudinal Analysis for the U.S., 1895-2005
    by Joseph P. Ferrie & Karen Rolf
  • 2011 Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets
    by Anup Malani & Tomas J. Philipson
  • 2011 The Impact of Pollution on Worker Productivity
    by Joshua S. Graff Zivin & Matthew J. Neidell
  • 2011 The Pragmatist’s Guide to Comparative Effectiveness Research
    by Amitabh Chandra & Anupam B. Jena & Jonathan S. Skinner
  • 2011 Learning During a Crisis: the SARS Epidemic in Taiwan
    by Daniel Bennett & Chun-Fang Chiang & Anup Malani
  • 2011 Technology Growth and Expenditure Growth in Health Care
    by Amitabh Chandra & Jonathan S. Skinner
  • 2011 An Overview of The Changing Body: Health, Nutrition, and Human Development in the Western World Since 1700
    by Robert W. Fogel & Nathaniel Grotte
  • 2011 Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry
    by Jonathan R. Clark & Robert Huckman
  • 2011 The Psychological Costs of War: Military Combat and Mental Health
    by Resul Cesur & Joseph J. Sabia & Erdal Tekin
  • 2011 Rural Hospital Ownership: Medical Service Provision, Market Mix, and Spillover Effects
    by Jill R. Horwitz & Austin Nichols
  • 2011 The Long-term Impact of Medicare Payment Reductions on Patient Outcomes
    by Vivian Y. Wu & Yu-Chu Shen
  • 2011 Exposure to Food Advertising On Television: Associations With Children’s Fast Food and Soft Drink Consumption and Obesity
    by Tatiana Andreyeva & Inas Rashad Kelly & Jennifer L. Harris
  • 2011 Health Shocks, Insurance Status and Net Worth: Intra- and Inter-Generational Effects
    by Dalton Conley & Jason Alan Thompson
  • 2011 Mother’s Schooling and Fertility under Low Female Labor Force Participation: Evidence from a Natural Experiment
    by Victor Lavy & Alexander Zablotsky
  • 2011 Superfund Cleanups and Infant Health
    by Janet Currie & Michael Greenstone & Enrico Moretti
  • 2011 Life Shocks and Homelessness
    by Marah A. Curtis & Hope Corman & Kelly Noonan & Nancy Reichman
  • 2011 Occupational Status and Health Transitions
    by G. Brant Morefield & David C. Ribar & Christopher J. Ruhm
  • 2011 The Equal Environments Assumption in the Post-Genomic Age: Using Misclassified Twins to Estimate Bias in Heritability Models
    by Dalton Conley & Emily Rauscher
  • 2011 Does Decreased Access to Emergency Departments Affect Patient Outcomes? Analysis of AMI Population 1996-2005
    by Yu-Chu Shen & Renee Y. Hsia
  • 2011 Insurance Mandates and Mammography
    by Marianne P. Bitler & Christopher S. Carpenter
  • 2011 International Happiness
    by David G. Blanchflower & Andrew J. Oswald
  • 2011 Impact of Education on Lifestyles: What Do Longitudinal Data Show?
    by Shah Danyal & Bichaka Fayissa & Jong-Sung Lee
  • 2011 Characteristics of Eligible Supplemental Nutrition Assistance Program Households with Elderly Individuals
    by Joshua Leftin
  • 2011 Promoting Public Benefits Access Through Web-Based Tools and Outreach
    by Jacqueline Kauff & Emily Sama-Miller & Gretchen Rowe & Cicely Thomas & Libby Makowsky
  • 2011 Reaching Those in Need: State Supplemental Nutrition Assistance Program Participation Rates in 2009
    by Karen E. Cunnyngham
  • 2011 Direct Certification in the National School Lunch Program: State Implementation Progress, School Year 2010-2011
    by Quinn Moore & Kevin Conway & Brandon Kyler
  • 2011 Determinants of Supplemental Nutrition Assistance Program Entry and Exit in the Mid-2000s
    by James Mabli & Thomas Godfrey & Laura Castner & Stephen Tordella & Priscilla Foran
  • 2011 Dynamics of Supplemental Nutrition Assistance Program Participation in the Mid-2000s
    by James Mabli & Stephen Tordella & Laura Castner & Thomas Godfrey & Priscilla Foran
  • 2011 Impact of Payment Errors on SNAP Participants in FY 2009
    by Carole Trippe & Daisy Ewell
  • 2011 Direct Certification in the National School Lunch Program: State Implementation Progress School Year 2010-2011
    by Quinn Moore & Kevin Conway & Brandon Kyler
  • 2011 Trends in Supplemental Nutrition Assistance Program Participation Rates: Fiscal Years 2002-2009
    by Joshua Leftin
  • 2011 Trends in Supplemental Nutrition Assistance Program Participation Rates: Fiscal Year 2002 to Fiscal Year 2009
    by Joshua Leftin & Esa Eslami & Mark Strayer
  • 2011 Characteristics of Supplemental Nutrition Assistance Program (SNAP) Households: Fiscal Year 2010
    by Esa Eslami & Kai Filion & Mark Strayer
  • 2011 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2010
    by Esa Eslami & Kai Filion & Mark Strayer
  • 2011 Determinants of Supplemental Nutrition Assistance Program Entry and Exit in the Mid-2000s
    by James Mabli & Thomas Godfrey & Laura Castner & Stephen Tordella & Priscilla Foran
  • 2011 Dynamics of Supplemental Nutrition Assistance Program Participation in the Mid-2000s
    by James Mabli & Stephen Tordella & Laura Castner & Thomas Godfrey & Priscilla Foran
  • 2011 Empirical Bayes Shrinkage Estimates of State Supplemental Nutrition Assistance Program Participation Rates in 2006-2008 for All Eligible People and the Working Poor
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2011 Benefit Redemption Patterns in the Supplemental Nutrition Assistance Program
    by Laura Castner & Juliette Henke
  • 2011 Benefit Redemption Patterns in the Supplemental Nutrition Assistance Program
    by Laura Castner & Juliette Henke
  • 2011 Planning a WIC Research Agenda
    by Institute of Medicine Food & Nutrition Board Committee to Review the WIC Food Packages of which Barbara Devaney is a member
  • 2011 A Bayesian Model of Sample Selection with a Discrete Outcome Variable: Detecting Depression in Older Adults
    by Maksym Obrizan
  • 2011 The Causal Effect of Education on Health: What is the Role of Health Behaviors?
    by Giorgio Brunello & Margherita Fort & Nichole Schneeweis & Rudolf Winter-Ebmer
  • 2011 The Causal Effect of Education on Health: What is the Role of Health Behaviors?
    by Giorgio Brunello & Margherita Fort & Nichole Schneeweis & Rudolf Winter-Ebmer
  • 2011 Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption
    by Anderson, D. Mark & Rees, Daniel I.
  • 2011 Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption
    by Anderson, D. Mark & Rees, Daniel I.
  • 2011 Explaining the Female Black-White Obesity Gap: A Decomposition Analysis of Proximal Causes
    by Johnston, David W. & Lee, Wang-Sheng
  • 2011 Explaining the Female Black-White Obesity Gap: A Decomposition Analysis of Proximal Causes
    by Johnston, David W. & Lee, Wang-Sheng
  • 2011 Race, Social Class, and Bulimia Nervosa
    by Goeree, Michelle S. & Ham, John C. & Iorio, Daniela
  • 2011 Race, Social Class, and Bulimia Nervosa
    by Goeree, Michelle S. & Ham, John C. & Iorio, Daniela
  • 2011 Unfit for Service: The Implications of Rising Obesity for U.S. Military Recruitment
    by Cawley, John & Maclean, Johanna Catherine
  • 2011 Unfit for Service: The Implications of Rising Obesity for U.S. Military Recruitment
    by Cawley, John & Maclean, J. Catherine
  • 2011 Destined for (Un)Happiness: Does Childhood Predict Adult Life Satisfaction?
    by Frijters, Paul & Johnston, David W. & Shields, Michael A.
  • 2011 Destined for (Un)Happiness: Does Childhood Predict Adult Life Satisfaction?
    by Frijters, Paul & Johnston, David W. & Shields, Michael A.
  • 2011 Early Life Health and Adult Earnings: Evidence from a Large Sample of Siblings and Twins
    by Lundborg, Petter & Nilsson, Anton & Rooth, Dan-Olof
  • 2011 Early Life Health and Adult Earnings: Evidence from a Large Sample of Siblings and Twins
    by Lundborg, Petter & Nilsson, Anton & Rooth, Dan-Olof
  • 2011 Does Early Life Health Predict Schooling Within Twin Pairs?
    by Lundborg, Petter & Nilsson, Anton & Rooth, Dan-Olof
  • 2011 Does Early Life Health Predict Schooling Within Twin Pairs?
    by Lundborg, Petter & Nilsson, Anton & Rooth, Dan-Olof
  • 2011 The Kid's Speech: The Effect of Stuttering on Human Capital Acquisition
    by Rees, Daniel I. & Sabia, Joseph J.
  • 2011 The Kid's Speech: The Effect of Stuttering on Human Capital Acquisition
    by Rees, Daniel I. & Sabia, Joseph J.
  • 2011 The Economics of Risky Health Behaviors
    by Cawley, John & Ruhm, Christopher J.
  • 2011 The Economics of Risky Health Behaviors
    by Cawley, John & Ruhm, Christopher J.
  • 2011 The Psychological Costs of War: Military Combat and Mental Health
    by Cesur, Resul & Sabia, Joseph J. & Tekin, Erdal
  • 2011 The Psychological Costs of War: Military Combat and Mental Health
    by Cesur, Resul & Sabia, Joseph J. & Tekin, Erdal
  • 2011 Health and Well-Being in the Crisis
    by Askitas, Nikos & Zimmermann, Klaus F.
  • 2011 Health and Well-Being in the Crisis
    by Askitas, Nikos & Zimmermann, Klaus F.
  • 2011 Prenatal Sex Selection and Girls' Well-Being: Evidence from India
    by Hu, Luojia & Schlosser, Analia
  • 2011 Prenatal Sex Selection and Girls' Well-Being: Evidence from India
    by Hu, Luojia & Schlosser, Analia
  • 2011 Who Searches for Low Prices? Population Characteristics and Price Dispersion in the Market for Prescription Drugs
    by Adrienne M. Ohler
  • 2011 The Causal Effect of Education on Health
    by Brunello, Giorgio & Fort, Margherita & Schneeweis, Nicole & Winter-Ebmer, Rudolf
  • 2011 Finite Mixture for Panels with Fixed Effects
    by Partha Deb & Pravin Trivedi
  • 2011 Race, Social Class, and Bulimia Nervosa
    by Michelle S. Goeree & John C. Ham & Daniela Iorio
  • 2011 Health Inequality over the Life-Cycle
    by Timothy Halliday
  • 2011 The Argentine Success Story and its Implications
    by Mark Weisbrot & Rebecca Ray & Juan Montecino & Sara Kozameh
  • 2011 Representative Ryan’s $30 Trillion Medicare Waste Tax
    by David Rosnick & Dean Baker
  • 2011 The Scorecard on Development, 1960-2010: Closing the Gap?
    by Mark Weisbrot & Rebecca Ray
  • 2011 The Ryan Medicare Plan: Winners and Losers
    by Dean Baker & David Rosnick
  • 2011 Time Inconsistency, Expectations and Technology Adoption: The Case of Insecticide Treated Nets
    by Alessandro Tarozzi & Aprajit Mahajan
  • 2011 Micro-Loans, Insecticide-Treated Bednets and Malaria: Evidence from a Randomized Controlled Trial in Orissa (India)
    by Alessandro Tarozzi & Aprajit Mahajan & Brian Blackburn & Daniel Kopf & Lakshmi Krishnan & Joanne Yoong
  • 2011 Gender Differences, HIV Risk Perception and Condom Use
    by Judith Lammers & Sweder van Wijnbergen & Daan Willebrands
  • 2011 La demande d'assurance dépendance dans un cadre trivarié
    by Bien, Franck & Plisson, Manuel & Chassagnon, Arnold
  • 2011 Health, Taxes, and Growth
    by Liutang Gong & Hongyi Li & Dihai Wang & Heng-fu Zou
  • 2011 The Causal Effect of Education on Health: What is the Role of Health Behaviors?
    by Brunello, Giorgio & Fort, Margherita & Schneeweis, Nicole & Winter-Ebmer, Rudolf
  • 2011 A Country for Old Men? An Analysis of the Determinants of Long-Term Home Care in Europe
    by S. Balia & R. Brau
  • 2011 A Model for the Delivery of Evidence-Based PSHE (Personal Wellbeing) in Secondary Schools
    by John Coleman & Daniel Hale & Richard Layard
  • 2011 A Guide to the MEPS-IC Government List Sample Microdata
    by Alice Zawacki
  • 2011 Curative Activities of Township Hospitals in Weifang Prefecture, China: An Analysis of Environmental and Supply-Side Determinants
    by Martine AUDIBERT & Jacky MATHONNAT & Aurore PELISSIER & Xiao Xian HUANG & Anning MA & Ningshan CHEN
  • 2011 Health Insurance Reform and Efficiency of Township Hospitals in Rural China: An Analysis from Survey Data
    by Xiao Xian HUANG & Aurore PELISSIER & Jacky MATHONNAT & Martine AUDIBERT & Anning MA
  • 2011 Agricultural primary commodity export and environmental degradation: what consequences for population’s health?
    by Alassane DRABO
  • 2011 Do Political Institutions protect the poor? Intra Countries Health Inequalities and Air Pollution in Developing Countries
    by Alassane DRABO
  • 2011 Genetic Markers as Instrumental Variables
    by Stephanie von Hinke Kessler Scholder & George Davey Smith & Debbie A. Lawlor & Carol Propper & Frank Windmeijer
  • 2011 School meal crowd out in the 1980s
    by Stephanie von Hinke Kessler Scholder
  • 2011 Healthcare in Italy: expenditure determinants and regional differentials
    by Maura Francese & Marzia Romanelli
  • 2011 Employment propensity: The roles of mental and physical health
    by Gail Pacheco & Don J. Webber
  • 2011 Can Patients Diagnosed with Schizophrenia Complete Choice-Based Conjoint Analysis Tasks?
    by John F.P. Bridges & Elizabeth T. Kinter & Annette Schmeding & Ina Rudolph & Axel Mhlbacher
  • 2011 Comparison of Scores Derived from the Box Score-11 Scale and the Pain Attribute of the Health Utilities Index-3
    by Michael Iskedjian & Barbara Jaszewski & Olivier Desjardins
  • 2011 Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations
    by Andrew Lloyd & Paul Hodgkins & Rahul Sasane & Ron Akehurst & Edmund J.S. Sonuga-Barke & Patrick Fitzgerald & Annabel Nixon & Haim Erder & John Brazier
  • 2011 Offering Results to Participants in a Diabetes Survey: Effects on Survey Response Rates
    by Jeanette Y. Ziegenfuss & Nilay D. Shah & James R. Deming & Holly K. Van Houten & Steven A. Smith & Timothy J. Beebe
  • 2011 Treatment Satisfaction Instruments for Different Purposes during a Product's Lifecycle: Keeping the End in Mind
    by Diana Rofail & Fiona Taylor & Antoine Regnault & Anna Filonenko
  • 2011 Societal Values in the Allocation of Healthcare Resources: Is it All About the Health Gain?
    by Tania Stafinski & Devidas Menon & Deborah Marshall & Timothy Caulfield
  • 2011 Acknowledgment
    by Adis International Limited
  • 2011 Medication Non-Compliance in Zagreb, Croatia
    by Marcel Leppe & Josip Culig & Jelena Boskovic
  • 2011 Impact of Walking Impairment in Multiple Sclerosis: Perspectives of Patients and Care Partners
    by Nicholas G. LaRocca
  • 2011 Establishing the Content Validity of the King's Health Questionnaire in Men and Women with Overactive Bladder in the US
    by Mary Kay. Margolis & Vasudha Vats & Karin S. Coyne & Con Kelleher
  • 2011 Elicitation of Ostomy Pouch Preferences: A Discrete-Choice Experiment
    by Ole Bonnichsen
  • 2011 Integrating Evidence and Individual Preferences Using a Web-Based Multi-Criteria Decision Analytic Tool: An Application to Prostate Cancer Screening
    by Michelle Cunich & Glenn Salkeld & Jack Dowie & Joan Henderson & Clare Bayram & Helena Britt & Kirsten Howard
  • 2011 Exploring Qualitative Research Synthesis: The Role of Patients' Perspectives in Health Policy Design and Decision Making
    by Helle Ploug. Hansen & Eva Draborg & Finn Brlum. Kristensen
  • 2011 Great Expectations: What Do Patients Using Complementary and Alternative Medicine Hope For?
    by E. Ernst & S.K. Hung
  • 2011 Analysis of Health-Related Quality-of-Life Instruments Measuring the Impact of Bariatric Surgery: Systematic Review of the Instruments Used and their Content Validity
    by Raed Tayyem & Abdulmajid Ali & John Atkinson & Colin R. Martin
  • 2011 Patient Advocacy in Research: Merely an Afterthought?
    by Musa Mayer
  • 2011 Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis
    by Michael Iskedjian & David W. Covert & John H. Walker
  • 2011 Eliciting Preferences for Reimbursed Drugs Selection Criteria in C�te d'Ivoire
    by Vakaramoko Diaby & Henri Di Kakou & Jean Lachaine
  • 2011 An Instrument to Assess the Needs of Patients with Type 2 Diabetes Mellitus for Health-Promotion Activities
    by Anneke N. van Dijk-de Vries & Inge G.P. Duimel-Peeters & Hubertus J.M. Vrijhoef
  • 2011 Impact of Gastrointestinal Problems on Adherence to Low-Dose Acetylsalicylic Acid: A Quantitative Study in Patients with Cardiovascular Risk
    by Christina Moberg & Jrgen Naesdal & Lars-Erik Svedberg & Delphine Duchateau & Nicola Harte
  • 2011 A Qualitative Study on Feasibility of a Web-Based Women's Health Portal and Information System
    by Min Yang & Mark Kosinski & Rosemarie Boulanger
  • 2011 Family Burden after Severe Brain Injury: The Italian Experience with Families and Volunteer Associations
    by Paola Mosconi & Mariangela Taricco & Mirna Bergamini & Luisella Bosisio Fazzi & Cinzia Colombo & Valentina Patrucco & Marinella Corti & Dario Giobbe & Massimo Guerreschi & Maria Rita. Magnarella & Giovanni Sallemi
  • 2011 Patient Preferences for Treatment of Achilles Tendon Pain: Results from a Discrete-Choice Experiment
    by Kent R. Sweeting & Jennifer A. Whitty & Paul A. Scuffham & Michael J. Yelland
  • 2011 Development of an Electronic Daily Uterine Fibroid Symptom Diary
    by Linda S. Deal & Valerie S.L. Williams & Sheri E. Fehnel
  • 2011 Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life: A Systematic Review of the Content Validity of Self-Administered Instruments Used to Assess Health-Related Quality of Life in End-Stage Renal Disease
    by Cheryl Glover & Pauline Banks & Amanda Carson & Colin R. Martin & Tim Duffy
  • 2011 Patient-Reported Outcomes, Patient-Reported Information: From Randomized Controlled Trials to the Social Web and Beyond
    by Mike Baldwin & Andrew Spong & Lynda Doward & Ari Gnanasakthy
  • 2011 Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence
    by Leela Barham
  • 2011 Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease
    by Greg L. Plosker
  • 2011 Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
    by Naiyana Praditsitthikorn & Yot Teerawattananon & Sripen Tantivess & Supon Limwattananon & Arthorn Riewpaiboon & Saibua Chichareon & Nantakan Ieumwananonthachai & Viroj Tangcharoensathien
  • 2011 To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies
    by Tania Stafinski & Devidas Menon & Christopher McCabe & Donald J. Philippon
  • 2011 Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review
    by Alexander Goehler & Benjamin P. Geisler & Jennifer M. Manne & Beate Jahn & Annette Conrads-Frank & Petra Schnell-Inderst & G. Scott. Gazelle & Uwe Siebert
  • 2011 Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence
    by Petros Pechlivanoglou & Robin De. Vries & Simon M.G.J. Daenen & Maarten J. Postma
  • 2011 Value-Based Pricing: Incentive for Innovation or Zero Net Benefit?
    by Dyfrig A. Hughes
  • 2011 Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation: Challenges in Practice
    by Mark Parker & Alan Haycox & Jane Graves
  • 2011 Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients
    by Annette C. Reboli & Coleman Rotstein & Daniel H. Kett & Michael Maschio & Shannon Cartier & Richard Chambers & Miriam Tarallo
  • 2011 Cost Estimation of Cardiovascular Disease Events in the US
    by Amy K. OSullivan & Jaime Rubin & Joshua Nyambose & Andreas Kuznik & David J. Cohen & David Thompson
  • 2011 US FDA Modernization Act, Section 114: Uses, Opportunities and Implications for Comparative Effectiveness Research
    by Peter J. Neumann & Pei-Jung Lin & Tom E. Hughes
  • 2011 Using QALYs in Cancer: A Review of the Methodological Limitations
    by Martina Garau & Koonal K. Shah & Anne R. Mason & Qing Wang & Adrian Towse & Michael F. Drummond
  • 2011 Cost-of-Illness Studies: A Guide to Critical Evaluation
    by Allison Larg & John R. Moss
  • 2011 Challenges in Health State Valuation in Paediatric Economic Evaluation: Are QALYs Contraindicated?
    by Wendy J. Ungar
  • 2011 The Case for Less, Not More, US FDA Regulation
    by John A. Vernon & Joseph H. Golec
  • 2011 Medication Costs to Private Insurers of Diversion of Medications for Attention-Deficit Hyperactivity Disorder
    by Arnie P. Aldridge & Larry A. Kroutil & Alexander J. Cowell & Daniel B. Reeves & David L. Van Brunt
  • 2011 Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders
    by Marieke Krol & Joc Papenburg & Marc Koopmanschap & Werner Brouwer
  • 2011 Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries
    by Omar Galrraga & Veronika J. Wirtz & Alejandro Figueroa-Lara & Yared Santa-Ana-Tellez & Ibrahima Coulibaly & Kirsi Viisainen & Antonieta Medina-Lara & Eline L. Korenromp
  • 2011 Presenting Evidence and Summary Measures to Best Inform Societal Decisions When Comparing Multiple Strategies
    by Simon Eckermann & Andrew R. Willan
  • 2011 Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?
    by Afschin Gandjour
  • 2011 Reflections on the Changing Face of German Pharmaceutical Policy: How Far is Germany from Value-Based Pricing?
    by Andreas Gerber & Stephanie Stock & Charalabos-Markos Dintsios
  • 2011 PAID 1.0 in Practice: A Brief Clarification Regarding its Possibilities and Limitations
    by Pieter van Baal & Werner Brouwer
  • 2011 Intravenous Esomeprazole: A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding
    by Gillian M. Keating
  • 2011 A Value Set for the EQ-5D Based on Experienced Health States: Development and Testing for the German Population
    by Reiner Leidl & Peter Reitmeir
  • 2011 The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia
    by Natasha Nanwa & Nicole Mittmann & Sandra Knowles & Claudia Bucci & Rita Selby & Neil Shear & Scott E. Walker & William Geerts
  • 2011 A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
    by James G. Xenakis & Elizabeth T. Kinter & K. Jack. Ishak & Alexandra J. Ward & Jen P. Marton & Richard J. Willke & Simon Davies & J. Jaime. Caro
  • 2011 Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different
    by Tania Stafinski & Devidas Menon & Donald J. Philippon & Christopher McCabe
  • 2011 Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US: A Literature Review
    by Bin Zhang & Prina Z. Donga & Mitra Corral & Medha Sasane & Jeffrey D. Miller & Chris L. Pashos
  • 2011 The Appropriate Elicitation of Expert Opinion in Economic Models: Making Expert Data Fit for Purpose
    by William Sullivan & Katherine Payne
  • 2011 Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developed Countries
    by Greg L. Plosker
  • 2011 The Authors' Reply
    by Zaheer-Ud-Din Babar & Shane L. Scahill
  • 2011 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Jonathan R. Harper
  • 2011 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Romn Prez Velasco & Yot Teerawattananon
  • 2011 Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence
    by Peter S. Hall & Claire Hulme & Christopher McCabe & Yemi Oluboyede & Jeff Round & David A. Cameron
  • 2011 Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives
    by Nicole Mittmann & Paul Hernandez & Carl Mellstrm & Lance Brannman & Tobias Welte
  • 2011 Cost Effectiveness of Treatments for Inflammatory Bowel Disease
    by Keith Bodger
  • 2011 Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer
    by Mark Jit & Marc Brisson
  • 2011 Health Economic and Infectious Disease Modelling: A Guide to Merging Streams
    by Andrea Anonychuk & Murray Krahn
  • 2011 Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial
    by Tallal Younis & Chris Skedgel
  • 2011 Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes
    by Katherine A. Lyseng-Williamson
  • 2011 Economic Burden of Renal Cell Carcinoma in the US: Part II - An Updated Analysis
    by Ya-Chen T. Shih & Chun-Ru Chien & Ying Xu & I-Wen Pan & Grace L. Smith & Thomas A. Buchholz
  • 2011 Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review
    by Ya-Chen T. Shih & Chun-Ru Chien & Ying Xu & I-Wen Pan & Grace L. Smith & Thomas A. Buchholz
  • 2011 Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice
    by Rahul Jain & Michael Grabner & Eberechukwu Onukwugha
  • 2011 Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay
    by Henry A. Glick
  • 2011 The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma: An Overview of Clinical and Economic Information
    by Andrea Messori & Dario Maratea & Chiara Nozzoli & Alberto Bosi
  • 2011 Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts
    by Katherine A. Lyseng-Williamson
  • 2011 Comparing Methods of Data Synthesis: Re-Estimating Parameters of an Existing Probabilistic Cost-Effectiveness Model
    by Mark Oppe & Maiwenn Al & Maureen Rutten-van Mlken
  • 2011 Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
    by Nicholas Latimer & Joanne Lord & Robert L. Grant & Rachel OMahony & John Dickson & Philip G. Conaghan
  • 2011 Advances in Cancer Therapeutics and Patient Access to New Drugs
    by George Dranitsaris & Ilse Truter & Martie S. Lubbe & Eitan Amir & William Evans
  • 2011 Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review
    by Chantal W.B. Boonacker & Pieter H. Broos & Elisabeth A.M. Sanders & Anne G.M. Schilder & Maroeska M. Rovers
  • 2011 Sample Size and Power for Cost-Effectiveness Analysis (Part 1)
    by Henry A. Glick
  • 2011 Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations
    by Pieter H.M. van Baal & Albert Wong & Laurentius C.J. Slobbe & Johan J. Polder & Werner B.F. Brouwer & G. Ardine. de Wit
  • 2011 Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations
    by John A. Nyman & Hawre J. Jalal
  • 2011 A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice
    by Afschin Gandjour
  • 2011 Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest
    by Simon Eckermann & Michael Coory & Andrew R. Willan
  • 2011 Impact of Treatment Success on Health Service Use and Cost in Depression: Longitudinal Database Analysis
    by Sarah Byford & Barbara Barrett & Nicolas Despigel & Alan Wade
  • 2011 A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and Canada
    by Mark Oremus & S. Carolina. Aguilar
  • 2011 Febuxostat for the Management of Hyperuricaemia in Patients with Gout: A NICE Single Technology Appraisal
    by Matt Stevenson & Abdullah Pandor
  • 2011 Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
    by Paul Mitchell & Lieven Annemans & Richard White & Meghan Gallagher & Simu Thomas
  • 2011 The Authors' Reply
    by Zaheer-Ud-Din Babar & Shane Scahill
  • 2011 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Asrul Akmal. Shafie & Mohamed Azmi. Hassali
  • 2011 Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia
    by Carl Rudolf. Blankart & Tom Stargardt & Jonas Schreygg
  • 2011 Calibrating Models in Economic Evaluation: A Comparison of Alternative Measures of Goodness of Fit, Parameter Search Strategies and Convergence Criteria
    by Jonathan Karnon & Tazio Vanni
  • 2011 Calibrating Models in Economic Evaluation: A Seven-Step Approach
    by Tazio Vanni & Jonathan Karnon & Jason Madan & Richard G. White & W. John. Edmunds & Anna M. Foss & Rosa Legood
  • 2011 Effects of Reference Pricing in Pharmaceutical Markets: A Review
    by Matteo Maria. Galizzi & Simone Ghislandi & Marisa Miraldo
  • 2011 Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis
    by Martin Hoyle
  • 2011 Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective
    by Helen Dakin & Morris Sherman & Scott Fung & Carrie Fidler & Anthony Bentley
  • 2011 Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection
    by Hui-Fang Hung & Hsiu-Hsi Chen
  • 2011 Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal
    by Rumona Dickson & Adrian Bagust & Angela Boland & Michaela Blundell & Helen Davis & Yenal Dundar & Juliet Hockenhull & Carlos Martin Saborido & James Oyee & Vidhya Sagar. Ramani
  • 2011 Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review
    by Judith Dams & Bernhard Bornschein & Jens Peter Reese & Annette Conrads-Frank & Wolfgang H. Oertel & Uwe Siebert & Richard Dodel
  • 2011 QALYs and Carers
    by Hareth Al-Janabi & Terry N. Flynn & Joanna Coast
  • 2011 Erratum
    by Adis International Limited
  • 2011 Acknowledgement
    by Adis International Limited
  • 2011 Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries
    by Greg L. Plosker
  • 2011 Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma
    by Ateesha F. Mohamed & A. Brett. Hauber & Maureen P. Neary
  • 2011 Willingness to Pay for Adverse Drug Event Regulatory Actions
    by Jacoline Bouvy & Just Weemers & Huub Schellekens & Marc Koopmanschap
  • 2011 Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women: A NICE Single Technology Appraisal
    by Graham Scotland & Norman Waugh & Pamela Royle & Paul McNamee & Rob Henderson & Rosemary Hollick
  • 2011 Sample Size Determination for Cost-Effectiveness Trials
    by Andrew R. Willan
  • 2011 Utility Estimation in Chronic Obstructive Pulmonary Disease: A Preference for Change?
    by Jennifer Petrillo & Floortje van Nooten & Paul Jones & Maureen Rutten-van Mlken
  • 2011 The Importance of the Comparator in Economic Evaluations: Working on the Efficiency Frontier
    by Mattias Neyt & Hans Van Brabandt
  • 2011 Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
    by Mickal Hiligsmann & Jean-Yves Reginster
  • 2011 Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs
    by Alain Denis & Lut Mergaert & Christel Fostier & Irina Cleemput & Frank Hulstaert & Steven Simoens
  • 2011 Does the Market Share of Generic Medicines Influence the Price Level?: A European Analysis
    by Pieter Dylst & Steven Simoens
  • 2011 Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature
    by Gery P. Guy & Donatus U. Ekwueme
  • 2011 A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy
    by Joseph Menzin & Lisa M. Lines & Daniel E. Weiner & Peter J. Neumann & Christine Nichols & Lauren Rodriguez & Irene Agodoa & Tracy Mayne
  • 2011 Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer
    by Martin Connock & Chris Hyde & David Moore
  • 2011 Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions: The Case for Reference Models
    by Hossein Haji Ali Afzali & Jonathan Karnon
  • 2011 A Review of the Cost Effectiveness of Bisphosphonates in the Treatment of Post-Menopausal Osteoporosis in Switzerland
    by Kurt Lippuner & Richard F. Pollock & Jayne Smith-Palmer & Thomas Meury & William J. Valentine
  • 2011 An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of C�te d'Ivoire
    by Vakaramoko Diaby & Jean Lachaine
  • 2011 Excess Costs Associated with Patients with Chronic Thromboembolic Pulmonary Hypertension in a US Privately Insured Population
    by Noam Y. Kirson & Howard G. Birnbaum & Jasmina I. Ivanova & Tracy Waldman & Vijay Joish & Todd Williamson
  • 2011 Early Retirement and Income Loss in Patients with Early and Advanced Parkinson's Disease
    by Scott Johnson & Matthew Davis & Anna Kaltenboeck & Howard Birnbaum & ElizaBeth Grubb & Marcy Tarrants & Andrew Siderowf
  • 2011 Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings
    by Sandra L. Tunis
  • 2011 Early Assessment of Medical Technologies to Inform Product Development and Market Access: A Review of Methods and Applications
    by Maarten J. IJzerman & Lotte M.G. Steuten
  • 2011 Assessing Quality of Life among British Older People Using the ICEPOP CAPability (ICECAP-O) Measure
    by Terry N. Flynn & Phil Chan & Joanna Coast & Tim J. Peters
  • 2011 Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial
    by Michael W. Kattan & Stephanie R. Earnshaw & Cheryl L. McDade & Libby K. Black & Gerald L. Andriole
  • 2011 Excess Costs Associated with Patients with Pulmonary Arterial Hypertension in a US Privately Insured Population
    by Noam Y. Kirson & Howard G. Birnbaum & Jasmina I. Ivanova & Tracy Waldman & Vijay Joish & Todd Williamson
  • 2011 Nutrition Therapy Cost Analysis in the US: Pre-Mixed Multi-Chamber Bag vs Compounded Parenteral Nutrition
    by Robin S. Turpin & Todd Canada & Frank Xiaoqing. Liu & Catherine J. Mercaldi & Alessandro Pontes-Arruda & Paul Wischmeyer
  • 2011 Drugs for Rare Diseases: Influence of Orphan Designation Status on Price
    by Eline Picavet & Marc Dooms & David Cassiman & Steven Simoens
  • 2011 Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis
    by Dirk Mueller & Afschin Gandjour
  • 2011 The Use of Decision-Analytic Models in Parkinson's Disease: A Systematic Review and Critical Appraisal
    by James Shearer & Colin Green & Carl E. Counsell & John P. Zajicek
  • 2011 Ordering Errors, Objections and Invariance in Utility Survey Responses: A Framework for Understanding Who, Why and What to Do
    by Eve Wittenberg & Lisa A. Prosser
  • 2011 Cost-Efficacy Analysis of the MONET Trial Using UK Antiretroviral Drug Prices
    by Brian Gazzard & Andrew Hill & Anne Anceau
  • 2011 Design of Patient Access Schemes in the UK: Influence of Health Technology Assessment by the National Institute for Health and Clinical Excellence
    by Szymon Jarosawski & Mondher Toumi
  • 2011 Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US
    by Keith L. Davis & Timothy J. Bell & Jacqueline M. Miller & Derek A. Misurski & Bela Bapat
  • 2011 Cost Effectiveness of Tobacco Control Policies in Vietnam: The Case of Population-Level Interventions
    by Hideki Higashi & Khoa D. Truong & Jan J. Barendregt & Phuong K. Nguyen & Mai L. Vuong & Thuy T. Nguyen & Phuong T. Hoang & Angela L. Wallace & Tien V. Tran & Cuong Q. Le & Christopher M. Doran
  • 2011 Patent Extension Policy for Paediatric Indications: An Evaluation of the Impact within Three Drug Classes in a State Medicaid Programme
    by Richard E. Nelson & Carrie McAdam-Marx & Megan L. Evans & Robert Ward & Benjamin Campbell & Diana Brixner & Joanne Lafleur
  • 2011 Assessing the Performance of a New Generic Measure of Health-Related Quality of Life for Children and Refining it for Use in Health State Valuation
    by Katherine Stevens
  • 2011 Valuing Health at Different Ages: Evidence from a Nationally Representative Survey in the US
    by Daniel Eisenberg & Gary L. Freed & Matthew M. Davis & Dianne Singer & Lisa A. Prosser
  • 2011 The Impact of Inclusion Criteria in Health Economic Assessments
    by Anke Richter & Patricia Thieda & Kylie Thaler & Gerald Gartlehner
  • 2011 The Economics of the NHS Cancer Drugs Fund
    by Alan Maynard & Karen Bloor
  • 2011 Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer
    by O. Yu. Atkov & A.V. Azarov & D.A. Zhukov & N. Nicoloyannis & L. Durand
  • 2011 Citizens' Preferences for Brand Name Drugs for Treating Acute and Chronic Conditions: A Pilot Study
    by Arina Denoth & Christophe Pinget & Jean-Blaise Wasserfallen
  • 2011 Public and Decision Maker Stated Preferences for Pharmaceutical Subsidy Decisions: A Pilot Study
    by Jennifer A. Whitty & Paul A. Scuffham & Sharyn R. Rundle-Thiele
  • 2011 Germany's Decision Rule for Setting Ceiling Prices of Drugs: A Comparative Analysis with Other Decision Rules
    by Afschin Gandjour
  • 2011 Impact of Fibromyalgia Severity on Health Economic Costs: Results from a European Cross-Sectional Study
    by Andreas Winkelmann & Serge Perrot & Caroline Schaefer & Kellie Ryan & Arthi Chandran & Alesia Sadosky & Gergana Zlateva
  • 2011 Current and Future Economic Burden of Osteoporosis in New Zealand
    by Paul Brown & Rob McNeill & William Leung & Eman Radwan & Jane Willingale
  • 2011 Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland: Implications Once Generic Atypicals are Available
    by Magda Wladysiuk & Aleksander Araszkiewicz & Brian Godman & Katarzyna Szabert; Prescribing Research Group, University of Liverpool Management School, Liverpool, UK; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden & Corrado Barbui & Alan Haycox
  • 2011 The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS: Costs, Healthcare Resources and Health Outcomes
    by Alison Sweet & David Lee & Kerry Gairy & Denver Phiri & Timothy Reason & Kevin Lock
  • 2011 Determinants of Out-of-Pocket Health Expenditure in China: Analysis Using China Health and Nutrition Survey Data
    by Xuedan You & Yasuki Kobayashi
  • 2011 Costs to Hospitals of Acquiring and Processing Blood in the US: A Survey of Hospital-Based Blood Banks and Transfusion Services
    by Richard W. Toner & Laura Pizzi & Brian Leas & Samir K. Ballas & Alyson Quigley & Neil I. Goldfarb
  • 2011 Valuing Child Health Utility 9D Health States with a Young Adolescent Sample: A Feasibility Study to Compare Best-Worst Scaling Discrete-Choice Experiment, Standard Gamble and Time Trade-Off Methods
    by Julie Ratcliffe & Leah Couzner & Terry Flynn & Michael Sawyer & Katherine Stevens & John Brazier & Leonie Burgess
  • 2011 The Chinese Healthcare System: Structure, Problems and Challenges
    by Jens Leth. Hougaard & Lars Peter. sterdal & Yi Yu
  • 2011 New Medical Management Trends and Policies throughout Central and Eastern Europe
    by Cristina Teodora NEAGU
  • 2011 The Appropriation Of New Arrangements Of Public Organizations: Locally Negotiate To Strategically Act
    by Corinne GRENIER
  • 2011 How ‘ya gonna keep ‘em down on the farm -After they’ve seen Paree
    by Woodrow H. SEARS
  • 2011 Selfmanagement And Emotional Intelligence
    by Ioana LEPADATU & Cornelia Tatu
  • 2011 Long-term health effects on the next generation of Ramadan fasting during pregnancy
    by van Ewijk, Reyn
  • 2011 Premium subsidies and social health insurance: Substitutes or complements?
    by Kifmann, Mathias & Roeder, Kerstin
  • 2011 The incidence of the healthcare costs of smoking
    by Cowan, Benjamin & Schwab, Benjamin
  • 2011 “It's driving her mad”: Gender differences in the effects of commuting on psychological health
    by Roberts, Jennifer & Hodgson, Robert & Dolan, Paul
  • 2011 Switching sickness funds in Israel: Adverse selection or risk selection? Some insights from the analysis of the relative costs of switchers
    by Shmueli, Amir
  • 2011 Overweight and poor? On the relationship between income and the body mass index
    by Jolliffe, Dean
  • 2011 Prevalence Rates and Racial disparities in undiagnosed pre-diabetes in the US population: Evidence from the National Health and Nutrition Examination survey of 2007-08
    by Achintya Ray
  • 2011 The role of family in suicide rate in Italy
    by Claudio Detotto & Valerio Sterzi
  • 2011 An exploratory analysis of the relationship between social interactions, income and health in Italy
    by Damiano Fiorillo & Fabio Sabatini
  • 2011 Health and Early Retirement: Evidence from French Data for individuals
    by Thomas Barnay & Karine Briard
  • 2011 Health care expenditures in Asia countries: Panel data analysis
    by Munic Boungnarasy
  • 2011 On the way of tobacco quitting: A VAR approach
    by Nicolas Gérard Vaillant & Christian Ben lakhdar & Thérèse Lebrun
  • 2011 A Note on Income Heterogeneity, Dietary Choice and Medical Services: Implications for Health Outcomes
    by Pedro Gomis-Porqueras & Junsang Lee
  • 2011 Economic Policies, Political Considerations and Overall Health
    by Stavros A. Drakopoulos
  • 2011 The Rise in Female Smoking in Russia: What to Do?
    by Ogloblin, C & Brock, G
  • 2011 Horizontal Inequity in Access to Health Care in Four South American Cities
    by Ana I. Balsa & Máximo Rossi & Patricia Triunfo
  • 2011 Taxe environnementale, morbidité et profil de productivité
    by Nathalie Mathieu-Bolh & Xavier Pautrel
  • 2011 Healthcare Financing In Recession
    by Bianca Mihart
  • 2011 Considerations Regarding 111e Economic Models For The Evaluation Of Health
    by Bianca Mihart Ph. D Student
  • 2011 The Study Of Healthcare Assessment In Pakistan (1991-2007)
    by Waseem IKRAM & Khalid ZAMAN & Mehboob AHMAD & Mohammad Raza Ullah Khan NIAZI
  • 2011, 4th quarter update health behaviours, economics of
    by Donald S. Kenkel
  • 2010 Benefit Transfers with Latent Class Models: Air Pollution Risk Management of Power Plants in China
    by Taro Ohdoko & Satoru Komatsu & Shinji Kaneko
  • 2010 Les vingt ans du Collège des économistes de la santé : avant-propos
    by Le Pen, Claude & Barnay, Thomas
  • 2010 Taking Economics Seriously
    by Dean Baker
  • 2010 The Hungry World: America's Cold War Battle against Poverty in Asia
    by Cullather, Nick
  • 2010 Substance Abuse Treatment and Motor Vehicle Fatalities
    by Beth A. Freeborn & Brian McManus
  • 2010 Estimating the Effect of Individual Time Preferences on the Use of Disease Screening
    by W. David Bradford & James Zoller & Gerard A. Silvestri
  • 2010 Fatal attraction? Access to early retirement and mortality
    by Andreas Kuhn & Jean-Philippe Wuellrich & Josef Zweimüller
  • 2010 Online but still divided: Inequality in private internet use in Germany
    by Coneus, Katja & Schleife, Katrin
  • 2010 Zum Kostenanstieg im Gesundheitswesen 2009: Wie teuer waren die Reformen?
    by Schnurr, Felix & Vatter, Johannes & Weimann, Frank
  • 2010 The Effects of Daughters on Health Choices and Risk Behaviour
    by N Powdthavee & S Wu & A Oswald
  • 2010 Measurement Invariance and Response Bias: A Stochastic Frontier Approach
    by Robert Rosenman & Vidhura Tennekoon & Laura G. Hill
  • 2010 Healthy Human Development Indices
    by Merwan Engineer & Nilanjana Roy & Sari Fink
  • 2010 Syphilis Cycles
    by David Aadland & David Finnoff & Kevin X.D. Huang
  • 2010 A Defense of the Current US Tax Treatment of Employer-Provided Medical Insurance
    by Kevin X. D. Huang & Gregory W. Huffman
  • 2010 Income Based Price Subsidies and Parallel Imports
    by Rajat Acharyya & Maria D.C. Garcia-Alonso
  • 2010 Global Climate Change and the Resurgence of Tropical Disease: An Economic Approach
    by Douglas Gollin & Christian Zimmermann
  • 2010 Cost Efficiency and Scale Economies in General Dental Practices in the U.S.: A Non-parametric and Parametric Analysis
    by Lei Chen & Subhash C. Ray
  • 2010 Including Children in Policy Responses to Economic Crises
    by Caroline Harper & Nicola Jones & Andy McKay
  • 2010 Merit-Aid and the Distribution of Entering Students Across Ontario University
    by Dooley, Martin D. & Payne, A. Abigail & Robb, A. Leslie
  • 2010 Influenza Immunization Campaigns: Is an Ounce of Prevention Worth a Pound of Cure?
    by Courtney J. Ward
  • 2010 Effect of Internet Health Information on Health Care Use
    by Agne Suziedelyte
  • 2010 Transition to Parent-Child Coresidence: Parental Needs and the Strategic Bequest Motive
    by Meliyanni Johar & Shiko Maruyama & Sayaka Nakamura
  • 2010 Happiness and Physical Activity in Special Populations:Evidence from Korean Survey Data
    by Young Hoon Lee & Ilhyeok Park
  • 2010 Relationship between education, health and crime: fable, fallacy or fact
    by Qadri, Faisal Sultan & Kadri, Adeel Sultan
  • 2010 Validating SHARE in France with other French surveys : health and income data
    by Garrouste, Christelle & Godefroy, Pascal & Laferrère, Anne
  • 2010 Optimizing the stake holder’s perspective on enhancing the service quality in health care
    by Nakkeeran, Senthil kumar & G, Thiagarajan
  • 2010 Health and nutrition profile of children in rural Kerala: A call for an action
    by Vipin chandran, K.P
  • 2010 Child Nutrition in Rural India: Some Policy Priorities and Strategies
    by Vipin Chandran, K.P & Sandhya, P
  • 2010 Climate Change: A Threat to Human Health
    by Vipin Chandran, K.P & Sandhya, P
  • 2010 Do people invest in local public goods with long-term benefits: Experimental evidence from a shanty town in Peru
    by De Hoop, Thomas & Van Kempen, Luuk & Fort, Ricardo
  • 2010 Emigration of Skilled Labor under Risk Aversion: The Case of Medical Doctors from Middle Eastern and North African Economies
    by Driouchi, Ahmed & Kadiri, Molk
  • 2010 Human Deprivation Index: A Measure of Multidimensional Poverty
    by Sivakumar, Marimuthu & Sarvalingam, A
  • 2010 Economic Policies, Socieconomic Factors and Overall Health: A Short Review
    by Drakopoulos, Stavros A.
  • 2010 AIDing Contraception: HIV and Recent Trends in Abortion Rates
    by Hussey, Andrew & Nikolsko-Rzhevskyy, Alex & Walker, Jay
  • 2010 Estimating Dynamic Discrete Choice Models with Hyperbolic Discounting, with an Application to Mammography Decisions
    by Hanming Fang & Yang Wang
  • 2010 Parental Education and Child Health - Understanding the Pathways of Impact in Pakistan
    by Monasa Aslam & Geeta Kingdon
  • 2010 Health Systems Institutional Characteristics: A Survey of 29 OECD Countries
    by Valérie Paris & Marion Devaux & Lihan Wei
  • 2010 Health-Care Reform in Korea
    by Randall S. Jones
  • 2010 Committing to Exercise: Contract Design for Virtuous Habit Formation
    by Jeremy D. Goldhaber-Fiebert & Erik Blumenkranz & Alan M. Garber
  • 2010 Health Shocks and Natural Resource Management: Evidence from Western Kenya
    by Joshua Graff Zivin & Maria Damon & Harsha Thirumurthy
  • 2010 Beware of Unawareness: Racial/Ethnic Disparities in Awareness of Chronic Diseases
    by Pinka Chatterji & Heesoo Joo & Kajal Lahiri
  • 2010 Identifying Sibling Influence on Teenage Substance Use
    by Joseph G. Altonji & Sarah Cattan & Iain Ware
  • 2010 The Medical Care Costs of Obesity: An Instrumental Variables Approach
    by John Cawley & Chad Meyerhoefer
  • 2010 Estimating Dynamic Discrete Choice Models with Hyperbolic Discounting, with an Application to Mammography Decisions
    by Hanming Fang & Yang Wang
  • 2010 The Impact of Education on Health Knowledge
    by Duha Tore Altindag & Colin Cannonier & Naci H. Mocan
  • 2010 Unfit for Service: The Implications of Rising Obesity for U.S. Military Recruitment
    by John Cawley & Johanna Catherine Maclean
  • 2010 Implications of Middle School Behavior Problems for High School Graduation and Employment Outcomes of Young Adults: Estimation of a Recursive Model
    by Mustafa C. Karakus & David S. Salkever & Eric P. Slade & Nicholas Ialongo & Elizabeth Stuart
  • 2010 Giving Mom a Break: The Impact of Higher EITC Payments on Maternal Health
    by William N. Evans & Craig L. Garthwaite
  • 2010 Do Bad Report Cards Have Consequences? Impacts of Publicly Reported Provider Quality Information on the CABG Market in Pennsylvania
    by Justin Wang & Jason Hockenberry & Shin-Yi Chou & Muzhe Yang
  • 2010 Effects of Overweight on Risky Sexual Behavior of Adolescent Girls
    by Susan Averett & Hope Corman & Nancy Reichman
  • 2010 Why did HIV decline in Uganda?
    by Marcella M. Alsan & David M. Cutler
  • 2010 The Risk of Out-of-Pocket Health Care Expenditure at End of Life
    by Samuel Marshall & Kathleen M. McGarry & Jonathan S. Skinner
  • 2010 Fertility in New York State in the Civil War Era
    by Michael R. Haines & Avery M. Guest
  • 2010 The Construction of Life Tables for the American Indian Population at the Turn of the Twentieth Century
    by J. David Hacker & Michael R. Haines
  • 2010 Inequality and Infant and Childhood Mortality in the United States in the Twentieth Century
    by Michael R. Haines
  • 2010 Binge Drinking & Sex in High School
    by Jeffrey S. DeSimone
  • 2010 Estimating Heterogeneous Treatment Effects of Medicaid Expansions on Take-up and Crowd-out
    by John C. Ham & I. Serkan Ozbeklik & Lara Shore-Sheppard
  • 2010 Income and the Utilization of Long-Term Care Services: Evidence from the Social Security Benefit Notch
    by Gopi Shah Goda & Ezra Golberstein & David C. Grabowski
  • 2010 Coordination, Switching Costs and the Division of Labor in General Medicine: An Economic Explanation for the Emergence of Hospitalists in the United States
    by David O. Meltzer & Jeanette W. Chung
  • 2010 Where Are The Health Care Entrepreneurs? The Failure of Organizational Innovation in Health Care
    by David M. Cutler
  • 2010 Genetic Interactions with Prenatal Social Environment: Effects on Academic and Behavioral Outcomes
    by Dalton Conley & Emily Rauscher
  • 2010 Binge Drinking and Risky Sex among College Students
    by Jeffrey S. DeSimone
  • 2010 The Effect of State Workers' Compensation Program Changes on the Use of Federal Social Security Disability Insurance
    by Melissa P. McInerney & Kosali I. Simon
  • 2010 Diet, Health and Work Intensity in England and Wales, 1700-1914
    by Bernard Harris & Roderick Floud & Robert W. Fogel & Sok Chul Hong
  • 2010 Public-Place Smoking Laws and Exposure to Environmental Tobacco Smoke (ETS)
    by Christopher Carpenter & Sabina Postolek & Casey Warman
  • 2010 Alcohol Regulation and Crime
    by Christopher Carpenter & Carlos Dobkin
  • 2010 The Relationship Between Health and Growth: When Lucas Meets Nelson-Phelps
    by Philippe Aghion & Peter Howitt & Fabrice Murtin
  • 2010 Public vs. Private Provision of Charity Care? Evidence from the Expiration of Hill-Burton Requirements in Florida
    by Douglas Almond & Janet Currie & Emilia Simeonova
  • 2010 Prices and Cigarette Demand: Evidence from Youth Tobacco Use in Developing Countries
    by Deliana Kostova & Hana Ross & Evan Blecher & Sara Markowitz
  • 2010 The Tax Exclusion for Employer-Sponsored Health Insurance
    by Jonathan Gruber
  • 2010 Which Parts of Globalization Matter for Catch-up Growth?
    by Paul M. Romer
  • 2010 Public Avoidance and the Epidemiology of novel H1N1 Influenza A
    by Byung-Kwang Yoo & Megumi Kasajima & Jay Bhattacharya
  • 2010 The Effects of Relative Food Prices on Obesity — Evidence from China: 1991-2006
    by Yang Lu & Dana Goldman
  • 2010 Asymmetric Information and the Demand for Voluntary Health Insurance in Europe
    by Kristian Bolin & Daniel Hedblom & Anna Lindgren & Bjorn Lindgren
  • 2010 Explaining the Rise in Educational Gradients in Mortality
    by David M. Cutler & Fabian Lange & Ellen Meara & Seth Richards & Christopher J. Ruhm
  • 2010 The Impact of Comparative Effectiveness Research on Health and Health Care Spending
    by Anirban Basu & Tomas J. Philipson
  • 2010 Attitudes towards blood and living organ donations
    by Juan M. Cabasés Hita & María Errea Rodríguez
  • 2010 Multiple Benefit Receipt Among Individuals Receiving Food Assistance and Other Government Assistance
    by Andrew Gothro & Carole Trippe
  • 2010 School-Age Children Income-Eligible for Child Nutrition Programs in Multiple-Month Periods by Type of Benefit, Based on 2004 SIPP Panel Core Data Waves 8, 9, and 10 (Analysis Period: July-October 2006)
    by Carole Trippe & Joel Smith
  • 2010 Non-Cash Categorical Eligibility for SNAP: State Policies and the Number and Characteristics of SNAP Households Categorically Eligible Through Those Policies
    by Carole Trippe & Jessica Gillooly
  • 2010 Assets of Low-Income Households by SNAP Eligibility and Participation in 2010
    by Carole Trippe & Bruce Schechter
  • 2010 Reaching Those in Need: State Supplemental Nutrition Assistance Program Participation Rates in 2008
    by Karen E. Cunnyngham & Laura A. Castner
  • 2010 Technical Working Paper: Creation of the September 2009 Baseline of the 2005 MATH SIPP+ Microsimulation Model and Database
    by Joel Smith
  • 2010 Food Consumption Patterns of Young Preschoolers: Are They Starting Off on the Right Path?
    by Mary Kay Fox & Elizabeth Condon & Ronette R. Briefel & Kathleen C. Reidy & Denise M. Deming
  • 2010 Food Consumption Patterns of Infants and Toddlers: Where Are We Now?
    by Anna Maria Siega-Riz & Denise M. Deming & Kathleen C. Reidy & Mary Kay Fox & Elizabeth Condon & Ronette R. Briefel
  • 2010 Nutrient Intakes of US Infants, Toddlers, and Preschoolers Meet or Exceed Dietary Reference Intakes
    by Nancy F. Butte & Mary Kay Fox & Ronette R. Briefel & Anna Maria Siega-Riz & Johanna T. Dwyer & Denise M. Deming & Kathleen C. Reidy
  • 2010 The Feeding Infants and Toddlers Study 2008: Study Design and Methods
    by Ronette R. Briefel & Laura M. Kalb & Elizabeth Condon & Denise M. Deming & Nancy A. Clusen & Mary Kay Fox & Lisa Harnack & Erin Gemmill & Mary Stevens & Kathleen C. Reidy
  • 2010 New Findings from the Feeding Infants and Toddlers Study: Data to Inform Action
    by Ronette R. Briefel
  • 2010 Feeding Infants & Toddlers Study, 2008
    by Various Authors
  • 2010 Supplemental Nutrition Assistance Program Caseload Trends and Changes in Measures of Unemployment, Labor Underutilization, and Program Policy from 2000 to 2008
    by James Mabli & Carolina Ferrerosa
  • 2010 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2009
    by Joshua Leftin & rew Gothro & Esa Eslami
  • 2010 Direct Certification in the National School Lunch Program: State Progress in Implementation
    by Dennis Ranalli & Janis Johnston & Edward Harper & Rosemary O'Connell & Jay Hirschman & Quinn Moore & Ira Nichols-Barrer & Nancy Cole
  • 2010 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2009
    by Joshua Leftin & rew Gothro & Esa Eslami
  • 2010 Direct Certification in the National School Lunch Program: State Implementation Progress School Year 2009-2010
    by Dennis Ranalli & Janis Johnston & Edward Harper & Rosemary O'Connell & Jay Hirschman & Quinn Moore & Ira Nichols-Barrer & Nancy Cole
  • 2010 WIC Turns 35: Program Effectiveness and Future Directions
    by Barbara Devaney
  • 2010 State Trends in Supplemental Nutrition Assistance Program Eligibility and Participation Among Elderly Individuals
    by Karen Cunnyngham
  • 2010 Developing and Evaluating Methods for Using American Community Survey Data to Support the School Meals Program: Interim Report
    by Allen Schirm & Nancy Kirkendall & editors
  • 2010 Sources of MyPyramid Intakes Among School Children
    by Elizabeth M. Condon & Mary Kay Fox
  • 2010 Trends in Supplemental Nutrition Assistance Program Participation Rates: 2001-2008
    by Joshua Leftin
  • 2010 Trends in Supplemental Nutrition Assistance Program Participation Rates: 2001 to 2008
    by Joshua Leftin
  • 2010 Empirical Bayes Shrinkage Estimates of State Supplemental Nutrition Assistance Program Participation Rates in 2005-2007 for All Eligible People and the Working Poor
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2010 Food Expenditures and Diet Quality Among Low-Income Households and Individuals
    by James Mabli & Laura Castner & James Ohls & Mary Kay Fox & Mary Kay Crepinsek & Elizabeth Condon
  • 2010 Food Expenditures and Diet Quality Among Low-Income Households and Individuals
    by James Mabli & Laura Castner & James Ohls & Mary Kay Fox & Mary Kay Crepinsek & Elizabeth Condon
  • 2010 Evaluation of School Nutrition Policy
    by Philip Gleason
  • 2010 Improving Food Environments in Schools: Tracking Progress
    by Mary Kay Fox
  • 2010 Selecting Policy Indicators and Developing Simulation Models for the National School Lunch and Breakfast Programs
    by Lisa Dragoset & Anne Gordon
  • 2010 Implementing Supplemental Nutrition Assistance Program in Puerto Rico: A Feasibility Study
    by Anne Peterson & Bryan Johnson & Benjamin E. Moulton & Emily O. Smith & Alexandra Suchman & Claire Wilson & Shiara Francisquini Oquendo & Jacqueline Kauff & Jonathan Ladinsky & Laura Castner
  • 2010 Implementing Supplemental Nutrition Assistance Program in Puerto Rico: A Feasibility Study
    by Anne Peterson & Bryan Johnson & Benjamin E. Moulton & Emily O. Smith & Alexandra Suchman & Claire Wilson & Shiara Francisquini Oquendo & Jacqueline Kauff & Jonathan Ladinsky & Laura Castner
  • 2010 Low-Income Household Spending Patterns and Measures of Poverty
    by Laura Castner & James Mabli
  • 2010 Children's Food Security and Intakes from School Meals
    by Elizabeth Potamites & Anne Gordon
  • 2010 Reaching Staff, Parents, and Community Partners to Prevent Childhood Obesity in Head Start, 2008
    by Rachel A. Gooze & Cayce C. Hughes & Daniel M. Finkelstein & Robert C. Whitaker
  • 2010 Strategies to Reduce Sodium Intake in the United States
    by Committee on Strategies to Reduce Sodium Intake of which Ronette Briefel is a member.
  • 2010 Publishing Nutrition Research: Validity, Reliability, and Diagnostic Test Assessment in Nutrition-Related Research
    by Philip M. Gleason & Jeffrey Harris & Patricia M. Sheean & Carol J. Boushey & Barbara Bruemmer
  • 2010 Estimated Effects on the Supplemental Nutrition Assistance Program of Eliminating California's SSI Cash-Out Policy
    by Karen Cunnyngham
  • 2010 Hunger in America 2010 National Report Prepared for Feeding America
    by James Mabli & Rhoda Cohen & Frank Potter & Zhanyun Zhao
  • 2010 Height, Health Human Capital and Quality of Life Among Older Chinese
    by Asadul Islam & Paul Raschky & Russell Smyth
  • 2010 Estimating dynamic consumption of antibiotics using panel data: the shadow effect of bacterial resistance
    by Massimo Filippini & Laura González & Giuliano Masiero
  • 2010 Supra-states and censoring in health utility modelling: an examination of their importance in the EQ-5D tariff
    by Richard Edlin & Roberta Longo & Christopher McCabe
  • 2010 Convergence of the Health Status at the Local Level: Empirical Evidence from Austria
    by Martin Gächter & Engelbert Theurl
  • 2010 Fatal Attraction? Access to Early Retirement and Mortality
    by Andreas Kuhn & Jean-Philipe Wuellrich & Josef Zweimüller
  • 2010 Emotional Prosperity and the Stiglitz Commission
    by Oswald, Andrew J.
  • 2010 Emotional Prosperity and the Stiglitz Commission
    by Oswald, Andrew J.
  • 2010 Overweight and Poor? On the Relationship between Income and the Body Mass Index
    by Jolliffe, Dean
  • 2010 Overweight and Poor? On the Relationship between Income and the Body Mass Index
    by Jolliffe, Dean
  • 2010 The Weight of the Crisis: Evidence from Newborns in Argentina
    by Bozzoli, Carlos & Quintana-Domeque, Climent
  • 2010 The Weight of the Crisis: Evidence from Newborns in Argentina
    by Bozzoli, Carlos & Quintana-Domeque, Climent
  • 2010 Religion and Child Health
    by Chiswick, Barry R. & Mirtcheva, Donka M.
  • 2010 Religion and Child Health
    by Chiswick, Barry R. & Mirtcheva, Donka M.
  • 2010 Is Employer-Based Health Insurance a Barrier to Entrepreneurship?
    by Fairlie, Robert W. & Kapur, Kanika & Gates, Susan
  • 2010 Is Employer-Based Health Insurance a Barrier to Entrepreneurship?
    by Fairlie, Robert W. & Kapur, Kanika & Gates, Susan
  • 2010 Left Behind: Intergenerational Transmission of Human Capital in the Midst of HIV/AIDS
    by Akbulut-Yuksel, Mevlude & Turan, Belgi
  • 2010 Left Behind: Intergenerational Transmission of Human Capital in the Midst of HIV/AIDS
    by Akbulut-Yuksel, Mevlude & Turan, Belgi
  • 2010 Fatal Attraction? Access to Early Retirement and Mortality
    by Kuhn, Andreas & Wuellrich, Jean-Philippe & Zweimüller, Josef
  • 2010 Fatal Attraction? Access to Early Retirement and Mortality
    by Kuhn, Andreas & Wuellrich, Jean-Philippe & Zweimüller, Josef
  • 2010 Global Climate Change and the Resurgence of Tropical Disease: An Economic Approach
    by Gollin, Douglas & Zimmermann, Christian
  • 2010 Global Climate Change and the Resurgence of Tropical Disease: An Economic Approach
    by Gollin, Douglas & Zimmermann, Christian
  • 2010 The Effect of Childhood Conduct Disorder on Human Capital
    by Koning, Pierre & Webbink, Dinand & Vujić, Sunčica & Martin, Nicholas G.
  • 2010 The Effect of Childhood Conduct Disorder on Human Capital
    by Koning, Pierre & Webbink, Dinand & Vujić, Sunčica & Martin, Nicholas G.
  • 2010 Does Education Reduce the Risk of Hypertension? Estimating the Biomarker Effect of Compulsory Schooling in England
    by Powdthavee, Nattavudh
  • 2010 Does Education Reduce the Risk of Hypertension? Estimating the Biomarker Effect of Compulsory Schooling in England
    by Powdthavee, Nattavudh
  • 2010 Winning Big but Feeling No Better? The Effect of Lottery Prizes on Physical and Mental Health
    by Apouey, Bénédicte & Clark, Andrew E.
  • 2010 Winning Big but Feeling No Better? The Effect of Lottery Prizes on Physical and Mental Health
    by Apouey, Bénédicte & Clark, Andrew E.
  • 2010 Anthropometry and socioeconomics in the couple: evidence from the PSID
    by Climent Quintana Domeque & Sonia Oreffice
  • 2010 The Impact of ICT on Health Promotion: A Randomized Experiment with Diabetic Patients
    by Ana Balsa & Nestor Gandelman
  • 2010 The Impact of ICT on Adolescents' Perceptions and Consumption of Substances
    by Ana Balsa & Nestor Gandelman & Rafael Porzecanski
  • 2010 Has the Preston Curve Broken Down?
    by Georgios Georgiadis & José Pineda & Francisco Rodríguez
  • 2010 Health Status and the Allocation of Time
    by Melinda Podor & Timothy Halliday
  • 2010 On the Fuzzy Boundaries between Public and Private in Health Care Organization and Funding Systems
    by Alessandro Petretto
  • 2010 The role of technology in health care expenditure in the EU
    by Kamil Dybczak & Bartosz Przywara
  • 2010 Health-Insurance Coverage Rates for US Workers, 1979-2008
    by Hye Jin Rho & John Schmitt
  • 2010 Reconciliation and Representation: The Share of the Population Represented by the Democratic Majority
    by Sarika Gupta
  • 2010 The Budget Deficit Scare Story and the Great Recession
    by Dean Baker
  • 2010 Does hospital competition save lives?: evidence from the English NHS patient choice reforms
    by Zack Cooper & Stephen Gibbons & Simon Jones & Alistair McGuire
  • 2010 Economic Policies, Socieconomic Factors and Overall Health: A Short Review
    by Stavros A. Drakopoulos
  • 2010 The Weight of the Crisis: Evidence from Newborns in Argentina
    by Carlos Bozzoli & Climent Quintana-Domeque
  • 2010 Health Cost Risk and Optimal Retirement Provision: A Simple Rule for Annuity Demand
    by Peijnenburg, J.M.J. & Nijman, T.E. & Werker, B.J.M.
  • 2010 Est-il profitable d'être médecin généraliste ? Carrières comparées des médecins généralistes et des cadres supérieurs
    by Samson, Anne-Laure & Dormont, Brigitte
  • 2010 Health, Happiness and Adaptation: an economic perspective
    by Antonio Bariletti & Guido Citoni
  • 2010 Parental Education and Child Health - Understanding the Pathways of Impact in Pakistan
    by Monazza Aslam & Geeta Kingdon
  • 2010 Limited Liability, Moral Hazard and Risk Taking - A Safety Net Game Experiment
    by Tibor Neugebauer & Sascha Füllbrunn
  • 2010 Limited Liability, Moral Hazard and Risk Taking - A Safety Net Game Experiment
    by Tibor Neugebauer & Sascha Füllbrunn
  • 2010 Limited Liability, Moral Hazard and Risk Taking - A Safety Net Game Experiment
    by Tibor Neugebauer & Sascha Füllbrunn
  • 2010 Fatal Attraction? Access to Early Retirement and Mortality
    by Kuhn, Andreas & Wuellrich, Jean-Philippe & Zweimüller, Josef
  • 2010 The effect of competition on process and outcome quality of hospital care: An empirical analysis for the Netherlands
    by Michiel Bijlsma & Pierre Koning & Victoria Shestalova & Ali Aouragh
  • 2010 Can Markets Save Lives? An Experimental Investigation of a Market for Organ Donations
    by Cary Deck & Erik O. Kimbrough
  • 2010 Does Hospital Competition Save Lives? Evidence from the English NHS Patient Choice Reforms
    by Zack Cooper & Steve Gibbons & Simon Jones & Alistair McGuire
  • 2010 The Impact of the New Rural Cooperative Medical Scheme on Activities and Financing of Township Hospitals in Weifang, China
    by Xiao Xian HUANG & Aurore PELISSIER & Jacky MATHONNAT & Martine AUDIBERT & Anning MA
  • 2010 Impact of Income Inequality on Health: Does Environment Quality Matter?
    by Alassane DRABO
  • 2010 Child height, health and human capital: evidence using genetic markers
    by Stephanie von Hinke Kessler Scholder & George Davey Smith & Debbie A. Lawlor & Carol Propper & Frank Windmeijer
  • 2010 Housing wealth or economic climate: Why do house prices matter for well-being?
    by Anita Ratcliffe
  • 2010 Genetic Markers as Instrumental Variables:An Application to Child Fat Mass and Academic Achievement
    by Stephanie von Hinke Kessler Scholder & George Davey Smith & Debbie A. Lawlor & Carol Propper & Frank Windmeijer
  • 2010 Health and Retirement Effects in a Collective Consumption Model of Older Households
    by Aline Bütikofer & Arthur Lewbel & Shannon Seitz
  • 2010 Adopting New Technologies in the Classroom
    by Pedro Gomis Porqueras & José A. Rodrigues-Neto
  • 2010 Analysis of Patients' Preferences: Direct Assessment and Discrete-Choice Experiment in Therapy of Adults with Attention-Deficit Hyperactivity Disorder
    by Axel C. Mhlbacher & Matthias Nbling
  • 2010 Using Best-Worst Scaling Choice Experiments to Measure Public Perceptions and Preferences for Healthcare Reform in Australia
    by Jordan J. Louviere & Terry N. Flynn
  • 2010 Adaptive Choice-Based Conjoint Analysis: A New Patient-Centered Approach to the Assessment of Health Service Preferences
    by Charles E. Cunningham & Ken Deal & Yvonne Chen
  • 2010 Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008
    by Deborah Marshall & John F.P. Bridges & Brett Hauber & Ruthanne Cameron & Lauren Donnalley & Ken Fyie & F. Reed. Johnson
  • 2010 Multi-Criteria Clinical Decision Support: A Primer on the Use of Multiple-Criteria Decision-Making Methods to Promote Evidence-Based, Patient-Centered Healthcare
    by James G. Dolan
  • 2010 Patient Preferences and Linear Scoring Rules for Patient-Reported Outcomes
    by Ateesha F. Mohamed & A. Brett. Hauber & F. Reed. Johnson & Cheryl D. Coon
  • 2010 Feasibility of Using Modified Adaptive Conjoint Analysis Importance Questions
    by Liana Fraenkel
  • 2010 Deborah Marshall, PhD: An Advocate for Patient-Centered Research
    by Rebecca L. Hancock-Howard
  • 2010 Quality of Life in Restless Legs Syndrome: A Systematic Review of Clinical Trials and a Critical Review of Instruments
    by Jane Speight & Ana Howarth
  • 2010 Electronic Patient Diaries and Questionnaires - ePRO Now Delivering on the Promise?
    by Brian Tiplady
  • 2010 Technology, Reform, and Personal Medical Care
    by Norman Makous
  • 2010 Patient Views on Determinants of Compliance with Tuberculosis Treatment in the Eastern Cape, South Africa: An Application of Q-Methodology
    by Jane Murray. Cramm & Job van Exel & Valerie Mller & Harry Finkenflgel
  • 2010 Towards Patient-Centered Care for Depression: Conjoint Methods to Tailor Treatment Based on Preferences
    by Marsha N. Wittink & Mark Cary & Thomas TenHave & Jonathan Baron & Joseph J. Gallo
  • 2010 Patient-Reported Outcomes in Rheumatoid Arthritis: Assessing the Equivalence of Electronic and Paper Data Collection
    by Brian Tiplady & Kirsteen Goodman & Geraldine Cummings & Dawn Lyle & Robert Carrington & Clare Battersby & Stuart H. Ralston
  • 2010 Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control
    by Robert A. Nathan & Anand A. Dalal & Richard H. Stanford & Eli O. Meltzer & Michael Schatz & Jennifer Derebery & Matthew Mintz & Michelle A. Thompson & Dana B. DiBenedetti
  • 2010 Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?
    by Deborah Marshall & S. Elizabeth McGregor & Gillian Currie
  • 2010 'New' Evidence for Clinical Practice Guidelines: Should we Search for 'Preference Evidence'?
    by Murray Krahn
  • 2010 Explorative Evaluation of the Impact of Premenstrual Disorder on Daily Functioning and Quality of Life
    by Lothar A.J. Heinemann & Thai Do Minh & Anna Filonenko & Kerstin Uhl-Hochgrber
  • 2010 Assessing Drug Treatment Preferences of Patients with Crohn's Disease: A Conjoint Analysis
    by Gary R. Lichtenstein & Heidi C. Waters & Jenna Kelly & Susan S. McDonald & Elaine L. Zanutto & David Hendricks & Mirza I. Rahman
  • 2010 Contemporary Adult Diabetes Mellitus Management Perceptions
    by William Corser & Catherine Lein & Margaret Holmes-Rovner & Ved Gossain
  • 2010 Effects of HIV Medication Complexity and Depression on Adherence to HIV Medication
    by Virender Kumar & William Encinosa
  • 2010 Development and Testing of the Insulin Treatment Experience Questionnaire (ITEQ)
    by Jrn Moock & Franz Hessel & Diana Ziegeler & Thomas Kubiak & Thomas Kohlmann
  • 2010 Pharmacological Rhythm and Rate Control Treatment for Atrial Fibrillation: Patient and Physician Satisfaction
    by Nils Edvardsson & Anders Westlund & Margareta Thimell & Karin Rise & Alexander Todoran & Tanja berg Kurn & John Kindblom & Olle Almgren
  • 2010 Is it Possible to Measure What Truly Matters? The Paradox of Clinical Audit in Developing Continence Service Standards for Older People
    by Patrick Brown & Jenny Billings & Adrian Wagg & Jonathan Potter
  • 2010 Assessing Preferences Regarding Healthcare Interventions that Involve Non-Health Outcomes: An Overview of Clinical Studies
    by Brent C. Opmeer & Corianne A.J.M. de Borgie & Ben W.J. Mol & Patrick M.M. Bossuyt
  • 2010 Cost Effectiveness of Darunavir/Ritonavir in Highly Treatment-Experienced, HIV-1-Infected Adults in the USA
    by Josephine Mauskopf & Anita Brogan & Silas Martin & Erik Smets
  • 2010 Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients: The POWER Experience
    by Andrew M. Hill & Bonaventura Clotet & Margaret Johnson & Matthias Stoll & Nicholas Bellos & Erik Smets
  • 2010 The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France
    by Xavier Colin & Antoine Lafuma & Dominique Costagliola & Jean-Marie Lang & Pascal Guillon
  • 2010 Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden
    by Ola Ghatnekar & Catharina Hjortsberg & Magnus Gissln & Stefan Lindbck & Mickael Lthgren
  • 2010 The Impact of Disease Stage on Direct Medical Costs of HIV Management: A Review of the International Literature
    by Adrian Levy & Karissa Johnston & Lieven Annemans & Andrea Tramarin & Julio Montaner
  • 2010 Modelling the Budget Impact of Darunavir in the Treatment of Highly Treatment-Experienced, HIV-Infected Adults in France
    by Xavier Colin & Antoine Lafuma & Dominique Costagliola & Erik Smets & Josephine Mauskopf & Pascal Guillon
  • 2010 Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era
    by Mark A. Boyd & Andrew M. Hill
  • 2010 Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts: Evidence from POWER
    by Andrew M. Hill & Kelly Gebo & Lindsay Hemmett & Mickael Lthgren & Gabriele Allegri & Erik Smets
  • 2010 Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK
    by Karen Moeremans & Lindsay Hemmett & Jonas Hjelmgren & Gabriele Allegri & Erik Smets
  • 2010 US Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, HIV-Infected Adults with Evidence of Protease Inhibitor Resistance Included in the TITAN Trial
    by Anita Brogan & Josephine Mauskopf & Sandra E. Talbird & Erik Smets
  • 2010 Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK
    by Karen Moeremans & Lieven Annemans & Mickael Lthgren & Gabriele Allegri & Veronique Wyffels & Lindsay Hemmet & Karin Caekelbergh & Erik Smets
  • 2010 A Review of Economic Evaluations of Darunavir Boosted by Low-Dose Ritonavir in Treatment-Experienced Persons Living with HIV Infection
    by Josephine Mauskopf & Lieven Annemans & Andrew M. Hill & Erik Smets
  • 2010 The Authors' Reply
    by Laura McCullagh & Lesley Tilson & Cathal Walsh & Michael Barry
  • 2010 The Authors' Reply
    by Alok Kapoor & Nila Radhakrishnan & Kenneth J. Smith
  • 2010 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:: A Systematic Review
    by Jonathan M. Plumb & Andreas Clemens & Brigitta U. Monz
  • 2010 An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus
    by W. Robert. Simons & Michael A. Hagan
  • 2010 Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
    by Tatia Chay. Woodward & Eskinder Tafesse & Peter Quon & Arthur Lazarus
  • 2010 A New Method for Examining the Cost Savings of Reducing COPD Exacerbations
    by Douglas W. Mapel & Michael Schum & Eva Lydick & Jeno P. Marton
  • 2010 Frequency of Treatment-Effect Modification Affecting Indirect Comparisons: A Systematic Review
    by Michael Coory & Susan Jordan
  • 2010 Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider
    by Terry N. Flynn
  • 2010 The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods
    by Simon Eckermann & Jon Karnon & Andrew R. Willan
  • 2010 Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome
    by Kate McKeage & Katherine A. Lyseng-Williamson
  • 2010 Economic Burden of Epilepsy among the Privately Insured in the US
    by Jasmina I. Ivanova & Howard G. Birnbaum & Yohanne Kidolezi & Ying Qiu & David Mallett & Sue Caleo
  • 2010 Assessing the Relationship between Computational Speed and Precision: A Case Study Comparing an Interpreted versus Compiled Programming Language using a Stochastic Simulation Model in Diabetes Care
    by Phil McEwan & Klas Bergenheim & Yong Yuan & Anthony P. Tetlow & Jason P. Gordon
  • 2010 Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review
    by Jaume Puig-Junoy
  • 2010 Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review
    by Patricia R. Blank & Konstantin J. Dedes & Thomas D. Szucs
  • 2010 Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms
    by Joseph Golec & John A. Vernon
  • 2010 Time for Cooperation in Health Economics among the Modelling Community
    by Rene J.G. Arnold & Sean Ekins
  • 2010 Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial
    by Edward C.F. Wilson & David Price & Stanley D. Musgrave & Erika J. Sims & Lee Shepstone & Jamie Murdoch & H. Miranda. Mugford & Annie Blyth & Elizabeth F. Juniper & Jon G. Ayres & Stephanie Wolfe & Daryl Freeman & Richard F.T. Gilbert & Elizabeth V. Hillyer & Ian Harvey
  • 2010 Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy: A Pragmatic Trial
    by Edward C.F. Wilson & Erika J. Sims & Stanley D. Musgrave & Lee Shepstone & Annie Blyth & Jamie Murdoch & H. Miranda. Mugford & Elizabeth F. Juniper & Jon G. Ayres & Stephanie Wolfe & Daryl Freeman & Richard F.T. Gilbert & Ian Harvey & Elizabeth V. Hillyer & David Price
  • 2010 Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma
    by Arthur S. Zbrozek & Gary Hudes & Donna Levy & Andrew Strahs & Anna Berkenblit & Robert DeMarinis & Shreekant Parasuraman
  • 2010 Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia: A Decision Model
    by Jack Brown & Joseph A. Paladino
  • 2010 The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study
    by Jihyung Hong & Catherine Reed & Diego Novick & Josep Maria. Haro & Frank Windmeijer & Martin Knapp
  • 2010 The State of Health Economic Evaluation Research in Nigeria: A Systematic Review
    by Paul Gavaza & Karen L. Rascati & Abiola O. Oladapo & Star Khoza
  • 2010 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement: A Systematic Review
    by Alok Kapoor & Warren Chuang & Nila Radhakrishnan & Kenneth J. Smith & Dan Berlowitz & Jodi B. Segal & Jeffrey N. Katz & Elena Losina
  • 2010 Does the Inclusion of a Cost Attribute Result in Different Preferences for the Surgical Treatment of Primary Basal Cell Carcinoma?: A Comparison of Two Discrete-Choice Experiments
    by Brigitte A.B. Essers & Debby van Helvoort-Postulart & Martin H. Prins & Martino Neumann & Carmen D. Dirksen
  • 2010 Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
    by Stephanie R. Earnshaw & Cheryl L. McDade & Libby K. Black & Christopher F. Bell & Michael W. Kattan
  • 2010 Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    by Roisin Adams & Cathal Walsh & Douglas Veale & Barry Bresnihan & Oliver FitzGerald & Michael Barry
  • 2010 Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?
    by Lesley Chim & Patrick J. Kelly & Glenn Salkeld & Martin R. Stockler
  • 2010 Methodological Concerns with Economic Evaluations of Meningococcal Vaccines
    by Teresa L. Kauf
  • 2010 Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal
    by Adrian Bagust & Janette Greenhalgh & Angela Boland & Nigel Fleeman & Claire McLeod & Rumona Dickson & Yenal Dundar & Christine Proudlove & Richard Shaw
  • 2010 Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs
    by D. Clay. Ackerly & Seth W. Glickman & Kevin A. Schulman
  • 2010 Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer's Disease: A UK Evaluation Using Discrete-Event Simulation
    by Denis Getsios & Steve Blume & K. Jack. Ishak & Grant D.H. Maclaine
  • 2010 Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US
    by Crystal Pike & Howard G. Birnbaum & Matt Schiller & Hari Sharma & Russel Burge & Eric T. Edgell
  • 2010 Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory Setting
    by Richard Dodel & Svenja Happe & Ines Peglau & Geert Mayer & Jrgen Wasem & Jens-Peter Reese & Guido Giani & Max Geraedts & Claudia Trenkwalder & Wolfgang H. Oertel & Karin Stiasny-Kolster
  • 2010 Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature
    by Huseyin Naci & Rachael Fleurence & Julie Birt & Amy Duhig
  • 2010 Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal
    by Mark Rodgers & Susan Griffin & Mike Paulden & Russell Slack & Steven Duffy & John R. Ingram & Nerys Woolacott & Mark Sculpher
  • 2010 Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally
    by Mark Sculpher
  • 2010 Towards More Consistent Use of Generic Quality-of-Life Instruments
    by Mattias Neyt
  • 2010 Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
    by Jeroen P. Jansen & Sabine Gaugris & Ernest H. Choy & Andrew Ostor & Julian T. Nash & Wiro Stam
  • 2010 Pharmacoeconomic Evaluation in Ireland: A Review of the Process
    by Lesley Tilson & Aisling OLeary & Cara Usher & Michael Barry
  • 2010 Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis
    by Rachael L. Fleurence & D. Eldon. Spackman & Christopher Hollenbeak
  • 2010 Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review
    by William A. Prescott & Fred Doloresco & Jack Brown & Joseph A. Paladino
  • 2010 A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
    by Jean-Eric Tarride & Robert Hopkins & Gord Blackhouse & James M. Bowen & Matthias Bischof & Camilla Von Keyserlingk & Daria OReilly & Feng Xie & Ron Goeree
  • 2010 Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation
    by Gillian M. Keating & Katherine A. Lyseng-Williamson
  • 2010 Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding
    by Alan N. Barkun & Viviane Adam & Joseph J.Y. Sung & Ernst J. Kuipers & Joachim Mossner & Dennis Jensen & Robert Stuart & James Y. Lau & Emma Naucler & Jan Kilhamn & Helena Granstedt & Bengt Liljas & Tore Lind
  • 2010 Estimation of a Valuation Function for a Diabetes Mellitus-Specific Preference-Based Measure of Health: The Diabetes Utility Index�
    by Murali Sundaram & Michael J. Smith & Dennis A. Revicki & Lesley-Ann Miller & Suresh Madhavan & Gerry Hobbs
  • 2010 The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK
    by Agnes Benedict & Lara Verdian & Grant Maclaine
  • 2010 Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the US
    by John F.P. Bridges & Eberechukwu Onukwugha & C. Daniel. Mullins
  • 2010 Measuring Quality of Life for Certain Events versus Pre-Specified Points in Time
    by Mattias Neyt
  • 2010 Can't Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products
    by Adrian Towse & Louis P. Garrison
  • 2010 Access with Evidence Development in the UK: Past Experience, Current Initiatives and Future Potential
    by Andrew Briggs & Karen Ritchie & Elisabeth Fenwick & Kalipso Chalkidou & Peter Littlejohns
  • 2010 Access with Evidence Development: The US Experience
    by Penny E. Mohr & Sean R. Tunis
  • 2010 Access with Evidence Development Schemes: A Framework for Description and Evaluation
    by Christopher J. McCabe & Tania Stafinski & Richard Edlin & Devidas Menon
  • 2010 Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems
    by Tania Stafinski & Christopher J. McCabe & Devidas Menon
  • 2010 Principles of Design of Access with Evidence Development Approaches: A Consensus Statement from the Banff Summit
    by Devidas Menon & Christopher J. McCabe & Tania Stafinski & Richard Edlin
  • 2010 We Know Accurately Only When We Know Little
    by Stuart MacLeod & Craig Mitton
  • 2010 Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer
    by Katherine A. Lyseng-Williamson
  • 2010 Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US
    by Virginia M. Rosen & Douglas C.A. Taylor & Hemangi Parekh & Ankur Pandya & David Thompson & Andreas Kuznik & David D. Waters & Michael Drummond & Milton C. Weinstein
  • 2010 Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation
    by Eric Deconinck & Houda Miadi-Fargier & Claude Le. Pen & Pauline Brice
  • 2010 The Cost and Incidence of Prescribing Errors Among Privately Insured HIV Patients
    by Fred J. Hellinger & William E. Encinosa
  • 2010 Adverse Drug Interactions: Moving from Perception to Action
    by Ryan Mayhew & June M. McKoy & Thanh Ha Luu & Isaac Lopez & Melissa Frick & Charles L. Bennett
  • 2010 Should Financial Incentives be Used to Differentially Reward 'Me-Too' and Innovative Drugs?
    by Brita Pekarsky
  • 2010 The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect in Symptomatic Knee Cartilage Lesions in Belgium
    by Laetitia Gerlier & Mark Lamotte & Micheline Wille & Peter C. Kreuz & Johan Vanlauwe & Dominique Dubois & Franois M. Meurgey
  • 2010 Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance
    by Klaus Kaier & Uwe Frank
  • 2010 A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States
    by Ifigeneia Mavranezouli
  • 2010 Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices
    by Lizheng Shi & Jinan Liu & Yordanka Koleva & Vivian Fonseca & Anupama Kalsekar & Manjiri Pawaskar
  • 2010 The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments
    by Andrea Manca & Mark J. Sculpher & Ron Goeree
  • 2010 The Economics of a 'Liberated' NHS
    by Nancy J. Devlin
  • 2010 Is There a Role for Pharmacoeconomics in Developing Countries?
    by Babar Zaheer-Ud-Din & Shane Scahill
  • 2010 Methods of Model Calibration: Observations from a Mathematical Model of Cervical Cancer
    by Douglas C.A. Taylor & Vivek Pawar & Denise Kruzikas & Kristen E. Gilmore & Ankur Pandya & Rowan Iskandar & Milton C. Weinstein
  • 2010 An Analysis of NICE's 'Restricted' (or 'Optimized') Decisions
    by Phill ONeill & Nancy J. Devlin
  • 2010 Evaluation of Benefit-Risk
    by Silvio Garattini
  • 2010 New Prescription for the Spanish Drug Sector: Fighting against Public Deficit without Wasting Ammunition
    by Fernando Antoanzas & Pedro Gmez
  • 2010 Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses: A Decision Tree Model
    by Edward C.F. Wilson
  • 2010 Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
    by Mario Eandi & Lorenzo Pradelli & Sergio Iannazzo & Silvia Chiroli & Giuseppe Pontoriero
  • 2010 Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
    by Teresa L. Kauf & Raymond A. Farkouh & Stephanie R. Earnshaw & Maria E. Watson & Penny Maroudas & Mike G. Chambers
  • 2010 Economic Implications of Sleep Disorders
    by Tracy L. Skaer & David A. Sclar
  • 2010 Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review
    by William B. Wong & Josh J. Carlson & Rahber Thariani & David L. Veenstra
  • 2010 Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials
    by C. Daniel. Mullins & Danielle Whicher & Emily S. Reese & Sean Tunis
  • 2010 No Head-to-Head Trial? Simulate the Missing Arms
    by J. Jaime. Caro & K. Jack. Ishak
  • 2010 There's a Reason They Call Them Dummy Variables: A Note on the Use of Structural Equation Techniques in Comparative Effectiveness Research
    by William H. Crown
  • 2010 Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
    by James E. Signorovitch & Eric Q. Wu & Andrew P. Yu & Charles M. Gerrits & Evan Kantor & Yanjun Bao & Shiraz R. Gupta & Parvez M. Mulani
  • 2010 Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs
    by Judith Cahill & Neal Learner
  • 2010 Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward
    by Adrian Thomas & Audrey Phillips & Robert Donnelly & Catherine Tak. Piech
  • 2010 Comparative Effectiveness Research: The View from a Pharmaceutical Company
    by Marc L. Berger & David Grainger
  • 2010 Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding?
    by Robert S. Epstein & J. Russell. Teagarden
  • 2010 Comparative Effectiveness Research and the Psychology of Medical Practice: The Vicissitudes of Knowledge Implementation
    by Jerome P. Kassirer & John B. Wong
  • 2010 Perspective and Desire in Comparative Effectiveness Research: The Relative Unimportance of Mere Preferences, the Central Importance of Context
    by Anthony J. Culyer
  • 2010 Comparative Effectiveness Regulations and Pharmaceutical Innovation
    by John A. Vernon & Joseph H. Golec & J. Stedman. Stevens
  • 2010 Cost-Effectiveness Analysis in Markets with High Fixed Costs
    by David M. Cutler & Keith M. Marzilli. Ericson
  • 2010 Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research: Strangers, Bedfellows or Strange Bedfellows?
    by Louis P. Garrison
  • 2010 The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research
    by David Meltzer & Anirban Basu & Rena Conti
  • 2010 Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia: South Korea, Taiwan, Thailand and Japan
    by Isao Kamae
  • 2010 International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US
    by Adrian R. Levy & Craig Mitton & Karissa M. Johnston & Brian Harrigan & Andrew H. Briggs
  • 2010 Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS: Past, Present and Future
    by Kalipso Chalkidou & Tom Walley
  • 2010 Perspectives on Comparative Effectiveness Research: Views from Diverse Constituencies
    by Dave Nellesen & Howard G. Birnbaum & Paul E. Greenberg
  • 2010 Introducing Perspectives on Comparative Effectiveness Research
    by Howard G. Birnbaum & Paul E. Greenberg
  • 2010 Cost Effectiveness of Establishing a Neonatal Screening Programme for Phenylketonuria in Libya
    by Erikas Sladkevicius & Rodney J. Pollitt & Ali Mgadmi & Julian F. Guest
  • 2010 Catastrophic Healthcare Payments and Impoverishment in the Occupied Palestinian Territory
    by Awad Mataria & Firas Raad & Mohammad Abu-Zaineh & Cam Donaldson
  • 2010 The Use of Research Abstracts in Formulary Decision Making by the Joint Oncology Drug Review of Canada
    by Adam V. Weizman & Josh Griesman & Chaim M. Bell
  • 2010 Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa) in Sweden
    by Michael Willis & Ulf Persson & York Zoellner & Birgit Gradl
  • 2010 Reforming the English NHS: A Continuing Journey
    by Karen Bloor & Alan Maynard
  • 2010 The Missing Technology: An International Comparison of Human Capital Investment in Healthcare
    by Bianca K. Frogner
  • 2010 Critique of an Economic Evaluation Using the Drummond Checklist
    by Christopher M. Doran
  • 2010 Economic Efficiency of Alcohol Policy
    by Christopher M. Doran & Thameemul A. Jainullabudeen
  • 2010 Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe
    by Alain Denis & Lut Mergaert & Christel Fostier & Irina Cleemput & Steven Simoens
  • 2010 Cost Effectiveness of Long-Acting Risperidone in Sweden
    by Marja Hensen & Bart Heeg & Mickael Lthgren & Ben van Hout
  • 2010 Cost of Illness and Drivers of Cost in Atrial Fibrillation in Sweden and Germany
    by Linus Jnsson & sa Eliasson & John Kindblom & Olle Almgren & Nils Edvardsson
  • 2010 Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007
    by Javier Orofino & Javier Soto & Miguel A. Casado & Itziar Oyagez
  • 2010 Burden and Cost of Hospital Admissions for Vaccine-Preventable Paediatric Pneumococcal Disease and Non-Typable Haemophilus influenzae Otitis Media in New Zealand
    by Richard J. Milne & Stephen Vander Hoorn
  • 2010 Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada
    by Sandra L. Tunis & Luc Sauriol & Michael E. Minshall
  • 2010 Costs and Consequences of Clopidogrel versus Aspirin for Secondary Prevention of Ischaemic Events in (High-Risk) Atherosclerotic Patients in Sweden: A Lifetime Model Based on the CAPRIE Trial and High-Risk CAPRIE Subpopulations
    by J. Floris S. Logman & Bart M.S. Heeg & Johan Herlitz & Ben A. van Hout
  • 2010 Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] Questionnaire: Reliability and Validity among Singaporeans with Type 2 Diabetes Mellitus
    by Swee Sung. Soon & Su Yen. Goh & Yong Mong. Bee & Jiat Ling. Poon & Shu Chuen. Li & Julian Thumboo & Hwee Lin. Wee
  • 2010 The Effect of Protest Zeros on Estimates of Willingness to Pay in Healthcare Contingent Valuation Analysis
    by William M. Fonta & H. Eme. Ichoku & Jane Kabubo-Mariara
  • 2010 Oncologist Preferences for Health States Associated with the Treatment of Advanced Ovarian Cancer
    by Lisa M. Hess & Daniel C. Malone & Grant H. Skrepnek & Pamela G. Reed & Edward Armstrong & Stephen Joel. Coons
  • 2010 Gary Buurman, 1944-2010
    by Stuart Birks
  • 2010 A Systematic Data Review of the Cost of Rehydration Therapy
    by Jay Pershad
  • 2010 Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany
    by Thilo M. Schaufler & Malte Wolff
  • 2010 Productivity Loss Resulting from Coronary Heart Disease in Australia
    by Henry Zheng & Fred Ehrlich & Janaki Amin
  • 2010 Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Programme
    by Ying Qiu & Alex Z. Fu & Gordon G. Liu & Dale B. Christensen
  • 2010 Public Option and Private Profits: What do Markets Expect?
    by Fabio Milani
  • 2010 Cost Effectiveness of CT Colonography for UK NHS Colorectal Cancer Screening of Asymptomatic Adults Aged 60-69 Years
    by David Lee & Dominic Muston & Alison Sweet & Chris Cunningham & Andrew Slater & Kevin Lock
  • 2010 Willingness to Pay for Maternal Health Outcomes: Are Women Willing to Pay More than Men?
    by Laura Ternent & Paul McNamee & David Newlands & Danielle Belemsaga & Adjima Gbangou & Suzanne Cross
  • 2010 Health System Choice: A Pilot Discrete-Choice Experiment Eliciting the Preferences of British and Australian Citizens
    by Paul A. Scuffham & Jennifer A. Whitty & Matthew Taylor & Ruth C. Saxby
  • 2010 Do Reduced Inpatient Costs Associated with Highly Active Antiretroviral Therapy (HAART) Balance the Overall Cost for HIV Treatment?
    by Paul G. Farnham
  • 2010 Cost-Effectiveness Analysis of Treatments for Premenstrual Dysphoric Disorder
    by Regina Rendas-Baum & Min Yang & Joseph Gricar & Gene V. Wallenstein
  • 2010 Organization and Estimated Patient-Borne Costs of Oral Anticoagulation Therapy in Italy: Results from a Survey
    by Lorenzo Pradelli & Sergio Iannazzo & Orietta Zaniolo & Paola Botrugno
  • 2010 Outpatient Medication Costs of Patients with Cystic Fibrosis in Germany
    by Daniela Eidt-Koch & Thomas O.F. Wagner & Thomas Mittendorf & J.-Matthias Graf von der Schulenburg
  • 2010 The Authors' Reply
    by George Dranitsaris & Sanjay Mehta
  • 2010 Ongoing Pharmaceutical Reforms in France: Implications for Key Stakeholder Groups
    by Catherine Sermet & Veronique Andrieu & Brian Godman & Eric Van Ganse & Alan Haycox & Jean-Pierre Reynier
  • 2010 Oral Therapies for the Treatment of Pulmonary Arterial Hypertension: a Population-Based Cost-Minimization Analysis
    by Marie-Claude Lefebvre & Elke Hunsche
  • 2010 Healthcare Costs in Renal Transplant Recipients Using Branded versus Generic Ciclosporin
    by J. Harold. Helderman & Ning Kang & Antonio P. Legorreta & Judy Y. Chen
  • 2010 Inpatient Costs of Endophthalmitis Evaluated for the Whole of France
    by Xavier Colin & Gilles Berdeaux & Antoine Lafuma & Annie Salvanet-Bouchara & Laurent Kodjikian
  • 2010 Analytical Strategies for Characterizing Chemotherapy Diffusion with Patient-Level Population-Based Data
    by Cami S. Sima & Katherine S. Panageas & Glenn Heller & Deborah Schrag
  • 2010 Is the Societal Approach Wide Enough to Include Relatives?: Incorporating Relatives' Costs and Effects in a Cost-Effectiveness Analysis
    by Thomas Davidson & Lars-ke Levin
  • 2010 Considering the Value Associated with Innovation in Health Technology Appraisal Decisions (Deliberations): A NICE Thing to do?
    by Colin Green
  • 2010 A Covariance Structure Analysis of the Intrafamilial Effects of Well-Being: the Case of Antioquia (Colombia), 2003
    by Liliana María Gallego
  • 2010 Millennium Development Goals and Infant Mortality in India: A Distant Dream or a Reality
    by Asima Sahu & Subhalaxmi Mohapatra
  • 2010 Abolishing poverty: the history and significance of the North American Guaranteed Annual Income Social Experiments
    by Evelyn Forget
  • 2010 Análisis del Sistema Sanitario de Euskadi
    by Jon Iñaki Betolaza San Miguel
  • 2010 Does governance matter in the fight against hiv/aids epidemic? evidence from cross-country analysis
    by LEANDRE BASSOLE
  • 2010 A comparative assessment of mortality among the widowers and widows in Taiwan
    by Shu-Hsi Ho & Wen-Shai Hung
  • 2010 Value Elicitation using BDM and a Discrete Choice Mechanism
    by Jutta Roosen & Stephan Marette & Sandrine Blanchemanche
  • 2010 Threshold Effects in Cigarette Addiction: An Application of the Threshold Model in Dynamic Panels
    by Yi-Chi Chen & Chang-Ching Lin
  • 2010 Mind the Weather: A Panel Data Analysis of Time-Invariant Factors and Traffic Fatalities
    by Pavel A. Yakovlev & Margaret Inden
  • 2010 Spurious correlation in estimation of the health production function: A note
    by Sule Akkoyunlu & Frank R. Lichtenberg & Boriss Siliverstovs & Peter Zweifel
  • 2010 Income inequality and health status: role of institutions quality
    by Alassane Drabo
  • 2010 Are Hospital Pharmacies More Efficient if They Employ Nurses?
    by Daniel L. Friesner & Matthew Q. McPherson & Robert Rosenman
  • 2010 Do institutions, inequality and cultural differences affect cadaveric versus live-kidney harvesting?
    by Nejat Anbarci & Mustafa Caglayan
  • 2010 Scheidungskinder rauchen mehr
    by Marco Francesconi & Stephen P. Jenkins & Quirin Schimeta & Thomas Siedler
  • 2010 Health, Taxes, and Growth
    by Liutang Gong & Hongyi Li & Dihai Wang & Heng-fu Zou
  • 2010 Los efectos intrafamiliares del bienestar: aplicación de un modelo de estructura de covarianza al caso de Antioquia, 2003
    by Gallego, Liliana María
  • 2010 Comportement du consommateur face à un risque endogène immédiat
    by Gildas Appéré & Frédéric Dupont & Muriel Travers
  • 2010 The Private Health Insurance Market In The European Union
    by Bianca Mihart Ph. D Student
  • 2010 An Econometric model for the evolution of the Romanian Interbank Bid Rate (ROBID) in the context of the international financial crisis
    by Zapodeanu Daniela Author & Cociuba Mihail-Ioan
  • 2010 Electronic Medical Record - Success Or Failure In The Medical Decision From The Romanian Health System ?
    by Assist. Adina Bălan Ph. D
  • 2009 Chaos and Organization in Health Care
    by Thomas H. Lee & James J. Mongan
  • 2009 La demanda de alcohol entre los jóvenes españoles desde una perspectiva de género
    by Gil Lacruz, Ana Isabel
  • 2009 Can Health Foreign Assistance Break the Medical Brain Drain?
    by Moullan, Yasser
  • 2009 Genetic Markers as Instrumental Variables: An Application to Child Fat Mass and Academic Achievement
    by von Hinke Kessler Scholder S
  • 2009 Catching the habit: a study of inequality of opportunity in smoking-related mortality
    by Balia S & Jones A.M
  • 2009 Re-visiting the Health Care Luxury Good Hypothesis: Aggregation, Precision, and Publication Biases?
    by Costa-Font, J & Gemmill M & Rubert G
  • 2009 The Costs of a Quiet Disorder: Direct and Indirect Costs of Idiopathic Intracranial Hypertension
    by Daniel Friesner & Robert Rosenman & Brenna Lobb & Emanuel Tanne
  • 2009 The Public Finance of Healthy Behavior
    by Robert Rosenman
  • 2009 Participation in Universal Prevention Programs
    by Robert Rosenman & Scott Goates & Laura Hill
  • 2009 Weak IPR and Imitation in the South and International Exhaustion of Patent Rights in the North for Innovated Drugs: A Policy Game
    by Rajat Acharyya & Maria D.C. Garcia-Alonso
  • 2009 Health Systems, Inequality and Incentives to Innovate
    by Rajat Archaryya & María del Carmen García-Alonso
  • 2009 Horizontal Inequity in Access to Health Care in Four South American Cities
    by Ana Balsa & Máximo Rossi & Patricia Triunfo
  • 2009 Why Are Ghettos Bad? Examining the Role of the Metropolitan Educational Environment
    by Robert Bifulco & Delia Furtado & Stephen L. Ross
  • 2009 Are Drinkers Prone To Engage In Risky Sexual Behaviors?
    by Gil-Lacruz, Ana Isabel & Gil Lacruz, Marta & Oliva Moreno, Juan
  • 2009 Fiscal incidence analysis: Healthcare
    by Alex van Den Heever
  • 2009 Estimating Welfare in Insurance Markets Using Variation in Prices
    by Mark Cullen & Liran Einav & Amy Finkelstein
  • 2009 Bednets, Information and Malaria in Orissa
    by Brian Blackburn & Aprajit Mahajan & Alessandro Tarozzi & Joanne Yoong
  • 2009 It’s driving her mad: gender differences in the effects of commuting on psychological well-being
    by Jennifer Roberts & Robert Hodgson & Paul Dolan
  • 2009 The Relationship between Stress and Social Capital among Police Officers
    by Martin Gächter & David Savage & Benno Torgler
  • 2009 Taxes, Health Insurance and Women's Self-Employment
    by Velamuri, Malathi
  • 2009 The Impact of Health Card Program on Access to Reproductive Health Services: An Indonesian Experience
    by Landiyanto, Erlangga Agustino
  • 2009 Parallel imports, drug innovation and international patent protection: a policy game
    by Acharyya, Rajat & Garcia-Alonso, Maria
  • 2009 Geoadditive latent variable modelling of count data on multiple sexual partnering in Nigeria
    by Adebayo, Samson B. & Fahrmeir, Ludwig & Seiler, Christian
  • 2009 Agricultural productivity and mortality: evidence from Kagera, Tanzania
    by Ikegami, Munenobu
  • 2009 Poverty and Health in India: A Comparative Study about Pre-Reform and Post-Reform Periods
    by sarvalingam, a & sivakumar, marimuthu
  • 2009 28th out of 30: Poor medicine and unhealthy Americans
    by Fullbrook, Edward
  • 2009 Performance and Congestion Analysis of the Portuguese Hospital Services
    by Simões, Pedro & Cunha Marques, Rui
  • 2009 Taxes, Health Insurance and Women’s Self-Employment
    by Velamuri, Malathi
  • 2009 Short run and long run dynamics of impact of health status on economic growth Evidence from Pakistan
    by Akram, Naeem
  • 2009 Strategy at the crossroads: The case of the navy hospital ships
    by Webb, Natalie J & Richter, Anke
  • 2009 Health care expenditure and GDP: An international panel smooth transition approach
    by Chakroun, Mohamed
  • 2009 Hopping on the Methadone Bus
    by Lippert, Steffen & Schumacher, Christoph
  • 2009 Endogenous fertility, endogenous lifetime and economic growth: the role of health and child policies
    by Luciano Fanti & Luca Gori
  • 2009 The Long-Term Care Workforce: Overview and Strategies to Adapt Supply to a Growing Demand
    by Rie Fujisawa & Francesca Colombo
  • 2009 Towards a Framework for Assessing Family Policies in the EU
    by Henning Lohmann & Frauke H. Peter & Tine Rostgaard & Katharina Spiess
  • 2009 Health-Care Reform in Japan: Controlling Costs, Improving Quality and Ensuring Equity
    by Randall S. Jones
  • 2009 System Size, Lock-in and Network Effects for Patient Records
    by Catherine Tucker & Amalia Miller
  • 2009 The Effects of Product Liability Exemption in the Presence of the FDA
    by Tomas J. Philipson & Eric C. Sun & Dana Goldman
  • 2009 Is a WIC Start a Better Start? Evaluating WIC’s Impact on Infant Health Using Program Introduction
    by Hilary W. Hoynes & Marianne E. Page & Ann Huff Stevens
  • 2009 An Economic Evaluation of the War on Cancer
    by Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman
  • 2009 The Impact of Minimum Wage Rates on Body Weight in the United States
    by David O. Meltzer & Zhuo Chen
  • 2009 Accidental Death and the Rule of Joint and Several Liability
    by Daniel Carvell & Janet Currie & W. Bentley MacLeod
  • 2009 The Welfare Effects of Medical Malpractice Liability
    by Darius N. Lakdawalla & Seth A. Seabury
  • 2009 Insurer Bargaining and Negotiated Drug Prices in Medicare Part D
    by Darius Lakdawalla & Wesley Yin
  • 2009 Induced Innovation and Social Inequality: Evidence from Infant Medical Care
    by David M. Cutler & Ellen Meara & Seth Richards
  • 2009 The Effect of Maternal Depression and Substance Abuse on Child Human Capital Development
    by Richard G. Frank & Ellen Meara
  • 2009 Variance in Death and Its Implications for Modeling and Forecasting Mortality
    by Shripad Tuljapurkar & Ryan D. Edwards
  • 2009 Estimating Causal Effects of Early Occupational Choice on Later Health: Evidence Using the PSID
    by Jason M. Fletcher & Jody L. Sindelar
  • 2009 The Impact of Job Stress on Smoking and Quitting: Evidence from the HRS
    by Padmaja Ayyagari & Jody L. Sindelar
  • 2009 Effects of Venue-Specific State Clean Indoor Air Laws on Smoking-Related Outcomes
    by Marianne P. Bitler & Christopher Carpenter & Madeline Zavodny
  • 2009 Low Life Expectancy in the United States: Is the Health Care System at Fault?
    by Samuel H. Preston & Jessica Y. Ho
  • 2009 The Effect of OEF/OIF Deployment Intensity on the Rate of Posttraumatic Stress Disorder Among Active Duty Population
    by Yu-Chu Shen & Jeremy Arkes & Boon Wah Kwan & Lai Yee Tan & Thomas V. Williams
  • 2009 Does Health Insurance Make You Fat?
    by Jay Bhattacharya & Kate Bundorf & Noemi Pace & Neeraj Sood
  • 2009 Federal Life Sciences Funding and University R&D
    by Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood
  • 2009 Medical Licensing Board Characteristics and Physician Discipline: An Empirical Analysis
    by Marc T. Law & Zeynep K. Hansen
  • 2009 Tobacco Use, Taxation and Self Control in Adolescence
    by Jason M. Fletcher & Partha Deb & Jody L. Sindelar
  • 2009 Sin Taxes: Do Heterogeneous Responses Undercut Their Value?
    by Padmaja Ayyagari & Partha Deb & Jason Fletcher & William T. Gallo & Jody L. Sindelar
  • 2009 Job Loss: Eat, drink and try to be merry?
    by Partha Deb & William T. Gallo & Padmaja Ayyagari & Jason M. Fletcher & Jody L. Sindelar
  • 2009 Cumulative Effects of Job Characteristics on Health
    by Jason M. Fletcher & Jody L. Sindelar & Shintaro Yamaguchi
  • 2009 Obesity, Self-esteem and Wages
    by Naci H. Mocan & Erdal Tekin
  • 2009 Food Prices and the Dynamics of Body Weight
    by Dana Goldman & Darius Lakdawalla & Yuhui Zheng
  • 2009 Censored Quantile Instrumental Variable Estimates of the Price Elasticity of Expenditure on Medical Care
    by Amanda E. Kowalski
  • 2009 The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
    by Frank R. Lichtenberg
  • 2009 Economic Contextual Factors and Child Body Mass Index
    by Lisa M. Powell & Frank J. Chaloupka
  • 2009 Why Do Mothers Breastfeed Girls Less Than Boys? Evidence and Implications for Child Health in India
    by Seema Jayachandran & Ilyana Kuziemko
  • 2009 Physical Activity: Economic and Policy Factors
    by Melayne M. McInnes & Judith A. Shinogle
  • 2009 Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
    by Anupam Jena & Tomas Philipson
  • 2009 Direct and Indirect Effects of Teenage Body Weight on Adult Wages
    by Euna Han & Edward C. Norton & Lisa M. Powell
  • 2009 Differences in the U.S. Trends in the Prevalence of Obesity Based on Body Mass Index and Skinfold Thickness
    by Richard V. Burkhauser & John Cawley & Maximilian D. Schmeiser
  • 2009 Impact of "Seguro Popular" on Prenatal Visits in Mexico, 2002-2005: Latent Class Model of Count Data with a Discrete Endogenous Variable
    by Jeffrey E. Harris & Sandra G. Sosa-Rubi
  • 2009 Effects of Weight on Adolescent Educational Attainment
    by Robert Kaestner & Michael Grossman & Benjamin Yarnoff
  • 2009 Studying the Child Obesity Epidemic With Natural Experiments
    by Robert Sandy & Gilbert Liu & John Ottensmann & Rusty Tchernis & Jeffrey Wilson & O.T. Ford
  • 2009 Food Stamp Program and Consumption Choices
    by Neeraj Kaushal & Qin Gao
  • 2009 Outcomes in a Program that Offers Financial Rewards for Weight Loss
    by John Cawley & Joshua A. Price
  • 2009 The Relationship Between Neighborhood Quality and Obesity Among Children
    by Bisakha Sen & Stephen Mennemeyer & Lisa C. Gary
  • 2009 Where Does the Wage Penalty Bite?
    by Christian A. Gregory & Christopher J. Ruhm
  • 2009 Welfare Spending and Mortality Rates for the Elderly Before the Social Security Era
    by Adrian Stoian & Price V. Fishback
  • 2009 Education and the Prevalence of Pain
    by Steven J. Atlas & Jonathan S. Skinner
  • 2009 The Long Term Consequences of Famine on Survivors: Evidence from a Unique Natural Experiment using China's Great Famine
    by Xin Meng & Nancy Qian
  • 2009 Technology Diffusion and Productivity Growth in Health Care
    by Jonathan Skinner & Douglas Staiger
  • 2009 Coping with Chronic Disease? Chronic Disease and Disability in Elderly American Population 1982-1999
    by Gabriel Aranovich & Jay Bhattacharya & Alan M. Garber & Thomas E. MaCurdy
  • 2009 Changes in U.S. Hospitalization and Mortality Rates Following Smoking Bans
    by Kanaka D. Shetty & Thomas DeLeire & Chapin White & Jayanta Bhattacharya
  • 2009 Income and Health Spending: Evidence from Oil Price Shocks
    by Daron Acemoglu & Amy Finkelstein & Matthew J. Notowidigdo
  • 2009 The Effect of Fast Food Restaurants on Obesity and Weight Gain
    by Janet Currie & Stefano DellaVigna & Enrico Moretti & Vikram Pathania
  • 2009 Do Teenagers Respond to HIV Risk Information? Evidence from a Field Experiment in Kenya
    by Pascaline Dupas
  • 2009 Life Expectancy and Old Age Savings
    by Mariacristina De Nardi & Eric French & John Bailey Jones
  • 2009 Recent Trends in Height by Gender and Ethnicity in the US in Relation to Levels of Income
    by John Komlos
  • 2009 The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation
    by Guy David & Sara Markowitz & Seth Richards
  • 2009 Can Health Foreign Assistance Break the Medical Brain Drain ?
    by Yasser Moullan
  • 2009 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2008
    by Kari Wolkwitz & Carole Trippe
  • 2009 Using the MyPyramid Equivalents Database to Estimate MyPyramid Equivalents for the Third School Nutrition Dietary Assessment Study
    by Elizabeth Condon & Mary Kay Fox
  • 2009 A National Survey of Obesity Prevention Practices in Head Start
    by Robert C. Whitaker & Rachel A. Gooze & Cayce C. Hughes & Daniel M. Finkelstein
  • 2009 Reaching Those in Need: State Supplemental Nutrition Assistance Program Participation Rates in 2007
    by Karen E. Cunnyngham & Laura A. Castner
  • 2009 Direct Certification in the National School Lunch Program: State Implementation Progress
    by Dennis Ranalli & Edward Harper & Rosemary O'Connell & Jay Hirschman & Nancy Cole & Quinn Moore & Brandon Coffee-Borden
  • 2009 School Meals: Building Blocks for Healthy Children
    by Committee on Nutrition Standards for National School Lunch & Breakfast Programs of which Mary Kay Fox is a member
  • 2009 Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2008
    by Kari Wolkwitz & Carole Trippe
  • 2009 Publishing Nutrition Research: A Review of Epidemiologic Methods
    by Barbara Bruemmer & Jeffrey Harris & Phil Gleason & Carol J. Boushey & Patricia M. Sheean & Sujata Archer & Linda Van Horn
  • 2009 WIC Eligibles and Coverage, 1994-2007: Estimates of the Population of Women, Infants, and Children Eligible for WIC Benefits
    by Ed Harper & Jay Hirschman & James Mabli & Sandi Nelson & Kerianne Hourihan
  • 2009 Child and Adult Care Food Program (CACFP): Improper Payments Data Collection Pilot Project
    by Rhoda Cohen & Lara Hulsey & Stacie Feldman & Claudia Gentile & John Hall
  • 2009 WIC Eligibles and Coverage, 1994-2007: Estimates of the Population of Women, Infants, and Children Eligible for WIC Benefits
    by Ed Harper & Jay Hirschman & James Mabli & Sandi Nelson & Kerianne Hourihan
  • 2009 School Meal Program Participation and Its Association with Dietary Patterns and Childhood Obesity
    by Philip Gleason & Ronette Briefel & er Wilson & Allison Hedley Dodd
  • 2009 Effects of Economic Conditions and Program Policy on State Food Stamp Program Caseloads: 2000 to 2006
    by James Mabli & Emily Sama Martin & Laura Castner
  • 2009 Trends in Supplemental Nutrition Assistance Program Participation Rates: 2000-2007
    by Joshua Leftin & Kari Wolkwitz
  • 2009 Trends in Supplemental Nutrition Assistance Program Participation Rates: 2000 to 2007
    by Joshua Leftin & Kari Wolkwitz
  • 2009 Factors Associated with School Meal Participation and the Relationship Between Different Participation Measures
    by Quinn Moore & Lara Hulsey & Michael Ponza
  • 2009 Dynamics of WIC Program Participation by Infants and Children, 2001 to 2003
    by Laura Castner & James Mabli & Julie Sykes
  • 2009 Dynamics of WIC Program Participation by Infants and Children, 2001 to 2003
    by Laura Castner & James Mabli & Julie Sykes
  • 2009 Empirical Bayes Shrinkage Estimates of State Food Stamp Program Participation Rates in 2004-2006 for All Eligible People and the Working Poor
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2009 Who Picks Up the Tab? Reducing Payment Errors in School Nutrition Programs
    by Michael Ponza & Philip Gleason & Lara Hulsey & Quinn Moore
  • 2009 The Third School Nutrition Dietary Assessment Study: Background and Study Design
    by Anne R. Gordon & Rhoda Cohen & Mary Kay Crepinsek & Mary Kay Fox & John Hall & Eric Zeidman
  • 2009 School Breakfast Program But Not School Lunch Program Participation Is Associated with Lower Body Mass Index
    by Philip M. Gleason & Allison Hedley Dodd
  • 2009 Availability and Consumption of Competitive Foods in US Public Schools
    by Mary Kay Fox & Anne Gordon & Renée Nogales & Ander Wilson
  • 2009 Association Between School Food Environment and Practices and Body Mass Index of US Public School Children
    by Mary Kay Fox & Allison Hedley Dodd & er Wilson & Philip M. Gleason
  • 2009 Meals Offered and Served in US Public Schools: Do They Meet Nutrient Standards?
    by Mary Kay Crepinsek & Anne R. Gordon & Patricia M. McKinney & Elizabeth M. Condon & Ander Wilson
  • 2009 Consumption of Low-Nutrient, Energy-Dense Foods and Beverages at School, Home, and Other Locations Among School Lunch Participants and Nonparticipants
    by Ronette R. Briefel & er Wilson & Philip M. Gleason
  • 2009 School Food Environments and Practices Affect Dietary Behaviors of US Public School Children
    by Ronette R. Briefel & Mary Kay Crepinsek & Charlotte Cabili & er Wilson & Philip M. Gleason
  • 2009 Nutritional Quality of the Diets of US Public School Children and the Role of the School Meal Programs
    by Melissa A. Clark & Mary Kay Fox
  • 2009 School Meals: Types of Foods Offered to and Consumed By Children at Lunch and Breakfast
    by Elizabeth M. Condon & Mary Kay Crepinsek & Mary Kay Fox
  • 2009 The Third School Nutrition Dietary Assessment Study: Summary and Implications
    by Anne R. Gordon & Mary Kay Crepinsek & Ronette R. Briefel & Melissa A. Clark & Mary Kay Fox
  • 2009 An Introduction to Qualitative Research for Food and Nutrition Professionals
    by Jeffrey E. Harris & Philip M. Gleason & Patricia M. Sheean & Carol Boushey & Judith A. Beto & Barbara Bruemmer
  • 2009 Preferences over the Fair Division of Goods: Information, Good, and Sample Effects in a Health Context
    by Jeremiah Hurely & Neil Buckley & Katherine Cuff & Mita Giacomini & David Cameron
  • 2009 Physician Sovereignty: The Dangerous Persistence of an Obsolete Idea. Herbert Lourie Memorial Lecture on Health Policy
    by David Lawrence
  • 2009 Comparing Population Distributions from bin-Aggregated Sample Data: an Application to Historical Height Data from France
    by Jean-Yves Duclos & Josée Leblanc & David Sahn
  • 2009 Prévention en médecine générale : approche néo-institutionnelle des systèmes de santé français et québécois
    by Mehdi Ammi & André-Pierre Contandriopoulos & Raynald Pineault
  • 2009 New Evidence on the Role of Remittances on Health Care Expenditures by Mexican Households
    by Amuedo-Dorantes, Catalina & Pozo, Susan
  • 2009 New Evidence on the Role of Remittances on Health Care Expenditures by Mexican Households
    by Amuedo-Dorantes, Catalina & Pozo, Susan
  • 2009 Health Inequality over the Life-Cycle
    by Halliday, Timothy
  • 2009 Health Inequality over the Life-Cycle
    by Halliday, Timothy J.
  • 2009 Health Status and the Allocation of Time
    by Halliday, Timothy J. & Podor, Melinda
  • 2009 Health Status and the Allocation of Time
    by Halliday, Timothy & Podor, Melinda
  • 2009 Approaches to Estimating the Health State Dependence of the Utility Function
    by Finkelstein, Amy & Luttmer, Erzo F.P. & Notowidigdo, Matthew J.
  • 2009 Approaches to Estimating the Health State Dependence of the Utility Function
    by Finkelstein, Amy & Luttmer, Erzo F.P. & Notowidigdo, Matthew J.
  • 2009 Determinants of Labor Market Outcomes of Disabled Men Before and After the Americans with Disabilities Act of 1990
    by Choe, Chung
  • 2009 Horizontal inequity in access to health care in four South American cities
    by Ana I. Balsa & Máximo Rossi & Patricia Triunfo
  • 2009 Retaining the Thin Blue Line: What Shapes Workers' Intentions not to Quit the Current Work Environment
    by Martin G?chter & David A. Savage & Benno Torgler
  • 2009 The relationship between Stress, Strain and Social Capital
    by Martin G?chter & David A. Savage & Benno Torgler
  • 2009 Preferences over the Fair Division of Goods: Information, Good, and Sample Effects in a Health Context
    by Jeremiah Hurley & Neil Buckley & Kate Cuff & Mita Giacomini & David Cameron
  • 2009 The effect of non-medical factors on variations in the performance of colonoscopy among different health care settings
    by Karine Lamiraud & Alberto Holly & Bernard Burnand & Pascal Juillerat & Vincent Wietlisbach & Florian Froehlich & Jean-Jacques Gonvers & John-Paul Vader
  • 2009 Non-employment, Ill-being and Subjective Well-being
    by Zsuzsa Kapitany
  • 2009 Health Inequality over the Life-Cycle
    by Timothy J. Halliday
  • 2009 Health Status and the Allocation of Time
    by Melinda Podor & Timothy J. Halliday
  • 2009 On the distributional consequences of epidemics
    by Raouf Boucekkine & Jean-Pierre Laffargue
  • 2009 Winning Big but Feeling no Better? The Effect of Lottery Prizes on Physical and Mental Health
    by Benedicte Apouey & Andrew E. Clark
  • 2009 Fatter Attraction: Marital Status and the Relationship between BMI and Labor Supply
    by Sonia Oreffice & Climent Quintana-Domeque
  • 2009 Free Ride: The Senate Health Bill’s Approach to “Employer Responsibility” Means Some Large Employers Get to Take It Easy
    by Shawn Fremstad
  • 2009 Taming the Deficit: Saving Our Children from Themselves
    by Dean Baker & David Rosnick
  • 2009 Bolivia: The Economy During the Morales Administration
    by Mark Weisbrot & Rebecca Ray & Jake Johnston
  • 2009 Honduras: Recent Economic Performance
    by Jose Antonio Cordero
  • 2009 Job Sharing: Tax Credits to Prevent Layoffs and Stimulate Employment
    by Dean Baker
  • 2009 Free Trade in Health Care: The Gains from Globalized Medicare and Medicaid
    by Dean Baker & Hye-Jin Rho
  • 2009 Reimbursement Roulette: The Baucus Bill’s Too Playful Approach to “Play-or-Pay” in Health Care Reform
    by Shawn Fremstad
  • 2009 More Budget Belt-Tightening Means More Job Losses for States
    by Matt Sherman
  • 2009 Employer Responsibility in Health Care Reform: Potential Effects on Low- and Moderate-Income Workers
    by Shawn Fremstad
  • 2009 Cut Loose: State and Local Layoffs of Public Employees in the Current Recession
    by Matt Sherman & Nathan Lane
  • 2009 Half in Ten: Why Taking Disability into Account is Essential to Reducing Income Poverty and Expanding Economic Inclusion
    by Shawn Fremstad
  • 2009 Update on the Ecuadorian Economy
    by Mark Weisbrot & Luis Sandoval
  • 2009 The State and Local Drag on the Stimulus
    by Dean Baker & Rivka Deutsch
  • 2009 Pay for Play? Tax Credits for Paid Time Off
    by Dean Baker
  • 2009 The Chávez Administration at 10 Years: The Economy and Social Indicators
    by Mark Weisbrot & Rebecca Ray & Luis Sandoval
  • 2009 Measuring the Impact of Microfinance on Child Health Outcomes in Indonesia
    by Stephen B. DeLoach & Erika Lamanna
  • 2009 The effect of bans and taxes on passive smoking
    by Jérôme Adda & Francesca Cornaglia
  • 2009 Re-visiting the health care luxury good hypothesis: aggregation, precision, and publication biases?
    by Joan Costa-i-Font & Marin Gemmill & Gloria Rubert
  • 2009 Bednets, Information and Malaria in Orissa
    by Aprajit Mahajan & Alessandro Tarozzi & Joanne Yoong & Brian Blackburn
  • 2009 Estimation of Treatment Effect of Asthma Case Management Using Propensity Score Methods
    by Sylvia Brandt & Sara Gale & Ira Tager
  • 2009 "Do I Really Need to Go to Rehab? I'd Say No, No, No.": Estimating Price Elasticities of Convalescent Care Programs
    by Nicolas R. Ziebarth
  • 2009 "Do I Really Need to Go to Rehab? I'd say No, No, No.": Estimating Price Elasticities of Convalescent Care Programs
    by Nicolas R. Ziebarth
  • 2009 Asymmetric information and pooling contracts in hospital sector
    by Mougeot, Michel & Naegelen, Florence
  • 2009 Religious Participation and Risky Health Behaviors among Adolescents
    by Jennifer M. Mellor & Beth A. Freeborn
  • 2009 Can Foreign Health Assistance Reduce the Medical Brain Drain?
    by Yasser MOULLAN
  • 2009 On the Distributional Consequences of Epidemics
    by Raouf BOUCEKKINE & Jean-Pierre LAFFARGUE
  • 2009 The Relationship between Stress and Social Capital among Police Officers
    by Martin Gächter & David A. Savage & Benno Torgler
  • 2009 Income and Health Spending: Evidence from Oil Price Shocks
    by Acemoglu, Daron & Finkelstein, Amy & Notowidigdo, Matthew J.
  • 2009 Mortality in Russia: Microanalysis
    by Irina Denisova
  • 2009 The Effect of Bans and Taxes on Passive Smoking
    by Jérôme Adda & Francesca Cornaglia
  • 2009 Smoking Habits: Like Father, Like Son, Like Mother, Like Daughter
    by Maria Loureiro & Anna Sanz-de-Galdeano & Daniela Vuri
  • 2009 Comparing population distributions from bin-aggregated sample data: An application to historical height data from France
    by Jean-Yves Duclos & Josée Leblanc & David Sahn
  • 2009 Comparing population distributions from bin-aggregated sample data: An application to historical height data from France
    by Jean-Yves Duclos & Josée Leblanc & David Sahn
  • 2009 Can nutritional label use influence body weight outcomes?
    by Andreas Drichoutis & Rodolfo M. Nayga, Jr. & Panagiotis Lazaridis
  • 2009 A model of nutrition information search with an application to food labels
    by Drichoutis, Andreas & Lazaridis, Panagiotis & Nayga, Rodolfo
  • 2009 The relationship between height and economic development in Spain. A historical perspective
    by Ramón María-Dolores & José Miguel Martínez Carrión
  • 2009 Using Qualitative Research to Inform the Development of a Comprehensive Outcomes Assessment for Asthma
    by Diane M. Turner-Bowker & Renee N. Saris-Baglama & Michael A. DeRosa & Christine A. Paulsen & Christopher P. Bransfield
  • 2009 How do People with Different Levels of Activation Self-Manage their Chronic Conditions?
    by Anna Dixon & Judith Hibbard & Martin Tusler
  • 2009 Patients' Preferences for Generic and Branded Over-the-Counter Medicines: An Adaptive Conjoint Analysis Approach
    by Merja Halme & Kari Linden & Kimmo Kri
  • 2009 Using the Pediatric Asthma Therapy Assessment Questionnaire to Measure Asthma Control and Healthcare Utilization in Children
    by Gregory B. Diette & Shiva G. Sajjan & Elizabeth A. Skinner & Thomas W. Weiss & Albert W. Wu & Leona E. Markson
  • 2009 First Things First: Difficulty with Current Medications is Associated with Patient Willingness to Add New Ones
    by Brian J. Zikmund-Fisher & Timothy P. Hofer & Mandi L. Klamerus & Eve A. Kerr
  • 2009 Using Self-Regulation Theory to Examine Patient Goals, Barriers, and Facilitators for Taking Medication
    by Suzan N. Kucukarslan & Sheena Thomas & Abraham Bazzi & Deborah Virant-Young
  • 2009 Gender Differences in the Selection of an Action Plan for Patients with Type 2 Diabetes Mellitus
    by Jim Nuovo & Thomas Balsbaugh & Bridget Levich
  • 2009 Behind Closed Doors: What Happens when Patients and Providers Talk about Prostate-Specific Antigen Screening?: Survey of the Effects of a Community-Based Intervention
    by Lauren McCormack & Pamela Williams-Piehota & Carla Bann
  • 2009 Public Involvement in Setting a National Research Agenda: A Mixed Methods Evaluation
    by Sandy Oliver & David G. Armes & Gill Gyte
  • 2009 Development and Validation of a Functional Health Literacy Test
    by Xu-Hao Zhang & Julian Thumboo & Kok-Yong Fong & Shu-Chuen Li
  • 2009 Using the Health Utilities Index in Routine Clinical Care: Process, Feasibility, and Acceptability: A Randomized Controlled Trial
    by Maria-Jose Santana & David H. Feeny
  • 2009 Use of, Satisfaction with, and Willingness to Switch Prescription and Over-The-Counter Treatments for Chronic Urticaria: An Online Survey
    by Donald E. Stull & Sonia Gavriel
  • 2009 A Model of Patient Choice with Mid-Therapy Information
    by William C. Grant & Teresa L. Kauf
  • 2009 Paying for Enhanced Service: Comparing Patients' Experiences in a Concierge and General Medicine Practice
    by Justin M. Ko & David G. Fairchild & Dana G. Safran
  • 2009 Upper Gastrointestinal Symptoms Experienced by Users of Low-Dose Aspirin (Acetylsalicylic Acid) [75-325 mg/day] for Primary and Secondary Coronary Artery Disease Prevention: Perspectives from Patient Focus Groups
    by Mary Kay. Margolis & Elisabeth Srstadius & J�rgen N�sdal & Stephanie Manson & Karin Coyne
  • 2009 The Impact on Patient Health Outcomes of Interventions Targeting the Patient-Physician Relationship
    by Stephen M. Auerbach
  • 2009 Jordan Louviere, PhD: Honoring a Pioneer in the Study of Patient and Citizen Choice
    by Terry Flynn
  • 2009 Personal Health Budgets for the UK NHS: A Revolution for the Patient?
    by Peter Beresford
  • 2009 The Effect of Item Screeners on the Quality of Patient Survey Data: A Randomized Experiment of Ambulatory Care Experience Measures
    by Hector P. Rodriguez & Ted von. Glahn & Angela Li & William H. Rogers & Dana Gelb. Safran
  • 2009 Health-Related Quality of Life and Quality of Life in Type 2 Diabetes: Relationships in a Cross-Sectional Study
    by Murali Sundaram & Jan Kavookjian & Julie Hicks. Patrick
  • 2009 Healthcare Experiences of Limited English-Proficient Asian American Patients: A Cross-Sectional Mail Survey
    by Quyen Ngo-Metzger & Dara H. Sorkin & Russell S. Phillips
  • 2009 Impact of Natalizumab on Patient-Reported Outcomes in a Clinical Practice Setting: A Cross-Sectional Survey
    by Siddhesh A. Kamat & Krithika Rajagopalan & Judith J. Stephenson & Sonalee Agarwal
  • 2009 Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
    by Ronald R. White & Greg Lenhart & Puneet K. Singhal & Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier & Arthur W. Segraves
  • 2009 Utilities of the EQ-5D: Transferable or Not?
    by Saskia Knies & Silvia M.A.A. Evers & Math J.J.M. Candel & Johan L. Severens & Andr J.H.A. Ament
  • 2009 The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
    by Daniel Polsky & Daria Eremina & Gregory Hess & Jerrold Hill & Scott Hulnick & Adam Roumm & Joanna L. Whyte & Joel Kallich
  • 2009 Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
    by Petra Menn & Rolf Holle
  • 2009 A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
    by Sandra L. Tunis
  • 2009 Methods for Measuring Temporary Health States for Cost-Utility Analyses
    by Davene R. Wright & Eve Wittenberg & J. Shannon. Swan & Rebecca A. Miksad & Lisa A. Prosser
  • 2009 The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?
    by John E. Brazier & Simon Dixon & Julie Ratcliffe
  • 2009 Determinants of Willingness to Pay for a New Therapy in a Sample of Menopausal-Aged Women
    by Andrej Rasch & Jan-Marc Hodek & Claus Runge & Wolfgang Greiner
  • 2009 The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
    by Jasmina I. Ivanova & Howard G. Birnbaum & Seth Samuels & Matthew Davis & Amy L. Phillips & Dennis Meletiche
  • 2009 Economic Burden of Follicular Non-Hodgkin's Lymphoma
    by Talia Foster & Jeffrey D. Miller & Mark E. Boye & Mason W. Russell
  • 2009 A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes
    by Gianluca Baio & Pierluigi Russo
  • 2009 Estimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations
    by Dyfrig A. Hughes & Lesley Tilson & Michael Drummond
  • 2009 Case-Control Studies in Pharmacoeconomic Research: An Overview
    by J. Jaime. Caro & Krista F. Huybrechts
  • 2009 Legal and Economic Perspectives Concerning US Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers
    by Paul E. Kalb & Paul E. Greenberg
  • 2009 Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn's Disease
    by Andrew P. Yu & Scott Johnson & Si-Tien Wang & Pavel Atanasov & Jackson Tang & Eric Wu & Jingdong Chao & Parvez M. Mulani
  • 2009 Cost-Effectiveness Analysis of Capecitabine Compared with Bolus 5-Fluorouracil/l-Leucovorin for the Adjuvant Treatment of Colon Cancer in Japan
    by Takeru Shiroiwa & Takashi Fukuda & Kojiro Shimozuma & Yasuo Ohashi & Kiichiro Tsutani
  • 2009 Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome
    by Jaime Latour-Perez & Eva de-Miguel-Balsa
  • 2009 Costs of Illness in a Russian Cohort of Patients with Parkinson's Disease
    by Yaroslav Winter & Sonja von Campenhausen & Georgy Popov & Jens P. Reese & Jens Klotsche & Kai Btzel & Eugene Gusev & Wolfgang H. Oertel & Richard Dodel & Alla Guekht
  • 2009 Economic Evaluations in the EURONHEED: A Comparative Analysis
    by Florencia Hutter & Fernando Antoanzas
  • 2009 Societal and Patient Burden of Fibromyalgia Syndrome
    by Lieven Annemans & Katell Le Lay & Charles Taeb
  • 2009 Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
    by Natasha K. Stout & Amy B. Knudsen & Chung Yin. Kong & Pamela M. McMahon & G. Scott. Gazelle
  • 2009 Is it Time for Reporting Guidelines for Calibration Methods?
    by Scott B. Cantor
  • 2009 How to Deal with Cost Differences at Baseline
    by Antoinette D.I. van Asselt & Ghislaine A.P.G. van Mastrigt & Carmen D. Dirksen & Arnoud Arntz & Johan L. Severens & Alfons G.H. Kessels
  • 2009 Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants
    by Howard G. Birnbaum & Rym Ben-Hamadi & Paul E. Greenberg & Matthew Hsieh & Jackson Tang & Camille Reygrobellet
  • 2009 Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies
    by Ling-Hsiang Chuang & Paul Kind
  • 2009 Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis
    by Elise M. Pelletier & Boyung Shim & Rami Ben-Joseph & J. Jaime. Caro
  • 2009 Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease
    by Maureen P.M.H. Rutten-van Mlken & Martine Hoogendoorn & Leida M. Lamers
  • 2009 Pharmacoeconomic Considerations in Treating Actinic Keratosis
    by Marjorie V. Neidecker & Mary Lynn. Davis-Ajami & Rajesh Balkrishnan & Steven R. Feldman
  • 2009 Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group
    by Anthony T. Newall & Heath Kelly & Stuart Harsley & Paul A. Scuffham
  • 2009 Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs
    by Brian Godman & Ulrich Schwabe & Gisbert Selke & Bjrn Wettermark
  • 2009 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium
    by Irina Cleemput & Nancy Thiry
  • 2009 The Author's Reply
    by Lieven Annemans, on behalf of the authors
  • 2009 Pharmaceutical Risk-Sharing Agreements
    by Afschin Gandjour
  • 2009 Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections
    by Kamal M.F. Itani & Kasem S. Akhras & Robert Stellhorn & Alvaro Quintana & David Budd & Sanjay Merchant
  • 2009 Utility Assessment in Patients with Mental Disorders: Validity and Discriminative Ability of the Time Trade-Off Method
    by Hans-Helmut Knig & Oliver H. Gnther & Matthias C. Angermeyer & Christiane Roick
  • 2009 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations
    by Linus Jnsson & Anders Wimo
  • 2009 Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A
    by Jeroen Luyten & Philippe Beutels
  • 2009 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature
    by Alyssa B. Schultz & Chin-Yu Chen & Dee W. Edington
  • 2009 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics
    by Joseph Cook & Graeme Hunter & John A. Vernon
  • 2009 Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines
    by Uwe Siebert & Gaby Sroczynski & Pamela Aidelsburger & Siegbert Rossol & Jurgen Wasem & Michael P. Manns & John G. McHutchison & John B. Wong
  • 2009 Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder: Results from the MATRIX Study
    by Laura T. Pizzi & Amy Talati & Eric Gemmen & Naomi V. Dahl & Thomas J. Bunz & Peter K. Sand
  • 2009 Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective
    by Mattias Neyt & Chris De Laet & Annemieke De Ridder & Hans Van Brabandt
  • 2009 Willingness to Pay for Cancer Prevention
    by Timothy L. Hunt & Bryan R. Luce & Matthew J. Page & Robin Pokrzywinski
  • 2009 Reviewing the Cost Effectiveness of Rotavirus Vaccination: The Importance of Uncertainty in the Choice of Data Sources
    by Joke Bilcke & Philippe Beutels
  • 2009 Economic and Human Costs of Restless Legs Syndrome
    by Thomas Reinhold & Falk Mller-Riemenschneider & Stefan N. Willich & Bernd Brggenjrgen
  • 2009 Cost Effectiveness of Herpes Zoster Vaccine in Canada
    by Mehdi Najafzadeh & Carlo A. Marra & Eleni Galanis & David M. Patrick & David M. Patrick
  • 2009 Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected
    by Allan Wailoo & Aki Tsuchiya & Christopher McCabe
  • 2009 Swimming Upstream: Comparative Effectiveness Research in the US
    by Jeremy A. Greene
  • 2009 Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK
    by Jeroen P. Jansen & Ritesh Kumar & Yehuda Carmeli
  • 2009 Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
    by David R. Rappange & Werner B.F. Brouwer & Rudolf T. Hoogenveen & Pieter H.M. Van Baal
  • 2009 Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
    by Aline Gauthier & Andrea Manca & Susan Anton
  • 2009 Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster
    by Tracy A. Lieu & G. Thomas. Ray & Ismael R. Ortega-Sanchez & Ken Kleinman & Donna Rusinak & Lisa A. Prosser
  • 2009 Cost Effectiveness of Facility-Based Care, Home-Based Care and Mobile Clinics for Provision of Antiretroviral Therapy in Uganda
    by Joseph B. Babigumira & Ajay K. Sethi & Kathleen A. Smyth & Mendel E. Singer
  • 2009 Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan
    by Ya-Chen Tina. Shih & I-Wen Pan & Yi-Wen Tsai
  • 2009 Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program
    by Sripen Tantivess & Yot Teerawattananon & Anne Mills
  • 2009 Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region
    by Federico Augustovski & Cynthia Iglesias & Andrea Manca & Michael Drummond & Adolfo Rubinstein & Sebastin Garca. Mart
  • 2009 Cost Effectiveness in Low- and Middle-Income Countries: A Review of the Debates Surrounding Decision Rules
    by Samuel D. Shillcutt & Damian G. Walker & Catherine A. Goodman & Anne J. Mills
  • 2009 The Future of Health Technology Assessment in Healthcare Decision Making in Asia
    by Bong-Min Yang
  • 2009 Developing Nations Special Issue
    by Mendel E. Singer
  • 2009 Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
    by Peng Liubao & Wan Xiaomin & Tan Chongqing & Jon Karnon & Chen Gannong & Li Jianhe & Cui Wei & Luo Xia & Cao Junhua
  • 2009 30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
    by Peter J. Neumann & Chi-Hui Fang & Joshua T. Cohen
  • 2009 A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting
    by Laura McCullagh & Lesley Tilson & Cathal Walsh & Michael Barry
  • 2009 Budget-Impact Analyses: A Critical Review of Published Studies
    by Ewa Orlewska & Laszlo Gulcsi
  • 2009 Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
    by John A. Vernon & Robert Goldberg & Joseph Golec
  • 2009 New Anticoagulants for the Prevention of Deep Venous Thrombosis: Time to Consider Cost Effectiveness?
    by Stavros Apostolakis & Eduard Shantsila & Gregory Y.H. Lip
  • 2009 Demand for Outpatient Healthcare: Empirical Findings from Rural India
    by Sisira Sarma
  • 2009 Cost Savings Associated with Filling a 3-Month Supply of Prescription Medicines
    by Atonu Rabbani & G. Caleb. Alexander
  • 2009 A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine
    by Derek Misurski & Maureen J. Lage & Rosalind Fabunmi & Kristina S. Boye
  • 2009 The Cost Effectiveness of Home-Based Provision of Antiretroviral Therapy in Rural Uganda
    by Elliot Marseille & James G. Kahn & Christian Pitter & Rebecca Bunnell & William Epalatai & Emmanuel Jawe & Willy Were & Jonathan Mermin
  • 2009 Cost Effectiveness of Antiretrovirals - Long Term or Short Term?
    by Steffen Flessa
  • 2009 Assessing Comparative Effectiveness Research in the US
    by Joshua P. Cohen & John F.P. Bridges
  • 2009 Which Barriers Prevent the Efficient Use of Resources in Medical Device Sectors?
    by Steven Simoens
  • 2009 The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK
    by Zhimei Liu & Quan V. Doan & Jennifer Malin & Robert Leonard
  • 2009 Economic Evaluation of Sinfrontal in the Treatment of Acute Maxillary Sinusitis in Adults
    by Kyra C. Kneis & Afschin Gandjour
  • 2009 Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study
    by Ivar Snb. Kristiansen & Dag Nyholm & Dag Isacson
  • 2009 Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
    by Joseph Golec
  • 2009 Value-Based Insurance Design in Medicare
    by William E. Encinosa
  • 2009 Soft Regulations in Pharmaceutical Policy Making: An Overview of Current Approaches and their Consequences
    by Bjrn Wettermark & Brian Godman & Bengt Jacobsson & Flora M. Haaijer-Ruskamp
  • 2009 Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
    by Stephanie R. Earnshaw & Jonathan Graham & MerriKay Oleen-Burkey & Jane Castelli-Haley & Kenneth Johnson
  • 2009 Implementing Differential Pricing for Essential Medicines via Country-Specific Bilateral Negotiated Discounts
    by Ebenezer Kwabena. Tetteh
  • 2009 Aversion to Geographic Inequality and Geographic Variation in Preferences in the Context of Healthcare
    by Carlota Quintal
  • 2009 Comparative Utility of Aripiprazole and Haloperidol in Schizophrenia: Post Hoc Analysis of Two 52-Week, Randomized, Controlled Trials
    by John M. Kane & Edward Kim & Hong J. Kan & Zhenchao Guo & John A. Bates & Richard Whitehead & Andrei Pikalov
  • 2009 Development of a Budget-Impact Model to Quantify Potential Cost Savings from Prescription Opioids Designed to Deter Abuse or Ease of Extraction
    by Alan G. White & Howard G. Birnbaum & Dov B. Rothman & Nathaniel Katz
  • 2009 Oral Therapies for the Treatment of Pulmonary Arterial Hypertension: A Population-Based Cost-Minimization Analysis
    by George Dranitsaris & Sanjay Mehta
  • 2009 Direct Economic Burden of High-Risk and Metastatic Melanoma in the Elderly: Evidence from the SEER-Medicare Linked Database
    by Keith L. Davis & Debanjali Mitra & Srividya Kotapati & Ramy Ibrahim & Jedd D. Wolchok
  • 2009 Cost Effectiveness of Sirolimus-Eluting Stents Compared with Bare Metal Stents in Acute Myocardial Infarction: Insights from the TYPHOON Trial
    by Florence Canoui-Poitrine & Grgoire Jeanblanc & Corinne Alberti & Priscilla Armoogum & Ana Cebrian & Didier Carri & Patrick Henry & Emmanuel Teiger & Michel Slama & Christian Spaulding & Isabelle Durand-Zaleski
  • 2009 Health-Promoting Schools: Evidence for a Holistic Approach to Promoting Health and Improving Health Literacy
    by Albert Lee
  • 2009 Informing Disinvestment through Cost-Effectiveness Modelling: Is Lack of Data a Surmountable Barrier?
    by Jonathan Karnon & Jill Carlton & Carolyn Czoski-Murray & Kevin Smith
  • 2009 Regional Health Accounts for Pakistan—Provincial and District Health Expenditures and the Degree of Districts Fiscal Autonomy on Health
    by Christian Lorenz & Muhammad Khalid
  • 2009 Eu Integration, Health Standards And Economic Development
    by Mattoscio Nicola & Colantonio Emiliano & Carlei Vittorio & Furia Donatella
  • 2009 Interdependencies of Health, Education and Poverty: The Case of South Mediterranean Economies/Interdependencias de salud, educación y pobreza: el caso de las Economías Sur-Mediterráneas
    by DRIOUCHI, AHMED & BOBOC, CRISTINA & ZOUAG, NADA
  • 2009 The Policy Views of American Economic Association Members: The Results of a New Survey
    by Robert Whaples
  • 2009 Long-term Care Insurance Facilities and Interregional Migration of the Elderly in Japan
    by Akihiro Kawase & Katsuyoshi Nakazawa
  • 2009 Prevention of diseases and preventive co-payment rate
    by François Maréchal
  • 2009 Partial vaccination programs and the eradication of infectious diseases
    by Wataru Kureishi
  • 2009 Education, Health And Economic Development: A Survey Of Quantitative Economic Studies, 2001-2009
    by GUISAN, Maria-Carmen
  • 2009 Informe EEDI/ESID 2009: Desarrollo Socio-Económico de América Latina, Europa, países de la OCDE y mundial, 2000-2008
    by GUISAN, Maria-Carmen
  • 2009 A Note On Infant Mortality And Foreign Health-Aid
    by Elsy T. KIZHAKETHALACKAL
  • 2009 Capital humain et coûts de friction. Quels critères de choix pour l'évaluation des pertes de production ?
    by Hélène Sultan-Taïeb & Philippe Tessier & Sophie Béjean
  • 2009 Économie de la santé dans les pays en développement des paradigmes en mutation
    by Jean-Paul Moatti & Bruno Ventelou
  • 2009 Equity in Access to Health Services in Developing Countries
    by Jean-Claude Berthélemy & Juliette Seban
  • 2008 Optimal Public Policy with Endogenous Mortality
    by Rangan Gupta & Emmanuel Ziramba
  • 2008 Mortality, Fertility, and Persistent Income Inequality
    by Jayanta Sarkar
  • 2008 The Relationship between Suicidal Behavior and Productive Activities of Young Adults
    by Erdal Tekin & Sara Markowitz
  • 2008 Foreign Aid and Human Development: The Impact of Foreign Aid to the Health Sector
    by Claudia R. Williamson
  • 2008 The Intergenerational Transmission of Health in Early Childhood
    by Coneus, Katja & Spieß, Christa Katharina
  • 2008 Mental Health of Parents and Life Satisfaction of Children: A Within-Family Analysis of Intergenerational Transmission of Well-Being
    by N Powdthavee & A Vignoles
  • 2008 Trade-off between formal and informal care in Spain
    by Jimenez-Martin, S & Prieto, C. V
  • 2008 Health effects on labour market exits and entries
    by García-Gómeza, P & Jones, A.M & Rice, N
  • 2008 Trade-off between formal and informal care in Spain
    by Sergi Jiménez-Martín & Cristina Vilaplana Prieto
  • 2008 Income-Based Price Subsidies, Parallel Imports and Markets Access to New Drugs for the Poor
    by Rajat Acharyya & Maria D.C. Garcia-Alonso
  • 2008 Malmquist indexes with quasi-fixed inputs: An application to school districts in Québec
    by Pierre Ouellette & Valérie Vierstraete
  • 2008 Screening Tests, Information, and the Health-Education Gradient
    by Ciro Avitabile & Tullio Jappelli & Mario Padula
  • 2008 The Rise in Obesity Across the Atlantic: An Economic Perspective
    by Giorgio Brunello & Pierre-Carl Michaud & Anna Sanz-de-Galdeano
  • 2008 Making Sense Of The Labor Market Height Premium: Evidence From The British Household Panel Survey
    by Anne Case & Christina Paxson & Mahnaz Islam
  • 2008 An Empirical Model of Learning under Ambiguity: The Case of Clinical Trials
    by Fernandez, Jose
  • 2008 The NICE Cost-Effectiveness Threshold: What it is and What that Means
    by McCabe, C & Claxton, K & Culyer, AJ
  • 2008 Social Correlates of Health choices: A study in Rural Tamil Nadu
    by Kannan, Srinivasan
  • 2008 Lifetime Fairness? Taxes, Subsidies, Age-Based Penalties, and the Price of Health Insurance in Australia
    by Connelly, Luke B. & Brown III, H. Shelton
  • 2008 Child Health and the Income Gradient: Evidence from Australia
    by Khanam, Rasheda & Nghiem, Hong Son & Connelly, Luke B.
  • 2008 Russian economic report No.16 (June 2008), The World Bank
    by Bogetic, Zeljko & Ulatov, Sergey & Emelyanova, Olga & Smits, Karlis
  • 2008 The role of economics in the QUERI program: QUERI Series
    by Smith, Mark W & Barnett, Paul G
  • 2008 Fécondité, Santé et Participation des femmes au Marché du Travail
    by Zamo-Akono, C. & Tsafack-Nanfosso, R.
  • 2008 Can Too Much TV Ground You for Life? Television Viewing and Child Outcomes
    by Samrat Bhattacharya & Abdul Munasib
  • 2008 Socio-Economic Differences in Mortality: Implications for Pensions Policy
    by Edward R. Whitehouse & Asghar Zaidi
  • 2008 Delivering Cost-Efficient Public Services in Health Care, Education and Housing in Chile
    by Diego Moccero
  • 2008 Do Child Tax Benefits Affect the Wellbeing of Children? Evidence from Canadian Child Benefit Expansions
    by Kevin Milligan & Mark Stabile
  • 2008 Are Health Insurance Markets Competitive?
    by Leemore Dafny
  • 2008 Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy
    by Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari
  • 2008 No Time to Lose? Time Constraints and Physical Activity
    by John Mullahy & Stephanie A. Robert
  • 2008 Tobit at Fifty: A Brief History of Tobin's Remarkable Estimator, of Related Empirical Methods, and of Limited Dependent Variable Econometrics in Health Economics
    by Kohei Enami & John Mullahy
  • 2008 Child Health and Young Adult Outcomes
    by Janet Currie & Mark Stabile & Phongsack Manivong & Leslie L. Roos
  • 2008 Identification and Estimation of 'Irregular' Correlated Random Coefficient Models
    by Bryan S. Graham & James Powell
  • 2008 Health Capital and the Prenatal Environment: The Effect of Maternal Fasting During Pregnancy
    by Douglas Almond & Bhashkar Mazumder
  • 2008 The Effect of Gun Shows on Gun-Related Deaths: Evidence from California and Texas
    by Mark Duggan & Randi Hjalmarsson & Brian A. Jacob
  • 2008 Peer Effects and Human Capital Accumulation: the Externalities of ADD
    by Anna Aizer
  • 2008 Socioeconomic Status and Health: Dimensions and Mechanisms
    by David M. Cutler & Adriana Lleras-Muney & Tom Vogl
  • 2008 International evidence on well-being
    by David G. Blanchflower
  • 2008 The Effect of Medicare Coverage for the Disabled on the Market for Private Insurance
    by John F. Cogan & R. Glenn Hubbard & Daniel P. Kessler
  • 2008 Inside the War on Poverty: The Impact of Food Stamps on Birth Outcomes
    by Douglas Almond & Hilary W. Hoynes & Diane Whitmore Schanzenbach
  • 2008 Individual Laboratory-Measured Discount Rates Predict Field Behavior
    by Christopher F. Chabris & David Laibson & Carrie L. Morris & Jonathon P. Schuldt & Dmitry Taubinsky
  • 2008 Is American Health Care Uniquely Inefficient?
    by Alan M. Garber & Jonathan Skinner
  • 2008 The Value of Life in General Equilibrium
    by Anupam Jena & Casey Mulligan & Tomas J. Philipson & Eric Sun
  • 2008 State and Federal Approaches to Health Reform: What Works for the Working Poor?
    by Ellen Meara & Meredith Rosenthal & Anna Sinaiko & Katherine Baicker
  • 2008 The Impact of Income on the Weight of Elderly Americans
    by John Cawley & John R. Moran & Kosali I. Simon
  • 2008 What Good Is Wealth Without Health? The Effect of Health on the Marginal Utility of Consumption
    by Amy Finkelstein & Erzo F.P. Luttmer & Matthew J. Notowidigdo
  • 2008 Health, Human Capital, and African American Migration Before 1910
    by Trevon D. Logan
  • 2008 Under the Weather: Health, Schooling, and Economic Consequences of Early-Life Rainfall
    by Sharon L. Maccini & Dean Yang
  • 2008 Making Sense of the Labor Market Height Premium: Evidence From the British Household Panel Survey
    by Anne Case & Christina Paxson & Mahnaz Islam
  • 2008 Obesity and Skill Attainment in Early Childhood
    by John Cawley & C. Katharina Spiess
  • 2008 On Inferring Demand for Health Care in the Presence of Anchoring, Acquiescence, and Selection Biases
    by Jay Bhattacharya & Adam Isen
  • 2008 The Other Ex-Ante Moral Hazard in Health
    by Jay Bhattacharya & Mikko Packalen
  • 2008 Is Medicine an Ivory Tower? Induced Innovation, Technological Opportunity, and For-Profit vs. Non-Profit Innovation
    by Jay Bhattacharya & Mikko Packalen
  • 2008 The Cognitive Link Between Geography and Development: Iodine Deficiency and Schooling Attainment in Tanzania
    by Erica M. Field & Omar Robles & Máximo Torero
  • 2008 50,000 People a Day: The Use of Federally Funded Services for Intimate Partner Violence
    by Radha Iyengar & Lindsay Sabik & Cindy Southworth & Sarah Tucker & Cynthia Fraser
  • 2008 Neighborhood Violence and Urban Youth
    by Anna Aizer
  • 2008 The Effect of Tax Preferences on Health Spending
    by John F. Cogan & R. Glenn Hubbard & Daniel P. Kessler
  • 2008 Covering the Uninsured in the U.S
    by Jonathan Gruber
  • 2008 Baseline Report on the Farming Practices Survey
    by Kenneth Fortson & Daniel Player & Randall Blair & Anu Rangarajan
  • 2008 Nutrition Standards and Meal Requirements for National School Lunch and Breakfast Programs: Phase I. Proposed Approach for Recommending Revisions
    by Mary Kay Fox & other members of the Committee on Nutrition Standards for National School Lunch & Breakfast Programs
  • 2008 Empirical Bayes Shrinkage Estimates of State Food Stamp Program Participation Rates in 2003-2005 for All Eligible People and the Working Poor
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2008 Diet Quality of American School-Age Children by School Lunch Participation Status: Data from the National Health and Nutrition Examination Survey, 1999-2004
    by Nancy Cole & Mary Kay Fox
  • 2008 Diet Quality of American Young Children by WIC Participation Status: Data from the National Health and Nutrition Examination Survey, 1999-2004
    by Nancy Cole & Mary Kay Fox
  • 2008 Promoting Health, Preventing Chronic Disease, and Fighting Hunger: Assessment of USDA Food Assistance
    by Mary Kay Fox
  • 2008 Reaching Those in Need: State Food Stamp Participation Rates in 2006
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2008 I Am Moving, I Am Learning: Early Findings from the Implementation of an Obesity Prevention Enhancement in Head Start Region III
    by Daniel Finkelstein & Robert Whitaker & Elaine Hill & Mary Kay Fox & Linda Mendenko & Kimberly Boller
  • 2008 Application of Adult-Based Dietary Guidelines to Children: Evidence, Knowledge Gaps, and Policy Implications
    by Ronette R. Briefel & Allison Hedley Dodd & Charlotte Cabili & Carol West Suitor
  • 2008 Summary of Published Evidence Related to the Dietary Guidelines for Children, 2004-2008
    by Allison Hedley Dodd & Charlotte Cabili & Ronette R. Briefel & Nyna Williams & Carol West Suitor
  • 2008 Simulated Effects of Changes to State and Federal Asset Eligibility Policies for the Food Stamp Program
    by Karen Cunnyngham & James Ohls
  • 2008 Technical Documentation for the Fiscal Year 2007 FSPQC Database and QC Minimodel
    by Kari Wolkwitz & Daisy Ewell
  • 2008 Characteristics of Food Stamp Households: Fiscal Year 2007
    by Kari Wolkwitz & Joshua Leftin
  • 2008 School Food Environments and Policies in U.S. Public Schools
    by Daniel M. Finkelstein & Elaine L. Hill & Robert C. Whitaker
  • 2008 Trends in Food Stamp Program Participation Rates: 2000 to 2006
    by Kari Wolkwitz
  • 2008 Detailed Tables of Food Stamp Program Participation Rates: 2000 to 2005
    by Kari Wolkwitz
  • 2008 Trends in Food Stamp Program Participation Rates: 2000 to 2006
    by Kari Wolkwitz
  • 2008 Tightening Income Documentation in a Means-Tested Program. Who Stays Away?
    by Philip Gleason & John Burghardt & Paul Strasberg & Lara Hulsey
  • 2008 Modernization of the Food Stamp Program in Florida
    by Scott Cody & Renée Nogales & Emily Sama Martin
  • 2008 Direct Certification in the National School Lunch Program Expands Access for Children
    by Philip Gleason
  • 2008 Stili di vita, salute e accesso ai servizi sanitari: un’analisi delle disuguaglianze nella provincia di Modena
    by Anita Chiarolanza & Massimo Brunetti & Paolo Silvestri
  • 2008 Do People Become Healthier after Being Promoted?
    by Boyce, Christopher J. & Oswald, Andrew J.
  • 2008 Do People Become Healthier after Being Promoted?
    by Boyce, Christopher J. & Oswald, Andrew J.
  • 2008 Polarisation and Health
    by Blanco Pérez, Cristina & Ramos, Xavi
  • 2008 Polarisation and Health
    by Blanco Perez, Cristina & Ramos, Xavi
  • 2008 Race, Ethnicity and the Dynamics of Health Insurance Coverage
    by Fairlie, Robert W. & London, Rebecca A.
  • 2008 Race, Ethnicity and the Dynamics of Health Insurance Coverage
    by Fairlie, Robert W. & London, Rebecca A.
  • 2008 The Rise in Obesity across the Atlantic: An Economic Perspective
    by Brunello, Giorgio & Michaud, Pierre-Carl & Sanz-de-Galdeano, Anna
  • 2008 The Rise in Obesity across the Atlantic: An Economic Perspective
    by Brunello, Giorgio & Michaud, Pierre-Carl & Sanz-de-Galdeano, Anna
  • 2008 Heterogeneity, State Dependence and Health
    by Halliday, Timothy
  • 2008 Heterogeneity, State Dependence and Health
    by Halliday, Timothy J.
  • 2008 The Impact of Income Shocks on Health: Evidence from Cohort Data
    by Adda, Jérôme & Banks, James & von Gaudecker, Hans-Martin
  • 2008 The Impact of Income Shocks on Health: Evidence from Cohort Data
    by Adda, Jérôme & Banks, James & Gaudecker, Hans-Martin von
  • 2008 Studying the Child Obesity Epidemic With Natural Experiments
    by Robert Sandy & Gilbert Liu & John Ottensmann & Rusty Tchernis & Jeffrey Wilson
  • 2008 When consumption heals producers: the effect of fair trade on marginalised producers’ health and productivity
    by Leonardo Becchetti & Giuseppina Gianfreda
  • 2008 Catastrophic health expenditure and household well-being
    by Ramses H. Abul Naga & Karine Lamiraud
  • 2008 Costs and Benefits of Elderly Prescription Drug Coverage: Evidence from Veterans’ Health Care
    by Melissa Boyle
  • 2008 A theory of dynamics and inequalities under epidemics
    by Raouf Boucekkine & Jean-Pierre Laffargue
  • 2008 The Impact on Child Health from Access to Water and Sanitation and Other Socioeconomic Factors
    by Gauri Khanna
  • 2008 Analyzing the determinants of willingness-to-pay values for testing the validity of the contingent valuation method. Application to home care compared to hospital care
    by Raphaël Remonnay & Nathalie Havet & Magali Morelle & Marie-Odile Carrère
  • 2008 Les évaluations de coûts en santé sont-elles transférables ?
    by Marie-Odile Carrère & Lionel Perrier & Pascal Pommier & Patrick Sylvestre-Baron
  • 2008 The Impact of the Medicare Drug Benefit on Health Care Spending by Older Households
    by Dean Baker & Ben Zipperer
  • 2008 Who receives statins? Variations in physicians’ prescribing patterns for patients with coronary heart disease, dyslipidemia, and diabetes
    by Charles R. Link & Simon Condliffe & Bryan Townsend
  • 2008 The Intergenerational Transmission of Health in Early Childhood
    by Katja Coneus & C. Katharina Spieß
  • 2008 Bondades y Limitaciones de la Focalización con Proxy Means Tests: El Caso del Sisben en Colombia
    by Martha Bottia & Lina Cardona & Carlos Medina
  • 2008 Diferencias en los índices de masa corporal en Colombia en 2005: una aplicación de los indicadores de desigualdad
    by Luis Fernando Gamboa & Nohora Forero Ramírez
  • 2008 Re-visiting the Health Care Luxury Good Hypothesis: Aggregation, Precision, and Publication Biases?
    by Joan Costa-Font & Marin Gemmill & Gloria Rubert
  • 2008 Alcoholic beverages as determinants of traffic fatalities
    by José Mª Arranz & Ana I. Gil
  • 2008 Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study
    by Kavita Gajria & Mark Kosinski & Jeff Schein & Shane Kavanagh & Dominique Dubois
  • 2008 How Much Time Do Patients Spend on Outpatient Visits?: The American Time Use Survey
    by Louise B. Russell & Yoko Ibuka & Deborah Carr
  • 2008 The Burden of Restless Legs Syndrome: An Assessment of Work Productivity, Sleep, Psychological Distress, and Health Status Among Diagnosed and Undiagnosed Individuals in an Internet-Based Panel
    by Sheri Fehnel & Laurie Zografos & Tammy Curtice & Hemal Shah & Lori McLeod
  • 2008 Association of Pre-Existing Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients
    by Steven B. Zeliadt & Scott D. Ramsey & Arnold L. Potosky & Neeraj K. Arora & David K. Blough & Ingrid Oakley-Girvan & Ann S. Hamilton & Stephen K. Van Den Eeden & David F. Penson
  • 2008 Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy
    by Candida M. Mastroianni & Caterina Viscomi & Silvia Ceniti & Rosanna De Simone & Aldo Filice & Gennaro Gadaleta Caldarola & Stefania Infusino & Caterina Manfredi & Antonio Rea & Claudia Sandomenico & Salvatore Turano & Francesco Serrano & Giovanni Condemi & Carla Cortese & Tullia Prantera & Salvatore Palazzo
  • 2008 Hormonal Contraceptive Users' Self-Reported Benefits, Adverse Reactions, and Fears in 2001 and 2007
    by Miia Tiihonen & Hanna-Mari Leppanen & Anna-Mari Heikkinen & Riitta Ahonen
  • 2008 Obesity and Symptom Burden in Family Medicine Patients
    by James E. Rohrer & Norman H. Rasmussen & Margaret S. Houston & Kurt B. Angstman
  • 2008 Understanding and Assessing the Impact of Alcoholism on Quality of Life: A Systematic Review of the Content Validity of Instruments Used to Assess Health-Related Quality of Life in Alcoholism
    by Matthew D. Reaney & Colin Martin & Jane Speight
  • 2008 Erik Rifkin, PhD: Writer, Researcher, Patient, and Citizen Advocate
    by Jennifer Chang
  • 2008 Association Between Measures of Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis and Osteoarthritis
    by Marita Cross & Helen Lapsley & Annica Barcenilla & Peter Brooks & Lyn March
  • 2008 The Relationship Between Physician Friendliness and Caring, and Patient Satisfaction: Findings from an Internet-Based Survey
    by Adam A. Uhas & Fabian T. Camacho & Steven R. Feldman & Rajesh Balkrishnan
  • 2008 Does Behavioral Bootstrapping Boost Weight Control Confidence?: A Pilot Study
    by James E. Rohrer & Kristin S. Vickers-Douglas & Robert J. Stroebel
  • 2008 Making Patient-Centered Care More Visible: Planetree's Vision
    by Carrie Brady
  • 2008 Honoring the Life of a Pioneer in Patient-Centered Care: Harvey Picker, PhD (1915-2008)
    by Susan B. Frampton & Sara Guastello
  • 2008 Translation and Validation of the Chinese Diabetic Foot Ulcer Scale - Short Form
    by Lan Fong Hui & Daniel Yee-Tak Fong & Michael Yam & Wing Yuk Ip
  • 2008 The Use of Multi-Criteria Decision Analysis Weight Elicitation Techniques in Patients with Mild Cognitive Impairment: A Pilot Study
    by Janine A. van Til & James G. Dolan & Anne M. Stiggelbout & Karin C.G.M. Groothuis & Maarten J. IJzerman
  • 2008 Psychometric Performance of the National Eye Institute 25-Item Visual Function Questionnaire: In Turkish Diabetic Retinopathy Patients
    by Akinci Fevzi & Yildirim Aysegul
  • 2008 A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer
    by Alistair E. Ring & Kerry A. Cheong & Claire L. Watkins & David Meddis & David Cella & Peter G. Harper
  • 2008 Lillie Shockney: Breast Cancer Survivor, Advocate, and Researcher
    by John F.P. Bridges
  • 2008 When Time is Not on Your Side: Patient Experiences with Waiting for Home Care and Admission to a Nursing or Residential Home
    by N. Job A. van Exel & Marion de Ruiter & Werner B.F. Brouwer
  • 2008 Honoring Pioneers in Patient-Centered Outcomes Research
    by John F.P. Bridges & Christopher I. Carswell
  • 2008 Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study
    by Maribel Salas & Catarina I. Kiefe & Pamela J. Schreiner & Yongin Kim & Lucia Juarez & Sharina D. Person & O. Dale Williams
  • 2008 Age and Choice in Health Insurance: Evidence from a Discrete Choice Experiment
    by Karolin Becker & Peter Zweifel
  • 2008 If You Want Patients with Knee Osteoarthritis to Exercise, Tell Them about NSAIDs
    by Liana Fraenkel & Terri Fried
  • 2008 Concordance of Couples' Prostate Cancer Screening Recommendations from a Decision Analysis
    by Scott B. Cantor & Robert J. Volk & Murray D. Krahn & Alvah R. Cass & Jawaria Gilani & Susan C. Weller & Stephen J. Spann
  • 2008 The Role of The Patient in Promoting Patient-Centered Outcomes Research
    by Michael J. Klag & Ellen J. MacKenzie & Christopher I. Carswell & John F.P. Bridges
  • 2008 Subgroups and Heterogeneity in Cost-Effectiveness Analysis
    by Mark Sculpher
  • 2008 Exploring Uncertainty in Cost-Effectiveness Analysis
    by Karl Claxton
  • 2008 Valuing Health States for Use in Cost-Effectiveness Analysis
    by John Brazier
  • 2008 Use of Indirect and Mixed Treatment Comparisons for Technology Assessment
    by Alex Sutton & A.E. Ades & Nicola Cooper & Keith Abrams
  • 2008 Estimating `Costs' for Cost-Effectiveness Analysis
    by Alec Miners
  • 2008 The NICE Cost-Effectiveness Threshold: What it is and What that Means
    by Christopher McCabe & Karl Claxton & Anthony J. Culyer
  • 2008 NICE Methodology for Technology Appraisals: Cutting Edge or Tried and Trusted?
    by Louise Longworth & Carole Longson
  • 2008 NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective
    by Julia Earnshaw & Gavin Lewis
  • 2008 NICE's 2008 Methods Guide: Sensible Consolidation or Opportunities Missed?
    by Mark Sculpher
  • 2008 Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer
    by Kate McKeage & Katherine A. Lyseng-Williamson
  • 2008 Demand Forecasting for Preventive AIDS Vaccines: Economic and Policy Dimensions
    by Robert Hecht & Gian Gandhi
  • 2008 Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User's Guide
    by Emily Lancsar & Jordan Louviere
  • 2008 Assessing the Impact of Global Price Interdependencies
    by Anke Richter
  • 2008 Modelling Approaches: The Case of Schizophrenia
    by Bart M.S. Heeg & Joep Damen & Erik Buskens & Sue Caleo & Frank de Charro & Ben A. van Hout
  • 2008 Waiting for Reimbursement of New Medicines in Canada: It's Time for a Rethink
    by Brett J. Skinner
  • 2008 Cost-Effectiveness Analyses of Natalizumab (Tysabri(R)) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK
    by Ray Gani & Gavin Giovannoni & David Bates & Belinda Kemball & Steve Hughes & John Kerrigan
  • 2008 Generic Entry, Reformulations and Promotion of SSRIs in the US
    by Haiden A. Huskamp & Julie M. Donohue & Catherine Koss & Ernst R. Berndt & Richard G. Frank
  • 2008 Future Drug Prices and Cost-Effectiveness Analyses
    by Martin Hoyle
  • 2008 Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes: A Systematic Review on Content and Adherence to Guidelines
    by Stefan Vegter & Cornelis Boersma & Mark Rozenbaum & Bob Wilffert & GerJan Navis & Maarten J. Postma
  • 2008 The Author's Reply
    by Adam E. Block
  • 2008 Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
    by Jon Jureidini & Barbara Mintzes & Melissa Raven
  • 2008 Pharmaceutical Risk-Sharing Agreements
    by Joseph P. Cook & John A. Vernon & Richard Manning
  • 2008 Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe
    by Bjorn Wettermark & Brian Godman & Karolina Andersson & Lars L. Gustafsson & Alan Haycox & Vittorio Bertele'
  • 2008 Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis
    by Dirk Mueller & Eva Weyler & Afschin Gandjour
  • 2008 Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers
    by Paul Howard & Christopher Knight & Annabel Boler & Christine Baker
  • 2008 Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada
    by Deborah A. Marshall & Patrick R. Douglas & Michael F. Drummond & George W. Torrance & Stuart MacLeod & Orlando Manti & Lokanadha Cheruvu & Ron Corvari
  • 2008 Cost of Epilepsy: A Systematic Review
    by Adam Strzelczyk & Jens Peter Reese & Richard Dodel & Hajo M. Hamer
  • 2008 Economic Burden of Heart Failure in the Elderly
    by Lawrence Liao & Larry A. Allen & David J. Whellan
  • 2008 Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-alpha Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia
    by Shelby D. Reed & Kevin J. Anstrom & Yanhong Li & Kevin A. Schulman
  • 2008 A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units
    by Ana M.C. Sogayar & Flavia R. Machado & Alvaro Rea-Neto & Amselmo Dornas & Cintia M.C. Grion & Suzana M.A. Lobo & Bernardo R. Tura & Carla L.O. Silva & Ruy G.R. Cal & Idal Beer & Vilto Michels & Jorge Safi & Marcia Kayath & Eliezer Silva
  • 2008 Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making
    by Lieven Annemans
  • 2008 Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States
    by Nick Bansback & Roberta Ara & Jonathan Karnon & Aslam Anis
  • 2008 Economic Evaluation of Interventions to Treat Opiate Dependence: A Review of the Evidence
    by Christopher M. Doran
  • 2008 Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment
    by Nancy Kline Leidy & Margaret Vernon
  • 2008 Cost-Effectiveness Analysis: Developing Nations Left Behind
    by Mendel E. Singer
  • 2008 Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study
    by Martin Knapp & Frank Windmeijer & Jacqueline Brown & Stathis Kontodimas & Spyridon Tzivelekis & Josep Maria Haro & Mark Ratcliffe & Jihyung Hong & Diego Novick
  • 2008 An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes
    by Scott D. Ramsey & Lauren D. Clarke & Craig S. Roberts & Sean D. Sullivan & Scott J. Johnson & Larry Z. Liu
  • 2008 Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model
    by Simon Kreck & Jochen Klaus & Reiner Leidl & Christian von Tirpitz & Alexander Konnopka & Herbert Matschinger & Hans-Helmut Konig
  • 2008 The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4
    by Paul A. Scuffham & Jennifer A. Whitty & Andrew Mitchell & Rosalie Viney
  • 2008 Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions
    by Sanjoy Roy & S. Suresh Madhavan
  • 2008 An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare
    by Marc A. Koopmanschap & N. Job A. van Exel & Bernard van den Berg & Werner B.F. Brouwer
  • 2008 Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases
    by Kate McKeage & Greg L. Plosker
  • 2008 Community and Patient Values for Preventing Herpes Zoster
    by Tracy A. Lieu & Ismael Ortega-Sanchez & G. Thomas Ray & Donna Rusinak & W. Katherine Yih & Peter W. Choo & Irene Shui & Ken Kleinman & Rafael Harpaz & Lisa A. Prosser
  • 2008 Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens
    by Jeremy Chancellor & Samuel Aballea & Alison Lawrence & Rob Sheldon & Sandrine Cure & Juliette Plun-Favreau & Nick Marchant
  • 2008 Cost-Effectiveness Analyses of Vaccination Programmes: A Focused Review of Modelling Approaches
    by Sun-Young Kim & Sue J. Goldie
  • 2008 Projecting Vaccine Efficacy: Accounting for Geographic Strain Variations
    by Johnie Rose & Mendel E. Singer
  • 2008 Transparency of Economic Evaluations of Health Technologies
    by Joan Rovira
  • 2008 Meandering Down the Road to Transparency
    by Christopher I. Carswell & Joseph A. Paladino
  • 2008 Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents
    by Mei Sheng Duh & Jennifer R. Weiner & Leigh Ann White & Patrick Lefebvre & Paul E. Greenberg
  • 2008 Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies
    by Brian Godman & Alan Haycox & Ulrich Schwabe & Roberta Joppi & Silvio Garattini
  • 2008 Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness
    by Lisa A. Prosser & Megan A. O'Brien & Noelle-Angelique M. Molinari & Katherine H. Hohman & Kristin L. Nichol & Mark L. Messonnier & Tracy A. Lieu
  • 2008 The Burden of Schizophrenia on Caregivers: A Review
    by A. George Awad & Lakshmi N.P. Voruganti
  • 2008 Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide
    by James E. Stahl
  • 2008 Economic Burden of Psoriatic Arthritis
    by Christoph Ackermann & Arthur Kavanaugh
  • 2008 Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections
    by Robin de Vries & Simon Daenen & Keith Tolley & Axel Glasmacher & Archie Prentice & Sarah Howells & Hariette Christopherson & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma
  • 2008 Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study
    by Alan F. Cruess & Gergana Zlateva & Xiao Xu & Gisele Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas F. Goss
  • 2008 The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
    by Giovanni Fattore & Claudio Jommi
  • 2008 Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination
    by Roberto Pradas-Velasco & Fernando Antonanzas-Villar & Maria Puy Martinez-Zarate
  • 2008 Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis
    by Gabriel Rogers & Ruth Garside & Stuart Mealing & Martin Pitt & Rob Anderson & Matthew Dyer & Ken Stein & Margaret Somerville
  • 2008 Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies
    by Andrea M. Anonychuk & Andrea C. Tricco & Chris T. Bauch & Ba' Pham & Vladimir Gilca & Bernard Duval & Ava John-Baptiste & Gloria Woo & Murray Krahn
  • 2008 The New Myth: The Social Value of the QALY
    by Werner Brouwer & Job van Exel & Rachel Baker & Cam Donaldson
  • 2008 Modelling Downstream Effects in the Presence of Technological Change
    by Duncan Mortimer
  • 2008 Does `NICE blight' exist, and if so, why?
    by Alan Haycox
  • 2008 Acknowledgement
    by Adis International Limited
  • 2008 Book Review
    by Adis International Limited
  • 2008 A Cost-Utility Comparison of Four First-Line Medications in Painful Diabetic Neuropathy
    by Alec B. O'Connor & Katia Noyes & Robert G. Holloway
  • 2008 Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?
    by Leela Barham
  • 2008 Management and Prevention of Diabetic Foot Ulcers and Infections: A Health Economic Review
    by Ivy Chow & Elkin V. Lemos & Thomas R. Einarson
  • 2008 Measuring US Pharmaceutical Industry R&D Spending
    by Joseph Golec & John Vernon
  • 2008 Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data
    by Alan G. Wade & Jose-Luis Fernandez & Clement Francois & Karina Hansen & Natalya Danchenko & Nicolas Despiegel
  • 2008 Economic Impact and Long-Term Graft Outcomes of Mycophenolate Mofetil Dosage Modifications Following Gastrointestinal Complications in Renal Transplant Recipients
    by Gerardo Machnicki & Jean-Francois Ricci & Daniel C. Brennan & Mark A. Schnitzler
  • 2008 A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    by D. Eldon Spackman & David L. Veenstra
  • 2008 A Review of Health-Utility Data for Osteoarthritis: Implications for Clinical Trial-Based Evaluation
    by Hirsch S. Ruchlin & Ralph P. Insinga
  • 2008 The Impact of Influenza on Working Days Lost: A Review of the Literature
    by Martin Keech & Paul Beardsworth
  • 2008 Methods for the Meta-Analysis of Willingness-to-Pay Data: An Overview
    by George Van Houtven
  • 2008 Loss Aversion and Cost Effectiveness of Healthcare Programmes: Whose Aversion Counts Anyway?
    by Johan L. Severens
  • 2008 Loss Aversion and Cost Effectiveness of Healthcare Programmes
    by Afschin Gandjour
  • 2008 The Authors
    by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman
  • 2008 Assessing the Value of a Future Study
    by Afschin Gandjour
  • 2008 Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure: An Individual Patient-Based Simulation Model
    by Guiqing Yao & Nick Freemantle & Marcus Flather & Puvan Tharmanathan & Andrew Coats & Philip A. Poole-Wilson
  • 2008 Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients
    by W. Ken Redekop & Ewa Orlewska & Pawel Maciejewski & Frans F.H. Rutten & Louis W. Niessen
  • 2008 Multiple Sclerosis in the UK: Service Use, Costs, Quality of Life and Disability
    by Paul McCrone & Margaret Heslin & Martin Knapp & Paul Bull & Alan Thompson
  • 2008 Quality-of-Life Assessment in Rheumatoid Arthritis
    by Anthony S. Russell
  • 2008 Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?
    by David R. Rappange & Pieter H.M. van Baal & N. Job A. van Exel & Talitha L. Feenstra & Frans F.H. Rutten & Werner B.F. Brouwer
  • 2008 Funding a Clinical Trial: The Perspective of a Medicines Funder
    by Peter Alsop & Scott Metcalfe & Jackie Evans
  • 2008 Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing
    by Steven Simoens
  • 2008 Effectiveness of a Structured Intensive Weight Loss Program Using Health Educators
    by James E. Rohrer & Harvey D. Cassidy & Diane Dressel & Barbara Cramer
  • 2008 Relationship between the Change in Mental Health and Indicators of Medical Costs in the Prevention of Lifestyle-Related Disease
    by Reiko Ishihara & Chihoko Kame & Akira Babazono
  • 2008 An Economic Evaluation of Quantitative Ultrasonometry as Pre-Screening Test for the Identification of Patients with Osteoporosis
    by Mickael Hiligsmann & Olivier Ethgen & Olivier Bruyere & Jean-Yves Reginster
  • 2008 Assessing the Barriers to Engaging Challenging Populations in Disease Management Programs: The Medicaid Experience
    by Dylan H. Roby & Gerald F. Kominski & Nadereh Pourat
  • 2008 Health Beliefs and Culture: Essential Considerations for Outcome Measurement
    by Kamaldeep Bhui & Sokratis Dinos
  • 2008 Antimicrobial Stewardship Programs: Role in Optimizing Infectious Disease Outcomes
    by Christine J. Kubin
  • 2008 Information Technology to Support Self-Management in Chronic Care: A Systematic Review
    by Michael R. Solomon
  • 2008 Use of Collaboration to Improve Outcomes in Chronic Disease: An Overview
    by Monica Gilbert & Carole Staley & Sharryn Lydall-Smith & David J. Castle
  • 2008 Is the Rate of Generic Drug Prescribing a Fair Measure for Pay for Performance?
    by Stephen Buetow & Linda Bryant
  • 2008 Acknowledgment
    by Adis International Limited
  • 2008 Evaluation Methods in Disease Management Studies: 2004-07
    by Thomas Wilson & Martin MacDowell & Patricia Salber & Gary Montrose & Carolyn Hamm
  • 2008 Symptom Perspectives: Patient-Professional Differences and Communication
    by Cathy Michaels & Suzanne C. Lareau
  • 2008 Patients with Chronic Obstructive Pulmonary Disease: Between Reality and Expectations - A Patient
    by Wlodzimierz Vlady Rozenbaum
  • 2008 Patients with Alpha-1 Antitrypsin Deficiency: Disease Management Considerations
    by Rick Carter & Brian L. Tiep
  • 2008 Successful Smoking Cessation
    by Gary L. Huber & Vijay K. Mahajan
  • 2008 Clinical Decision Processes and Patient Engagement in Self-Management
    by Jean Bourbeau
  • 2008 Disease Management of Chronic Obstructive Pulmonary Disease from a Disease Management Organization Perspective: Providing Technology and Time to Address Gaps in Care
    by Christobel E. Selecky
  • 2008 Integrated Chronic Obstructive Pulmonary Disease Management in Primary Care
    by Niels H. Chavannes
  • 2008 Disease Management for Chronic Obstructive Pulmonary Disease: A Clinical Strategy
    by Brian L. Tiep & Mary C. Barnett
  • 2008 Asthma as a Model for Chronic Disease Management Programs: The Interplay between Pulmonary Function and Quality of Life
    by Aris C. Garro & Robert B. Klein
  • 2008 Optimizing Disease Management of Chronic Obstructive Pulmonary Disease
    by Philip Corsello & David Tinkelman
  • 2008 Approaches to Chronic Disease and Chronic Care: From Oxymoron to Modern Zeitgeist
    by Anna M. Tacon
  • 2008 The Emerging Chronic Obstructive Pulmonary Disease Epidemic: Clinical Impact, Economic Burden, and Opportunities for Disease Management
    by Rick Carter & Brian L. Tiep & Rebecca E. Tiep
  • 2008 Chronic Obstructive Pulmonary Disease: The Challenge and the Solution
    by Thomas L. Petty
  • 2008 Delivering Diabetes Self-Management Education (DSME) in Primary Care: The Pittsburgh Regional Initiative For Diabetes Education (PRIDE)
    by Linda M. Siminerio & Kristine Ruppert & Sharlene Emerson & Francis X. Solano & Gretchen A. Piatt
  • 2008 Disease Management Programs Targeting Obesity in Children: Setting the Scene for Wellness in the Future
    by Adrienne R. Hughes & John J. Reilly
  • 2008 Community Pharmacy, Disease State Management, and Adherence to Medication: A Review
    by Carol Lyn Armour & Lorraine Smith & Ines Krass
  • 2008 Clinical Pharmacy Services in the Home
    by Linda D. MacKeigan & Lisa M. Nissen
  • 2008 Launch of a National Mandatory Chronic Disease Prevention Program in Japan
    by Atsushi Kobayashi
  • 2008 Measuring Quality in Pay-for-Performance Programs: From `One-Size-Fits-All' Measures to Individual Patient Risk-Reduction Scores
    by Jennifer A. Meddings & Laurence F. McMahon
  • 2008 Pharmacy Continuity of Care: What do Community Pharmacists Need from an Acute Care Hospital to Improve Continuity of Pharmaceutical Care?
    by Cherokee Layson-Wolf & Jill A. Morgan
  • 2008 An Italian Chart for Cardiovascular Risk Estimate Including High-Density Lipoprotein-Cholesterol
    by Alessandro Menotti & Mariapaola Lanti
  • 2008 Clinical and Economic Effects of a Therapeutic Substitution Policy for Proton Pump Inhibitors in Aboriginal Patients in Northern Communities in Canada's Northwest Territories
    by Kathryn Gaebel & Neda Toeg & Mitchell Levine
  • 2008 Why it Pays for Hospitals to Initiate a Heart Failure Disease Management Program
    by Mauricio Velez & Bethany Westerfeldt & Peter S. Rahko
  • 2008 Creating the Virtual Team: Application to Diabetes Mellitus Disease Management
    by Roger Mazze
  • 2008 Pharmacist-Led Interventions for the Management of Cardiovascular Disease: Opportunities and Obstacles
    by Karen J. McConnell & Anne M. Denham & Kari L. Olson
  • 2008 Considerations in Culturally Directed Asthma Disease Management Programs
    by Michelle M. Cloutier
  • 2008 Employee Disease Management in US and Global Workplaces: Integrating Strategies and Expanding their Scope
    by Robin C. Rager & Joseph A. Leutzinger & Jeff A. Hochberg & Wolf Kirsten & David H. Chenoweth
  • 2008 The Potential and Pitfalls of Medicine Management: What Have We Learned So Far?
    by Alison Blenkinsopp & Christine M. Bond
  • 2008 Lessons from Early Experience with Pay for Performance
    by Tim Doran
  • 2008 Disease Management Update
    by Adis International Limited
  • 2008 Intensified Diabetes Care Monitoring and Physician Education: Impact on Outcomes and Costs of Care
    by Ann Donnelly & Prasad Kommareddi & Michael James & Jerry Van Horn & Christopher Zacker & Dan Belletti
  • 2008 Cost Analysis of a Maternity Disease Management Program
    by Gary Stanziano & Niki Istwan
  • 2008 Interdisciplinary Coordination for Breast Healthcare: A Rational Approach to Detection, Diagnosis, and Treatment
    by Benjamin O. Anderson & Cary S. Kaufman & Krystyna D. Kiel & Robert W. Carlson
  • 2008 Disease Management Update
    by Adis International Limited
  • 2008 Nursing Workload Associated with Hospital Patient Care
    by Nicole Mittmann & Soo Jin Seung & Luca F. Pisterzi & Pierre K. Isogai & Donna Michaels
  • 2008 General Pain and Frequency of Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records
    by James E. Rohrer & Stephen P. Merry & Steven C. Adamson & Darryl E. Barnes
  • 2008 Challenges and Applications of the Transtheoretical Model in Patients with Diabetes Mellitus
    by Ana Andres & Juana Gomez & Carmina Saldana
  • 2008 Poor Adherence to Medication in Adults with Rheumatoid Arthritis: Reasons and Solutions
    by Rachel A. Elliott
  • 2008 Challenges Facing Nurse-Led Disease Management for Heart Failure
    by Paul L. Hebert & Jane E. Sisk
  • 2008 Cost-Effectiveness Analysis of Entecavir versus Lamivudine in the First-Line Treatment of Australian Patients with Chronic Hepatitis B
    by Elizabeth Arnold & Yong Yuan & Uchenna Iloeje & Greg Cook
  • 2008 Does Extending Health Insurance Coverage to the Uninsured Improve Population Health Outcomes?
    by James A. Thornton & Jennifer L. Rice
  • 2008 Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France
    by Baudouin Standaert & Nathalie Parez & Bertrand Tehard & Xavier Colin & Bruno Detournay
  • 2008 A Pharmacoeconomic Analysis of Compliance Gains on Antipsychotic Medications
    by Joep Damen & Per-Olof Thuresson & Bart Heeg & Mickael Lothgren
  • 2008 Community-Based Interventions to Promote Increased Physical Activity: A Primer
    by Melissa Bopp & Elizabeth Fallon
  • 2008 The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand
    by Edward Norey & Tessa M. Simone & Shaker A. Mousa
  • 2008 The Impact of Banning Smoking in Workplaces: What are the Early Effects?
    by Shane Allwright
  • 2008 Cost Analysis of Amlodipine versus Enalapril in Patients with Coronary Artery Disease and Normal Blood Pressure: Findings from the CAMELOT Economic Substudy
    by Joseph Menzin & Luke Boulanger & Simon Tang & Kamlesh Thakker & Steven E. Nissen
  • 2008 The Association of Adherence to Antiretroviral Therapy with Healthcare Utilization and Costs for Medical Care
    by Edward M. Gardner & Moises E. Maravi & Cornelis Rietmeijer & Arthur J. Davidson & William J. Burman
  • 2008 Households' Willingness to Pay for a Motorcycle Helmet in Hanoi, Vietnam
    by Khanh H. Pham & Quynh X. Le Thi & Dennis J. Petrie & Jon Adams & Christopher M. Doran
  • 2008 Cost Effectiveness of Ultrasound and Bone Densitometry for Osteoporosis Screening in Post-Menopausal Women
    by Dirk Mueller & Afschin Gandjour
  • 2008 Direct Medical Costs for Type 2 Diabetes Mellitus Complications in the US Commercial Payer Setting: A Resource for Economic Research
    by Elise M. Pelletier & Paula J. Smith & Kristina S. Boye & Derek A. Misurski & Sandra L. Tunis & Michael E. Minshall
  • 2008 Cost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context
    by Mattias Neyt & Nancy Thiry & Dirk Ramaekers & Hans Van Brabandt
  • 2008 The Lifetime Cost of Hepatocellular Carcinoma: A Claims Data Analysis from a Medical Centre in Taiwan
    by Hui-Chu Lang & Jaw-Ching Wu & Sang-Hue Yen & Chung-Fu Lan & Shi-Liang Wu
  • 2008 Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia: A 12- and 24-Month Follow-Up from the e-STAR Database in Spain
    by Jose M. Olivares & Alfonso Rodriguez-Martinez & Jose A. Buron & David Alonso-Escolano & Alexander Rodriguez-Morales
  • 2008 Wealth Status and Risky Sexual Behaviour in Ghana and Kenya
    by Kofi Awusabo-Asare & Samuel K. Annim
  • 2008 Differences in Generic Drug Prices between the US and Canada
    by Malcolm Gooi & Chaim M. Bell
  • 2008 Cost Effectiveness of Screen-and-Treat Strategies for Low Bone Mineral Density: How Do We Screen, Who Do We Screen and Who Do We Treat?
    by John T. Schousboe
  • 2008 Swiss DRGs: Patient Heterogeneity and Hospital Payments
    by Michel Mougeot & Florence Naegelen
  • 2008 Catastrophic health care, poverty, and impoverishment in the Philippines
    by Ronaldo D. Ico
  • 2008 Public-Private Partnerships in Regional Hospitals:the Case of Clinical Hospital Osijek
    by Branimir Markovic & Marina Dukic
  • 2008 The Demand for Health Insurance and Use of Medical Services in Colombia: Differences Between Workers and the Self-Employed Workers
    by Juan Miguel Gallego
  • 2008 Policy focus: A robust normative evaluation of India's performance in allocating risks of death
    by Nicolas Gravel & Abhiroop Mukhopadhyay & Benoit Tarroux
  • 2008 Honestly, Who Else Would Fund Such Research? Reflections of a Non-Smoking Scholar
    by Michael L. Marlow
  • 2008 The impact of child health status on learning ability and school entrance age
    by Paolo Rungo
  • 2008 Analyzing the impact of prenatal care on infant health: do we have useful input and output measures?
    by Sankar Mukhopadhyay & Wei Yang & Wai Lee & Jeanne Wendel
  • 2008 Potential conflicts in the fight against counterfeit drugs
    by Paolo Rungo & Berta Rivera & Luis Currais
  • 2008 A model of parallel imports of pharmaceuticals with endogenous price controls
    by Katherine Sauer
  • 2008 Tobacco Chewing, Smoking and Health Knowledge: Evidence from Bangladesh
    by Shiferaw Gurmu & Mohammad Yunus
  • 2008 HEALTH, EDUCATION AND ECONOMIC GROWTH: TESTING FOR LONG-RUN RELATIONSHIPS AND CAUSAL LINKS in the United States
    by Aka, Bédia F. & Dumont, J.C.
  • 2008 Demanda por seguro de salud y uso de servicios médicos en Colombia: diferencias entre trabajadores dependientes e independientes
    by Juan Miguel Gallego
  • 2008 Assurance santé et sélection adverse. L'incidence des maladies invalidantes
    by David Alary & Franck Bien
  • 2007 Optimal Health Care Contracts under Physician Agency
    by Philippe Chone & Ching-to Albert Ma
  • 2007 Prevention and Dynamic Risk Adjustment
    by Karen Eggleston & Randall P. Ellis & Mingshan Lu
  • 2007 Desarrollo de los temas centrales del sistema sanitario en el Perú
    by Janice Seinfeld & Margarita Petrera
  • 2007 El proceso de reforma sanitaria peruana
    by Janice Seinfeld & Margarita Petrera
  • 2007 La reforma sanitaria como proceso
    by Janice Seinfeld & Margarita Petrera
  • 2007 Contexto, determinantes y retos del nuevo perfil epidemiológico en el Perú
    by Janice Seinfeld & Margarita Petrera
  • 2007 Repensando la salud en el Perú
    by
  • 2007 The Healthcare Fix: Universal Insurance for All Americans
    by Laurence J. Kotlikoff
  • 2007 Automobile Seatbelt Usage and the Value of Statistical Life
    by Jahn K. Hakes & W. Kip Viscusi
  • 2007 Salud y desarrollo económico. El caso de México
    by Lustig, Nora
  • 2007 Poverty, Undernutrition, and Child Mortality: Some Inter-Regional Puzzles and their Implications for Research and Policy
    by Klasen, Stephan
  • 2007 Looking for private information in self-assessed health
    by James Banks & Thomas Crossley & Simo Goshev
  • 2007 Unravelling the influence of smoking initiation and cessation on premature mortality using a common latent factor model
    by Silvia Balia & Andrew M. Jones
  • 2007 Hypertension and Happiness across Nations
    by Blanchflower, David G. & Oswald, Andrew J.
  • 2007 Hypertension and Happiness across Nations
    by Blanchflower, David G. & Oswald, Andrew J.
  • 2007 The Impact of Parental Income and Education on Child Health : Further Evidence for England
    by Doyle, Orla & Harmon, Colm & Walker, Ian
  • 2007 A Mean-Variance Portfolio Analysis of the Demand and Supply of a Potentially Infectious Service
    by Levy, Amnon
  • 2007 Malaria: Disease Impacts and Long-Run Income Differences
    by Douglas Gollin & Christian Zimmermann
  • 2007 Monitoring the Realization of the Right to Food: Adaptation and Validation of the U.S. Department of Agriculture Food Insecurity Module to Rural Senegal
    by Susan Randolph & Ibrahima Gaye & Ibrahima Hathie & Rafael Perez-Escamilla
  • 2007 The Impact of Parental Income and Education on Child Health. Further Evidence for England
    by Orla Doyle & Colm Harmon & Ian Walker
  • 2007 The Impact of the Indonesian Health Card Program: A Matching Estimator Approach
    by Meliyanni Johar
  • 2007 HIV/AIDS and Poverty in South Africa: a Bayesian Estimation
    by Fabrice Murtin & Federica Marzo
  • 2007 The Impact of Cell Phones and BAC Laws on Motor Vehicle Fatality Rates
    by Peter D. Loeb & William A. Clarke & Richard Anderson
  • 2007 Effects of Health and Education on Labour Force Participation
    by Patrick Laplagne & Maurice Glover & Anthony Shomos
  • 2007 Bayesian Estimation of Hispanic Fertility Hazards from Survey and Population Data
    by Michael S. Rendall & Mark S. Handcock & Stefan H. Jonsson
  • 2007 The Income Gradient In Children'S Health: A Comment On Currie, Shields And Wheatley Price
    by Anne Case & Diana Lee & Christina Paxson
  • 2007 The Income Gradient In Children'S Health: A Comment On Currie, Shields And Wheatley Price
    by Anne Case & Diana Lee & Christina Paxson
  • 2007 Who Does Bear the Costs of Compliance with Sanitary and Phytosanitary Measures in Poor Countries?
    by Shafaeddin, Mehdi
  • 2007 Sex, Gender And Health: A Conceptual Note
    by Manisha, Chawala & Himanshu Sekhar, Rout
  • 2007 Health And Health Economics: A Conceptual Framework
    by Himanshu Sekhar, Rout & Narayan C handra, Nayak
  • 2007 Determinants of Household Health Expenditure: Case of Urban Orissa
    by Bhabesh, Sen & Himanshu, Sekhar Rout
  • 2007 An action plan to assess the current situation of maternal & newborn care at government health facilities in Jharkhand, India
    by Kumar, Sudesh & Singh, Janet
  • 2007 R&D models: lessons from vaccine history
    by Wilson, Paul & Post, Sarah & Srinivas, Smita
  • 2007 Cost Measurement in Laparoscopic Surgery: Results from an Activity-Based Costing Application
    by Cinquini, Lino & Miolo Vitali, Paola & Pitzalis, Arianna & Campanale, Cristina
  • 2007 The Demand for Private Health Insurance in Malawi
    by Makoka, Donald & Kaluwa, Ben & Kambewa, Patrick
  • 2007 Poverty and Access to Maternal Health Care Services in Pakistan: Evidence from Perception Based Data
    by Haq, Rashida & Arshad, Nabeela
  • 2007 Small and medium enterprises and the enjoinment of economic human rights:evidence from Egypt
    by Alasrag, Hussien
  • 2007 Small enterprises as an instrument of enjoyment of the economic human rights in Egypt
    by Alasrag, Hussien
  • 2007 Health cost in Indonesia: evidences from IFLS and Susenas data
    by Sanjaya, M Ryan
  • 2007 Health and Wages - Panel data estimates considering selection and endogeneity
    by Jäckle, Robert & Himmler, Oliver
  • 2007 Privacy Protection and Technology Diffusion: The Case of Electronic Medical Records
    by Catherine Tucker & Amalia Miller
  • 2007 Impact of First Occupation on Health at Older Ages
    by Jody L. Sindelar & Jason Fletcher & Tracy Falba & Patricia Keenan & William T. Gallo
  • 2007 Mortality, Mass-Layoffs, and Career Outcomes: An Analysis using Administrative Data
    by Daniel Sullivan & Till von Wachter
  • 2007 Body Composition and Wages
    by Roy Wada & Erdal Tekin
  • 2007 How Much Uncompensated Care do Doctors Provide?
    by Jonathan Gruber & David Rodriguez
  • 2007 Employer Health Insurance Mandates and the Risk of Unemployment
    by Katherine Baicker & Helen Levy
  • 2007 The Impact of Research Grant Funding on Scientific Productivity
    by Brian Jacob & Lars Lefgren
  • 2007 Heterogeneous Impact of the "Seguro Popular" Program on the Utilization of Obstetrical Services in Mexico, 2001-2006: A Multinomial Probit Model with a Discrete Endogenous Variable
    by Sandra G. Sosa-Rubi & Omar Galarraga & Jeffrey E. Harris
  • 2007 The Income Gradient in Children's Health: A Comment on Currie, Shields and Wheatley Price
    by Anne Case & Diana Lee & Christina Paxson
  • 2007 Overweight in Adolescents: Implications for Health Expenditures
    by Alan C. Monheit & Jessica P. Vistnes & Jeannette A. Rogowski
  • 2007 Risk Tolerance and Alcohol Demand Among Adults and Older Adults
    by Dhaval Dave & Henry Saffer
  • 2007 Childhood Disadvantage and Obesity: Is Nurture Trumping Nature?
    by Patricia M. Anderson & Kristin F. Butcher & Diane Whitmore Schanzenbach
  • 2007 Social Interactions and Smoking
    by David M. Cutler & Edward L. Glaeser
  • 2007 Child Mental Health and Human Capital Accumulation: The Case of ADHD Revisited
    by Jason Fletcher & Barbara L. Wolfe
  • 2007 Family Structure and the Treatment of Childhood Asthma
    by Alex Y. Chen & José Escarce
  • 2007 Health Status, Health Care and Inequality: Canada vs. the U.S
    by June E. O'Neill & Dave M. O'Neill
  • 2007 The Effects of Mandatory Seatbelt Laws on Seatbelt Use, Motor Vehicle Fatalities, and Crash-Related Injuries among Youths
    by Christopher S. Carpenter & Mark Stehr
  • 2007 Consequences of Eliminating Federal Disability Benefits for Substance Abusers
    by Pinka Chatterji & Ellen Meara
  • 2007 The Effect of Alcohol Consumption on Mortality: Regression Discontinuity Evidence from the Minimum Drinking Age
    by Christopher Carpenter & Carlos Dobkin
  • 2007 Dynamic Inefficiencies in Employment-Based Health Insurance System Theory and Evidence
    by Hanming Fang & Alessandro Gavazza
  • 2007 The Value of Life Near its End and Terminal Care
    by Gary Becker & Kevin Murphy & Tomas Philipson
  • 2007 Fraternity Membership and Drinking Behavior
    by Jeffrey S. DeSimone
  • 2007 How Did SCHIP Affect the Insurance Coverage of Immigrant Children?
    by Thomas Buchmueller & Anthony Lo Sasso & Kathleen Wong
  • 2007 What Do Nonprofits Maximize? Nonprofit Hospital Service Provision and Market Ownership Mix
    by Jill R. Horwitz & Austin Nichols
  • 2007 Mental Health in Childhood and Human Capital
    by Janet Currie & Mark Stabile
  • 2007 The Economics, Technology and Neuroscience of Human Capability Formation
    by James J. Heckman
  • 2007 Does the Certainty of Arrest Reduce Domestic Violence? Evidence from Mandatory and Recommended Arrest laws
    by Radha Iyengar
  • 2007 Current and Future Prevalence of Obesity and Severe Obesity in the United States
    by Christopher J. Ruhm
  • 2007 How Do Workplace Smoking Laws Work? Quasi-Experimental Evidence from Local Laws in Ontario, Canada
    by Christopher Carpenter
  • 2007 Information and Communications Technology in Chronic Disease Care: Why is Adoption So Slow and Is Slower Better?
    by Michael C. Christensen & Dahlia Remler
  • 2007 Cigarette Taxes and Youth Smoking: New Evidence from National, State, & Local Youth Risk Behavior Surveys
    by Christopher Carpenter & Philip J. Cook
  • 2007 Patient Cost-Sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly
    by Amitabh Chandra & Jonathan Gruber & Robin McKnight
  • 2007 Is Well-being U-Shaped over the Life Cycle?
    by David G. Blanchflower & Andrew Oswald
  • 2007 Diabetes and the Rise of the SES Health Gradient
    by James Smith
  • 2007 Criminal Prosecution and HIV-related Risky Behavior
    by Adeline Delavande & Dana Goldman & Neeraj Sood
  • 2007 Africa's Lagging Demographic Transition: Evidence from Exogenous Impacts of Malaria Ecology and Agricultural Technology
    by Dalton Conley & Gordon C. McCord & Jeffrey D. Sachs
  • 2007 Integrated Insurance Design in the Presence of Multiple Medical Technologies
    by Dana Goldman & Tomas Philipson
  • 2007 Crowd-Out Ten Years Later: Have Recent Public Insurance Expansions Crowded Out Private Health Insurance?
    by Jonathan Gruber & Kosali Simon
  • 2007 Mandated Health Insurance Benefits and the Utilization and Outcomes of Infertility Treatments
    by M. Kate Bundorf & Melinda Henne & Laurence Baker
  • 2007 Do Instrumental Variables Belong in Propensity Scores?
    by Jay Bhattacharya & William B. Vogt
  • 2007 Sources of Variation in State-Level Food Stamp Participation Rates
    by Scott Cody & Allen Schirm & Elizabeth Stuart & Laura Castner & Alan Zaslavsky
  • 2007 Results from the "I Am Moving, I Am Learning" Stage 1 Survey
    by Daniel Finkelstein & Robert Whitaker & Elaine Hill & Mary Kay Fox & Linda Mendenko & Kimberly Boller
  • 2007 School Food Environments and Policies in U.S. Public Schools
    by Daniel Finkelstein & Elaine Hill & Robert C. Whitaker
  • 2007 The Rationale and Potential Consequences of the Revised WIC Food Packages
    by Barbara Devaney
  • 2007 WIC Turns 35: Program Effectiveness and Future Directions
    by Barbara Devaney
  • 2007 Dynamics of Food Stamp Program Participation, 2001-2003 Summary
    by Scott Cody & Laura A. Castner & James Mabli & Julie Sykes
  • 2007 Dynamics of Food Stamp Program Participation, 2001-2003
    by Scott Cody & Laura Castner & James Mabli & Julie Sykes
  • 2007 School Nutrition Dietary Assessment Study-III: Summary of Findings
    by Anne Gordon & Mary Kay Fox
  • 2007 The Association Between Maltreatment and Obesity Among Preschool Children
    by Robert C. Whitaker & Shannon M. Phillips & Sean M. Orzol & Hillary L. Burdette
  • 2007 Erroneous Payments in the NSLP and SBP Volume II: Sampling and Data Analysis Appendices. NSLP/SBP Access, Participation, Eligibility, and Certification Study
    by Michael Ponza & Philip Gleason & Eric Grau & John Hall & Lara Hulsey & Quinn Moore
  • 2007 Erroneous Payments in the NSLP and SBP. Volume I: Findings. NSLP/SBP Access, Participation, Eligibility, and Certification Study
    by Michael Ponza & Philip Gleason & Lara Hulsey & Quinn Moore
  • 2007 Reaching Those in Need: State Food Stamp Participation Rates in 2005
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2007 School Nutrition Dietary Assessment Study-III: Volume III: Sampling and Data Collection
    by Anne Gordon & John Hall & Eric Ziedman & Mary Kay Crepinsek & Melissa Clark & Elizabeth Condon
  • 2007 School Nutrition Dietary Assessment Study-III: Volume II: Student Participation and Dietary Intakes. Appendices
    by Anne Gordon & Mary Kay Fox & Melissa Clark & Renée Nogales & Elizabeth Condon & Philip Gleason & Ankur Sarin
  • 2007 School Nutrition Dietary Assessment Study-III: Volume II: Student Participation and Dietary Intakes
    by Anne Gordon & Mary Kay Fox & Melissa Clark & Renée Nogales & Elizabeth Condon & Philip Gleason & Ankur Sarin
  • 2007 School Nutrition Dietary Assessment Study-III: Volume I: School Food Service, School Food Environment, and Meals Offered and Served
    by Anne Gordon & Mary Kay Crepinsek & Renée Nogales & Elizabeth Condon
  • 2007 Characteristics of Food Stamp Households: Fiscal Year 2006
    by Kari Wolkwitz
  • 2007 Change in Food Security Status and Change in Weight Are Not Associated in Urban Women with Preschool Children
    by Robert C. Whitaker & Ankur Sarin
  • 2007 Tables Describing the Asset and Vehicle Holdings of Low-Income Households in 2002
    by Carole Trippe & Bruce Schechter
  • 2007 Trends in Food Stamp Program Participation Rates: 1999 to 2005
    by Kari Wolkwitz
  • 2007 Nutrition Education Research Brief: Message Framing, Use of Interactive Technology to Tailor Messages and Intervention Intensity
    by Mary Kay Fox & Charlotte Hanson & Ronette Briefel
  • 2007 Trends in Food Stamp Program Participation Rates: 1999 to 2005
    by Kari Wolkwitz
  • 2007 Dietary Methodology: Advancements in the Development of Short Instruments to Assess Dietary Fat
    by Ronette R. Briefel
  • 2007 Nutrition Standards for Foods in Schools: Leading the Way Toward Healthier Youth
    by Committee on Nutrition Standards for Foods in Schools & of which James Ohls was a member
  • 2007 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates in 2002-2004 for All Eligible People and the Working Poor
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2007 Addressing the Epidemic of Childhood Obesity Through School-Based Interventions: What Has Been Done and Where Do We Go from Here?
    by Karen E. Peterson & Mary Kay Fox
  • 2007 Review of Dietary Reference Intakes for Selected Nutrients: Application Challenges and Implications for Food and Nutrition Assistance Programs
    by Barbara Devaney & Mary Kay Crepinsek & Ken Fortson & Lisa Quay
  • 2007 Commentary: Should I Blame Mom or Dad? Identifying the Relative Contribution of Each Parent's Body Size to That of Their Offspring
    by Robert C. Whitaker
  • 2007 Looking for Private Information in Self-Assessed Health
    by James Banks & Thomas Crossley & Simo Goshev
  • 2007 Looking for Private Information in Self-Assessed Health
    by James Banks & Thomas Crossley & Simo Goshev
  • 2007 The Economic Impact of Medical Migration: a Receiving CountryÕs Perspective
    by Martine Rutten
  • 2007 The Economic Impact of Medical Migration: an Overview of the Literature
    by Martine Rutten
  • 2007 Malaria: Disease Impacts and Long-Run Income Differences
    by Gollin, Douglas & Zimmermann, Christian
  • 2007 Malaria: Disease Impacts and Long-Run Income Differences
    by Douglas Gollin & Christian Zimmermann
  • 2007 Agency in Health-Care: Are Medical Care-Givers Perfect Agents?
    by Neuman, Einat & Neuman, Shoshana
  • 2007 Agency in Health-Care: Are Medical Care-Givers Perfect Agents?
    by Einat Neuman & Shoshana Neuman
  • 2007 Hypertension and Happiness across Nations
    by David G. Blanchflower & Andrew J. Oswald
  • 2007 Hypertension and Happiness across Nations
    by Blanchflower, David G. & Oswald, Andrew J.
  • 2007 Sickness and injury leave in France: moral hazard or strain?
    by Michel Grignon & Thomas Renaud
  • 2007 Does Health Information Matter for Modifying Consumption? A Field Experiment Measuring the Impact of Risk Information on Fish Consumption
    by Jutta Roosen & Stéphan Marette & Sandrine Blanchemanche & Philippe Verger
  • 2007 Health Information and the Choice of Fish Species: An Experiment Measuring the Impact of Risk and Benefit Information
    by Stéphan Marette & Jutta Roosen & Sandrine Blanchemanche & Philippe Verger
  • 2007 Heterogeneity, State Dependence and Health
    by Timothy J. Halliday
  • 2007 Poverty, Undernutrition, and Child Mortality: Some Inter-Regional Puzzles and their Implications for Research and Policy
    by Stephan Klasen
  • 2007 Inequality measurement for ordered response health data
    by Ramses H. Abul Naga & Tarik Yalcin
  • 2007 Cost-benefit analysis of psychological therapy
    by Richard Layard & David Clark & Martin Knapp & Guy Mayraz
  • 2007 The relationship between alcohol consumption and self-reported health status using the EQ5D
    by Dennis Petrie & Chris Doran & Anthony Shakeshaft & Rob Sanson-Fisher
  • 2007 Substance Abuse Treatment and Motor Vehicle Fatalities
    by Beth A. Freeborn & Brian McManus
  • 2007 Competition and Crowding-Out among Public, Non-Profit and For-Profit Organizations: Evidence from Outpatient Substance Abuse Treatment
    by Andrew M. Cohen & Beth A. Freeborn & Brian McManus
  • 2007 A theory of dynamics and inequalities under epidemics
    by Raouf, BOUCEKKINE
  • 2007 Agency in Health-Care: Are Medical Care-Givers Perfect Agents?
    by Neuman, Einat & Neuman, Shoshana
  • 2007 A theory of dynamics and inequalities under epidemics
    by BOUCEKKINE, Raouf & LAFFARGUE, Jean-Pierre
  • 2007 Nutrición en el Caribe colombiano y su relación con el capital humano
    by Joaquín Viloria de la Hoz
  • 2007 Cost-Benefit Analysis of Psychological Therapy
    by David Clark & Martin Knapp & Richard Layard & Guy Mayraz
  • 2007 Investigación, políticas y desarrollo en el Perú
    by GRADE
  • 2007 The Authors' Reply
    by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos
  • 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
    by Philip Home & Adrian Bagust & Matthew Taylor & Philip Ambery & Samara Mendes da Costa
  • 2007 Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab
    by Julie Jacobson Vann & John Feaganes & Steven Wegner
  • 2007 Preferences of Community Pharmacists for Extended Roles in Primary Care: A Survey and Discrete Choice Experiment
    by Anthony Scott & Christine Bond & Jackie Inch & Aileen Grant
  • 2007 Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention
    by Bart M.S. Heeg & Ron J.G. Peters & Marc Botteman & Ben A. van Hout
  • 2007 Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus: Review and Analysis of the Literature
    by Andrew F. Shorr
  • 2007 Modelling Disease Progression in Alzheimer's Disease: A Review of Modelling Methods used for Cost-Effectiveness Analysis
    by Colin Green
  • 2007 The Increasingly Complex Fourth Hurdle for Pharmaceuticals
    by Joshua Cohen & Elly Stolk & Maartje Niezen
  • 2007 Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations
    by Lisa A. Prosser & James K. Hammitt & Ron Keren
  • 2007 A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease
    by Maureen P.M.H. Rutten-van Molken & Floortje E. van Nooten & Marion Lindemann & Manfred Caeser & Peter M.A. Calverley
  • 2007 A Stated Preference Binary Choice Experiment to Explore NICE Decision Making
    by Paul Tappenden & John Brazier & Julie Ratcliffe & James Chilcott
  • 2007 Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US
    by Joseph A. Paladino & Martin H. Adelman & Jerome J. Schentag & Paul B. Iannini
  • 2007 Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study
    by Roberto Dal Negro & Peter Piskorz & Roberto Vives & Magda Guilera & Vasilisa Sazonov Kocevar & Xavier Badia
  • 2007 The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis
    by Grant H. Skrepnek
  • 2007 Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature
    by Jaume Puig-Junoy & Ivan Moreno-Torres
  • 2007 When Drugs Don't Work: Economic Assessment of Enhancing Compliance with Interventions Supported by Electronic Monitoring Devices
    by Dyfrig Hughes
  • 2007 Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries
    by Liu Bao Peng & Chong Qing Tan & Xiao Min Wan & Wei Cui
  • 2007 Direct and Indirect Costs Attributable to Alcohol Consumption in Germany
    by Alexander Konnopka & Hans-Helmut Konig
  • 2007 The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale
    by Leida M. Lamers & Carin A. Uyl-de Groot & Ivonne Buijt
  • 2007 A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma
    by Ya-Chen Tina Shih & Josephine Mauskopf & Rohit Borker
  • 2007 Retrospective Economic and Outcomes Analyses Using Non-US Databases: A Review
    by Lizheng Shi & Eric Q Wu & Meredith Hodges & Andrew Yu & Howard Birnbaum
  • 2007 Cost Considerations in the Treatment of Colorectal Cancer
    by Frank G.A. Jansman & Maarten J. Postma & Jacobus R.B.J. Brouwers
  • 2007 Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia
    by John A. Vernon
  • 2007 Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads
    by Ron Goeree & Daria O'Reilly & Jean-Eric Tarride & Jim Bowen & Gord Blackhouse & Kaitryn Campbell & Rob Hopkins & Morgan Lim & Lisa Patterson
  • 2007 Building Bridges Between Academic Research and Policy Formulation: When Costing Less Means Costing More
    by Amiram Gafni & Stephen Birch
  • 2007 Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression
    by Adam E. Block
  • 2007 Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands
    by Maarten J. Postma & Annoesjka Novak & Huib W.K.F.H. Scheijbeler & Marlene Gyldmark & Marianne L.L. van Genugten & Jan C. Wilschut
  • 2007 Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia
    by Theodore Darkow & Henry J. Henk & Simu K. Thomas & Weiwei Feng & Jean-Francois Baladi & George A. Goldberg & Alan Hatfield & Jorge Cortes
  • 2007 A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers?
    by Yot Teerawattananon & Steve Russell & Miranda Mugford
  • 2007 Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis
    by S.D. Walter & Amiram Gafni & Stephen Birch
  • 2007 Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios
    by Stefan Gress & Dea Niebuhr & Uwe May & Jurgen Wasem
  • 2007 Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model
    by J. Alasdair Millar & Michael J. Millward
  • 2007 Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study
    by Kanlaya Teerawattananon & Saniorn Iewsakul & Chawewan Yenjitr & Somsanguan Ausayakhun & Watanee Yenjitr & Miranda Mugford & Yot Teerawattananon
  • 2007 Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives
    by Anthony Scott & Michela Tinelli & Christine Bond
  • 2007 The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation
    by Peter Wahlqvist & Gordon H. Guyatt & David Armstrong & Alessio Degl'Innocenti & Diane Heels-Ansdell & Samer El-Dika & Ingela Wiklund & Carlo A. Fallone & Lisa Tanser & Sander Veldhuyzen van Zanten & Peggy Austin & Alan N. Barkun & Naoki Chiba & Holger J. Schunemann
  • 2007 Health Utilities Using the EQ-5D in Studies of Cancer
    by A. Simon Pickard & Caitlyn T. Wilke & Hsiang-Wen Lin & Andrew Lloyd
  • 2007 Replace Pharmaceutical Patents Now
    by Earl L. Grinols & James W. Henderson
  • 2007 Book Review
    by Adis International Limited
  • 2007 Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective
    by Leon E. Cosler & Adi Eldar-Lissai & Eva Culakova & Nicole M. Kuderer & David Dale & Jeffrey Crawford & Gary H. Lyman
  • 2007 Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective
    by Thomas E. Delea & Oleg Sofrygin & Simu K. Thomas & Jean-Francois Baladi & Pradyumna D. Phatak & Thomas D. Coates
  • 2007 Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer
    by Steven B. Zeliadt & David F. Penson
  • 2007 The Economic Implications of Glaucoma: A Literature Review
    by Jordana K. Schmier & Michael T. Halpern & Mechelle L. Jones
  • 2007 Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients: An Overview of Instruments Developed to Date
    by Irina Cleemput & Fabienne Dobbels
  • 2007 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2007 Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada
    by Daniel T. Grima & Melissa F. Thompson & Luc Sauriol
  • 2007 Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients
    by Danielle E.M. Brunenberg & Gwenn E.C. Wetzels & Patricia J. Nelemans & Carmen D. Dirksen & Johan L. Severens & Henri E.J.H. Stoffers & Jan S.A.G. Schouten & Martin H. Prins & Peter W. de Leeuw & Manuela A. Joore
  • 2007 Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods
    by Diego F. Ossa & Andrew Briggs & Emma McIntosh & Warren Cowell & Tim Littlewood & Mark Sculpher
  • 2007 Do Drugs Reduce Utilisation of Other Healthcare Resources?
    by Pierre-Yves Cremieux & Pierre Ouellette & Patrick Petit
  • 2007 Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease
    by David F. Moore & Markus Ries & Evelyn L. Forget & Raphael Schiffmann
  • 2007 Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review
    by Pearl D. Gumbs & Monique W.M. Verschuren & Aukje K. Mantel-Teeuwisse & Ardine G. de Wit & Anthonius de Boer & Olaf H. Klungel
  • 2007 Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer
    by Steven Simoens
  • 2007 Measuring Preferences for Cost-Utility Analysis: How Choice of Method May Influence Decision-Making
    by Christine M. McDonough & Anna N.A. Tosteson
  • 2007 Is Medication Review by Pharmacists of Any Use?
    by Arnold G. Zermansky & Nick Freemantle
  • 2007 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2007 Home-Based Medication Review in Older People: Is it Cost Effective?
    by Margaret Pacini & Richard D. Smith & Edward C.F. Wilson & Richard Holland
  • 2007 Acute/Subacute Herpes Zoster: Healthcare Resource Utilisation and Costs in a Group of US Health Plans
    by Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier
  • 2007 Conjoint Analysis of French and German Parents' Willingness to Pay for Meningococcal Vaccine
    by David Bishai & Roger Brice & Isabelle Girod & Aneta Saleh & Jenifer Ehreth
  • 2007 Disease Burden of Overactive Bladder: Quality-of-Life Data Assessed Using ICI-Recommended Instruments
    by Ramandeep Basra & Con Kelleher
  • 2007 A `League Table' of Contingent Valuation Results for Pharmaceutical Interventions: A Hard Pill to Swallow?
    by Tracey H. Sach & Richard D. Smith & David K. Whynes
  • 2007 Time Preferences for Health in Northern Tanzania: An Empirical Analysis of Alternative Discounting Models
    by Bjarne Robberstad & John Cairns
  • 2007 Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment
    by Julie M. Donohue & Harold Alan Pincus
  • 2007 Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis
    by Mark J.C. Nuijten & Wolfgang Wittenberg & Maximilian Lebmeier
  • 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
    by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos
  • 2007 Rates and Probabilities in Economic Modelling: Transformation, Translation and Appropriate Application
    by Rachael L. Fleurence & Christopher S. Hollenbeak
  • 2007 Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants
    by Judith E. Bosmans & Oscar H. Brook & Hein P.J. van Hout & Martine C. de Bruijne & Hugo Nieuwenhuyse & Lex M. Bouter & Wim A.B. Stalman & Maurits W. van Tulder
  • 2007 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2007 NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used?
    by Denis Getsios & Kristen Migliaccio-Walle & Jaime J. Caro
  • 2007 When NICE Says No!
    by Alan Haycox
  • 2007 Acknowledgement
    by Adis International Limited
  • 2007 Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective
    by Bart Heeg & Joep Damen & Ben Van Hout
  • 2007 Economic Evidence at the Local Level: Options for Making it More Useful
    by Kees van Gool & Gisselle Gallego & Marion Haas & Rosalie Viney & Jane Hall & Robyn Ward
  • 2007 Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events
    by Greg L. Plosker & Katherine A. Lyseng-Williamson
  • 2007 Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2007 The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses
    by Marcio Machado & Michael Iskedjian & Ines A. Ruiz & Thomas R. Einarson
  • 2007 Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B
    by David L. Veenstra & Sean D. Sullivan & Lauren Clarke & Uche H. Iloeje & Eskinder Tafesse & Adrian Di Bisceglie & Kris V. Kowdley & Robert G. Gish
  • 2007 Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis
    by Amanda R. Patrick & Wolfgang C. Winkelmayer & Jerry Avorn & Michael A. Fischer
  • 2007 Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review
    by Alec H. Miners & Guiqing Yao & James Raftery & Rod S. Taylor
  • 2007 The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature
    by Rachael L. Fleurence & Cynthia P. Iglesias & Jeanene M. Johnson
  • 2007 It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies
    by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman
  • 2007 Warfarin Pharmacogenetics: Economic Considerations
    by Dyfrig A. Hughes & Munir Pirmohamed
  • 2007 Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia
    by Neale Cohen & Michael E. Minshall & Lyn Sharon-Nash & Katerina Zakrzewska & William J. Valentine & Andrew J. Palmer
  • 2007 Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
    by Sorrel E. Wolowacz & Neil Roskell & Steven Kelly & Fiona M. Maciver & Chris S. Brand
  • 2007 Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients
    by Ya-Chen Tina Shih & Nebiyou B. Bekele & Ying Xu
  • 2007 A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD
    by Laura Bojke & Edward Hornby & Mark Sculpher
  • 2007 Valuing Children's Health: A Comparison of Cost-Utility Analyses for Adult and Paediatric Health Interventions in the US
    by Joseph A. Ladapo & Peter J. Neumann & Ron Keren & Lisa A. Prosser
  • 2007 Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters
    by Jeffrey S. Hoch & Carolyn S. Dewa
  • 2007 Ninth Annual Disease Management Leadership Forum and First Disease Management Association of America-National Association of Manufacturers Integrated Care Summit: Las Vegas, Nevada, 16-19 September 2007
    by Ginny-Louise MacKay
  • 2007 Cost-Effectiveness Analysis of a Pharmacy Asthma Care Program in Australia
    by Adam Gordois & Carol Armour & Martha Brillant & Sinthia Bosnic-Anticevich & Deborah Burton & Lynne Emmerton & Ines Krass & Bandana Saini & Lorraine Smith & Kay Stewart
  • 2007 Nurse Practitioner-Based Diabetes Care Management: Impact of Telehealth or Telephone Intervention on Glycemic Control
    by Karen Chang & Rita Davis & Judy Birt & Pete Castelluccio & Peter Woodbridge & David Marrero
  • 2007 Patient and Physician Factors Contributing to Poor Outcomes in Patients with Asthma and COPD
    by Adrian Gillissen & Hubertus Wirtz & Uwe Juergens
  • 2007 Health Support of People with Disabilities in South Australia: Innovations in Policy and Practice
    by David Caudrey & Marguerite Dissinger
  • 2007 Disease Management of Chronic Heart Failure in the Elderly: Issues and Options
    by Ken McDonald
  • 2007 Acknowledgment
    by Adis International Limited
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Consensus Development and Application of ICD-9-CM Codes for Defining Chronic Illnesses and their Complications
    by Ariel Linden & Thomas J. Biuso & Gopal Allada & Alan F. Barker & Joaquin Cigarroa & Sai Praveen Haranath & Diana Rinkevich & Karl Stajduhar
  • 2007 Obesity and Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records
    by James E. Rohrer & Steven C. Adamson & Joseph W. Furst
  • 2007 Health Coaching as an Intervention in Health Management Programs
    by Susan W. Butterworth & Ariel Linden & Wende McClay
  • 2007 Selection of Proton Pump Inhibitors for Formulary Inclusion: Making Decisions Based on Appropriate Criteria
    by Stephen W. Nissen & Keith M. Olsen
  • 2007 Health Plan Employer Data and Information Set (HEDIS(R)) Criteria to Determine the Quality of Asthma Care in Children: What Are the Limitations?
    by Harold J. Farber & Michael Schatz
  • 2007 Perspectives on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: Outcomes From a Meeting of the Latin America Experts Group
    by Luis Bahamondes & Santiago Cordova-Eguez & Jose Enrique Pons & Lee Shulman
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 The Role of Medication Adherence as a Determinant of Blood Pressure Control in a Managed Care Population
    by Nilay D. Shah & MaryAnn E. Steiner & Lee C. Vermeulen & Lawrence A. Fleming & Patrick R. Cory
  • 2007 Consumer-Directed Health Plans and the Chronically Ill
    by Stephen T. Parente & Jon B. Christianson & Roger Feldman
  • 2007 Measuring the Quality of Healthcare: The Connection between Structure, Process, and Outcomes of Care, Using the Example of Myocardial Infarction Treatment in Germany
    by Ansgar Wubker
  • 2007 Evaluation of an Online Relapse Prevention Program for Bipolar Disorder: An Overview of the Aims and Methodology of a Randomized Controlled Trial
    by Caryl Barnes & Robin Harvey & Philip Mitchell & Michael Smith & Kay Wilhelm
  • 2007 Physician-Patient e-Visit Programs: Implementation and Appropriateness
    by Pamela Whitten & Lorraine Buis & Brad Love
  • 2007 Disease Management Programs for Glaucoma: Has the Vision Become a Reality?
    by Lawrence D. Goldberg
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Psychoeducational Approaches to Medication Adherence in Patients with Bipolar Disorder
    by Martha Sajatovic & Peijun Chen & Philipp Dines & Edwin R. Shirley
  • 2007 Treating Allergic Asthma with Omalizumab
    by Paul P. Belliveau & Monina R. Lahoz
  • 2007 Design, Measurement, and Evaluation of an Education Strategy in the Hospital Setting to Combat Antimicrobial Resistance: Theoretical Considerations and a Practical Example
    by Celine Pulcini & Sally Crofts & Diane Campbell & Peter Davey
  • 2007 Implementation of an HPV-Vaccination Program: Key Factors for Success
    by Shalini L. Kulasingam
  • 2007 Disease Management and the Medical Home Model: Competing or Complementary?
    by Vincent Kuraitis
  • 2007 Abandoning the UK NHS?
    by Tony Clive Hockley
  • 2007 The Role of Spirometry in Evaluating Therapeutic Responses in Advanced COPD
    by Pierantonio Laveneziana & Denis E. O'Donnell
  • 2007 The Rise of Specialty Pharmacy Costs: Issues for Providers, Payers, and Patients
    by Steve B. Miller & Tracy A. Hoffman & Jonah C. Houts & Jane L. Miller & Britton L. Pim & Andrew Behm
  • 2007 Exploring Disease Management Programs for Diabetes Mellitus: Proposal of a Novel Hybrid Model
    by Kerri L. Cavanaugh & Richard O. White & Russell L. Rothman
  • 2007 Physician Prescribing and Medicare Part D: Closing the Gaps
    by William H. Shrank
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Patient-Motivated Prevention of Lifestyle-Related Disease in Japan: A Randomized, Controlled Clinical Trial
    by Akira Babazono & Chihoko Kame & Reiko Ishihara & Eiji Yamamoto & Alan L. Hillman
  • 2007 Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings: Advantages and Limitations
    by Jay Hawkshead & Marie A. Krousel-Wood
  • 2007 Initiatives to Promote Effective Self-Care Skills in Children and Adolescents with Diabetes Mellitus
    by Barbara J. Anderson & Britta Svoren & Lori Laffel
  • 2007 Estimating the Effect of Regression to the Mean in Health Management Programs
    by Ariel Linden
  • 2007 Disease Management Update
    by Adis International Limited
  • 2007 Spotlight on the Pharmacoeconomics of Candesartan Cilexetil in Chronic Heart Failure and Hypertension
    by Greg L. Plosker & Susan J. Keam
  • 2007 The Impact of Nebulized Levalbuterol on Health Care Payments for Elderly Asthma and Chronic Obstructive Pulmonary Disease Patients in Medicaid Plans
    by Ronald J. Ozminkowski & Shaohung Wang & Stacey R. Long
  • 2007 Estimating the Impact of a Congestive Heart Failure Disease Management Program on Prescription Drug Use: A State Medicaid Program
    by Anthony C. Moscoso & Matthew J. Strand & Gregory D. Berg & Gary K. Grunwald
  • 2007 Hypertension Home Telemonitoring: Current Evidence and Recommendations for Future Studies
    by Mirou Jaana & Guy Pare & Claude Sicotte
  • 2007 Use of the Pre-Post Method to Measure Cost Savings in Disease Management: Issues and Implications
    by Ariel Linden
  • 2007 Initiatives and Barriers to Adopting Health Information Technology: A US Perspective
    by Henry A. DePhillips
  • 2007 I divari regionali in Italia sulla base degli indicatori sociali (1871-2001)
    by Emanuele Felice
  • 2007 Características socio-económicas de las personas con discapacidad en España: un estudio empírico/Socio-Economic Characteristics of People with Disabilities in Spain: an Empirical Study
    by PASCUAL SÁEZ, MARTA & CANTARERO PRIETO, DAVID
  • 2007 Effects of Education on Determinants of High Desired Fertility: Evidence from Ugandan Villages
    by Michal Bauer & Julie Chytilová & Pavel Streblov
  • 2007 Will rising household incomes solve China's micronutrient deficiency problems?
    by Bhavani Shankar & Yi Liu
  • 2007 A brief look at hospital profits by outpatient services offered
    by Charles Hegji
  • 2007 Propensity Score Matching with Limited Overlap
    by Onur Baser
  • 2007 City-Size and Health Outcomes: Lessons from the USA
    by Achintya Ray & Soumendra N. Ghosh
  • 2007 Health Econometric:Uncovering the Anthropometric Behavior on Women's Labor Market
    by Rodrigo A. Lopez-Pablos
  • 2007 Obesity and socio-economic inequalities in spain: evidence from the ECHP
    by David Cantarero & Marta Pascual
  • 2007 Ownership and rent-seeking behavior in specialty health care practices
    by Dan Friesner & Chris Stevens
  • 2007 Are Racial Disparities In Diabetes In The Usa Driven By Education Distribution?
    by Achintya Ray
  • 2007 Health Expenditure, Poverty and Economic Development in Latin America 2000-2005
    by Guisan, M.C. & Aguayo, E.
  • 2007 Production by sector in Africa, 2000-2005
    by GUISAN, Maria-Carmen & EXPOSITO, Pilar
  • 2007 Compensating The Poor Out Of Traditional Healing In Cameroon: A Nested Logit Analysis
    by KAMGNIA, Dia B.
  • 2007 El peso al nacer de los niños de la principal maternidad de Uruguay: 1995 a 2004
    by Jewell R. Todd & Patricia Triunfo & Rafael Aguirre
  • 2006 The macroeconomics of obesity
    by Pere Gomis Porqueras & Adrian Peralta-Alva
  • 2006 Asymmetric Information from Physician Agency: Optimal Payment and Healthcare Quantity
    by Philippe Chone & Ching-to Albert Ma
  • 2006 The Price of Smoking
    by Frank A. Sloan & Jan Ostermann & Christopher Conover & Donald H. Taylor, Jr. & Gabriel Picone
  • 2006 Alcohol Prices, Consumption, and Traffic Fatalities
    by Douglas J. Young & Agnieszka Bielinska-Kwapisz
  • 2006 Alternative methods for estimating systems of (health) equations
    by Casey Quinn
  • 2006 The Role of Health Insurance in Joint Retirement among Married Couples
    by Kanika Kapur & Jeannette Rogowski
  • 2006 “Índice de Vulnerabilidad Social en los países de la OCDE”
    by Álvarez, Inmaculada & Cárdenas, Edel
  • 2006 Simulating the Formation of Risk Perception
    by Jie-Shin Lin
  • 2006 The Impact of Poor Health on Education: New Evidence Using Genetic Markers
    by Weili Ding & Steven Lehrer & J. Niles Rosenquist & Janet Audrain-McGovern
  • 2006 Socioeconomic Status And Health In Childhood: A Comment On Chen, Martin, And Matthews
    by Anne Case & Christina Paxson & Tom Vogl
  • 2006 Stature and status: Height, ability, and labor market outcomes
    by Anne Case & Christina Paxson
  • 2006 Child Support Enforcement And Domestic Violence Among Non-Cohabiting Couples
    by Angela R. Fertig & Irwin Garfinkel & Sara S. McLanahan
  • 2006 Stature and status: Height, ability, and labor market outcomes
    by Anne Case & Christina Paxson
  • 2006 The Long-run Effects of HIV/AIDS in Kenya
    by Bruhns, Ramona
  • 2006 Gender Inequality In Household Health Expenditure: The Case Of Urban Orissa
    by Himanshu Sekhar, Rout
  • 2006 Linkages Between Income, Education And Health: Case Of Rural Orissa
    by Himanshu Sekhar, Rout
  • 2006 Market Effects of Generic Entry: The Role of Physicians and of Non-Bioequivalent Competitors
    by Gonzalez, Jorge & Sismeiro, Catarina & Dutta, Shantanu & Stern, Philip
  • 2006 الحقوق الاقتصادية والحق فى التنمية فى مصر
    by Alasrag, Hussien
  • 2006 Cost of inpatient rehabilitation care in the Department of Veterans Affairs
    by Wagner, Todd H. & Richardson, Samuel S. & Vogel, Bruce & Wing, Kristen & Smith, Mark W.
  • 2006 Publicly-provided Services and the Distribution of Resources
    by François Marical & Marco Mira d'Ercole & Maria Vaalavuo & Gerlinde Verbist
  • 2006 Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels
    by Allan Begosh & John Goldsmith & Ed Hass & Randall W. Lutter & Clark Nardinelli & John A. Vernon
  • 2006 Cross-Cohort Differences in Health on the Verge of Retirement
    by Beth J. Soldo & Olivia S. Mitchell & Rania Tfaily & John F. McCabe
  • 2006 Crime and Circumstance: The Effects of Infant Health Shocks on Fathers' Criminal Activity
    by Hope Corman & Kelly Noonan & Nancy E. Reichman & Ofira Schwartz-Soicher
  • 2006 Global Patterns of Income and Health: Facts, Interpretations, and Policies
    by Angus Deaton
  • 2006 Evaluating Effects of Tax Preferences on Health Care Spending and Federal Revenues
    by John F. Cogan & R. Glenn Hubbard & Daniel P. Kessler
  • 2006 AIDS Treatment and Intrahousehold Resource Allocations: Children's Nutrition and Schooling in Kenya
    by Joshua S. Graff Zivin & Harsha Thirumurthy & Markus Goldstein
  • 2006 The Effect of Subjective Survival Probabilities on Retirement and Wealth in the United States
    by David E. Bloom & David Canning & Michael Moore & Younghwan Song
  • 2006 The Effects of Education Quality on Income Growth and Mortality Decline
    by Eliot A. Jamison & Dean T. Jamison & Eric A. Hanushek
  • 2006 School Quality and the Black-White Achievement Gap
    by Eric A. Hanushek & Steven G. Rivkin
  • 2006 Welfare Reform and Indirect Impacts on Health
    by Marianne Bitler & Hilary W. Hoynes
  • 2006 Does Television Cause Autism?
    by Michael Waldman & Sean Nicholson & Nodir Adilov
  • 2006 Tradeoffs from Integrating Diagnosis and Treatment in Markets for Health Care
    by Christopher C. Afendulis & Daniel P. Kessler
  • 2006 Lead Pipes and Child Mortality
    by Karen Clay & Werner Troesken & Michael Haines
  • 2006 Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System
    by Neeraj Sood & Melinda Beeuwkes Buntin & Jose J. Escarce
  • 2006 Differential Mortality, Uncertain Medical Expenses, and the Saving of Elderly Singles
    by Mariacristina De Nardi & Eric French & John Bailey Jones
  • 2006 Do State Expenditures on Tobacco Control Programs Decrease Use of Tobacco Products Among College Students?
    by Christina Czart Ciecierski & Pinka Chatterji & Frank J. Chaloupka & Henry Wechsler
  • 2006 High School Alcohol Use and Young Adult Labor Market Outcomes
    by Pinka Chatterji & Jeffrey DeSimone
  • 2006 Do Female Physicians Capture Their Scarcity Value? The Case of OB/GYNs
    by Jessica Wolpaw Reyes
  • 2006 The Health Effects of Medicare for the Near-Elderly Uninsured
    by Daniel Polsky & Jalpa A. Doshi & Jose Escarce & Willard Manning & Susan M. Paddock & Liyi Cen & Jeannette Rogowski
  • 2006 Contingent Valuation Analysis of Willingness to Pay To Reduce Childhood Obesity
    by John Cawley
  • 2006 Willingness to Pay for Drug Rehabilitation: Implications for Cost Recovery
    by David Bishai & Jody Sindelar
  • 2006 Stature and Status: Height, Ability, and Labor Market Outcomes
    by Anne Case & Christina Paxson
  • 2006 How Do Youth with Mental Disorders Fare in the Juvenile Justice System?
    by Pinka Chatterji & Alison Cuellar
  • 2006 Employment and Adverse Selection in Health Insurance
    by Jayanta Bhattacharya & William B. Vogt
  • 2006 Health Insurance Enrollment Decisions: Preferences for Coverage, Worker Sorting, and Insurance Take Up
    by Alan C. Monheit & Jessica Primoff Vistnes
  • 2006 Education and Health: Evaluating Theories and Evidence
    by David M. Cutler & Adriana Lleras-Muney
  • 2006 Hospital Competition, Managed Care and Mortality After Hospitalization for Medical Conditions: Evidence From Three States
    by José J. Escarce & Arvind K. Jain & Jeannette Rogowski
  • 2006 The Effect of Female Education on Fertility and Infant Health: Evidence from School Entry Policies Using Exact Date of Birth
    by Justin McCrary & Heather Royer
  • 2006 The Boskin Commission Report: A Retrospective One Decade Later
    by Robert J. Gordon
  • 2006 The Impact of Poor Health on Education: New Evidence Using Genetic Markers
    by Weili Ding & Steven F. Lehrer & J. Niels Rosenquist & Janet Audrain-McGovern
  • 2006 What Do We Know About Competition and Quality in Health Care Markets?
    by Martin Gaynor
  • 2006 Balancing the Goals of Health Care Provision
    by Martin Feldstein
  • 2006 Willpower and the Optimal Control of Visceral Urges
    by Emre Ozdenoren & Stephen Salant & Dan Silverman
  • 2006 Love or Money? Health Insurance and Retirement Among Married Couples
    by Kanika Kapur & Jeannette Rogowski
  • 2006 Socioeconomic Status and Health in Childhood: A Comment on Chen, Martin and Matthews (2006)
    by Anne Case & Christina Paxson & Tom Vogl
  • 2006 Hospital Ownership and Quality of Care: What Explains the Different Results?
    by Karen Eggleston & Yu-Chu Shen & Joseph Lau & Christopher H. Schmid & Jia Chan
  • 2006 Econometric Risk Adjustment, Endogeneity, and Extrapolation Bias
    by John Mullahy
  • 2006 The Effects of State Medicaid Policies on the Dynamic Savings Patterns of the Elderly
    by Lara Gardner & Donna Gilleskie
  • 2006 The Effects of Health on Health Insurance Status in Fragile Families
    by Hope Corman & Anne Carroll & Kelly Noonan & Nancy E. Reichman
  • 2006 Intensive Medical Care and Cardiovascular Disease Disability Reductions
    by David M. Cutler & Mary Beth Landrum & Kate A. Stewart
  • 2006 Does Child Abuse Cause Crime?
    by Janet Currie & Erdal Tekin
  • 2006 Consumer Demand under Price Uncertainty: Empirical Evidence from the Market for Cigarettes
    by Mark Coppejans & Donna Gilleskie & Holger Sieg & Koleman Strumpf
  • 2006 Why Do Europeans Smoke More than Americans?
    by David M. Cutler & Edward L. Glaeser
  • 2006 The Effects of Retirement on Physical and Mental Health Outcomes
    by Dhaval Dave & Inas Rashad & Jasmina Spasojevic
  • 2006 The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
    by Genia Long & David Cutler & Ernst R. Berndt & Jimmy Royer & Andrée-Anne Fournier & Alicia Sasser & Pierre Cremieux
  • 2006 Insurance and Incentives for Medical Innovation
    by Alan M. Garber & Charles I. Jones & Paul M. Romer
  • 2006 Urban Poverty, School Attendance, and Adolescent Labor Force Attachment: Some Historical Evidence
    by Howard Bodenhorn
  • 2006 How Do the Better Educated Do It? Socioeconomic Status and the Ability to Cope with Underlying Impairment
    by David M. Cutler & Mary Beth Landrum & Kate A. Stewart
  • 2006 Ugly Criminals
    by Naci Mocan & Erdal Tekin
  • 2006 Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
    by Tomas J. Philipson & Anupam B. Jena
  • 2006 Do Hot Hands Exist Among Hedge Fund Managers? An Empirical Evaluation
    by Ravi Jagannathan & Alexey Malakhov & Dmitry Novikov
  • 2006 Perverse Incentives in the Medicare Prescription Drug Benefit
    by David McAdams & Michael Schwarz
  • 2006 Typically Unobserved Variables (TUVs) and Selection into Prenatal Inputs: Implications for Estimating Infant Health Production Functions
    by Nancy E. Reichman & Hope Corman & Kelly Noonan & Dhaval Dave
  • 2006 Regulating Advertisements: The Case of Smoking Cessation Products
    by Rosemary J. Avery & Donald S. Kenkel & Dean R. Lillard & Alan D. Mathios
  • 2006 Short, Medium, and Long Term Consequences of Poor Infant Health: An Analysis using Siblings and Twins
    by Phil Oreopoulos & Mark Stabile & Randy Walld & Leslie Roos
  • 2006 The Roles of High School Completion and GED Receipt in Smoking and Obesity
    by Donald S. Kenkel & Dean R. Lillard & Alan D. Mathios
  • 2006 Health Insurance and the Wage Gap
    by Helen Levy
  • 2006 The Determinants of Mortality
    by David M. Cutler & Angus S. Deaton & Adriana Lleras-Muney
  • 2006 Private Profits and Public Health: Does Advertising Smoking Cessation Products Encourage Smokers to Quit?
    by Rosemary Avery & Donald Kenkel & Dean R. Lillard & Alan Mathios
  • 2006 Health Care, Technological Change, and Altruistic Consumption Externalities
    by Tomas Philipson & Stephane Mechoulan & Anupam Jena
  • 2006 Maternal Feeding Strategies, Child Eating Behaviors, and Child BMI in Low-Income African-American Preschoolers
    by Scott W. Powers & Leigh A. Chamberlin & Kelly B. van Schaick & Susan N. Sherman & Robert C. Whitaker
  • 2006 Food Assistance Programs and the Economic Patterns of Single Mothers Following Poverty Exits
    by Quinn Moore & Anu Rangarajan & Peter Schochet
  • 2006 Dietary Effects of Universal-Free School Breakfast: Findings from the Evaluation of the School Breakfast Program Pilot Project
    by Mary Kay Crepinsek & Anita Singh & Lawrence S. Bernstein & Joan E. McLaughlin
  • 2006 Reaching Those in Need: State Food Stamp Participation Rates in 2004
    by Karen E. Cunnyngham & Laura A. Castner & Allen L. Schirm
  • 2006 Characteristics of Food Stamp Households: Fiscal Year 2005
    by Allison Barrett
  • 2006 Characteristics of Food Stamp Households: Fiscal Year 2005
    by Allison Barrett
  • 2006 Food Insecurity and the Risks of Depression and Anxiety in Mothers and Behavior Problems in Their Preschool-Aged Children
    by Robert C. Whitaker & Shannon M. Phillips & Sean M. Orzol
  • 2006 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates in 2002 and 2003 for All Eligible People and the Working Poor
    by Laura A. Castner & Allen L. Schirm
  • 2006 Food Stamp Program Participation Rates: 2004
    by Allison Barrett & Anni Poikolainen
  • 2006 State Food Stamp Participation Rates for the Working Poor in 2003
    by Laura A. Castner & Allen L. Schirm
  • 2006 Hunger in America 2006
    by Douglas L. O'Brien & Halley Torres Aldeen with contributing authors Rhoda Cohen & Jim Ohls & Myoung Kim
  • 2006 The impact of cannabis and cigarette use on health
    by Jenny Williams & Christopher L. Skeels
  • 2006 Designing the Financial Tools to Promote Universal Access to AIDS Care
    by Patarick Leoni & Stephane Luchini
  • 2006 Contingent Valuation of Mortality Risk Reduction in Developing Countries: A Mission Impossible?
    by Minhaj Mahmud
  • 2006 Poverty, Undernutrition, and Child Mortality: Some Inter-Regional Puzzles and their Implications for Research and Policy
    by Stephan Klasen
  • 2006 Poverty, Undernutrition, and Child Mortality: Some Inter-Regional Puzzles and their Implications for Research and Policy
    by Klasen, Stephan
  • 2006 Persistence in Infant Mortality: Evidence for the Indian States
    by Wiji Arulampalam & Sonia Bhalotra
  • 2006 Persistence in Infant Mortality: Evidence for the Indian States
    by Arulampalam, Wiji & Bhalotra, Sonia R.
  • 2006 Smoking Habits: Like Father, Like Son, Like Mother, Like Daughter
    by Maria L. Loureiro & Anna Sanz-de-Galdeano & Daniela Vuri
  • 2006 Smoking Habits: Like Father, Like Son, Like Mother, Like Daughter
    by Loureiro, Maria L. & Sanz-de-Galdeano, Anna & Vuri, Daniela
  • 2006 Sibling Death Clustering in India: State Dependence vs. Unobserved Heterogeneity
    by Wiji Arulampalam & Sonia Bhalotra
  • 2006 Sibling Death Clustering in India: State Dependence vs. Unobserved Heterogeneity
    by Arulampalam, Wiji & Bhalotra, Sonia R.
  • 2006 Quantifying the Cost of Passive Smoking on Child Health: Evidence from Children’s Cotinine Samples
    by Paul Frijters & Michael A. Shields & Stephen Wheatley Price & Jenny Williams
  • 2006 Quantifying the Cost of Passive Smoking on Child Health: Evidence from Children’s Cotinine Samples
    by Frijters, Paul & Shields, Michael A. & Price, Stephen Wheatley & Williams, Jenny
  • 2006 The Effect of Taxes and Bans on Passive Smoking
    by Jérôme Adda & Francesca Cornaglia
  • 2006 The Effect of Taxes and Bans on Passive Smoking
    by Adda, Jérôme & Cornaglia, Francesca
  • 2006 Does Child Abuse Cause Crime?
    by Janet Currie & Erdal Tekin
  • 2006 Does Child Abuse Cause Crime?
    by Currie, Janet & Tekin, Erdal
  • 2006 Ugly Criminals
    by Naci Mocan & Erdal Tekin
  • 2006 Ugly Criminals
    by Mocan, Naci & Tekin, Erdal
  • 2006 Welfare State Retrenchment: The Partisan Effect Revisited
    by Bruno Amable & Donatella Gatti & Jan Schumacher
  • 2006 Welfare State Retrenchment: The Partisan Effect Revisited
    by Amable, Bruno & Gatti, Donatella & Schumacher, Jan
  • 2006 Effects of Education on Determinants of High Desired Fertility: Evidence from Ugandan Villages
    by Michal Bauer & Julie Chytilová & Pavel Streblov
  • 2006 Understanding socio-economic inequalities in childhood respiratory health
    by Carol Propper & John A. Rigg
  • 2006 Reframing applied disease stigma research: a multilevel analysis of diabetes stigma in Ghana
    by Ama de-Graft Aikins
  • 2006 Lowering child mortality in poor countries: the power of knowledgeable parents
    by Peter Boone & Zhaoguo Zhan
  • 2006 The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya
    by Harsha Thirumurthy & Joshua Graff Zivin & Markus Goldstein
  • 2006 Arrest Avoidance: Law Enforcement and Price of Cocaine
    by Beth A. Freeborn
  • 2006 Individual Risk Attitudes: New Evidence from a Large, Representative, Experimentally-Validated Survey
    by Dohmen, Thomas J & Falk, Armin & Huffman, David & Schupp, Jürgen & Sunde, Uwe & Wagner, Gert Georg
  • 2006 Evaluating The Impact Of Health Care Reform In Colombia: From Theory To Practice
    by Alejandro Gaviria & Carlos Medina & Carolina Mejía
  • 2006 The Costs and Benefits of Front-loading and Predictability of Immunization
    by Owen Barder & Ethan Yeh
  • 2006 Governance and Corruption in Public Health Care Systems
    by Maureen Lewis
  • 2006 Estimation of Individual Demand for Alcohol
    by Yuriy Andrienko & A. Nemtsov
  • 2006 Understanding socio-economic inequalities in childhood respiratory health
    by Carol Propper & John A. Rigg
  • 2006 Lowering Child Mortality in Poor Countries: The Power of Knowledgeable Parents
    by Peter Boone & Zhaoguo Zhan
  • 2006 Problems and Prospects for Dynamic Microsimulation: A review and lessons for APPSIM
    by Rebecca Cassells & Ann Harding & Simon Kelly
  • 2006 The Economics of Consanguinity
    by Do, Q-T & Iyer, S. & Joshi, S.
  • 2006 Yardstick Competition when Quality is Endogenous: The Case of Hospital Regulation
    by Hanjo M. Koehler
  • 2006 Do Non-standard Working Hours Cause Negative Health Effects? Some Evidence from Panel Data
    by Aydogan Ulker
  • 2006 The Effect of Taxes and Bans on Passive Smoking
    by Jérôme Adda & Francesca Cornaglia
  • 2006 The Authors' Reply
    by Adrian A. Bagust & Marc Evans & Sophie Beale & Philip Home & Andrew Perry & Murray Stewart & Arran Shearer & Alan Martin & Lisa Hulme & Andreas Liebl & Oliver Schoeffski & Anita Goertz & Javier Ampudia-Blasco & Belen Martinez-Lage & Isabel Perez Escolano & Gonzalo Paris
  • 2006 Modelling Lifetime Metabolic Progression and Cost Effectiveness of Treatment Strategies for Type 2 Diabetes
    by Andrew J. Palmer & Craig J. Currie
  • 2006 Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF
    by Ting Hsiang Lin
  • 2006 Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia: Cost Effectiveness and Risk Sharing
    by John H. Wlodarczyk & Leslie G. Cleland & Anne M. Keogh & Keith D. McNeil & Kate Perl & Robert G. Weintraub & Trevor J. Williams
  • 2006 Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003
    by Yue-Chune Lee & Ming-Chin Yang & Yu-Tung Huang & Chien-Hsiang Liu & Sun-Bing Chen
  • 2006 Cost-of-Illness Studies: A Review of Current Methods
    by Ebere Akobundu & Jing Ju & Lisa Blatt & C. Daniel Mullins
  • 2006 Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework: Some Considerations
    by Emma McIntosh
  • 2006 The Value of Thinly Spread QALYs
    by Duncan Mortimer
  • 2006 Accuracy versus Transparency in Pharmacoeconomic Modelling: Finding the Right Balance
    by David M. Eddy
  • 2006 US FDA Guidance: Apropos of PROs
    by Paul Kind
  • 2006 National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
    by Slobodan M. Jankovic & Nebojsa Milivojevic
  • 2006 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
    by Michele Kohli & Cheryl Attard & Annette Lam & Daniel Huse & John Cook & Chantal Bourgault & Evo Alemao & Donald Yin & Michael Marentette
  • 2006 Costs of Inflammatory Bowel Disease in Germany
    by Renee Stark & Hans-Helmut Konig & Reiner Leidl
  • 2006 A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction
    by Mark Lamotte & Lieven Annemans & Pawel Kawalec & York Zoellner
  • 2006 Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease
    by Virginia L. Priest & Evan J. Begg & Sharon J. Gardiner & Christopher M.A. Frampton & Richard B. Gearry & Murray L. Barclay & David W.J. Clark & Paul Hansen
  • 2006 A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials
    by Darren J. Clayson & Diane J. Wild & Paul Quarterman & Isabelle Duprat-Lomon & Maria Kubin & Stephen Joel Coons
  • 2006 Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence
    by Michelle Orme & Annabel Boler
  • 2006 Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma
    by Pamela C. Heaton
  • 2006 Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2006 Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma
    by Gunnar Johansson & Emma B. Andreasson & Per E. Larsson & Claus F. Vogelmeier
  • 2006 Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation
    by Richard C. Oude Voshaar & Paul F.M. Krabbe & Wim J.M.J. Gorgels & Eddy M.M. Adang & Anton J.L.M. van Balkom & Eloy H. van de Lisdonk & Frans G. Zitman
  • 2006 Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country
    by Hwee-Lin Wee & Chee-Eng Tan & Su-Yen Goh & Shu-Chuen Li
  • 2006 Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies
    by John B. Wong
  • 2006 Cost of Lung Cancer: A Methodological Review
    by Laurent Molinier & Christophe Combescure & Cristos Chouaid & Jean-Pierre Daures & Bruno Housset & Didier Fabre & Alain Grand & Alain Vergnenegre
  • 2006 Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues
    by Yin Bun Cheung & Julian Thumboo
  • 2006 Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy
    by Fred J. Hellinger
  • 2006 NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
    by Nick Freemantle
  • 2006 The Authors' Reply
    by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg
  • 2006 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease
    by Nick Bosanquet & Andrew Yeates
  • 2006 Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?: Validation Among Paediatric Patients with Asthma in Singapore
    by Lee-Yee Chong & Oh-Moh Chay & Li Shu-Chuen
  • 2006 Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients: A Pharmacoeconomic Analysis
    by George Dranitsaris & Mark Vincent & Mark Crowther
  • 2006 Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germany
    by Peter K. Schadlich & Michael Kentsch & Manfred Weber & Wolfgang Kammerer & Josef Georg Brecht & Vijay Nadipelli & Eduard Huppertz
  • 2006 The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status
    by Jarmo Hahl & Helena Hamalainen & Tuula Simell & Olli Simell
  • 2006 The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
    by George W. Carides & Shahnaz Shahinfar & Erik J. Dasbach & William F. Keane & William C. Gerth & Charles M. Alexander & William H. Herman & Barry M. Brenner & the RENAAL Investigators
  • 2006 Healthcare Rationing in Spain: Framework, Descriptive Analysis and Consequences
    by Rosa Rodriguez-Monguio & Fernando Antonanzas Villar
  • 2006 Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy: Implications for Decision Making
    by Cornelis Boersma & Jarir Atthobari & Ron T. Gansevoort & Lolkje T.W. de Jong-Van den Berg & Paul E. de Jong & Dick de Zeeuw & Lieven J.P. Annemans & Maarten J. Postma
  • 2006 The Authors' Reply
    by Lawrence D. Goldberg & John G. Walt
  • 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
    by Javier Soto
  • 2006 Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer
    by Christopher Dunn & Susan J. Keam
  • 2006 Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial
    by Shelby D. Reed & Jasmina I. Radeva & Davey B. Daniel & Samir H. Mody & Jamie B. Forlenza & R. Scott McKenzie & Kevin A. Schulman
  • 2006 Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis: Pentoxifylline in the Treatment of Chronic Venous Leg Ulcers
    by Cynthia P. Iglesias & Karl Claxton
  • 2006 Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment
    by Janneke Kaper & Edwin J. Wagena & Constant P. van Schayck & Johan L. Severens
  • 2006 Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial
    by Laura Bojke & Mark Sculpher & Richard Stephens & Wendi Qian & Nick Thatcher & David Girling
  • 2006 Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus: A Systematic Literature Review
    by Sylvia M.C. Vijgen & Mirjam Hoogendoorn & Caroline A. Baan & G. Ardine de Wit & Wien Limburg & Talitha L. Feenstra
  • 2006 Accounting for Tastes: A German Perspective on the Inclusion of Patient Preferences in Healthcare
    by Florian Vogt & David L.B. Schwappach & John F.P. Bridges
  • 2006 The Authors' Reply
    by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt
  • 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
    by Stephanie Land
  • 2006 Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?
    by Marieke Krol & Werner Brouwer & Pedram Sendi
  • 2006 A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
    by Aslam H. Anis & Huiying Sun & Sonia Singh & John Woolcott & Bohdan Nosyk & Marc Brisson
  • 2006 Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK
    by Beate Sander & Frederick G. Hayden & Marlene Gyldmark & Louis P. Garrison
  • 2006 Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment
    by Zoe Philips & Laura Bojke & Mark Sculpher & Karl Claxton & Su Golder
  • 2006 Optimal Assignment of Treatments to Health States Using a Markov Decision Model: An Introduction to Basic Concepts
    by Mohan V. Bala & Josephine A. Mauskopf
  • 2006 Economic and Developmental Considerations for Pharmacogenomic Technology
    by John A. Vernon & Scott J. Johnson & W. Keener Hughen & Antonio Trujillo
  • 2006 The Burden of Age-Related Macular Degeneration
    by Jordana K. Schmier & Mechelle L. Jones & Michael T. Halpern
  • 2006 Bernard S. Bloom, PhD
    by Henry A. Glick
  • 2006 Rationing of Drugs for Rare Diseases
    by Dyfrig Hughes
  • 2006 Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension
    by Greg L. Plosker & Susan J. Keam
  • 2006 The Authors' Reply
    by Paul Kind & Sue Macran
  • 2006 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
    by A. Simon Pickard & Deborah Dobrez & David Cella
  • 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
    by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt
  • 2006 Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias
    by Jerrold Hill & Howard Fillit & Simu K. Thomas & Sobin Chang
  • 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
    by Lawrence D. Goldberg & John Walt
  • 2006 Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective
    by Jonathan Karnon & Thomas Delea & Stephen R.D. Johnston & Robert Smith & Jane Brandman & Jennifer Sung & Paul E. Goss
  • 2006 Trends in Outpatient Prescription Drug Use and Related Costs in the US: 1998-2003
    by Diane K. Wysowski & Laura A. Governale & Joslyn Swann
  • 2006 Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness
    by Jonathan Karnon
  • 2006 Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better?
    by Dyfrig Hughes
  • 2006 How Much is the Cost of Visual Impairment: the Author's Reply
    by Antoine Lafuma
  • 2006 How Much is the Cost of Visual Impairment: Caveat Emptor
    by Catherine Meads & Chris Hyde
  • 2006 Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK
    by Antoine Lafuma & Antoine Brezin & Stefania Lopatriello & Klaus Hieke & Julia Hutchinson & Viviane Mimaud & Gilles Berdeaux
  • 2006 The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia
    by Rachael L. DiSantostefano & Andrea K. Biddle & John P. Lavelle
  • 2006 A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
    by Mark Lamotte & Lieven Annemans & Thomas Evers & Maria Kubin
  • 2006 Combination Vaccine Against Invasive Meningococcal B and Pneumococcal Infections: Potential Epidemiological and Economic Impact in The Netherlands
    by Jasper M. Bos & Hans C. Rumke & Robert Welte & Lodewijk Spanjaard & Loek van Alphen & Maarten J. Postma
  • 2006 Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia Patients: Estimates from a Prospective Naturalistic Study
    by David Salkever & Eric Slade & Mustafa Karakus
  • 2006 Sociodemographic Differences in Quality of Life in Rheumatoid Arthritis
    by Erik J. Groessl & Theodore G. Ganiats & Andrew J. Sarkin
  • 2006 Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age?
    by Michael Drummond & Mark Sculpher
  • 2006 Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia
    by Andrew R. Willan & Ron Goeree & Eleanor M. Pullenayegum & Christopher McBurney & Gordon Blackhouse
  • 2006 Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis
    by Antonio Gomez-Outes & Eduardo Rocha & Javier Martinez-Gonzalez & Vijay V. Kakkar
  • 2006 Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK
    by Phil McEwan & Simon Dixon & Keshwar Baboolal & Pete Conway & Craig J. Currie
  • 2006 Interstitial Cystitis: Cost, Treatment and Co-morbidities in an Employed Population
    by Eric Q. Wu & Howard Birnbaum & Milena Mareva & Andrew Parece & Zihong Huang & David Mallett & Haya Taitel
  • 2006 Incorporating Carer Effects into Economic Evaluation
    by Simon Dixon & Mel Walker & Sam Salek
  • 2006 Too Important to Ignore: Informal Caregivers and Other Significant Others
    by Werner B.F. Brouwer
  • 2006 Costs of Irritable Bowel Syndrome in the UK and US
    by Stefanie Maxion-Bergemann & Frank Thielecke & Florian Abel & Rito Bergemann
  • 2006 Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis
    by A.E. Ades & Mark Sculpher & Alex Sutton & Keith Abrams & Nicola Cooper & Nicky Welton & Guobing Lu
  • 2006 The Authors' Reply
    by J.M. Bos & M.J. Postma & L. Annemans
  • 2006 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
    by Stuart Birks
  • 2006 Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension
    by Greg L. Plosker & Susan J. Keam
  • 2006 Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia
    by Wei Yu & Xinhua S. Ren & Austin F. Lee & Lawrence Herz & Yu-Hui Huang & Lewis E. Kazis
  • 2006 Cost Effectiveness of Tumour Necrosis Factor-alpha Inhibitors as First-Line Agents in Rheumatoid Arthritis
    by James R. Spalding & Joel Hay
  • 2006 Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations
    by Ulrike Ravens-Sieberer & Michael Erhart & Nora Wille & Ralf Wetzel & Jennifer Nickel & Monika Bullinger
  • 2006 Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis
    by Hege Urdahl & Andrea Manca & Mark J. Sculpher
  • 2006 Letter From the Commissioner's Office at the US FDA
    by John A. Vernon
  • 2006 Do Pharmacogenomic Tests Provide Value to Policy Makers?
    by Ya-Chen Tina Shih & Lajos Pusztai
  • 2006 Acknowledgement
    by Adis International Limited
  • 2006 Economic Evaluation in the US: What is the Missing Link?
    by Peter J. Neumann & Sean D. Sullivan
  • 2006 Economic Evaluations in the Canadian Common Drug Review
    by Andreas Laupacis
  • 2006 Building Bridges Between Academic Research and Policy Formulation: The PRUFE Framework - an Integral Part of Ontario's Evidence-Based HTPA Process
    by Ron Goeree & Leslie Levin
  • 2006 Economic Evaluation and Decision Making in the UK
    by Martin J. Buxton
  • 2006 Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers
    by Stephen Birch & Amiram Gafni
  • 2006 `Lost in Translation': Accounting for Between-Country Differences in the Analysis of Multinational Cost-Effectiveness Data
    by Andrea Manca & Andrew R. Willan
  • 2006 Analysis Sans Frontieres: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?
    by Mark J. Sculpher & Michael F. Drummond
  • 2006 Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven?
    by Andrew H. Briggs & Adrian R. Levy
  • 2006 Utility Measurement in Healthcare: The Things I Never Got To
    by George W. Torrance
  • 2006 Using Value of Information Analysis to Prioritise Health Research: Some Lessons from Recent UK Experience
    by Karl P. Claxton & Mark J. Sculpher
  • 2006 Recent Developments in Decision-Analytic Modelling for Economic Evaluation
    by Milton C. Weinstein
  • 2006 Better Analysis for Better Decisions: Facing Up to the Challenges
    by Michael F. Drummond & Mark J. Sculpher
  • 2006 Hospitalisation Costs of Cystic Fibrosis
    by Jonas Schreyogg & Helge Hollmeyer & Miriam Bluemel & Doris Staab & Reinhard Busse
  • 2006 Disability and Quality of Life in Post-Traumatic Stress Disorder: Impact of Drug Treatment
    by Soraya Seedat & Christine Lochner & Bavanisha Vythilingum & Dan J. Stein
  • 2006 Single-Inhaler Combination Therapy for Asthma: A Review of Cost Effectiveness
    by Manabu Akazawa & David A. Stempel
  • 2006 Therapeutic Options for the Prevention and Treatment of Postoperative Nausea and Vomiting: A Pharmacoeconomic Review
    by Jean Lachaine
  • 2006 Should We Abandon QALYs as a Resource Allocation Tool?
    by Sandeep Vijan
  • 2006 QALYs: Are They Helpful to Decision Makers?
    by Maurice McGregor & J. Jaime Caro
  • 2006 The Generalisability of Pharmacoeconomic Studies: Issues and Challenges Ahead
    by James M. Mason & Anne R. Mason
  • 2006 Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit?
    by Eduard Shantsila & Timothy Watson & Gregory Y.H. Lip
  • 2006 The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US
    by Patrick W. Sullivan & Thomas W. Arant & Samuel L. Ellis & Heather Ulrich
  • 2006 The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis
    by Paco M.J. Welsing & Johan L. Severens & Margriet Hartman & Anke M. van Gestel & Piet L.C.M. van Riel & Roland F.J.M. Laan
  • 2006 2006 Disease Management Leadership Forum Meeting Report: Denver, Colorado, 2-5 December 2006
    by Julie A. Meek
  • 2006 Economic Analysis of a Telemedicine Intervention to Improve Glycemic Control in Patients with Diabetes Mellitus: Illustration of a Novel Analytic Method
    by James M. Mason & Robert J. Young & John P. New & J. Martin Gibson & Andrew F. Long & Tina Gambling & Tim Friede
  • 2006 Psychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications
    by Natasa Gisev & J. Simon Bell & Andrew J. McLachlan & Manoranjenni Chetty & Timothy F. Chen
  • 2006 Combination Therapy for Asthma: Perspectives of the Patient, Provider, and Payer
    by Harold J. Farber & James Glauber
  • 2006 Targeted Screening and Treatment of Chronic Kidney Disease: Lessons Learned from the Kidney Early Evaluation Program
    by Joseph A. Vassalotti & Leslie Gracz-Weinstein & Monica R. Gannon & Wendy Weinstock Brown
  • 2006 Using Nicotine Replacement Therapy to Assist in Reducing Cigarette Consumption before Quitting: Another Strategy for Smoking Cessation?
    by Hayden McRobbie & Robyn Whittaker & Christopher Bullen
  • 2006 Putting a Public Health Face on Clinical Practice: Potential for Using an Infectious Disease Management Model for Chronic Disease Prevention
    by Donald O. Fedder & Harsha Desai & Migle Maciunskaite
  • 2006 Acknowledgment
    by Adis International Limited
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 The Role of Peginterferon alpha-2a (40kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection
    by Dene Simpson & Monique P. Curran
  • 2006 The Impact of Open Access to Atypical Antipsychotics on Treatment Costs for Medi-Cal Patients with Bipolar Disorder
    by Sangeeta Narayan & Kimberly L. Sterling & Jeffrey S. McCombs
  • 2006 Internet-Based Smoking Cessation Initiatives: Availability, Varieties, and Likely Effects on Outcomes
    by Anna M. McDaniel & Renee M. Stratton
  • 2006 Preparing for and Responding to Bioterrorist Attacks: The Role of Disease Management Initiatives
    by R. Gregory Evans & Steven J. Lawrence
  • 2006 Disease Management and Its Implications for Outpatient Physician Practice: A Memo for Physicians
    by Jaan Sidorov
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 Impact of a Diabetes Disease Management Program by Race and Ethnicity
    by Verna L. Welch & Natalia Vukshich Oster & Julie A. Gazmararian & Kimberly Rask & Laura Schild & Charles Cutler & Claire Spettell & Michael Reardon
  • 2006 Disease Management of the Frail Elderly Population
    by Stuart Levine & Judy Y. Reyes & Randy Schwartz & Dave Schmidt & Tim Schwab & Moon Leung
  • 2006 Poor Adherence to Anti-inflammatory Medication in Asthma: Reasons, Challenges, and Strategies for Improved Disease Management
    by Rachel A. Elliott
  • 2006 Developing a Specialist Patient Program for Migraine
    by Ann Turner
  • 2006 Adherence to Antipsychotic Treatment in Schizophrenia: What Role Does Cognitive Behavioral Therapy Play in Improving Outcomes?
    by Gary Donohoe
  • 2006 Measuring the Economic Value of Disease Management Programs
    by Don Fetterolf
  • 2006 In Search of Financial Savings from Disease Management: Applying the Number-Needed-to-Decrease Analysis to a Diabetic Population
    by Ariel Linden & Thomas J. Biuso
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 Community Direct Access Service for Early Detection and Treatment of Clinical Deterioration: Effectiveness and Impact on the Workload Pattern of a Hospital-Based Heart Failure Unit
    by Carmel Conlon & Christina O'Loughlin & Mark Ledwidge & Kenneth McDonald
  • 2006 Analysis of Factors Affecting Patient Satisfaction: Focus on Asthma Patients
    by Bayram Sahin & Mehtap Tatar
  • 2006 Impact of Telehealth on Healthcare Utilization by Congestive Heart Failure Patients
    by Craig A. Lehmann & Nancy Mintz & Jean Marie Giacini
  • 2006 Evaluation of an Asthma Disease Management Program in a Medicaid Population
    by Alice Lind & Louise Kaplan & Gregory D. Berg
  • 2006 Telemedicine for Diabetes Care
    by Toree H. Malasanos
  • 2006 Removing Prescription Charges for Patients with Mental Health Disorders: Would it Improve Patient Outcomes in the UK?
    by Ellen I. Schafheutle
  • 2006 Physician Voluntary Reporting Program
    by David W. Plocher
  • 2006 The Economic Burden of End-Stage Renal Disease with Hyperphosphatemia: A Study of Florida Medicaid
    by Annesha White & Folakemi Odedina & Hong Xiao & Ellen Campbell & Richard Segal
  • 2006 Process Optimization by Means of a Computerized Process Simulation Model in Cardiac Surgery
    by Richard Feyrer & Udo Kunzmann & Michael Weyand & Robert Cesnjevar
  • 2006 Promoting the Implementation of Best-Practice Guidelines Using a Matrix Tool: Focus on Cancer Care
    by Karen Luxford & David Hill & Richard Bell
  • 2006 Type 2 Diabetes Mellitus Treatment Patterns and Healthcare Costs in the Elderly Population
    by Gary Erwin & Shrividya Iyer & Rukmini Rajagopalan & James Astuto & Patricia Wilson & Justin Schaneman & Nathan Kleinman
  • 2006 Prescription to Over-the-Counter Switch of Second-Generation Antihistamines (Loratadine): A Review of Its Impact on Healthcare Costs and Resource Utilization
    by Kavita V. Nair
  • 2006 Disease Management Update
    by Adis International Limited
  • 2006 Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone
    by Monique P. Curran & Gillian M. Keating
  • 2006 The Cost of Lung Cancer Management in France from the Payor's Perspective
    by Alain Vergnenegre & Laurent Molinier & Christophe Combescure & Jean-Pierre Daures & Bruno Housset & Christos Chouaid
  • 2006 Population-Based Disease Management in the German Statutory Health Insurance: Implementation and Preliminary Results
    by Stephanie A.K. Stock & Marcus Redaelli & Karl W. Lauterbach
  • 2006 Clinical and Behavioral Impact of Implementing Community-Based Diabetes Disease Management in Japan
    by Hiroyuki Sakamaki & Shunya Ikeda & Naoki Ikegami & Michiko Norimoto & Shigemitsu Moriwaki
  • 2006 An Evaluation of the Factors Associated with Statin Dose Management and Low-Density Lipoprotein-Cholesterol Goal Attainment
    by Caron Ory & Christina Fontes & Setareh A. Williams & Gerald M. Borok & Kenneth McDonough & Eunice Chang
  • 2006 Disease Management for Hypertension: A Pilot Cluster Randomized Trial of 67 Australian General Practices
    by Deborah A. Turnbull & Justin J. Beilby & Tahereh Ziaian & Farooq Qureshi & Mark Nelson & Anne L. Tonkin & John E. Marley
  • 2006 Worksite Disease Management Programs for Depression: Potential Employer Benefits
    by Diane E. Steffick & John C. Fortney & Jeffrey L. Smith & Jeffrey M. Pyne
  • 2006 Access to Prescription Drugs: The Case of Medicaid
    by Peter J. Cunningham
  • 2006 The Author's Reply
    by Joshua Cohen
  • 2006 Comparing Patient Access to Pharmaceuticals in the UK and US
    by Joel W. Hay
  • 2006 Comparison of Individual and Group Valuation of Health State Scenarios across Communities in West Africa
    by Anayo Fidelis Akunne & John F.P. Bridges & Mamadou Sanon & Rainer Sauerborn
  • 2006 Maximising Responses to Discrete Choice Experiments: A Randomised Trial
    by Joanna Coast & Terry N. Flynn & Chris Salisbury & Jordan Louviere & Tim J. Peters
  • 2006 Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation
    by Tom Stargardt & Jonas Schreyogg
  • 2006 Analysis of Healthcare Financing, Supply and Utilisation Trends in the New EU Countries
    by Jane E. Ruseski
  • 2006 Handling Value Added Tax (VAT) in Economic Evaluations: Should Prices Include VAT?
    by Mickael Bech & Terkel Christiansen & Dorte Gyrd-Hansen
  • 2006 Quality and Cost in Healthcare: A Relationship Worth Examining
    by Craig Mitton & Francois Dionne & Stuart Peacock & Sam Sheps
  • 2006 Acknowledgement
    by Adis International Limited
  • 2006 Patients' Preferences for Healthcare System Reforms in Hungary: A Conjoint Analysis
    by Baktygul Akkazieva & Laszlo Gulacsi & Agnes Brandtmuller & Marta Pentek & John F.P. Bridges
  • 2006 Comparing Patient Access to Pharmaceuticals in the UK and US
    by Joshua Cohen & Catherine Cairns & Cherie Paquette & Laura Faden
  • 2006 Community-Based Youth Tobacco Control Interventions: Cost Effectiveness of the Full Court Press Project
    by Hana Ross & Lisa M. Powell & Joseph E. Bauer & David T. Levy & Richard M. Peck & Hye-Ryeon Lee
  • 2006 Modelling the Costs and Outcomes of Changing Rates of Screening for Alcohol Misuse by GPs in the Australian Context
    by Marian Shanahan & Anthony Shakeshaft & Richard P. Mattick
  • 2006 To Retain or Remove User Fees?: Reflections on the Current Debate in Low- and Middle-Income Countries
    by Chris D. James & Kara Hanson & Barbara McPake & Dina Balabanova & Davidson Gwatkin & Ian Hopwood & Christina Kirunga & Rudolph Knippenberg & Bruno Meessen & Saul S. Morris & Alexander Preker & Yves Souteyrand & Abdelmajid Tibouti & Pascal Villeneuve & Ke Xu
  • 2006 Estimating Technical Efficiency in the Hospital Sector with Panel Data: A Comparison of Parametric and Non-Parametric Techniques
    by Luigi Siciliani
  • 2006 Supplier-Induced Demand: Reconsidering the Theories and New Australian Evidence
    by Jeffrey R.J. Richardson & Stuart J. Peacock
  • 2006 How Cost-of-Illness Studies Can be Made More Useful for Illicit Drug Policy Analysis
    by Timothy J. Moore & Jonathan P. Caulkins
  • 2006 Centralising Drug Review to Improve Coverage Decisions: Economic Lessons From (and For) Canada
    by Steve Morgan & Meghan McMahon & Craig Mitton
  • 2006 Factors Associated with Physicians' Choice of Working Sector: A National Longitudinal Survey in Finland
    by Terhi Kankaanranta & Jari Vainiomaki & Ville Autio & Hannu Halila & Harri Hyppola & Mauri Isokoski & Santero Kujala & Esko Kumpusalo & Kari Mattila & Irma Virjo & Jukka Vanska & Pekka Rissanen
  • 2006 Australian General Practice: Where Have the GP Services Gone?
    by Ian McRae
  • 2006 A Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance: A Case Study of Methicillin-Resistant Staphylococcus aureus (MRSA)
    by Richard D. Smith & Milton Yago & Michael Millar & Joanna Coast
  • 2006 Recycling Blood: Sharing the Benefits of Cell Salvage
    by Bernard Crotty
  • 2006 Using Economic Analyses for Local Priority Setting: The Population Cost-Impact Approach
    by Richard F. Heller & Islay Gemmell & Edward C.F. Wilson & Richard Fordham & Richard D. Smith
  • 2006 The Relationship between Ex Ante Mortality Risk and End-of-Life Medical Costs
    by David H. Howard & Steven D. Culler & Benjamin G. Druss & Kenneth E. Thorpe
  • 2006 Genetic Health Technology and Economic Evaluation: A Critical Review
    by James Jarrett & Miranda Mugford
  • 2006 Methodological Aspects in the Assessment of Treatment Effects in Observational Health Outcomes Studies
    by Josep Maria Haro & Stathis Kontodimas & Miguel Angel Negrin & Mark Ratcliffe & David Suarez & Frank Windmeijer
  • 2006 Health Reform, Equity and Primary Healthcare: Taking Off the Make-Up
    by Stephen Thomas & Okore Okorafor & Sandi Mbatsha
  • 2006 Smoking Behavior and Rank-Dependent Expected-Uitility
    by Christophe Courbage
  • 2006 Cigarette Taxes and the Master Settlement Agreement
    by Justin G. Trogdon & Frank A. Sloan
  • 2006 Principal Agency Theory and Health Care Utilization
    by Helen Schneider & Alan Mathios
  • 2006 Risk Adjustment Schemes in Social Health Insurance: Adjusting for Cost Differences Between Insurance Plans
    by Stefan Felder
  • 2006 El Problema De La Obesidad: El Caso De Las Regiones Españolas/The Obesity Problem: The Case Of Spanish Regions
    by CANTARERO PRIETO, DAVID & Y PASCUAL SÁEZ, MARTA
  • 2006 The Economic Costs Of Anxiety In Spain/Los Costes Económicos De Los Desórdenes De La Ansiedad En España
    by OLIVA-MORENO,JUAN & LÓPEZ-BASTIDA, JULIO & MONTEJO, ANGEL LUIS
  • 2006 The Role of Group Purchasing Organizations (GPOs) in the U.S. Medical Industry Supply Chain/El Papel De Las Organizaciones De Grupos De Compra (Gpos) En La Cadena De Suministros Médicos En Estados Unidos
    by L. WEINSTEIN, BERNARD
  • 2006 The Influence of Proverty, Deprivation and Social class on Health inequality: a review of American and Canadian Literature/La Influencia de la Pobreza, de la Privación y de la Clase Social en la Desigualdad de la Salud: Una revisión de la Literatura Americana y Canadiense
    by THOUEZ, JEAN-PIERRE
  • 2006 Correlates of hospital quality: a preliminary study
    by Charles Hegji
  • 2006 Health benefits and uncertainty: an experimental analysis of the effects of risk presentation on auction bids for a healthful product
    by W. Douglass Shaw & Andres Silva & Rodolfo M. Nayga, Jr.
  • 2006 Assessing benefit-incidence results using decompositions. The case of health policy in Argentina
    by Leonardo Gasparini
  • 2006 Compensating the Poor out of Traditional Healing in Cameroon: A Nested Logit Analysis
    by Kamgnia, D.B.
  • 2006 Desarrollo Económico De África En 2000-2005: Educación, Gasto En Salud, Población Y Renta
    by Guisan, M. Carmen & Exposito, Pilar
  • 2006 Assessing Health Reform in Colombia: From Theory to Practice
    by Alejandro Gaviria & Carlos Medina & Carolina Mejia
  • 2006 How Efficient is Public Spending in Education?
    by Santiago Herrera & Gaobo Pang
  • 2006 Evolutions in health services quality approach
    by Lelia Chiru
  • 2005 Out-of-Pocket Health Spending Between Low- and High-Income Populations: Who is at Risk of Having High Financial Burdens?
    by Yu-Chu Shen & Joshua McFeeters
  • 2005 Asymmetric Information from Physician Agency:Optimal Payment and Healthcare Quantity
    by Philippe Chone & Ching-to Albert Ma
  • 2005 Illustrating Adverse Selection in Health Insurance Markets with a Classroom Game
    by Jennifer M. Mellor
  • 2005 A Note on Financing Health-Care Reform: Some Simple Arguments Concerning Marginal Tax Burden
    by Wolfgang Buchholz
  • 2005 Endogenous longevity, biological deterioration and economic growth
    by Marcos Sanso & Rosa M. Aísa
  • 2005 The labour supply of nurses in the UK: evidence from the British Household Panel Survey
    by Nigel Rice
  • 2005 Mortality, lifestyle and socio-economic status
    by Silvia Balia & Andrew M Jones
  • 2005 Obesity, Wages and Employment in Europe
    by Jaume Garcia & Climent Quintana-Domeque
  • 2005 Body size, activity, employment and wages in Europe: A first approach
    by Jaume Garcia Villar & Climent Quintana
  • 2005 Before and After the Black Death: Money, Prices, and Wages in Fourteenth-Century England
    by John H. A. Munro
  • 2005 Endogenous Mortality, Human Capital and Endogenous Growth
    by Osang, Thomas & Sarkar, Jayanta
  • 2005 Economic Uncertainties in Valuing Reductions in Children's Environmental Health Risks
    by Krupnick, Alan & Hoffmann, Sandra & Adamowicz, Wictor
  • 2005 Towards Novel Nonparametric Statistical Methods and Bioinformatics Tools for Clinical and Translational Sciences
    by Wittkowski, Knut M.
  • 2005 In Search of Efficiency: Improving Health Care in Hungary
    by Alessandro Goglio
  • 2005 Psychiatric Disorders and Labor Market Outcomes: Evidence from the National Latino and Asian American Study
    by Pinka Chatterji & Margarita Alegria & Mingshan Lu & David Takeuchi
  • 2005 The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya
    by Harsha Thirumurthy & Joshua Graff-Zivin & Markus Goldstein
  • 2005 The Welfare Effects of Restricted Hospital Choice in the US Medical Care Market
    by Katherine Ho
  • 2005 Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
    by Tomas J. Philipson & Anupam B. Jena
  • 2005 From the Cradle to the Labor Market? The Effect of Birth Weight on Adult Outcomes
    by Sandra E. Black & Paul J. Devereux & Kjell Salvanes
  • 2005 Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
    by Tomas J. Philipson & Ernst R. Berndt & Adrian H. B. Gottschalk & Matthew W. Strobeck
  • 2005 The Effects of Cardiac Specialty Hospitals on the Cost and Quality of Medical Care
    by Jason R. Barro & Robert S. Huckman & Daniel P. Kessler
  • 2005 Race and Health Disparities Among Seniors in Urban Areas in Brazil
    by Antonio J. Trujillo & John A. Vernon & Laura Rodriguez Wong & Gustavo Angeles
  • 2005 Health Risk, Income, and Employment-Based Health Insurance
    by M. Kate Bundorf & Bradley Herring & Mark Pauly
  • 2005 Estimation and Identification of Merger Effects: An Application to Hospital Mergers
    by Leemore S. Dafny
  • 2005 Entry and Competition in Local Hospital Markets
    by Jean M. Abraham & Martin S. Gaynor & William B. Vogt
  • 2005 The Effect of Child Access Prevention Laws on Non-Fatal Gun Injuries
    by Jeff DeSimone & Sara Markowitz
  • 2005 Disability Risk and the Value of Disability Insurance
    by Amitabh Chandra & Andrew A. Samwick
  • 2005 Insurance and Innovation in Health Care Markets
    by Darius Lakdawalla & Neeraj Sood
  • 2005 Endogenous Fertility, Mortality and Economic Growth: Can a Malthusian Framework Account for the Conflicting Historical Trends in Population?
    by Isaac Ehrlich & Jinyoung Kim
  • 2005 Biology as Destiny? Short and Long-Run Determinants of Intergenerational Transmission of Birth Weight
    by Janet Currie & Enrico Moretti
  • 2005 Health Insurance and the Obesity Externality
    by Jay Bhattacharya & Neeraj Sood
  • 2005 Does Falling Smoking Lead to Rising Obesity?
    by Jonathan Gruber & Michael Frakes
  • 2005 Accounting for the Effect of Health on Economic Growth
    by David N. Weil
  • 2005 Firms' Demand for Employment-Based Mental Health Benefits
    by Judith Shinogle & David Salkever
  • 2005 Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA
    by Ernst R. Berndt & Adrian H. B. Gottschalk & Matthew W. Strobeck
  • 2005 Do Report Cards Tell Consumers Anything They Don't Already Know? The Case of Medicare HMOs
    by Leemore Dafny & David Dranove
  • 2005 Can Ranking Hospitals on the Basis of Patients' Travel Distances Improve Quality of Care?
    by Daniel P. Kessler
  • 2005 The Impact of State Physical Education Requirements on Youth Physical Activity and Overweight
    by John Cawley & Chad D. Meyerhoefer & David Newhouse
  • 2005 Hospital Integration and Vertical Consolidation: An Analysis of Acquisitions in New York State
    by Robert S. Huckman
  • 2005 Does Corporate Ownership Matter? Service Provision in the Hospital Industry
    by Jill R. Horwitz
  • 2005 Forsaking All Others? The Effects of "Gay Marriage" on Risky Sex
    by Thomas S. Dee
  • 2005 Patents, Price Controls, and Access to New Drugs: How Policy Affects Global Market Entry
    by Jean O. Lanjouw
  • 2005 The Determinants of the Willingness to be an Organ Donor
    by Naci Mocan & Erdal Tekin
  • 2005 The Great Escape: A Review Essay on Fogel's 'The Escape from Hunger and Premature Death, 1700-2100'
    by Angus Deaton
  • 2005 The Incidence of the Healthcare Costs of Obesity
    by Jay Bhattacharya & M. Kate Bundorf
  • 2005 Treatment Effect Bounds: An Application to Swan-Ganz Catheterization
    by Jay Bhattacharya & Azeem Shaikh & Edward Vytlacil
  • 2005 Technology Adoption From Hybrid Corn to Beta Blockers
    by Jonathan Skinner & Douglas Staiger
  • 2005 Suicidal Behavior and the Labor Market Productivity of Young Adults
    by Erdal Tekin & Sara Markowitz
  • 2005 Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
    by Joseph Golec & Shantaram Hegde & John A. Vernon
  • 2005 The Effects of Competition on Variation in the Quality and Cost of Medical Care
    by Daniel P. Kessler & Jeffrey J. Geppert
  • 2005 The Competitive Effects of Drug Withdrawals
    by John Cawley & John A. Rizzo
  • 2005 Hospital Ownership Mix Efficiency in the US: An Exploratory Study
    by Rexford E. Santerre & John A. Vernon
  • 2005 Cohort Turnover and Productivity: The July Phenomenon in Teaching Hospitals
    by Robert S. Huckman & Jason Barro
  • 2005 Reading, Writing and Raisinets: Are School Finances Contributing to Children's Obesity?
    by Patricia M. Anderson & Kristin F. Butcher
  • 2005 Technology, Monopoly, and the Decline of the Viatical Settlements Industry
    by Neeraj Sood & Abby Alpert & Jay Bhattacharya
  • 2005 The Labor Market Effects of Rising Health Insurance Premiums
    by Katherine Baicker & Amitabh Chandra
  • 2005 Assessing Consumer Gains from a Drug Price Control Policy in the U.S
    by Rexford Santerre & John A. Vernon
  • 2005 Testing for Ownership Mix Efficiency: The Case of the Nursing Home Industry
    by Rexford E. Santerre & John A. Vernon
  • 2005 The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions
    by Thomas A. Abbott & John A. Vernon
  • 2005 Water, Water, Everywhere: Municipal Finance and Water Supply in American Cities
    by David Cutler & Grant Miller
  • 2005 Stemming the Tide? The Effect of Expanding Medicaid Eligibility on Health Insurance
    by Lara D. Shore-Sheppard
  • 2005 Drinking and Academic Performance in High School
    by Jeff DeSimone & Amy M. Wolaver
  • 2005 Improving Data to Analyze Food and Nutrition Policies
    by Panel on Enhancing the Data Infrastructure in Support of Food & Nutrtion Programs & Research & Decision Making & of which Ronette Briefel was a member. Committee on National Statistics & National Research Council
  • 2005 Preventing Childhood Obesity: Health in the Balance
    by Institute of Medicine Committee on Prevention of Obesity in Children & Youth & of which Robert C. Whitaker was a member
  • 2005 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates in 2000-2002 for All Eligible People and the Working Poor
    by Laura A. Castner & Allen L. Schirm
  • 2005 Characteristics of Food Stamp Households: Fiscal Year 2004
    by Anni Poikolainen
  • 2005 Reaching Those in Need: State Food Stamp Participation Rates in 2003
    by Laura A. Castner & Allen L. Schirm
  • 2005 Assessing the Nutrient Intakes of Vulnerable Subgroups
    by Barbara Devaney & Myoung Kim & Alicia Carriquiry & Gabriel Camano-Garcia
  • 2005 State Food Stamp Participation Rates for the Working Poor in 2002
    by Laura A. Castner & Allen L. Schirm
  • 2005 Reaching Out: Nutrition Assistance for the Elderly. Volume II: Demonstration Summaries
    by Scott Cody & James Ohls
  • 2005 Reaching Out: Nutrition Assistance for the Elderly. Volume I: Evaluation Findings
    by Scott Cody & James Ohls
  • 2005 Reaching Out: Nutrition Assistance for the Elderly
    by Scott Cody & James Ohls
  • 2005 Food Stamp Program Participation Rates: 2003
    by Karen Cunnyngham
  • 2005 Food Stamp Program Entry and Exit: An Analysis of Participation Trends in the 1990s
    by Scott Cody & Phil Gleason & Bruce Schechter & Miki Satake & Julie Sykes
  • 2005 Food Stamp Program Entry and Exit: Participation Trends in the 1990s
    by Scott Cody & Phil Gleason & Bruce Schechter & Miki Satake & Julie Sykes
  • 2005 Findings from the Evaluation of the Elderly Nutrition Demonstrations
    by Scott Cody & Jim Ohls
  • 2005 Innovative WIC Practices
    by Anne Gordon & Heather Hartline-Grafton & Renée Nogales
  • 2005 WIC Food Packages: Time for a Change
    by Food & Nutrition Board Committee to Review the WIC Food Packages of which Barbara Devaney is a member
  • 2005 The National School Lunch Program: Ensuring that Free and Reduced-Price Meal Benefits Go to the Poor
    by Philip Gleason & John Burghardt
  • 2005 Reaching Those in Need: State Food Stamp Participation Rates in 2002
    by Laura A. Castner & Allen L. Schirm
  • 2005 The Health Behaviors of Immigrants and Native-born People in Canada
    by James Ted McDonald
  • 2005 From the Cradle to the Labor Market? The Effect of Birth Weight on Adult Outcomes
    by Sandra E. Black & Paul J. Devereux & Kjell G. Salvanes
  • 2005 From the Cradle to the Labor Market? The Effect of Birth Weight on Adult Outcomes
    by Black, Sandra E. & Devereux, Paul J. & Salvanes, Kjell G.
  • 2005 Taxes, Cigarette Consumption and Smoking Intensity
    by Jérôme Adda & Francesca Cornaglia
  • 2005 Taxes, Cigarette Consumption and Smoking Intensity
    by Adda, Jérôme & Cornaglia, Francesca
  • 2005 The Impact of Parental Income and Education on the Health of their Children
    by Orla Doyle & Colm Harmon & Ian Walker
  • 2005 The Impact of Parental Income and Education on the Health of their Children
    by Doyle, Orla & Harmon, Colm P. & Walker, Ian
  • 2005 Unhealthy Assimilation: Why Do Immigrants Converge to American Health Status Levels?
    by Heather Antecol & Kelly Bedard
  • 2005 Unhealthy Assimilation: Why Do Immigrants Converge to American Health Status Levels?
    by Antecol, Heather & Bedard, Kelly
  • 2005 Time Discounting and the Body Mass Index
    by Lex Borghans & Bart H. H. Golsteyn
  • 2005 Time Discounting and the Body Mass Index
    by Borghans, Lex & Golsteyn, Bart H.H.
  • 2005 Suicidal Behavior and the Labor Market Productivity of Young Adults
    by Tekin, Erdal & Markowitz, Sara
  • 2005 Suicidal Behavior and the Labor Market Productivity of Young Adults
    by Erdal Tekin & Sara Markowitz
  • 2005 The Health Status of Indigenous and Non-Indigenous Australians
    by Booth, Alison L. & Carroll, Nick
  • 2005 The Health Status of Indigenous and Non-Indigenous Australians
    by Booth, Alison & Carroll, Nick
  • 2005 Socio-Economic Status, Health Shocks, Life Satisfaction and Mortality: Evidence from an Increasing Mixed Proportional Hazard Model
    by Frijters, Paul & Haisken-DeNew, John P. & Shields, Michael A.
  • 2005 Socio-Economic Status, Health Shocks, Life Satisfaction and Mortality: Evidence from an Increasing Mixed Proportional Hazard Model
    by Frijters, Paul & Haisken-DeNew, John & Shields, Michael A.
  • 2005 International Multidimensional Comparisons of Inequality in Disposable Income and Access to Public Goods
    by Nicolas Gravel & Patrick Moyes & Benoît Tarroux
  • 2005 Heterogeneity, State Dependence and Health
    by Timothy J Halliday
  • 2005 Collective Equipoise, Disappointment and the Therapeutic Misconception: On the Consequences of Selection for Clinical Research
    by Peter Thompson & Margaret M. Byrne
  • 2005 Individual Risk Attitudes: New Evidence from a Large, Representative, Experimentally-Validated Survey
    by Thomas Dohmen & Armin Falk & David Huffman & Uwe Sunde & Juergen Schupp & Gert Wagner
  • 2005 Healer shopping in Africa: new evidence from rural-urban qualitative study of diabetes experiences
    by Ama de-Graft Aikins
  • 2005 Mental health: the choice of therapy for all
    by Richard Layard
  • 2005 Estimation of individual demand for alcohol
    by Andrienko Yury & Nemtsov Aleksandr
  • 2005 Why Does the Relationship between Economic Status and Child Health Strengthen for Older Children in the U.S.? Evidence from the Medical Expenditures Panel Survey and the Panel Study of Income Dynamics
    by Charles Link & Simon Condliffe
  • 2005 Protección Social y Empleo en América Latina: Estudio sobre la Base de Encuestas de Hogares
    by Leonardo Gasparini
  • 2005 The SHARE survey: presentation and first results for the French edition
    by D. BLANCHET & T. DEBRAND & P. DOURGNON & P. POLLET
  • 2005 The Impact of Parental Income and Education on the Health of their Children
    by Doyle, Orla & Harmon, Colm & Walker, Ian
  • 2005 Reestimación y actualización del costo económico en Argentina de la mortalidad atribuible al tabaco en adultos
    by Mariana Conte Grand
  • 2005 Acquisition and disclosure of genetic information under alternative policy regimes
    by Deborah Wilson
  • 2005 Overcrowding and Indigenous Health in Australia
    by Alison Booth & Nick Carroll
  • 2005 Socio-Economic Status, Health Shocks, Life Satisfaction and Mortality: Evidence from an Increasing Mixed Proportional Hazard Model
    by Paul Frijters & John Haisken-DeNew & Michael Shields
  • 2005 The Health Status of Indigenous and Non-Indigenous Australians
    by Alison Booth & Nick Carroll
  • 2005 Book Review
    by Adis International Limited
  • 2005 Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections
    by Greg L. Plosker & David P. Figgitt
  • 2005 Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery
    by Adrienne Heerey & Sanjeev Suri
  • 2005 Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops
    by Guillaume Desjeux & Laurent Galoisy-Guibal & Cyrille Colin
  • 2005 A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults
    by Emily Beth Devine & Zafar Hakim & Jesse Green
  • 2005 Economic Implications of Biological Therapies for Crohn's Disease: Review of Infliximab
    by Keith Bodger
  • 2005 The Role of Economic Evaluation in Vaccine Decision Making: Focus on Meningococcal Group C Conjugate Vaccine
    by Robert Welte & Caroline L. Trotter & W. John Edmunds & Maarten J. Postma & Philippe Beutels
  • 2005 The Authors' Reply
    by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan
  • 2005 Incorporation of Uncertainty in Health Economic Modelling Studies
    by Mark Nuijten
  • 2005 An Economic Evaluation of Rizatriptan in the Treatment of Migraine
    by Melissa Thompson & Marek Gawel & Brigitte Desjardins & Nicole Ferko & Daniel Grima
  • 2005 Cost of Illness and its Predictors for Parkinson's Disease in Germany
    by Annika E. Spottke & Martin Reuter & Olaf Machat & Bernhard Bornschein & Sonja von Campenhausen & Karin Berger & Rudolf Koehne-Volland & Jurgen Rieke & Alexander Simonow & Dirk Brandstaedter & Uwe Siebert & Wolfgang H. Oertel & Gudrun Ulm & Richard Dodel
  • 2005 Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme
    by Janne A. Martikainen & Akseli Kivioja & Taru Hallinen & Pia Vihinen
  • 2005 Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy
    by Suzanne Polinder & Willem Jan Meerding & Job van Exel & Werner Brouwer
  • 2005 Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK
    by Louis S. Matza & Kristina Secnik & Sally Mannix & F. Randy Sallee
  • 2005 Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited
    by Elizabeth A. Calhoun & Glen T. Schumock & June M. McKoy & Simon Pickard & Karen A. Fitzner & Elizabeth A. Heckinger & Eowyn F. Powell & Kathyrn R. McCaffrey & Charles L. Bennett
  • 2005 Pharmaceutical Policy regarding Generic Drugs in Belgium
    by Steven Simoens & Kristien De Bruyn & Marc Bogaert & Gert Laekeman
  • 2005 Real-World Trials to Answer Real-World Questions
    by Nick Freemantle & Lawrence Blonde & Bjorn Bolinder & Robert A. Gerber & F.D. Richard Hobbs & Luc Martinez & Stuart Ross
  • 2005 The Authors' Reply
    by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi
  • 2005 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
    by Eduardo Carracedo-Martinez
  • 2005 Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease
    by Kristen Migliaccio-Walle & J. Jaime Caro & Khajak J. Ishak & Judith A. O'Brien
  • 2005 Economic Assessment of Adjustable Maintenance Treatment with Budesonide/Formoterol in a Single Inhaler versus Fixed Treatment in Asthma
    by Bernd Bruggenjurgen & Dagmar Selim & Peter Kardos & Kai Richter & Claus Vogelmeier & Stephanie Roll & Wolfgang Meyer-Sabellek & Roland Buhl & Stefan N Willich
  • 2005 Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations
    by Kun-Sei Lee & Werner B.F. Brouwer & Sang-Il Lee & Hye-Won Koo
  • 2005 The State of Patient-Reported Outcomes in Atrial Fibrillation: A Review of Current Measures
    by Karin Coyne & Mary Kay Margolis & Susan Grandy & Peter Zimetbaum
  • 2005 Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications
    by Mirella De Civita & Dean Regier & Abul H. Alamgir & Aslam H. Anis & Mark J. FitzGerald & Carlo A. Marra
  • 2005 Price Differentiation and Transparency in the Global Pharmaceutical Marketplace
    by David B. Ridley
  • 2005 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
    by J.M. Bos & Maarten J. Postma & Lieven Annemans
  • 2005 Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease
    by Michael Spencer & Andrew H. Briggs & Ronald F. Grossman & Laureen Rance
  • 2005 The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK
    by Marco Barbieri & John B. Wong & Michael Drummond
  • 2005 Pharmacoeconomic Evaluation of Antidepressants: A Critical Appraisal of Methods
    by Sheikh Usman Iqbal & Mark Prashker
  • 2005 Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials
    by Dennis A. Revicki & Louis S. Matza & Emuella Flood & Andrew Lloyd
  • 2005 Remission from Depression: A Review of Venlafaxine Clinical and Economic Evidence
    by Donald Han & Edward C.Y. Wang
  • 2005 The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis
    by William Abramovits & Mark Boguniewicz & Amy S. Paller & Diane L. Whitaker-Worth & Mary M. Prendergast & Michael Tokar & Kuo B. Tong
  • 2005 Health Utilities in Alzheimer's Disease and Implications for Cost-Effectiveness Analysis
    by Peter J. Neumann
  • 2005 Incorporation of Uncertainty in Health Economic Modelling Studies
    by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan
  • 2005 On Pharmacogenomics and Cost-Effectiveness Analysis at the Individual Level
    by Mohan V. Bala & Gary A. Zarkin
  • 2005 Cost Effectiveness of Imatinib Compared with Interferon-alpha or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia
    by Kim Dalziel & Ali Round & Ruth Garside & Ken Stein
  • 2005 Reductions in Anaemia and Fatigue are Associated with Improvements in Productivity in Cancer Patients Receiving Chemotherapy
    by Ernst Berndt & Joel Kallich & Anne McDermott & Xiao Xu & Howard Lee & John Glaspy
  • 2005 Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy
    by Lucie Blais & Odile Sheehy & Jean-Marc Saint-Hilaire & Gilles-Pierre Bernier & Philippe Godfroid & Jacques LeLorier
  • 2005 Economic Considerations in the Prescribing of Third-Generation Antidepressants
    by Stuart Montgomery & John J. Doyle & Lee Stern & Christopher R. McBurney
  • 2005 The Health-Related Quality of Life and Economic Burden of Constipation
    by Cheryl Dennison & Manishi Prasad & Andrew Lloyd & Samir K. Bhattacharyya & Ravinder Dhawan & Karin Coyne
  • 2005 Valuing Patient and Caregiver Time: A Review of the Literature
    by Jennifer E. Tranmer & Denise N. Guerriere & Wendy J. Ungar & Peter C. Coyte
  • 2005 Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?
    by Adam La Caze
  • 2005 Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder
    by Ellen W. Freeman
  • 2005 Willingness to Pay for a QALY: Theoretical and Methodological Issues
    by Dorte Gyrd-Hansen
  • 2005 Quality Control in the Regulation of Pharmaceuticals
    by Alan Maynard
  • 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency
    by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz
  • 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide in Rheumatoid Arthritis in Germany: I. Selected DMARDs and Patient-Related Costs
    by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz
  • 2005 Cost Effectiveness of Budesonide/Formoterol in a Single Inhaler for COPD Compared with Each Monocomponent Used Alone
    by Claes-Goran Lofdahl & Asa Ericsson & Klas Svensson & Emma Andreasson
  • 2005 Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease: A Review of the Literature
    by Helen Doll & Marc Miravitlles
  • 2005 Review of the Cost Effectiveness of Immunisation Strategies for the Control of Epidemic Meningococcal Meningitis
    by Mark A. Miller & Cathryn K. Shahab
  • 2005 Pharmacoeconomic Analyses Using Discrete Event Simulation
    by J. Jaime Caro
  • 2005 Future Challenges for the Economic Evaluation of Healthcare: Patient Preferences, Risk Attitudes and Beyond
    by John F.P. Bridges
  • 2005 Meningococcal Vaccination: Cui Bono?
    by Thomas D. Szucs
  • 2005 Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
    by Natalie C. Edwards & Marcia F.T. Rupnow & Chris L. Pashos & Marc F. Botteman & Ronald J. Diamond
  • 2005 The Case of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Rheumatoid Arthritis: A Budget Impact Analysis
    by Jan Sorensen & Lis S. Andersen
  • 2005 A Pharmacoeconomic Evaluation of Statins in the Treatment of Hypercholesterolaemia in the Primary Care Setting in Spain
    by Pedro J. Tarraga-Lopez & Angel Celada-Rodriguez & Miguel Cerdan-Oliver & Juan Solera-Albero & Jose M Ocana-Lopez & Mateo A. Lopez-Cara & Jaime De Miguel-Clave
  • 2005 Oral Serotonin Receptor Agonists: A Review of Their Cost Effectiveness in Migraine
    by Jennifer H. Lofland & David B. Nash
  • 2005 International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis: A Systematic Literature Review
    by Hubertus Rosery & Rito Bergemann & Stefanie Maxion-Bergemann
  • 2005 The Economic Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: Can Drugs Ease the Burden?
    by Daniel L. Murman & Christopher C. Colenda
  • 2005 Penny and Pound Wise: Pharmacoeconomics from a Governmental Perspective
    by Mike F. van Oostenbruggen & Ronald B. Jansen & Katja Mur & Huib Kooijman
  • 2005 The Relationship between Productivity and Health-Related QOL: An Exploration
    by Werner B.F. Brouwer & Willem-Jan Meerding & Leida M. Lamers & Johan L. Severens
  • 2005 EMEA: For Patients or For Industry?
    by Silvio Garattini
  • 2005 Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease
    by Greg L. Plosker & Katherine A. Lyseng-Williamson
  • 2005 The Impact of Anaemia and its Treatment on Employee Disability and Medical Costs
    by Ernst Berndt & William Crown & Joel Kallich & Stacey Long & Xue Song & Gary H. Lyman
  • 2005 Cost-Minimisation Analysis of Sivelestat for Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome
    by Naoki Aikawa & Seitaro Fujishima & Makoto Kobayashi & Shozo Matsuoka & Taira Abiru
  • 2005 Evaluation of the Cost Effectiveness of Escitalopram versus Venlafaxine XR in Major Depressive Disorder
    by Jose-Luis Fernandez & Stuart Montgomery & Clement Francois
  • 2005 Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs
    by Philip Jacobs & Arto Ohinmaa & Bruce Brady
  • 2005 Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease
    by Joel W. Hay & Kimberly L. Sterling
  • 2005 The Case for Stratified Cost-Effectiveness Analysis by Baseline Health-Related QOL: Theory and Sensitivity Analysis
    by Joseph Schaafsma
  • 2005 The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project
    by Gerard de Pouvourville & Philippe Ulmann & John Nixon & Stephanie Boulenger & Julie Glanville & Michael Drummond
  • 2005 The Friction-Cost Method: Replacement for Nothing and Leisure for Free?
    by Werner B.F. Brouwer & Marc A. Koopmanschap
  • 2005 Friction-Cost Method as an Alternative to the Human-Capital Approach in Calculating Indirect Costs
    by Howard Birnbaum
  • 2005 Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder
    by Kristina Secnik & Andrine Swensen & Maureen J. Lage
  • 2005 A Randomised Trial of the Cost Effectiveness of Buprenorphine as an Alternative to Methadone Maintenance Treatment for Heroin Dependence in a Primary Care Setting
    by Anthony H. Harris & Elena Gospodarevskaya & Alison J. Ritter
  • 2005 Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer
    by Davide Radice & Alberto Redaelli
  • 2005 Household-Based Costs and Benefits of Vaccinating Healthy Children in Daycare Against Influenza Virus: Results from a Pilot Study
    by Maria Pisu & Martin I. Meltzer & Eugene S. Hurwitz & Michael Haber
  • 2005 Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda
    by Marc Koopmanschap & Alex Burdorf & Karin Jacob & Willem Jan Meerding & Werner Brouwer & Hans Severens
  • 2005 A Review of the Costs of Managing Childhood Epilepsy
    by Ettore Beghi & Barbara Frigeni & Massimiliano Beghi & Paola De Compadri & Livio Garattini
  • 2005 Pharmacoeconomic Impact of Non-Compliance with Statins
    by Andrew M. Peterson & William F. McGhan
  • 2005 Role of Pharmacoeconomic Analysis in R&D Decision Making: When, Where, How?
    by Paul Miller
  • 2005 Rizatriptan: A Pharmacoeconomic Review of its Use in the Acute Treatment of Migraine
    by Paul L. McCormack & Rachel H. Foster
  • 2005 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease
    by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg
  • 2005 Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness
    by Katia Noyes & Andrew W. Dick & Robert G. Holloway & The Parkinson Study Group
  • 2005 A Willingness-To-Pay Assessment of Parents' Preference for Shorter Duration Treatment of Acute Otitis Media in Children
    by Delphine Gueylard Chenevier & Jacques LeLorier
  • 2005 Estimating Mean Total Costs in the Presence of Censoring: A Comparative Assessment of Methods
    by Tracey A. Young
  • 2005 Willingness to Pay for Inhaled Insulin: A Contingent Valuation Approach
    by Hamid Sadri & Linda D. MacKeigan & Lawrence A. Leiter & Thomas R. Einarson
  • 2005 Cost-Effectiveness Acceptability Curves and a Reluctance to Lose
    by Johan L. Severens & Danielle E.M. Brunenberg & Elisabeth A.L. Fenwick & Bernie O'Brien & Manuela A. Joore
  • 2005 No Room for Kinkiness in a Public Healthcare System
    by Jack Dowie
  • 2005 The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development - The Authors' Reply
    by Joseph A. DiMasi & Cherie Paquette
  • 2005 Comment on _The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development_
    by Aidan Hollis
  • 2005 Acknowledgement
    by Adis International Limited
  • 2005 The Importance of Drug Adverse Effects Compared with Seizure Control for People with Epilepsy: A Discrete Choice Experiment
    by Andrew Lloyd & Emma McIntosh & Martin Price
  • 2005 Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer
    by Niels Neymark & Pilar Lianes & Egbert F. Smit & Jan P. van Meerbeeck
  • 2005 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
    by Paul Kind & Susan Macran
  • 2005 Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy
    by Patricia Brown & Moran Ki & Betsy Foxman
  • 2005 Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature
    by Ralph P. Insinga & Erik J. Dasbach & Elamin H. Elbasha
  • 2005 Antiviral Agents for Influenza: A Comparison of Cost-Effectiveness Data
    by Larry D. Lynd & Ron Goeree & Bernie J. O'Brien
  • 2005 Economic Evaluations of Healthcare Programmes and Decision Making: The Influence of Economic Evaluations on Different Healthcare Decision-Making Levels
    by Marieke E. van Velden & Johan L. Severens & Annoesjka Novak
  • 2005 Reporting Pharmacoeconomic Evaluations
    by C.I. Carswell & J.A. Paladino
  • 2005 Pharmacological Management of Overactive Bladder: A Systematic and Critical Review of Published Economic Evaluations
    by Denis Getsios & Wissam El-Hadi & Ingrid Caro & J. Jaime Caro
  • 2005 Measuring Health-Related Quality of Life in Older Patient Populations: A Review of Current Approaches
    by Anne Hickey & Maja Barker & Hannah McGee & Ciaran O'Boyle
  • 2005 Transparency in Economic Evaluations
    by Suzanne Hill
  • 2005 Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure
    by Katherine F. Croom & Greg L. Plosker
  • 2005 Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon-alpha-2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1
    by Maria Buti & Miguel A. Casado & Leslie Fosbrook & Rafael Esteban
  • 2005 Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease
    by Dyfrig A. Hughes & Keith Bodger & Peter Bytzer & Dirk de Herdt & Dominique Dubois
  • 2005 Using Policy Simulation to Predict Drug Plan Expenditure when Planning Reimbursement Changes
    by Colin R. Dormuth & Sean Burnett & Sebastian Schneeweiss
  • 2005 The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach
    by Peter Hertzman
  • 2005 Cost Effectiveness of a Clinical Decision Support System Based on the Recommendations of the European Society of Cardiology and Other Societies for the Management of Hypercholesterolemia: Report of a Cluster-Randomized Trial
    by Albert Cobos & Jordi Vilaseca & Cesar Asenjo & Juan Pedro-Botet & Emilia Sanchez & Alicia Val & Eva Torremade & Cristina Espinosa & Salvador Bergonon
  • 2005 Consumer Knowledge of the Impact of a Change in Prescription Drug Benefit Design
    by Roger Feldman & Jean Abraham & Linda Davis & Caroline Carlin
  • 2005 Utilization and Medical Care Expenditures in Patients with Chronic Obstructive Pulmonary Disease: A Managed Care Claims Data Analysis
    by Kristina S. Yu-Isenberg & Ann Vanderplas & Eunice Y. Chang & Hemal Shah
  • 2005 Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis: Effects on Calcium Intake, Exercise Frequency, and Medication Use
    by John T. Schousboe & Rowan C. DeBold & Linda S. Kuno & Thomas W. Weiss & Ya-Ting Chen & Thomas A. Abbott
  • 2005 Efficiency of Interventions in HIV Infection, 1994-2004
    by Guy Harling & Robin Wood & Eduard J. Beck
  • 2005 How Should Functionally Equivalent Drugs be Reimbursed?: A Retrospective Analysis of Reimbursement for Epoetin-alpha and Darbepoetin-alpha in 2001-3 and the Cost Implications for CMS
    by Panos G. Kanavos & Omer R. Saka
  • 2005 Acknowledgment
    by Adis International Limited
  • 2005 US FDA Drug Classification System
    by Alan J. Johnson & Edward Fleegler & Gregory D. Berg
  • 2005 Management of Hormone-Responsive Postmenopausal Breast Cancer: Defining the Role of Anastrozole
    by Lynda R. Wiseman & Lesley J. Scott
  • 2005 Clinical and Utilization Outcomes for a Heart Failure Care Support Program: A Matched-Cohort Study
    by Alan Johnson & Gregory Berg & Edward Fleegler & Jeanne Lehn
  • 2005 Predicted Effects of a New Combination Vaccine on Childhood Immunization Coverage Rates and Vaccination Activities
    by Allen S. Meyerhoff & David P. Greenberg & R. Jake Jacobs
  • 2005 Evaluation and Treatment of Depression in Managed Care (Part II): Quality Improvement Programs
    by Christy L. Beaudin & Teresa L. Kramer
  • 2005 Evaluation and Treatment of Depression (Part I): Benefits for Patients, Providers, and Payors
    by Teresa L. Kramer & Christy L. Beaudin & Carol R. Thrush
  • 2005 Using the Internet in Asthma Management: Current Concepts and Challenges
    by Ashok M. Patel
  • 2005 Cost of Acute Myocardial Infarction in Hong Kong
    by Vivian W.Y. Lee & Wai Kwong Chan & Nelson L.C. Lam & Kenneth K.C. Lee
  • 2005 Impact of Bipolar Disorder on Employers: Rationale for Workplace Interventions
    by Leslie B. Montejano & Ron Z. Goetzel & Ronald J. Ozminkowski
  • 2005 The Performance Gap between Clinical Trials and Patient Treatment for Dyslipidemia: A Comprehensive Review
    by Joseph J. Saseen & Setareh A. Williams & Robert J. Valuck & John C. O'Donnell & Kenneth McDonough
  • 2005 The Challenge of Suicide Prevention: An Overview of National Strategies
    by Martin Anderson & Rachel Jenkins
  • 2005 Impact of Coaching Patients on Coronary Risk Factors: Lessons from The COACH Program
    by Margarite J. Vale & Michael V. Jelinek & James D. Best
  • 2005 Use of Short-Acting Insulin Secretagogues for Type 2 Diabetes Mellitus: Considerations for National Health Systems
    by Maribel Salas & Jamie Banks
  • 2005 Impact of Practice Changes on an Antiretroviral Budget in an HIV Care Program
    by Hartmut B Krentz & M. John Gill
  • 2005 Work Loss, Healthcare Utilization, and Costs among US Employees with Chronic Pain
    by Laura T. Pizzi & Chureen T. Carter & Jamie B. Howell & Susan M. Vallow & Albert G. Crawford & Evan D. Frank
  • 2005 Psychoeducational Programs for Patients with Epilepsy
    by Theodor W. May & Margarete Pfafflin
  • 2005 Economic, Patient Preference, and Health-Related Quality of Life Considerations for Intranasal Corticosteroids in Allergic Rhinitis: Implications for Managed Care
    by Gireesh V. Gupchup & Matthew E. Borrego & Richard Santos & Bijal M. Shah
  • 2005 Evaluating Disease Management Program Effectiveness: An Introduction to the Bootstrap Technique
    by Ariel Linden & John L. Adams & Nancy Roberts
  • 2005 Impact of Insurance Coverage on the Use and Effects of Smoking Cessation Medications
    by Leif I. Solberg
  • 2005 Consultation-Liaison Psychiatry: Advantages for Healthcare Systems
    by James A. Bourgeois & Donald M. Hilty & Mark E. Servis & Robert E. Hales
  • 2005 Prescription to Over-the-Counter Switching of Drugs: Methodological Issues and Implications for Non-Sedating Antihistamines
    by John A. Rizzo & Ronald J. Ozminkowski & Ron Z. Goetzel
  • 2005 Effectiveness of Interventions to Increase Adherence to Statin Therapy
    by Jacqueline Muller-Nordhorn & Stefan N. Willich
  • 2005 Management of Metastatic Colorectal Cancer: Defining the Role of Capecitabine
    by Lynda R. Wiseman & Katherine A. Lyseng-Williamson
  • 2005 Examining the Association Between Preventive Screenings and Subsequent Health Services Utilization by Patients with Type 2 Diabetes Mellitus
    by Fevzi Akinci & Joseph S. Coyne & Joni Minear & Kenn Daratha & Dan Simonson
  • 2005 Identifying Future High-Healthcare Users: Exploring the Value of Diagnostic and Prior Utilization Information
    by Amy K. Rosen & Fei Wang & Maria E. Montez & Carter C. Rakovski & Dan R. Berlowitz & Jaime C. Lucove
  • 2005 Using Propensity Scores to Construct Comparable Control Groups for Disease Management Program Evaluation
    by Ariel Linden & John L. Adams & Nancy Roberts
  • 2005 Walking for the Management of Obesity
    by Mikael Fogelholm
  • 2005 Impact of a Clinical Decision Support System on the Management of Patients with Hypercholesterolemia in the Primary Healthcare Setting
    by Alex Bassa & Miguel del Val & Albert Cobos & Eva Torremade & Salvador Bergonon & Carlos Crespo & Max Brosa & Silvia Munio & Cristina Espinosa
  • 2005 Early Intervention in Psychosis: Rationale and Evidence for Effectiveness
    by Bethan Reading & Max Birchwood
  • 2005 Telemanagement in Chronic Heart Failure: A Review
    by Ruth M. Kleinpell & Boaz Avitall
  • 2005 Clinical Outcomes Associated with Pharmacist Involvement in Patients with Dyslipidemia: A Review
    by L. Brian Cross & Andrea S. Franks
  • 2005 Non-Pharmacological Treatments for Chronic Pain: A Disease Management Context
    by Dennis C. Turk & Bill McCarberg
  • 2005 Drug-Eluting Stents in the Management of Coronary Artery Disease: Implications for Payors and Hospitals
    by James B. Hermiller
  • 2005 The Incremental Cost Effectiveness of Withdrawing Pulmonary Artery Catheters from Routine Use in Critical Care
    by Katherine Stevens & Christopher McCabe & Carys Jones & Joanne Ashcroft & Sheila Harvey & Kathy Rowan
  • 2005 Determining Priority for Liver Transplantation: A Comparison of Cost per QALY and Discrete Choice Experiment-Generated Public Preferences
    by Julie Ratcliffe & Martin Buxton & Tracey Young & Louise Longworth
  • 2005 The Cost Effectiveness of Universal versus Selective Newborn Screening for Sickle Cell Disease in the US and the UK: A Critique
    by Scott D. Grosse & Richard S. Olney & Mary Ann Baily
  • 2005 The Australian Health Policy Changes of 1999 and 2000: An Evaluation
    by Sandra Hopkins & Peter Zweifel
  • 2005 What Value Health?: A Review of Health State Values Used in Early Technology Assessments for NICE
    by Ken Stein & Alison Fry & Ali Round & Ruairidh Milne & John Brazier
  • 2005 How to Present the Business Case for Healthcare Quality to Employers
    by Sean Nicholson & Mark V. Pauly & Daniel Polsky & Catherine M. Baase & Gary M. Billotti & Ronald J. Ozminkowski & Marc L. Berger & Claire E. Sharda
  • 2005 Should Patients Have a Greater Role in Valuing Health States?
    by John Brazier & Ron Akehurst & Alan Brennan & Paul Dolan & Karl Claxton & Chris McCabe & Mark Sculpher & Aki Tsuchyia
  • 2005 Acknowledgement
    by Stuart Birks & Gary Buurman
  • 2005 Book Review
    by Adis International Limited
  • 2005 Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine: A Study Conducted for the Netherlands
    by Cornelis Boersma & Rogier M. Klok & Jasper M. Bos & Mark Naunton & Paul B. van den Berg & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma
  • 2005 Barriers to the Equitable Funding of Primary Healthcare in South Africa
    by Stephen Thomas & Okore A. Okorafor & Sandi Mbatsha
  • 2005 Methodological Challenges Posed by Economic Evaluations of Early Childhood Intervention Programmes
    by Stavros Petrou & Ron Gray
  • 2005 Can We Use Contingent Valuation to Assess the Demand for Childhood Immunisation in Developing Countries?: A Systematic Review of the Literature
    by Raymond Y.T. Yeung & Richard D. Smith
  • 2005 Prisoner Healthcare Co-Payment Policy: A Cost-Cutting Measure that Might Threaten Inmates' Health
    by Niyi Awofeso
  • 2005 Can Privatising Selected Services Benefit the Public Healthcare System?: The Greek Case
    by Dimitris Niakas & Mamas Theodorou & Lycurgus Liaropoulos
  • 2005 The Chinese Pharmaceutical Market at the Crossroads: Pro-Competition Solutions to Improve Access, Quality and Affordability
    by Y. Richard Wang
  • 2005 The Infrastructure of Obesity and the Obesity Epidemic: Implications for Public Policy
    by Kenneth R. Stanton & Zoltan J. Acs
  • 2005 The Impact of Deficit Reduction on the Nursing Labour Market in Canada: Unintended Consequences of Fiscal Reform
    by Marko Vujicic & Robert G. Evans
  • 2005 What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?
    by Jaume Puig-Junoy
  • 2005 Using Contingent Choice Methods to Assess Consumer Preferences About Health Plan Design
    by M. Susan Marquis & Melinda Beeuwkes Buntin & Kanika Kapur & Jill M. Yegian
  • 2005 Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials
    by Andrea Manca & Stephen Palmer
  • 2005 Comparing the Preferences of Health Professionals and Members of the Public for Setting Healthcare Priorities: Experiences from Australia
    by Virginia Wiseman
  • 2005 Procedural Justice in Public Healthcare Resource Allocation
    by Aki Tsuchiya & Luis Silva Miguel & Richard Edlin & Allan Wailoo & Paul Dolan
  • 2005 Prescribing Incentive Schemes: A Useful Approach?
    by Anne R. Mason & Michael F. Drummond & Jane A. Hunter & Adrian K. Towse & Jonathan Cooke
  • 2005 Medicare Coverage and Reimbursement of Outpatient Prescription Drugs in the US: History, Recent Changes and Outlook for the Future
    by Sharon Forrest & Mireille M Goetghebeur & Joel Hay
  • 2005 A Wolf Dressed in Sheep's Clothing: Perhaps Quality Measures are Just Unmeasured Severity
    by John F.P. Bridges & Avi Dor & Michael Grossman
  • 2005 Untangling the Debate Surrounding Strategies for Achieving Sustainable High Coverage of Insecticide-Treated Nets
    by Warren Stevens
  • 2005 Decentralisation Strategies and Provider Incentives in Healthcare: Evidence from the English National Health Service
    by Russell Mannion & Maria Goddard & Michael Kuhn & Angela Bate
  • 2005 Using Value of Information Analysis to Inform Publicly Funded Research Priorities
    by Laura Ginnelly & Karl Claxton & Mark J. Sculpher & Sue Golder
  • 2005 Affordability of Medicines and Patients' Cost-Reducing Behaviour: Empirical Evidence Based on SUR Estimates from Italy and the UK
    by Vincenzo Atella & Ellen Schafheutle & Peter Noyce & Karen Hassell
  • 2005 Key Performance Indicators for the Implementation of Social Health Insurance
    by Guy Carrin & Chris James
  • 2005 Impact of Demographic Changes on Healthcare Expenditures and Funding in the EU
    by Afschin Gandjour & Juliette Greb & Eckart Bomsdorf & Karl Wilhelm Lauterbach
  • 2005 Mental Illness and the Demand for Alcohol, Cocaine, and Cigarettes
    by Henry Saffer & Dhaval Dave
  • 2005 Socio-Economic Status And Health: Evidence From The Echp
    by David Cantarero & Marta Pascual
  • 2005 A new outcome measure for cost-utility analyses of screening programs
    by Juan D. Moreno-Ternero & Carmen Herrero
  • 2005 Structural change in cigarette demand: cusum tests using panel data
    by John Schroeter & Aju Fenn
  • 2005 Bargaining and idle public sector capacity in health care
    by Xavier Martinez-Giralt & Barros Pedro Pita
  • 2005 Nonprofit and for-profit providers in Japanfs at-home care industry: evidence on quality of service and household choice
    by Satoshi Shimizutani & Haruko Noguchi
  • 2005 Causal effect of early initiation on adolescent smoking patterns
    by M. Christopher Auld
  • 2005 Tax credits, insurance, and the use of medical care
    by Michael Smart & Mark Stabile
  • 2004 Short-term Effects of Breast Cancer on Labor Market Attachment: Results from a Longitudinal Study
    by Cathy Bradley & David Neumark & Heather Bednarek & Maryjean Schenk
  • 2004 The effect of direct-to-consumer pharmaceutical advertising on health choices: an empirical investigation using panel data
    by Mark Showalter & James Cardon
  • 2004 The effects of meternal education versus cognitive test scores on child nutrition in Kenya
    by Melanie Fox-Kean & Alok Bhargava
  • 2004 Pricing the Priceless: A Health Care Conundrum
    by Joseph P. Newhouse
  • 2004 Frontiers in Health Policy Research: Volume 7
    by
  • 2004 Employment-Based Health Insurance and the Effectiveness of Intrafirm Competition between Insurance Providers
    by W. David Bradford & Lee Rivers Mobley
  • 2004 Welche Vorteile bringt eine Pauschalprämie für die Finanzierung des Gesundheitswesens?
    by Andreas Haufler
  • 2004 Demographic development and moral hazard: Health insurance with medical savings accounts
    by Schreyögg, Jonas
  • 2004 Density versus Quality in Health Care Provision: Using Household Data to Make Budgetary Choices in Ethiopia
    by Paul Collier & Stefan Dercon & John Mackinnon
  • 2004 Los Factores de Riesgo y el Peso al Nacer en el Uruguay
    by Todd Jewell & Patricia Triunfo & Rafael Aguirre
  • 2004 The Lasting Impact of Childhood Health and Circumstance
    by Anne Case & Angela Fertig & Christina Paxson
  • 2004 Medicare Balance Billing Restrictions: Impacts on Physicians and Beneficiaries
    by Robin McKnight
  • 2004 Fluctuations in a Dreadful Childhood: Synthetic Longitudinal Height Data, Relative Prices and Weather in the Short-Term Health of American Slaves
    by Richard H. Steckel
  • 2004 The Determinants of Progressive Era Reform: The Pure Food and Drugs Act of 1906
    by Marc T. Law & Gary D. Libecap
  • 2004 Tax Policy for Health Insurance
    by Jonathan Gruber
  • 2004 Tobacco Spending and its Crowd-Out of Other Goods
    by Susan H. Busch & Mireia Jofre-Bonet & Tracy A. Falba & Jody L. Sindelar
  • 2004 An Investigation of the Effects of Alcohol Policies on Youth STDs
    by Michael Grossman & Robert Kaestner & Sara Markowitz
  • 2004 Vertical Equity Consequences of Very High Cigarette Tax Increases: If the Poor are the Ones Smoking, How Could Cigarette Tax Increases be Progressive?
    by Greg Colman & Dahlia K. Remler
  • 2004 Behavioral Economics and Health Economics
    by Richard G. Frank
  • 2004 Autopsy on an Empire: Understanding Mortality in Russia and the Former Soviet Union
    by Elizabeth Brainerd & David M. Cutler
  • 2004 The Measurement and Evolution of Health Inequality: Evidence from the U.S. Medicare Population
    by Jonathan Skinner & Weiping Zhou
  • 2004 Testing a Roy Model with Productivity Spillovers: Evidence from the Treatment of Heart Attacks
    by Amitabh Chandra & Douglas Staiger
  • 2004 Healthcare Markets, the Safety Net and Access to Care Among the Uninsured
    by Jose Escarce & Carole Roan Gresenz & Jeanette A. Rogowski
  • 2004 Explaining Diversities in Age-Specific Life Expectancies and Values of Life Saving: A Numerical Analysis
    by Isaac Ehrlich & Yong Yin
  • 2004 Socioeconomic Status and Medical Care Expenditures in Medicare Managed Care
    by Kanika Kapur & Jeannette A. Rogowski & Vicki A. Freedman & Steven L. wickstrom & John L. Adams & Jose J. Escarce
  • 2004 Does the Impact of Managed Care on Substance Abuse Treatment Services Vary By Profit Status?
    by Jody Sindelar & Todd Olmstead
  • 2004 The Value of Life and the Rise in Health Spending
    by Robert E. Hall & Charles I. Jones
  • 2004 How Much Might Universal Health Insurance Reduce Socioeconomic Disparities in Health? A Comparison of the US and Canada
    by Sandra L. Decker & Dahlia K. Remler
  • 2004 The Effect of Malpractice Liability on the Delivery of Health Care
    by Katherine Baicker & Amitabh Chandra
  • 2004 Abortion Legalization and Lifecycle Fertility
    by Elizabeth Oltmans Ananat & Jonathan Gruber & Phillip B. Levine
  • 2004 Detecting Medicare Abuse
    by David Becker & Daniel Kessler & Mark McClellan
  • 2004 Health in an Age of Globalization
    by Angus Deaton
  • 2004 Illicit Drug Use Among Arrestees and Drug Prices
    by Dhaval Dave
  • 2004 The Effects of Cocaine and Heroin Prices on Drug-Related Emergency Department Visits
    by Dhaval Dave
  • 2004 Welfare Reform and Health
    by Marianne Bitler & Jonah Gelbach & Hilary Hoynes
  • 2004 HIV Breakthroughs and Risk Sexual Behavior
    by Dana Goldman & Darius Lakdawalla & Neeraj Sood
  • 2004 The Role of Public Health Improvements in Health Advances: The 20th Century United States
    by David M. Cutler & Grant Miller
  • 2004 Money, Sex, and Happiness: An Empirical Study
    by David G. Blanchflower & Andrew J. Oswald
  • 2004 The Role of Information in Medical Markets: An Analysis of Publicly Reported Outcomes in Cardiac Surgery
    by David M. Cutler & Robert S. Huckman & Mary Beth Landrum
  • 2004 Child Mental Health and Human Capital Accumulation: The Case of ADHD
    by Janet Currie & Mark Stabile
  • 2004 Home Care Reimbursement, Long-term Care Utilization, and Health Outcomes
    by Robin McKnight
  • 2004 Consumer Demand for Health Information on the Internet
    by M. Kate Bundorf & Laurence Baker & Sara Singer & Todd Wagner
  • 2004 Time-Inconsistency and Welfare
    by Jay Bhattacharya & Darius Lakdawalla
  • 2004 The Illusion of Sustainability
    by Michael Kremer & Edward Miguel
  • 2004 Changes in the Disparities in Chronic Disease during the Course of the Twentieth Century
    by Robert W. Fogel
  • 2004 Does the Length of Maternity Leave Affect Maternal Health?
    by Pinka Chatterji & Sara Markowitz
  • 2004 Modelling Tobacco Consumption with a Zero-Inflated Ordered Probit Model
    by Mark N. Harris & Xueyan Zhao
  • 2004 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates in 1999-2001 for All Eligible People and for the Working Poor
    by Laura A. Castner & Allen L. Schirm
  • 2004 State Food Stamp Participation Rates for the Working Poor in 2001
    by Laura A. Castner & Allen L. Schirm
  • 2004 Tightening Income Documentation in a Means-Tested Program: Who Stays Away?
    by Philip Gleason & John Burghardt & Lara Hulsey
  • 2004 Characteristics of Food Stamp Households: Fiscal Year 2003
    by Karen Cunnyngham & Beth Brown
  • 2004 Evaluation of the Elderly Nutrition Pilots: Preliminary Findings
    by Elizabeth Dagata & Scott Cody
  • 2004 Trends in Food Stamp Program Participation Rates: 1999 to 2002
    by Karen Cunnyngham
  • 2004 Preventing Childhood Obesity: Health in the Balance
    by Institute of Medicine Committee on Prevention of Obesity in Children & Youth & of which Robert C. Whitaker was a member
  • 2004 Evaluation of the National School Lunch Program Application/Verification Pilot Projects, Volume V: Analysis of Applications
    by Lara Hulsey & Philip Gleason & James Ohls
  • 2004 Evaluation of the National School Lunch Program Application/Verification Pilot Projects, Volume IV: Analysis of Pilot Operations and Costs
    by John Burghardt & Tania Tasse & James Ohls
  • 2004 Evaluation of the National School Lunch Program Application/Verification Pilot Projects, Volume III: Impacts on Participation
    by Philip Gleason & Lara Hulsey & John Burghardt
  • 2004 Trends in Food Stamp Program Participation Rates: 1999 to 2002
    by Karen Cunnyngham
  • 2004 Proposed Criteria for Selecting the WIC Food Packages: A Preliminary Report of the Committee to Review the WIC Food Packages
    by Institute of Medicine Committee to Review the WIC Food Packages & Food & Nutrition Board & of which Barbara Devaney was a member
  • 2004 Food Stamp Program Elderly Nutrition Demonstrations: Interim Report on Elderly Participation Patterns
    by Scott Cody
  • 2004 Evaluation of the National School Lunch Program Application/Verification Pilot Projects: Survey Instruments and Case Study of NSLP Outcomes in Large Metropolitan School Districts
    by Mathematica Policy Research & Inc.
  • 2004 Case Study of National School Lunch Program Verification Outcomes in Large Metropolitan School Districts
    by John Burghardt & Tim Silva & Lara Hulsey
  • 2004 Measuring Competitive Foods in Schools: A Point of Sales Approach. Final Report School Competitive Foods Study
    by Rhoda Cohen & Angelina KewalRamani & Renée Nogales & James Ohls & Michael Sinclair
  • 2004 Simplified Reporting and Transitional Benefits in the Food Stamp Program: Case Studies of State Implementation. Final Report
    by Carole Trippe & Liz Schott & Nancy Wemmerus & Andrew Burwick
  • 2004 Prototype Notebook: Short Questions on Dietary Intake, Knowledge, Attitudes, and Behaviors
    by Heather Hartline-Grafton & Rebecca Nyman & Ronette Briefel & Rhoda Cohen
  • 2004 Reaching Those in Need: State Food Stamp Participation Rates in 2001
    by Laura A. Castner & Allen L. Schirm
  • 2004 Evaluation of the National School Lunch Program Application/Verification Pilot Projects, Volume II: Data Collection, Study Methods and Supplementary Tables on Certification Impacts
    by John Burghardt & Philip Gleason & Michael Sinclair & Rhoda Cohen & Lara Hulsey & Julita Milliner-Waddell
  • 2004 Evaluation of the National School Lunch Program Application/Verification Pilot Projects, Volume I: Impacts on Deterrence, Barriers, and Accuracy
    by John Burghardt & Philip Gleason & Michael Sinclair & Rhoda Cohen & Lara Hulsey & Julita Milliner-Waddell
  • 2004 Welche Vorteile bringt eine Pauschalprämie für die Finanzierung des Gesundheitswesens? Einige einfache Äquivalenzresultate
    by Haufler, Andreas
  • 2004 Determinantes de la Utilización de los Servicios de Salud: El Caso de los Niños en la Argentina
    by Julieta Trías
  • 2004 QALYs, Person Trade-Offs, and the Pareto Principle
    by Lars Peter Østerdal
  • 2004 Is the Child Health / Family Income Gradient Universal? Evidence from England
    by Currie, Alison & Shields, Michael A. & Wheatley Price, Stephen
  • 2004 Is the Child Health / Family Income Gradient Universal? Evidence from England
    by Currie, Alison & Shields, Michael A. & Wheatley Price, Stephen
  • 2004 Health insurance for the poor in India
    by Ahuja, Rajeev
  • 2004 Health insurance for the poor in India
    by Ahuja, Rajeev
  • 2004 Health insurance for the poor in India
    by Ahuja, Rajeev
  • 2004 El seguro escolar gratuito y el seguro materno infantil : análisis de su incidencia e impacto sobre el acceso a los servicios de salud y sobre la equidad en el acceso
    by Miguel Jaramillo & Sandro Parodi
  • 2004 The impact of low income on child health: evidence from a birth cohort study
    by Simon Burgess & Carol Propper & John A. Rigg
  • 2004 Alcohol Consumption in Australia: An Application of the Ordered Generalised Extreme Value Model
    by Xueyan Zhao & Mark Harris & Preety Ramful
  • 2004 Determinantes de la Utilización de los Servicios de Salud: El caso de los niños en la Argentina
    by Julieta Trías
  • 2004 Mortalité et inégalités de revenu en France
    by Jusot, Florence
  • 2004 Illustrating Adverse Selection in Health Insurance Markets with a Classroom Game
    by Jennifer M. Mellor
  • 2004 Four scenarios for the future of the public sector and healthcare
    by Frits Bos & Rudy Douven & Esther Mot
  • 2004 The Impact of Low Income on Child Health: Evidence from a Birth Cohort Study
    by Simon Burgess & Carol Propper & John A. Rigg
  • 2004 Inequality in Infant Survival Rates in India: Identification of State-Dependence Effects
    by Wiji Arulampalam & Sonia Bhalotra
  • 2004 Why Economics is good for your health - 2004 Royal Economic Society Public Lecture
    by Carol Propper
  • 2004 Local Neighbourhood and Mental Health: Evidence from the UK
    by Carol Propper & Kelvyn Jones & Anne Bolster & Simon Burgess & Ron Johnston & Rebecca Sarker
  • 2004 The Impact of Low-Income on Child Health: Evidence from a Birth Cohort Study
    by Simon Burgess & Carol Propper & John Rigg
  • 2004 A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery
    by Sean D. Sullivan & Bruce L. Davidson & Susan R. Kahn & James E. Muntz & Gerry Oster & Gary Raskob
  • 2004 The Burden of Migraine in Spain: Beyond Direct Costs
    by Xavier Badia & Sol Magaz & Laura Gutierrez & Jordi Galvan
  • 2004 A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer
    by Jeremy Holmes & David Dunlop & Lindsay Hemmett & Peter Sharplin & Uday Bose
  • 2004 Cost Effectiveness and Cost Utility of Adjuvant Interferon alpha in Cutaneous Melanoma: A Review
    by Ralph Crott
  • 2004 Global Registries for Measuring Pharmacoeconomic and Quality-of-Life Outcomes: Focus on Design and Data Collection, Analysis and Interpretation
    by Lisa Kennedy & Ann-Marie Craig
  • 2004 Outcome Measures for Pharmacoeconomics Education
    by Vittorio Maio & Jennifer H. Lofland
  • 2004 Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level
    by Agota Szende & Klas Svensson & Elisabeth Stahl & Agnes Meszaros & Gyula Y. Berta
  • 2004 An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK
    by Paul A. Scuffham & Stephen Chaplin
  • 2004 Growth Hormone Therapy and Quality of Life in Adults and Children
    by Deborah J. Radcliffe & Joseph S. Pliskin & J.B. Silvers & Leona Cuttler
  • 2004 Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?
    by Mohan V. Bala & Gary A. Zarkin
  • 2004 The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics
    by Christopher R. Flowers & David Veenstra
  • 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply
    by Sean D. Sullivan & Kavita Patel & Jesse Green
  • 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive
    by Miguel Arguedas
  • 2004 Drotrecogin Alfa (Activated): A Pharmacoeconomic Review of its Use in Severe Sepsis
    by James E. Frampton & Rachel H. Foster
  • 2004 Management and Costs of Treating Lung Cancer Patients in a University Hospital
    by Konstantin J. Dedes & Thomas D. Szucs & Stephan Bodis & Markus Joerger & Adam Lowy & Erich W. Russi & Hans C. Steinert & Walter Weder & Rolf A. Stahel
  • 2004 Economic Evaluations of Treatments for Systemic Fungal Infections: A Systematic Review of the Literature
    by Simon Dixon & Emma McKeen & Margaret Tabberer & Suzy Paisley
  • 2004 Adherence to Guidelines for Community-Acquired Pneumonia: Does it Decrease Cost of Care?
    by Patricia D. Brown
  • 2004 Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus
    by Greg L. Plosker & David P. Figgitt
  • 2004 Measuring Treatment Preferences and Willingness to Pay for Docetaxel in Advanced Ovarian Cancer
    by George Dranitsaris & Julia Elia-Pacitti & Wayne Cottrell
  • 2004 Economic Implications of Treatment-Resistant Depression Among Employees
    by Paul Greenberg & Patricia K. Corey-Lisle & Howard Birnbaum & Maryna Marynchenko & Ami Claxton
  • 2004 The Economic Burden of Allergic Rhinitis: A Critical Evaluation of the Literature
    by Shelby D. Reed & Todd A. Lee & Douglas C. McCrory
  • 2004 Bernard J. O'Brien, BA, MSc, PhD
    by Deborah A. Freund
  • 2004 Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective
    by Kurt Neeser & Georg Lubben & Uwe Siebert & Wendelin Schramm
  • 2004 Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK
    by Alan Lenox-Smith & Pete Conway & Chris Knight
  • 2004 Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections
    by Joseph L. Kuti & Srividya Kotapati & Peter Williams & Blair Capitano & Charles H. Nightingale & David P. Nicolau
  • 2004 How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?
    by Bruce R. Schackman & Heather Taffet Gold & Patricia W. Stone & Peter J. Neumann
  • 2004 Longitudinal versus Cross-Sectional Methodology for Estimating the Economic Burden of Breast Cancer: A Pilot Study
    by C. Daniel Mullins & Junling Wang & Jesse L. Cooke & Lisa Blatt & Claudia R. Baquet
  • 2004 Economic Impact of Respiratory Syncytial Virus-Related Illness in the US: An Analysis of National Databases
    by L. Clark Paramore & Vincent Ciuryla & Gabrielle Ciesla & Larry Liu
  • 2004 The NICE Reference Case Requirement: More Pain for What, if Any, Gain?
    by Amiram Gafni & Stephen Birch
  • 2004 The NICE Reference Case Requirement: Implications for Drug Manufacturers and Health Systems
    by Paul C. Langley
  • 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C
    by Sean D. Sullivan & Antonio Craxi & Alfredo Alberti & Giovanni Giuliani & Claudio De Carli & Neil Wintfeld & Kavita K. Patel & Jesse Green
  • 2004 Development and Validation of an Acceptability and Satisfaction Questionnaire for a Contraceptive Vaginal Ring, NuvaRing(R)
    by Annoesjka Novak & Christine de la Loge & Linda Abetz
  • 2004 A
    by Manishi Prasad & Peter Wahlqvist & Rich Shikiar & Ya-Chen Tina Shih
  • 2004 Aggressive Non-Hodgkin
    by Stephen M. Beard & Lucy Wall & Louise Gaffney & Fiona Sampson
  • 2004 Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French Version: In a Population of Patients Treated for Ocular Hypertension and Glaucoma
    by Jean-Phillipe Nordmann & Muriel Viala & Kate Sullivan & Benoit Arnould & Gilles Berdeaux
  • 2004 Cost Effectiveness of Interventions for Lateral Epicondylitis: Results from a Randomised Controlled Trial in Primary Care
    by Ingeborg B.C. Korthals-de Bos & Nynke Smidt & Maurits W. van Tulder & Maureen P.M.H. Rutten-van Molken & Herman J. Ader & Danielle A.W.M. van der Windt & Willem J.J. Assendelft & Lex M. Bouter
  • 2004 A Review of Health-Related Workplace Productivity Loss Instruments
    by Jennifer H. Lofland & Laura Pizzi & Kevin D. Frick
  • 2004 Cost-of-Illness Studies in Diabetes Mellitus
    by Lorraine Ettaro & Thomas J. Songer & Ping Zhang & Michael M. Engelgau
  • 2004 Education in Pharmacoeconomics: An International Multidisciplinary View
    by Karen L. Rascati & Michael F. Drummond & Lieven Annemans & Peter G. Davey
  • 2004 Cost of Stress Urinary Incontinence: A Claims Data Analysis
    by Howard G. Birnbaum & Stephanie A. Leong & Emily F. Oster & Kraig Kinchen & Peter Sun
  • 2004 Health Economic Evaluation of Non-Melanoma Skin Cancer and Actinic Keratosis
    by Mitchell K. Higashi & David L. Veenstra & Paul C. Langley
  • 2004 The Generation Gap: Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions
    by Ron Keren & Susmita Pati & Chris Feudtner
  • 2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors' Reply
    by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer
  • 2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature
    by Thomas Hammerschmidt & Kurt Banz & Stefan Wagenpfeil & Albrecht Neiss & Peter Wutzler
  • 2004 Infliximab: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
    by Katherine A. Lyseng-Williamson & Rachel H. Foster
  • 2004 Cost-Effective Strategies in the Prevention of Diabetic Nephropathy
    by Jonathan D. Rippin & Anthony H. Barnett & Stephen C. Bain
  • 2004 Allocation of Resources Between Smoking Cessation Methods and Lovastatin Treatment of Hypercholesterolaemia: Based on Cost Effectiveness and the Social Welfare Function
    by Pedro Plans-Rubio
  • 2004 A Multicentre Study of Patient Survival, Disability, Quality of Life and Cost of Care: Among Patients with AIDS in Northern Italy
    by Andrea Tramarin & Stefano Campostrini & Maarten J. Postma & Guido Calleri & Keith Tolley & Nicoletta Parise & Fausto de Lalla
  • 2004 Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data
    by Ulf-G. Gerdtham & Douglas Lundin
  • 2004 Assessing the Value of Antipsychotics for Treating Schizophrenia: The Importance of Evaluating and Interpreting the Clinical Significance of Individual Service Costs
    by Sandra L. Tunis & Haya Ascher-Svanum & Michael Stensland & Bruce J. Kinon
  • 2004 The Economic Implications of Non-Adherence after Renal Transplantation
    by Irina Cleemput & Katrien Kesteloot & Yves Vanrenterghem & Sabina De Geest
  • 2004 The Effect of Cost Construction Based on Either DRG or ICD-9 Codes or Risk Group Stratification on the Resulting Cost-Effectiveness Ratios
    by Elinor C.G. Chumney & Andrea K. Biddle & Kit N. Simpson & Morris Weinberger & Kathryn M. Magruder & William N. Zelman
  • 2004 Discrete Choice Experiment to Derive Willingness To Pay for Methyl Aminolevulinate Photodynamic Therapy Versus Simple Excision Surgery in Basal Cell Carcinoma
    by Adele Weston & Patrick FitzGerald
  • 2004 Economic Costs to Business of the HIV/AIDS Epidemic
    by Gordon G. Liu & Jeff J. Guo & Scott R. Smith
  • 2004 Valuing Prevention Through Economic Evaluation: Some Considerations Regarding the Choice of Discount Model for Health Effects with Focus on Infectious Diseases
    by Jasper M. Bos & Philippe Beutels & Lieven Annemans & Maarten J. Postma
  • 2004 Acknowledgement
    by Adis International Limited
  • 2004 Cost Effectiveness of Raloxifene in the Treatment of Osteoporosis in Sweden: An Economic Evaluation Based on the MORE Study
    by Fredrik Borgstrom & Olof Johnell & John A. Kanis & Anders Oden & David Sykes & Bengt Jonsson
  • 2004 Relative Cost Effectiveness of Depo-Provera(R), Implanon(R), and Mirena(R) in Reversible Long-Term Hormonal Contraception in the UK
    by Susan J. Varney & Julian F. Guest
  • 2004 Validation of the Work and Health Interview
    by Walter F. Stewart & Judith A. Ricci & Carol Leotta & Elsbeth Chee
  • 2004 Measurement of Health-Related QOL in Diabetes Mellitus
    by Ken Watkins & Cathleen M. Connell
  • 2004 Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall
    by Elly A. Stolk & Gijs van Donselaar & Werner B.F. Brouwer & Jan J.V. Busschbach
  • 2004 Etanercept: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2004 Use and Cost of Antiretrovirals in France 1995-2000: An Analysis Based on the Medical Dossier on Human Immunodeficiency (release 2) Database
    by Yves A. Flori & Marc le Vaillant
  • 2004 Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence
    by Dyfrig A. Hughes & Dominique Dubois
  • 2004 Clinical and Economic Impact of Epoetins in Cancer Care
    by Monia Marchetti & Giovanni Barosi
  • 2004 Economic Impact of Migraine and Other Episodic Headaches in France: Data from the GRIM2000 Study
    by Andre Pradalier & Jean-Paul Auray & Abdelkader El Hasnaoui & Kazem Alzahouri & Jean-Francois Dartigues & Gerard Duru & Patrick Henry & Michel Lanteri-Minet & Christian Lucas & Guy Chazot & Anne-Francois Gaudin
  • 2004 Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?
    by Akira Babazono & Motonobu Miyazaki & Hiroshi Une & Eiji Yamamoto & Toshihide Tsuda & Yoshio Mino & Alan L. Hillman
  • 2004 Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective
    by Peter K. Schadlich & Josef G. Brecht & Badrudin Rangoonwala & Eduard Huppertz
  • 2004 Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus
    by Frederick B. Dong & Stephen W. Sorensen & Diane L. Manninen & Theodore J. Thompson & Venkat Narayan & Carlyn E. Orians & Edward W. Gregg & Richard C. Eastman & Erik J. Dasbach & William H. Herman & Jeffrey M. Newman & Andrew S. Narva & David J. Ballard & Michael M. Engelgau
  • 2004 Comparisons of Hypertension-Related Costs from Multinational Clinical Studies
    by C. Daniel Mullins & Mirko Sikirica & Viran Seneviratne & Jeonghoon Ahn & Kasem S. Akhras
  • 2004 The Costs and Benefits of Community Thrombolysis for Acute Myocardial Infarction: A Decision-Analytic Model
    by Luke Vale & Harvey Steffens & Cam Donaldson
  • 2004 Cost-Benefit Analysis of First-Generation Antihistamines in the Treatment of Allergic Rhinitis
    by Patrick W. Sullivan & Sheryl L. Follin & Michael B. Nichol
  • 2004 Pharmacoeconomic Burden of Undertreating Hypertension
    by Luca Degli Esposti & Giorgia Valpiani
  • 2004 Pharmacoeconomic Implications of New Therapies in Sepsis
    by Kelly A. Wood & Derek C. Angus
  • 2004 Pharmacoeconomic Analysis of Bemiparin and Enoxaparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery
    by Jesus Honorato & Antonio Gomez-Outes & Antonio Navarro-Quilis & Javier Martinez-Gonzalez & Eduardo Rocha & Andre Planes
  • 2004 Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation
    by Craig I. Coleman & James S. Kalus & C. Michael White & Anne P. Spencer & James P. Tsikouris & Jenny O. Chung & Kenneth W. Kenyon & Martin Ziska & Jeffrey Kluger & Prabashni Reddy
  • 2004 A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries
    by Robert Welte & Talitha Feenstra & Hans Jager & Reiner Leidl
  • 2004 Varicella Vaccination in Italy: An Economic Evaluation of Different Scenarios
    by Laurent Coudeville & Alain Brunot & Carlo Giaquinto & Carlo Lucioni & Benoit Dervaux
  • 2004 Acute Rhinosinusitis: A Pharmacoeconomic Review of Antibacterial Use
    by Jean-Blaise Wasserfallen & Francoise Livio & Giorgio Zanetti
  • 2004 Transferability of Economic Evaluation Results
    by Fernando Antonanzas
  • 2004 Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma
    by Richard D. OConnor & Harold Nelson & Rohit Borker & Amanda Emmett & Priti Jhingran & Kathleen Rickard & Paul Dorinsky
  • 2004 Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost Effectiveness of Therapy
    by Hilmar Burchardi & Heinz Schneider
  • 2004 Assessing the Use of Retrospective Databases in Conducting Economic Evaluations of Drugs: The Case of Asthma
    by Fredrik Berggren
  • 2004 Incorporation of Statistical Uncertainty in Health Economic Modelling Studies Using Second-Order Monte Carlo Simulations
    by Mark J.C. Nuijten
  • 2004 Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia: Impact of Adherence to Infectious Diseases Society of America Guidelines
    by Joanne J. Orrick & Richard Segal & Thomas E. Johns & Wayne Russell & Feng Wang & Donald D. Yin
  • 2004 Healthcare Costs with Tiotropium Plus Usual Care versus Usual Care Alone Following 1 Year of Treatment in Patients with Chronic Obstructive Pulmonary Disorder (COPD)
    by Mitchell Friedman & Shailendra S. Menjoge & Susan F. Anton & Steven Kesten
  • 2004 Economic Aspects of Pneumococcal Pneumonia: A Review of the Literature
    by Diana De Graeve & Philippe Beutels
  • 2004 Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia: An Economic Perspective
    by Mauro Percudani & Corrado Barbui & Michele Tansella
  • 2004 The Measurement of Contingent Valuation for Health Economics
    by Ahmed M. Bayoumi
  • 2004 On Cost Effectiveness and Sample Size in Clinical Trials. The Author's Reply
    by Martin E. Backhouse
  • 2004 On Cost Effectiveness and Sample Size in Clinical Trials
    by Augustinus A.M. Hart & Marcel G.W. Dijkgraaf
  • 2004 Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation: Impact of Bioavailability on Costs and Outcomes
    by Nicole Mittmann & Paul I. Oh & Scott E. Walker & William R. Bartle
  • 2004 Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox(R)/Asasantin(R)) in France
    by Jean-Pierre Marissal & Bernard Selke
  • 2004 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
    by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi
  • 2004 From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer
    by Samuel Limat & Marie-Christine Woronoff-Lemsi & Celine Menat & Anne Madroszyk-Flandin & Yacine Merrouche
  • 2004 An Economic Model of 2-Hour Post-Dose Ciclosporin Monitoring in Renal Transplantation
    by Paul A. Keown & Bryce Kiberd & Robert Balshaw & Shideh Khorasheh & Carlo Marra & Philip Belitsky & Zoltan Kalo
  • 2004 Effectiveness, Quality of Life, and Cost of Caring for Children in France with Recurrent Acute Rhinopharyngitis Managed by Homeopathic or Non-Homeopathic General Practitioners: A Pragmatic, Prospective Observational Study
    by Melanie Trichard & Gilles Chaufferin & Christian Dubreuil & Nicolas Nicoloyannis & Gerard Duru
  • 2004 The Burden of Osteoporosis and the Case for Disease Management
    by William D. Fraser
  • 2004 Long-Term Drug Treatment of GERD: Economic Issues for Formulary Decision Makers
    by James Chan & Theodore R. Levin
  • 2004 Development of a Regionalized, Comprehensive Care Network for Pediatric Sickle Cell Disease to Improve Access to Care in a Rural State
    by Lee M. Hilliard & Mary H. Maddox & Shenghui Tang & Thomas H. Howard
  • 2004 Socioeconomic Implications of Long-Term Warfarin Use
    by Joseph Menzin & Talia Foster & Rebecca Audette
  • 2004 Improving Treatment Regimen Adherence in Coronary Heart Disease by Targeting Patient Types
    by Robin S. Turpin & Jeffrey B. Simmons & Janice F. Lew & Charles M. Alexander & Marie A. Dupee & Patricia Kavanagh & Ellen R. Cameron
  • 2004 Thiazolidinediones for Diabetes Mellitus: Considerations for Reimbursements by Third-Party Payors
    by Andrew J. Palmer & William J. Valentine & Joshua A. Ray
  • 2004 Barrett
    by Deepak V. Gopal & Mark Reichelderfer & Eric A. Gaumnitz & Josephine Harter & Blair A. Jobe
  • 2004 Acknowledgments
    by Adis International Limited
  • 2004 Management of Benign Prostatic Hyperplasia: Defining the Role of Tamsulosin
    by Katherine F. Croom & Antona J. Wagstaff
  • 2004 Caring for Hypertension on Initiation: Costs and Effectiveness (CHOICE): A Naturalistic Design and Rationale for the Study of Patterns of Care in Hypertension
    by Jaime J. Caro & Norman Hollenberg & Joseph D Jackson & Krista A Payne & Gil LItalien
  • 2004 Overview of Disease Management Approaches: Implications for Corporate-Sponsored Programs
    by Shirley A. Musich & Alyssa B. Schultz & Wayne N. Burton & Dee W. Edington
  • 2004 National Performance Measures for Diabetes Mellitus Care: Implications for Health Care Providers
    by Fevzi Akinci & Joseph Coyne & Bernard Healey & Joni Minear
  • 2004 Pulmonary Rehabilitation Programs: Improving Outcomes in Elderly Patients with COPD
    by Jorg D. Leuppi & Roland M. Bingisser
  • 2004 Impact of a Migraine Disease Management Program: Humanistic Outcomes
    by Henry X. Hu & Glen D. Solomon & Kathleen Conboy & Lisa Deml & Leona E. Markson
  • 2004 Economic Benefits of Including Environmental Issues as a Component of Comprehensive Asthma Care: A Managed Care Perspective
    by Doug Brugge & James Hyde & Bonnie H. Weinbach & Jonathan I. Levy & Suzanne Steinbach
  • 2004 Reducing the Incidence of Type 2 Diabetes Mellitus: A Healthcare Plan and Program Implementation Perspective
    by Nicolaas P. Pronk & Jackie Boucher & Robert W. Jeffery & Nancy E. Sherwood & Raymond Boyle
  • 2004 Opportunities for Pharmacists to Aid in the Management of Acid-Peptic Disorders
    by C. Wayne Weart & Harry Leider
  • 2004 Specialist and Generalist Care for Type 1 Diabetes Mellitus: Differential Impact on Processes and Outcomes
    by Janice C. Zgibor & Trevor J. Orchard
  • 2004 Short-Term Aggressive Disease Management Programs for Heart Failure: Effect on Drug Utilization, Clinical Outcomes, and Costs
    by Kwame O. Akosah & Stephanie Carothers
  • 2004 Performance Measurement of Disease Management Programs: Examination of Recent Guidelines
    by Barry M. Zajac
  • 2004 Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
    by Greg L. Plosker & Tim Ibbotson
  • 2004 A Surveillance System for the Real-Time Reporting of Influenza Activity
    by Helmut Uphoff & Irena Groniewicz & Marc Soriano & Isabel Burckhardt-Batista
  • 2004 Dosing Patterns of Anti-TNF Therapy in Patients with Rheumatoid Arthritis in a Managed Care Setting
    by Karen Stockl & Manal Jarrar & Neeta Tandon
  • 2004 The Costs of Non-Adherence to Oral Antihyperglycemic Medication in Individuals with Diabetes Mellitus and Concomitant Diabetes Mellitus and Cardiovascular Disease in a Managed Care Environment
    by T. Jeffrey White & Ann Vanderplas & Eunice Chang & Christopher M. Dezii & Geoffrey D. Abrams
  • 2004 Atypical Antipsychotics as First-Line Treatments for Schizophrenia: Advantages for Stakeholders in the UK Healthcare System
    by Ann M. Mortimer
  • 2004 Optimizing Drug Prescribing in Managed Care Populations: Improving Clinical and Economic Outcomes
    by Rachel Czubak & Jasmine Tucker & Barbara J. Zarowitz
  • 2004 The Department of Health (England) Action Plan for Improving Services for People with Epilepsy: Will It Improve Quality of Care?
    by Frank M.C. Besag
  • 2004 Improvements in Asthma Pharmacotherapy and Self-Management: An Example of a Population-Based Disease Management Program
    by Richard A. Feifer & Robert R. Verbrugge & Mona Khalid & Rebecca Levin & Gwendolyn B. OKeefe & Ronald E. Aubert
  • 2004 Impact of Three-Tier Pharmacy Benefit Structures on Consumer Attitudes, Pharmacy, Medical Utilization and Costs: A Critical Review
    by Kavita V. Nair & Robert J. Valuck
  • 2004 Impact of Guidelines on Healthcare from the Patient and Payor Perspective: Example of the American Pain Society Guidelines
    by Bill McCarberg
  • 2004 Management of Overactive Bladder: Defining the Role of Extended-Release Tolterodine
    by Susan J. Keam & Caroline M. Perry
  • 2004 Management of Genital Herpes: Defining the Role of Valaciclovir
    by Antona J. Wagstaff & Susan J. Keam & David P. Figgitt
  • 2004 Employer-Based Disease Management Programs in Cancer: Experience to Date
    by Frederick C. Lee
  • 2004 Management of Mild to Moderate Alzheimer Disease: Defining the Role of Rivastigmine
    by Greg L. Plosker & Gillian M. Keating
  • 2004 Management of Parkinson Disease: Defining the Role of Ropinirole
    by David Murdoch & Susan M. Cheer & Antona J. Wagstaff
  • 2004 Prevention and Treatment of Osteoporosis in Postmenopausal Women: Defining the Role of Alendronate
    by Susan J. Keam & Greg L. Plosker
  • 2004 Adalimumab for Rheumatoid Arthritis: Considerations for Reimbursement by Third-Party Payors
    by Leo van de Putte & Michael B. Nichol
  • 2004 Nurses
    by Erik Magnus Saether
  • 2004 Burning a Hole in the Budget: Tobacco Spending and its Crowd-Out of Other Goods
    by Susan H. Busch & Mireia Jofre-Bonet & Tracy A. Falba & Jody L. Sindelar
  • 2004 Income-Related Inequality in the Use of Dental Services in Finland
    by Lien Nguyen & Unto Hakkinen
  • 2004 Tackling Regional Health Inequalities in France by Resource Allocation: A Case for Complementary Instrumental and Process-Based Approaches?
    by Martine M. Bellanger & Alain Jourdain
  • 2004 Consumer Mobility in Social Health Insurance Markets: A Five-Country Comparison
    by Trea Laske-Aldershof & Erik Schut & Konstantin Beck & Stefan Gress & Amir Shmueli & Carine Van de Voorde
  • 2004 Senior Citizens and the Burden of Prescription Drug Outlays: What Lessons for the Medicare Prescription Drug Benefit?
    by Panos Kanavos & Marin Gemmill
  • 2004 How Much Might Universal Health Insurance Reduce Socioeconomic Disparities in Health?: A Comparison of the US and Canada
    by Sandra L. Decker & Dahlia K. Remler
  • 2004 Is Patient Choice an Effective Mechanism to Reduce Waiting Times?
    by Diane Dawson & Rowena Jacobs & Steve Martin & Peter Smith
  • 2004 Do Patients Always Prefer Quicker Treatment?: A Discrete Choice Analysis of Patients
    by Peter Burge & Nancy Devlin & John Appleby & Charlene Rohr & Jonathan Grant
  • 2004 Guest Editorial
    by Adam Oliver
  • 2004 Aggregating Public Preferences for Healthcare: Putting Theory into Practice
    by Virginia Wiseman
  • 2004 Examining Within-Country Variation of Maternity Costs in the Context of a Multicountry, Multicentre Randomised Controlled Trial
    by Guy Hutton & Julia Fox-Rushby & Miranda Mugford & Jadsada Thinkhamrop & Bandit Thinkhamrop & Ana Maria Galvez & Manuel Alvarez
  • 2004 Medicare Payment Policy and the Controversy over Hospital Cost Shifting
    by Rick Mayes & Jason S. Lee
  • 2004 Listening to the Decision Makers: Sustainability of PBMA in Alberta
    by Craig Mitton & San Patten & Cam Donaldson
  • 2004 Productivity Research and Healthcare Delivery Innovation
    by Karen Eggleston & Jerome Grossman & David Cutler
  • 2004 Observations on Health Financing Reform in the Republic of Georgia, 1996-2002
    by Kees Schaapveld & Grant Rhodes
  • 2004 Calculating Society
    by Jeff Richardson & Richard D. Smith
  • 2004 Healthcare Expenditure and Ageing: A Comment
    by J. Francois Outreville
  • 2004 EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group
    by Karen Gerard & Tricia Nicholson & Mark Mullee & Raj Mehta & Paul Roderick
  • 2004 The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement
    by Andrew Briggs & Mark Sculpher & Jill Dawson & Ray Fitzpatrick & David Murray & Henrik Malchau
  • 2004 Improving Road Safety and Residential Quality of Life: Evaluating the Automated Wayside Horn System
    by Roy E. Lucke & Richard A. Raub & Thomas E. Thunder
  • 2004 The Economics of Prevention in a Post-Managed-Care Environment
    by Cyril F. Chang & Teresa M. Waters & David M. Mirvis
  • 2004 Should We Maximise QALYs?: A Debate with Respect to Peak-End Evaluation
    by Adam Oliver
  • 2004 Do Interventions to Increase Income Improve the Health of the Poor in Developed Economies and Are Such Policies Cost Effective?
    by Anne Ludbrook & Kathy Porter
  • 2004 Modelling the Ability of Risk Adjusters to Reduce Adverse Selection in Managed Care
    by Randall S. Stafford & Donglin Li & Roger B. Davis & Lisa I. Iezzoni
  • 2004 Comparing Utility Scores Before and After Hearing-Aid Provision: Results According to the EQ-5D, HUI3 and SF-6D
    by Garry R. Barton & John Bankart & Adrian C. Davis & Quentin A. Summerfield
  • 2004 Driver Perception Response Time During the Signal Change Interval
    by Pin-Kai Goh & Yiik-Diew Wong
  • 2004 A Tribute to the Life and Work of Bernie O
    by John F.P. Bridges
  • 2004 The Value of Life and Accident Costing: A Willingness-to-Pay Study Amongst Motorcyclists in Malaysia
    by Mohd Y. Mohd Fauzi & Mohd N. Nor Ghani & Radin S. Radin Umar & Hashim Ahmad Hariza
  • 2004 Healthcare Payment Incentives: A Comparative Analysis of Reforms in Taiwan, South Korea and China
    by Karen Eggleston & Chee-Ruey Hsieh
  • 2004 The Impact of Physician Payment Methods on Raising the Efficiency of the Healthcare System: An International Comparison
    by Steven Simoens & Antonio Giuffrida
  • 2004 The Reliability of Willingness to Pay for Changes in Health Status
    by Richard D. Smith
  • 2004 Road Safety and Accident Prevention
    by Richard Tay
  • 2004 An Alternative Approach to Resource Allocation: Weighted Capacity to Benefit Plus MESH Infrastructure
    by Gavin Mooney & Shane Houston
  • 2004 Self-Reported Effectiveness of Double-Fine Zones as a Speed Control Measure
    by Barnie Jones & Kevin Haas & Alan Kirk & Andrew Griffith
  • 2004 Editorial Foreword
    by Adis International Limited
  • 2004 Child Health and Poverty in Pakistan
    by G. M. Arif
  • 2004 The Value of Life: Estimates with Risks by Occupation and Industry
    by W. Kip Viscusi
  • 2004 Deserción Escolar y Trabajo Juvenil: ¿Dos Caras de una Decisión?
    by Claudio Sapelli & Arístides Torche
  • 2004 Análisis de las diferencias salariales por discapacidad en España: el caso de los varones
    by Ricardo Pagán & Andrés J. Marchante
  • 2004 Endogenous longevity, health and economic growth: a slow growth for a longer life?
    by Rosa Aísa & Fernando Pueyo
  • 2004 Standard error and confidence interval for QALY weights
    by Hiroshi Gunji & Chie Hanaoka
  • 2004 Les enjeux de la régulation spatiale des dépenses de santé bucco-dentaire en France
    by Élina Dévoué
  • 2004 Les consentements à payer pour des programmes de prévention sanitaire incluent-ils de l'altruisme ?. Enseignements d'une enquête sur la fièvre Q
    by Olivier Chanel & Stéphane Luchini & Alain Paraponaris & Christel Protière & Jean-Christophe Vergnaud
  • 2004 Assurance maladie et risque moral ex ante. L'incidence du type de risque sanitaire
    by Franck Bien
  • 2004 Valorisation économique des effets de la pollution atmosphérique
    by Olivier Chanel & Elsa Faugère & Ghislain Geniaux & Robert Kast & Stéphane Luchini & Pascale Scapecchi
  • 2003 Pauvreté et développement socialement durable
    by Jean-Luc Dubois & Jean-Pierre Lachaud & Jean-Marc Montaud & André Pouille
  • 2003 Frontiers in Health Policy Research: Volume 6
    by
  • 2003 Die Zukunft der Gemeinnützigkeit von Krankenhäusern
    by Henke, Klaus-Dirk & Berhanu, Samuel & Mackenthun, Birgit
  • 2003 Gerechtigkeit in Gesundheitssystemen aus ökonomischer Perspektive
    by Schreyögg, Jonas
  • 2003 Medical savings accounts: Eine internationale Bestandsaufnahme des Konzeptes der Gesundheitssparkonten
    by Schreyögg, Jonas
  • 2003 Maternal Employment and Adolescent Risky Behavior
    by Alison Aughinbaugh & Maury Gittleman
  • 2003 Schooling and Parental Death
    by Paul Gertler & David I. Levine & Minnie Ames
  • 2003 The Productivity Consequences of Two Ergonomic Interventions
    by Kelly DeRango & Ben Amick, III & Michelle Robertson & Ted Rooney & Anne Moore & Lianna Bazzani
  • 2003 Physician Dual Practice: Access Enhancement or Demand Inducement?
    by Anupa Bir & Karen Eggleston
  • 2003 Individual Mortality and Macro Economic Conditions from Birth to Death
    by Maarten Lindeboom & France Portrait & Gerard J. van den Berg
  • 2003 Mandatory Minimum Sentencing, Drug Purity, and a Test of Rational Drug Use
    by Ronald B. Davies
  • 2003 Investment in Population Health in Five OECD Countries
    by Jan Bennett
  • 2003 The Effectiveness of Public Expenditure in Portugal
    by Chiara Bronchi
  • 2003 Information Asymmetry, Insurance, and the Decision to Hospitalize
    by Åke Blomqvist & Pierre Thomas Léger
  • 2003 Health care expenditure in rural India
    by Selvaraju, V.
  • 2003 The Effects of Offering Health Plan Choice within Employment-Based Purchasing Groups
    by M. Kate Bundorf
  • 2003 Advance Directives and Medical Treatment at the End of Life
    by Daniel Kessler & Mark B. McClellan
  • 2003 The Role of Consumer Knowledge of Insurance Benefits in the Demand for Preventative Health
    by Stephen T. Parente & David Salkever & Joan DaVanzo
  • 2003 Parental Medicaid Expansions and Health Insurance Coverage
    by Anna Aizer & Jeffrey Grogger
  • 2003 Who Gets Health Care?
    by Robert W. Fogel & Chulhee Lee
  • 2003 Tax Credits and the Use of Medical Care
    by Michael Smart & Mark Stabile
  • 2003 Aggregation and Insurance Mortality Estimation
    by William H. Dow & Kristine A. Gonzalez & Luis Rosero-Bixby
  • 2003 Broken Down by Work and Sex: How Our Health Declines
    by Anne C. Case & Angus Deaton
  • 2003 Insurance and the Utilization of Medical Services
    by Jonathan Meer & Harvey S. Rosen
  • 2003 Outcome Versus Service Based Payment in Health Care: Lessons from African Traditional Healers
    by Kenneth Leonard & Joshua Graff Zivin
  • 2003 The Impact of Physician Intervention and Tobacco Control Policies on Average Daily Cigarette Consumption Among Adult Smokers
    by John A. Tauras & Lan Liang
  • 2003 Product Choice and Product Switching
    by Andrew B. Bernard & Peter K. Schott & Stephen Redding
  • 2003 From Cradle to Grave? The Lasting Impact of Childhood Health and Circumstance
    by Anne Case & Angela Fertig & Christina Paxson
  • 2003 The Quantity and Quality of Life and the Evolution of World Inequality
    by Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares
  • 2003 Marijuana Decriminalization: What does it mean in the United States?
    by Rosalie Liccardo Pacula & Jamie F. Chriqui & Joanna King
  • 2003 Do Minimum Wages Affect Non-wage Job Attributes? Evidence on Fringe Benefits and Working Conditions
    by Kosali Ilayperuma Simon & Robert Kaestner
  • 2003 Alcohol Prohibition and Cirrhosis
    by Angela K. Dills & Jeffrey K. Miron
  • 2003 Alcohol Advertising and Alcohol Consumption by Adolescents
    by Henry Saffer & Dhaval Dave
  • 2003 Alcohol Abuse and Suicide Attempts Among Youth - Correlation or Causation?
    by Pinka Chatterji & Dhaval Dave & Robert Kaestner & Sara Markowitz
  • 2003 Does Returning to Work After Childbirth Affect Breastfeeding Practices?
    by Pinka Chatterji & Kevin Frick
  • 2003 Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
    by Tomas Philipson & Stephane Mechoulan
  • 2003 Race and Pregnancy Outcomes in the Twentieth Century: A Long-Term Comparison
    by Dora L. Costa
  • 2003 Subsidies to Employee Health Insurance Premiums and the Health Insurance Market
    by Jonathan Gruber & Ebonya Washington
  • 2003 Lead Water Pipes and Infant Mortality in Turn-of-the-Century Massachusetts
    by Werner Troesken
  • 2003 Geography and Racial Health Disparities
    by Amitabh Chandra & Jonathan Skinner
  • 2003 Health Policy and Technological Change: Evidence from the Vaccine Industry
    by Amy Finkelstein
  • 2003 Why Have Americans Become More Obese?
    by David Cutler & Edward Glaeser & Jesse Shapiro
  • 2003 Bargaining in the Shadow of the Law: Divorce Laws and Family Distress
    by Betsey Stevenson & Justin Wolfers
  • 2003 Health Plan Conversions: Are They in the Public Interest?
    by Nancy Dean Beaulieu
  • 2003 The Role of Retiree Health Insurance in the Employment Behavior of Older Men
    by David M. Blau & Donna B. Gilleskie
  • 2003 Illicit Drug Use and Educational Attainment
    by Pinka Chatterji
  • 2003 Health and Wealth Accumulation: Evidence from Nineteenth-Century America
    by Chulhee Lee
  • 2003 The Effect of Organizational Context on Individual Performance
    by Robert S. Huckman & Gary P. Pisano
  • 2003 Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study
    by Richard G. Frank & Ernst R. Berndt & Alisa B. Busch
  • 2003 Selection and Improvement: Physician Responses to Financial Incentives
    by Jason Barro & Nancy Beaulieu
  • 2003 Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data
    by Willard G. Manning & Anirban Basu & John Mullahy
  • 2003 Dietary Reference Intakes: Applications in Dietary Planning
    by A report of the Subcommittees on Interpretation & Uses of Dietary Reference Intakes & Upper Reference Levels of Nutrients of which Barbara Devaney was a member
  • 2003 Trends in Food Stamp Program Participation Rates: 1999 to 2001
    by Karen Cunnyngham
  • 2003 Trends in Food Stamp Program Participation Rates: 1999 to 2001
    by Karen Cunnyngham
  • 2003 Characteristics of Food Stamp Households: Fiscal Year 2002
    by Randy Rosso & Melissa Faux
  • 2003 Direct Certification in the National School Lunch Program: Impacts on Program Access and Integrity
    by Philip Gleason & Tania Tasse & Kenneth Jackson & Patricia Nemeth
  • 2003 NSLP Certification Accuracy Research: Summary of Preliminary Findings
    by Prepared by the Food & Nutrition Service based on Mathematica research
  • 2003 Characteristics of Food Stamp Households: Fiscal Year 2002
    by Melissa Faux & Randy Rosso
  • 2003 Feeding Low-Income Children When School Is Out: The Summer Food Service Program
    by Anne Gordon & Ronette Briefel
  • 2003 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates for 1998-2000
    by Laura A. Castner & Allen L. Schirm
  • 2003 Reaching More Hungry Children: The Seamless Summer Food Waiver
    by Tania Tasse & Jim Ohls
  • 2003 The Seamless Summer Feeding Waiver
    by Tania Tasse & James Ohls & Jim Cashion
  • 2003 Characteristics of Food Stamp Households: Fiscal Year 2001
    by Randy Rosso
  • 2003 Child Participation in WIC: Medicaid Costs and Use of Health Care Services
    by Paul A. Buescher & Stephanie J. Horton & Barbara L. Devaney & Sarah J. Roholt & Alice J. Lenihan & J. Timothy Whitmire & Jonathan B. Kotch
  • 2003 Feeding Low-Income Children When School Is Out: The Summer Food Service Program
    by Anne Gordon & Ronette Briefel & Karen Needels & Nancy Wemmerus & Teresa Zavitsky & Randy Rosso & Tania Tasse & Laura Kalb & Anne Peterson & Darryl Creel
  • 2003 Disability, Gender and the Labour Market
    by Jones, Melanie K. & Latreille, Paul L. & Sloane, Peter J.
  • 2003 Disability, Gender and the Labour Market
    by Jones, Melanie K. & Latreille, Paul L. & Sloane, Peter J.
  • 2003 Individual Mortality and Macro-Economic Conditions from Birth to Death
    by Lindeboom, Maarten & Portrait, France & van den Berg, Gerard J.
  • 2003 Individual Mortality and Macro-Economic Conditions from Birth to Death
    by Lindeboom, Maarten & Portrait, France & van den Berg, Gerard J.
  • 2003 Redistributing to the sick: How should health expenditures be integrated into the tax system?
    by Billy Jack
  • 2003 Financing Pharmaceutical Innovation: When Should Poor Countries Contribute?
    by Billy Jack & Jenny Lanjouw
  • 2003 Unofficial payments for acute state hospital care in Kazakhstan. A model of physician behaviour with price discrimination and vertical service differentiation
    by Xavier, Ana & Robin Thompson
  • 2003 Competition and Quality: Evidence from the NHS Internal Market 1991-1999
    by Propper, Carol & Simon Burgess & Denise Abraham
  • 2003 Producción académica en Economía de la Salud en Colombia, 1980-2002
    by Karem Espinosa Echavarría & Jairo Humberto Restrepo Zea & Sandra Rodríguez Acosta
  • 2003 Estimación del costo económico en Argentina de la mortalidad atribuible al tabaco en adultos
    by Mariana Conte Grand & Pablo Perel & Raúl Pitarque & Gustavo Sánchez
  • 2003 Sibling Death Clustering in India: Genuine Scarring vs Unobserved Heterogeneity
    by Wiji Arulampalam & Sonia Bhalotra
  • 2003 Explaining differences in hospital performance: Does the answer lie in the labour market?
    by Simon Burgess & Denise Gossage & Carol Propper
  • 2003 Competition and Quality: Evidence from the NHS Internal Market 1991-1999
    by Simon Burgess & Denise Gossage & Carol Propper
  • 2003 Rescuing Patients from the Rule of Efficiency: A Need to Debate the
    by Sophia Kessabi & Richard de Abreu Lourenco & Michael Wonder
  • 2003 Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France
    by Anne-Chantal Braud & Christine Levy-Piedbois & Pascal Piedbois & Youri Piedbois & Alain Livartovski & Beatrice Le Vu & Jean Tredaniel & Francois Reboul & Yvelise Brewer & Said Talbi & Francois Blanchon & Britta Paschen & Isabelle Durand-Zaleski
  • 2003 Economic Evaluation of Norethisterone Acetate/Ethinylestradiol (FemHRT(R)) for Women with Menopausal Symptoms
    by Douglas Coyle & Ann Cranney & Peter Tugwell
  • 2003 The Comparative Medical Costs of Atherothrombotic Disease in European Countries
    by Emile Levy & Sylvie Gabriel & Jerome Dinet
  • 2003 Assessing the Economic Impact of Adverse Drug Effects
    by Rosa Rodriguez-Monguio & Maria Jose Otero & Joan Rovira
  • 2003 Costs of Bipolar Disorder
    by Leah S. Kleinman & Ana Lowin & Emuella Flood & Gian Gandhi & Eric Edgell & Dennis A. Revicki
  • 2003 Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in Germany
    by Christa Claes & Johann-Matthias Graf von der Schulenburg
  • 2003 The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy
    by Alain J. Nordmann & Murray Krahn & Alexander G. Logan & Gary Naglie & Allan S. Detsky
  • 2003 Labour Force Participation Among Individuals with Hepatitis C in the US
    by Philip Jacobs & Ying Chu Ng & Tania Stafinski & Roger Dodd & Bryce Larke & Winnie Wong
  • 2003 The Economics of Screening and Treatment in Type 2 Diabetes Mellitus
    by Maria Raikou & Alistair McGuire
  • 2003 Quality of Life and Economic Considerations in the Management of Prostate Cancer
    by Marco Turini & Alberto Redaelli & Paola Gramegna & Davide Radice
  • 2003 A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients
    by Jon Karnon & Trefor Jones
  • 2003 Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
    by Andreas Maetzel & Jorg Ruof & Melva Covington & Anne Wolf
  • 2003 Using Gross National Product to Calculate Acceptable Immunisation Costs: Deploying Cost-Effectiveness Calculations in Reverse
    by Vineet Tyagi & Saroj K. Singh & Ashu Sawhney & Vikas Taneja & Jacob M. Puliyel
  • 2003 Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery
    by Sean D. Sullivan & Susan R. Kahn & Bruce L. Davidson & Lars Borris & Patrick Bossuyt & Gary Raskob
  • 2003 Cytomegalovirus Infection in Solid Organ Transplantation: Economic Implications
    by Ananya Das
  • 2003 Pharmaceutical Care Programmes for the Elderly: Economic Issues
    by Grainne E. Crealey & Ian K. Sturgess & James C. McElnay & Carmel M. Hughes
  • 2003 Factors Affecting UK Primary-Care Costs of Managing Patients with Asthma over 5 Years
    by Roben Das Gupta & Julian F. Guest
  • 2003 Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps
    by Fredrik Berggren & Leif Johansson
  • 2003 Peginterferon alpha-2a (40kD) [Pegasys(R)] Improves HR-QOL Outcomes Compared with Unmodified Interferon alpha-2a [Roferon(R)-A]: In Patients with Chronic Hepatitis C
    by Jens Rasenack & Stefan Zeuzem & S. Victor Feinman & E. Jenny Heathcote & Michael Manns & Eric M. Yoshida & Mark G. Swain & Edward Gane & Moises Diago & Dennis A. Revicki & Amy Lin & Neil Wintfeld & Jesse Green
  • 2003 Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer's Disease
    by Anders Wimo & Bengt Winblad & Albrecht Stoffler & Yvonne Wirth & Hansjorg Mobius
  • 2003 The Cost Effectiveness of Two New Antiepileptic Therapies in the Absence of Direct Comparative Data: A First Approximation
    by Ben A. van Hout & Dennis D. Gagnon & Pauline Mcnulty & Anthony O'Hagan
  • 2003 Cost Effectiveness of Alendronate (Fosamax(R)) for the Treatment of Osteoporosis and Prevention of Fractures
    by Olof Johnell & Bengt Jonsson & Linus Jonsson & Dennis Black
  • 2003 A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention
    by Jarmo Hahl & Tuula Simell & Antti Kupila & Paivi Keskinen & Mikael Knip & Jorma Ilonen & Olli Simell
  • 2003 Ontario's Formulary Committee: How Recommendations Are Made
    by Anne M. PausJenssen & Peter A. Singer & Allan S. Detsky
  • 2003 A Study of Influenza and Influenza-Related Complications among Children in a Large US Health Insurance Plan Database
    by Jeanne Loughlin & Nick Poulios & Pavel Napalkov & Yann Wegmuller & Arnold S. Monto
  • 2003 Unit Costs of Inpatient Hospital Days
    by Jan B. Oostenbrink & Tineke Buijs-Van der Woude & Michel van Agthoven & Marc A. Koopmanschap & Frans F.H. Rutten
  • 2003 Cost Comparisons of Pharmacological Strategies in Open-Heart Surgery
    by Prabashni Reddy & Jessica Song
  • 2003 Health-Related Quality-of-Life Assessments in Patients with Advanced Cancer of the Prostate
    by Jan Adolfsson
  • 2003 Specialist Nurse Management Programmes: Economic Benefits in the Management of Heart Failure
    by Simon Stewart & John D. Horowitz
  • 2003 Bedside Rapid Flu Test and Zanamivir Prescription in Healthy Working Adults: A Cost-Benefit Analysis
    by Michael Schwarzinger & Bruno Housset & Fabrice Carrat
  • 2003 Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma: In Four European Countries
    by Jeanfrancois Rouland & Claude Lepen & Carlos Gouveiapinto & Patrizia Berto & Gilles Berdeaux
  • 2003 A Meta-Analysis of Quality-of-Life Estimates for Stroke
    by Tammy O. Tengs & Ting H. Lin
  • 2003 The Burden of Age-Related Macular Degeneration: Results of a Cohort Study in Two French Referral Centres
    by Julia Bonastre & Claude Le Pen & Gisele Soubrane & Gabriel Quentel
  • 2003 Treatment of Atopic Dermatitis and Impact on Quality of Life: A Review with Emphasis on Topical Non-Corticosteroids
    by Roman Schiffner & Julia Schiffner-Rohe & Michael Landthaler & Wilhelm Stolz
  • 2003 NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales
    by Amiram Gafni & Stephen Birch
  • 2003 European Healthcare Policies for Controlling Drug Expenditure
    by Silvia M. Ess & Sebastian Schneeweiss & Thomas D. Szucs
  • 2003 Discounting in Cost-Utility Analysis of Healthcare Interventions: Reassessing Current Practice
    by Brian J. Cohen
  • 2003 Cost Effectiveness and Cost Utility of Acetylcysteine versus Dimethyl Sulfoxide for Reflex Sympathetic Dystrophy
    by Hiske E.M. van Dieten & Roberto S.G.M. Perez & Maurits W. van Tulder & Jaap J. de Lange & Wouter W.A. Zuurmond & Herman J. Ader & Hindrik Vondeling & Maarten Boers
  • 2003 Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients: A UK Perspective
    by Stephen J. Walters & Malcolm Whitfield & Ronald L. Akehurst & James B. Chilcott
  • 2003 Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson's Disease
    by Michael Iskedjian & Thomas R. Einarson
  • 2003 Cost of Illness of Atopic Dermatitis in Children: A Societal Perspective
    by Andrew S. Kemp
  • 2003 Comparative Cost Effectiveness of Angiotensin II Receptor Blockers in a US Managed Care Setting: Olmesartan Medoxomil Compared with Losartan, Valsartan, and Irbesartan
    by W. Robert Simons
  • 2003 Potential Costs and Effects of the National Service Framework for Coronary Heart Disease in the UK
    by Venanzio Vella
  • 2003 Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies
    by Niklas Zethraeus & Magnus Johannesson & Bengt Jonsson & Mickael Lothgren & Magnus Tambour
  • 2003 Economic Evaluations of Varicella Vaccination Programmes: A Review of the Literature
    by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer
  • 2003 Generic Clozapine: A Cost-Saving Alternative to Brand Name Clozapine?
    by Gordon Tse & Deborah Thompson & Ric M. Procyshyn
  • 2003 An Evaluation of the Cost Effectiveness of Drotrecogin Alfa (Activated) Relative to the Number of Organ System Failures
    by Madeline Betancourt & Peggy S. McKinnon & R. Michael Massanari & Salmaan Kanji & David Bach & John W. Devlin
  • 2003 The Health Economics of Bladder Cancer: A Comprehensive Review of the Published Literature
    by Marc F. Botteman & Chris L. Pashos & Alberto Redaelli & Benjamin Laskin & Robert Hauser
  • 2003 Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia
    by Marc Esser & Helmut Brunner
  • 2003 Development and Validation of the Diabetic Foot Ulcer Scale-Short Form (DFS-SF)
    by Carla M. Bann & Sheri E. Fehnel & Dennis D. Gagnon
  • 2003 The Cost Effectiveness of Tacrolimus versus Microemulsified Cyclosporin: A 10-Year Model of Renal Transplantation Outcomes
    by Michelle E. Orme & Wieslaw A. Jurewicz & Nagappan Kumar & Tracy L. McKechnie
  • 2003 Economic Implications of Attention-Deficit Hyperactivity Disorder for Healthcare Systems
    by Cynthia L. Leibson & Kirsten Hall Long
  • 2003 Screening, Prevention and Socioeconomic Costs Associated with the Treatment of Colorectal Cancer
    by Alberto Redaelli & Carole W. Cranor & Gary J. Okano & Pat Ray Reese
  • 2003 Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain
    by Josep Darba
  • 2003 Escitalopram: A Pharmacoeconomic Review of its Use in Depression
    by Katherine F. Croom & Greg L. Plosker
  • 2003 The Cost Effectiveness of Apligraf(R) Treatment of Diabetic Foot Ulcers
    by W. Ken Redekop & Joseph McDonnell & Paul Verboom & Kornelia Lovas & Zoltan Kalo
  • 2003 Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer
    by Silas C. Martin & Dennis D. Gagnon & Lucy Zhang & Carsten Bokemeyer & Marinus Van Marwijk Kooy & Ben van Hout
  • 2003 Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb/IIIa Inhibitors: In the Management of Acute Coronary Syndromes
    by Nick Bosanquet & Bengt Jonsson & Keith A.A. Fox
  • 2003 Reductions in Individual Work Productivity Associated with Type 2 Diabetes Mellitus
    by Jill E. Lavigne & Charles E. Phelps & Alvin Mushlin & Wayne M. Lednar
  • 2003 Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain: A Pilot Study
    by Juan Oliva & Cesar Roa & Juan del Llano
  • 2003 Methods to Analyse Cost Data of Patients Who Withdraw in a Clinical Trial Setting
    by Jan B. Oostenbrink & Maiwenn J. Al & Maureen P.M.H. Rutten-van Molken
  • 2003 Heartburn in Patients with Gastro-Oesophageal Reflux Disease in Germany and Sweden: A Study on Patients
    by Roger Jones & Silke Horbach & Peter Sander & Tina Ryden-Bergsten
  • 2003 Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes: In Patients with Bipolar I Disorder in France
    by Marie de Zelicourt & Roland Dardennes & Helene Verdoux & Gian Gandhi & Babak Khoshnood & Eric Chomette & Marie-Laure Papatheodorou & Eric T. Edgell & Christian Even & Francis Fagnani
  • 2003 Evaluating Minimal Clinically Important Differences for the Acne-Specific Quality of Life Questionnaire
    by Lori D. McLeod & Sheri E. Fehnel & Jane Brandman & Tara Symonds
  • 2003 Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?
    by Josephine Mauskopf & Frans Rutten & Warren Schonfeld
  • 2003 Prevention of Recurrent Rhinopharyngitis in At-Risk Children in France: A Cost-Effectiveness Model for a Nonspecific Immunostimulating Bacterial Extract (OM-85 BV)
    by Jean-Jacques Pessey & Francoise Megas & Benoit Arnould & Florence Baron-Papillon
  • 2003 A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada
    by Jean A. Maroun & Carl Asche & Francoise Romeyer & Jayanti Mukherjee & Christine Cripps & Amit Oza & Jamie R. Skillings & Jacques Letarte
  • 2003 Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer
    by Linus Jonsson
  • 2003 Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies
    by Christian Krauth & Noushin Jalilvand & Tobias Welte & Reinhard Busse
  • 2003 Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2003 The Incorporation of Potential Confounding Variables in Markov Models
    by Mark J.C. Nuijten & Frans Rutten
  • 2003 Quality of Life in Patients with Rheumatoid Arthritis: Which Drugs Might Make a Difference?
    by Barbara Blumenauer & Ann Cranney & Jennifer Clinch & Peter Tugwell
  • 2003 Practical Aspects of Designing and Conducting Pharmacoeconomic Studies in Japan
    by Jim Doherty & Keiko Sato
  • 2003 Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes
    by Greg L. Plosker & Tim Ibbotson
  • 2003 Validation of Expert Opinion in Identifying Comorbidities Associated with Atopic Dermatitis/Eczema
    by Charles N. Ellis & Lynn A. Drake & Mary M. Prendergast & William Abramovits & Mark Boguniewicz & C. Ralph Daniel & Mark Lebwohl & Seth R. Stevens & Diane L. Whitaker-Worth & Kuo B. Tong
  • 2003 Defining Monetary Values for Quality of Life Improvements: An Exploratory Study
    by Jean Lachaine & Claudine Laurier & Andre-Pierre Contandriopoulos
  • 2003 Recurrent Genital Herpes Treatments and Their Impact on Quality of Life
    by Mathijs H. Brentjens & Kimberly A. Yeung-Yue & Patricia C. Lee & Stephen K. Tyring
  • 2003 Integer/Linear Mathematical Programming Models: A Tool for Allocating Healthcare Resources
    by Stephanie R. Earnshaw & Susan L. Dennett
  • 2003 Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus
    by Joe W. Ramsdell & Seth N. Braunstein & Jennifer M. Stephens & Christopher F. Bell & Marc F. Botteman & Scott T. Devine
  • 2003 Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer
    by Patricia Marino & Anne-Gaelle Le Corroller & Thao Palangie & Maud Janvier & Michel Fabbro & Laurent Molinier & Thierry Delozier & Alain Livartowski & Jean-Paul Moatti & Patrice Viens
  • 2003 Cost Evaluation of Basiliximab Treatment for Renal Transplant Patients in Japan
    by Tomonori Hasegawa & Hidehiko Imai & Sunao Miki
  • 2003 The Impact of Treatment for Gastro-Oesophageal Reflux Disease on Health-Related Quality of Life: A Literature Review
    by Manishi Prasad & Anne M. Rentz & Dennis A. Revicki
  • 2003 A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?
    by Suzanne Hill & Nick Freemantle
  • 2003 Lower Respiratory Tract Infections: Impact on the Workplace
    by Howard G. Birnbaum & Melissa Morley & Stephanie Leong & Paul Greenberg & Gene L. Colice
  • 2003 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective
    by Ewa Orlewska & Andrzej Budaj & Dariusz Tereszkowski-Kaminski
  • 2003 Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling
    by Susan J. Taylor & Carol L. Armour
  • 2003 Cost Effectiveness of Adding Folinic Acid to Fluorouracil Plus Levamisole as Adjuvant Chemotherapy in Patients with Colon Cancer in Germany
    by Brigitta U.M. Monz & Hans-Helmut Konig & Reiner Leidl & Ludger Staib & Karl-Heinrich Link
  • 2003 Determinants of Drug Costs in Hospitalised Patients with Haemophilia: Impact of Recombinant Activated Factor VII
    by Jean Philippe Galanaud & Nathalie Pelletier-Fleury & Helene Logerot-Lebrun & Thierry Lambert
  • 2003 Olanzapine versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs among Texas Medicaid Recipients
    by Karen L. Rascati & Michael T. Johnsrud & M. Lynn Crismon & Maureen J. Lage & Beth L. Barber
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Validation of the Pneumonia Severity Index Among Patients Treated at Home or in the Hospital
    by Brian S. Armour & Stephen R. Pitts & M. Melinda Pitts & Jennifer Wike & Linda Alley & Jeff Etchason
  • 2003 School-Based Prevention Programs for Eating Disorders: Achievements and Opportunities
    by Riccardo Dalle Grave
  • 2003 Comprehensive Case Management Models For Pulmonary Tuberculosis
    by Patrick Chaulk & Vahe A. Kazandjian
  • 2003 What is the Return on Investment Associated with Diabetes Disease Management?: A Report from One Managed Care Organization in Pennsylvania, USA
    by Jaan Sidorov & Peter Paulick & Lila Sobel
  • 2003 A Review of Telemedicine and Asthma
    by Claire Wainwright & Richard Wootton
  • 2003 The MELD System for Liver Allocation: Implications for Patients and Payors
    by Richard B. Freeman
  • 2003 Certification for Disease-Specific Care Programs
    by Charles A. Mowll
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 New Biochemical Tools for Diagnosing Acute Coronary Syndromes: Impact on Patient Outcomes and Resource Utilization in Hospitals
    by W. Frank Peacock & Fred Wilson
  • 2003 Acute Care for Elders Units: Practical Considerations for Optimizing Health Outcomes
    by Robert M. Palmer & Steven R. Counsell & Seth C. Landefeld
  • 2003 Supporting Herbal Resource Needs for Health Plan Members: Complementary and Alternative Medicine by Telephone
    by Jodi A. Chaffin & Jolene J. Thoennes & Jackie L. Boucher & Nicolaas P. Pronk
  • 2003 Improving the Health Status of US Working Adults with Type 2 Diabetes Mellitus: A Review
    by Fevzi Akinci & Bernard J. Healey & Joseph S. Coyne
  • 2003 Chronic Disease Management: A Definition And Systematic Approach To Component Interventions
    by Susan L. Norris & Russell E. Glasgow & Michael M. Engelgau & Patrick J. OConnor & David McCulloch
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Utilization and Financial Outcomes of an Asthma Disease Management Program Delivered to Medicaid Members: Results of a Three-Group Comparison Study
    by Alan E. Johnson & Ming Yin & Gregory Berg
  • 2003 Cost Effectiveness of Diabetes Mellitus Management Programs: A Health Plan Perspective
    by Todd Gilmer & Patrick J. OConnor
  • 2003 The Role of Evidence-Based Medicine in Disease Management
    by Paul H. Keckley
  • 2003 Diabetes Self-Management Education Research: An International Review of Intervention Methods, Theories, Community Partnerships and Outcomes
    by Leonard Jack, Jr
  • 2003 How Can Social Workers Improve Outcomes and Costs in Disease Management?
    by Nancy Claiborne & Henry Vandenburgh
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Identifying Future High-Cost Cases Through Predictive Modeling
    by Yang Zhao & Arlene S. Ash & John Haughton & Benjamin McMillan
  • 2003 Disease Management of Migraine and the Importance of Stratified Care
    by Richard B. Lipton & Marcelo E. Bigal & Wsalter F. Stewart
  • 2003 Screening for Depression in Patients with Chronic Illness: Why and How?
    by Jeffrey M. Davis & Christine M. Gershtein
  • 2003 Disease Management Programs in the Geriatric Setting: Practical Considerations
    by Kenneth J. Steinman & Michael A. Steinman & Theodore I. Steinman
  • 2003 Medicaid Disease Management Programs: Findings from Three Leading US State Programs
    by Jeann L. Gillespie & Louis F. Rossiter
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 A Comparative Cost Analysis of Participating versus Non-Participating Somatizing Patients Referred to a Behavioral Medicine Group in a Health Maintenance Organization
    by Steven E. Locke & Patricia Ford & Thomas McLaughlin
  • 2003 Educating the Public About Stroke: Role in Improving Outcomes
    by Richard N. Bradley
  • 2003 Disease-Specific Self-Management Programs in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Comprehensive and Critical Evaluation
    by Jean Bourbeau
  • 2003 Health Screening and Health Promotion Programs for the Elderly
    by Adam Drewnowski & Elaine Monsen & Diana Birkett & Susan Gunther & Susan Vendeland & Jeff Su & Gillian Marshall
  • 2003 Telemedicine from the Payor Perspective: Considerations for Reimbursement Decisions
    by Pamela Whitten & Emily Kuwahara
  • 2003 Can Genomics Deliver on the Promise of Improved Outcomes and Reduced Costs?: Background and Recommendations for Health Insurers
    by Marc S. Williams
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Estimating Influenza-Related Hospital Admissions in Children and Adults: A Time Series Analysis
    by Paul A. Scuffham
  • 2003 Active Management of Patients with Chronic Renal Insufficiency: The Effect on Hospital Days During the Initial Hemodialysis Period
    by Ilan Zawadzki & Moshe Fridman & Wing Chan & Seonyoung Ryu
  • 2003 Importance of Cultural Sensitivity in Therapeutic Transactions: Considerations for Healthcare Providers
    by Oyedeji Ayonrinde
  • 2003 The Effectiveness of Asthma Nurse Intervention: The Need for Change
    by Christine Wrench & Alyn H. Morice
  • 2003 Structured Outpatient Education and Treatment Programs for Patients with Diabetes Mellitus and/or Hypertension: The German Experience
    by Monika Gruesser & Karola Hoffstadt & Viktor Joergens
  • 2003 Teledermatology Can Produce High-Quality Care at Low Cost
    by Keng Chen & Stephen Shumack & Richard Wootton
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Spotlight on Insulin Lispro in Diabetes Mellitus This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (14): 989-1025
    by Christopher J. Dunn & Greg L. Plosker
  • 2003 Results of a Men's Urological Health Screening Program at Lockheed Martin Aeronautical Systems
    by Pamella Thomas & Ron Z. Goetzel & Ronald J. Ozminkowski & Vahan S. Kassabian & David C. Schutt
  • 2003 Antidepressant Treatment Patterns and Success Rates in a Managed Care Organization
    by Edward P. Armstrong
  • 2003 Electronic Management Systems in Diabetes Mellitus: Impact on Patient Outcomes
    by Riccardo Bellazzi
  • 2003 Designing and Evaluating Health Promotion Programs: Simple Rules for a Complex Issue
    by Nicolaas P. Pronk
  • 2003 Physician Financial Incentives in Managed Care: Resource Use, Quality and Cost Implications
    by Brian S. Armour & Mmelinda Pitts
  • 2003 An Overview of Community Pharmacist Interventions: Assessing Cost-Effectiveness and Patients' Willingness To Pay
    by Shu Chuen Li
  • 2003 Interdisciplinary Team-Based Disease Management of Heart Failure
    by Thomas G. Di Salvo & Lynne Warner Stevenson
  • 2003 Assessment Methods for Patient-Reported Outcomes
    by Michael R. Hufford & Saul Shiffman
  • 2003 Ethical Considerations in Disease Management: A Managed Care Perspective
    by Robert A. Baldor
  • 2003 Disease Management Update
    by Adis International Limited
  • 2003 Spotlight on Galantamine in Alzheimer's Disease This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (13): 919-942
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2003 Assessing Beneficiary Health Outcomes and Disease Management Initiatives in Medicare
    by Samuel C. Haffer & Sonya E. Bowen & Erin Dowd Shannon & Brenda M. Fowler
  • 2003 Economic Impact of Patient Adherence with Antidepressant Therapy Within a Managed Care Organization
    by T. Jeffrey White & Ann Vanderplas & Caron Ory & Christopher M. Dezii & Eunice Chang
  • 2003 Determinants of Quality of In-Hospital Care for Patients with Acute Coronary Syndromes
    by Ian A. Scott
  • 2003 Reducing Racial and Ethnic Disparities in Disease Management to Improve Health Outcomes
    by Dennis P. Andrulis
  • 2003 Predictive Modeling in Health Plans
    by Randy C. Axelrod & David Vogel
  • 2003 Long-Term Care Insurance in Japan: Its Frameworks, Issues and Roles
    by Kiyomi Asahara & Yumiko Momose & Sachiyo Murashima
  • 2003 Acknowledgment
    by Adis International Limited
  • 2003 Management of Rheumatoid Arthritis: Defining the Role of Leflunomide
    by Christopher I. Carswell & Caroline M. Perry & Tim Ibbotson
  • 2003 Clinical and Utilization Outcomes for a Pediatric and Adolescent Telephonic Asthma Care Support Program: A Propensity Score-Matched Cohort Study
    by Gregory D. Berg & Alan Johnson & Edward Fleegler
  • 2003 Impact of Antimicrobial Control Programs on Patient Outcomes: Pharmacy Perspective
    by David T. Bearden & George P. Allen
  • 2003 Health Outcomes Assessment in Cancer: Current Measurement Strategies and Recommendations for Improvement
    by William F. Lawrence & Carolyn M. Clancy
  • 2003 The Approaches to Schizophrenia Communication (ASC) Tool: Including the Patient Perspective in Treatment
    by Albana M. Dassori & Alexander L. Miller & Peter J. Weiden
  • 2003 Specialist Nurse-Led Intervention in Outpatients with Congestive Heart Failure: Impact on Clinical and Economic Outcomes
    by Nicholas D. Palmer & Barbara Appleton & Erwin A. Rodrigues
  • 2003 Management of Postmenopausal Osteoporosis: Defining the Role of Raloxifene
    by Keri Wellington & Greg L. Plosker
  • 2003 Antibacterials for Viral Respiratory Infections: Results of a Physician-Based Intervention in a Predominantly Preferred Provider Organization Setting
    by John Berthiaume & Helen O. Chernicoff & Jaok J. Kim & Richard S. Chung & Roberta C. Pang & Antonio P. Legorreta
  • 2003 Global Efforts for Reducing the Burden of Smoking
    by Frank J. Chaloupka & Prabhat Jha & Marlo A. Corrao & Vera Luiza da Costa e Silva & Hana Ross & Christina C. Ciecierski & Derek Yach
  • 2003 Provider Training and Education in Disease Management: Current and Innovative Technology
    by Myra L. Muramoto & Jean Campbell & Zenen Salazar
  • 2003 Long-Term Effects of Second-Generation Cholinesterase Inhibitors on Clinical Outcomes and Costs of Alzheimer
    by J. Jaime Caro & Denis Getsios
  • 2003 A Schema for Effective Osteoporosis Management: Outcomes of the Geisinger Health System Osteoporosis Program
    by Eric D. Newman
  • 2003 Distance to Hospital and Children's Use of Preventive Care: Is Being Closer Better, and for Whom?
    by Janet Currie & Patricia B. Reagan
  • 2003 Producción académica en Economía de la Salud en Colombia, 1980-2002
    by Karem Espinosa Echavarría & Humberto Restrepo Zea & Sandra Rodríguez Acosta
  • 2003 Tax financed government health expenditure and growth with capital deepening externality
    by Kei Hosoya
  • 2003 Econometric Models of Private and Public Health Expenditure in OECD countries, 1970-96
    by Guisan, M.Carmen & Arranz, Matilde
  • 2002 Work and health in Switzerland: Immigrants and Natives
    by Rainer Winkelmann
  • 2002 La Creación de Empresas Mediante la Experimentación sobre Modelo: un Proyecto
    by Ortigueira, Luis C.
  • 2002 Density versus Quality in Health Care Provision: Using Household Data to Make Budgetary Choices in Ethiopia
    by Paul Collier & Stefan Dercon & John Mackinnon
  • 2002 Coping with Population Ageing in Hungary
    by Andrew Burns & Jaromir Cekota
  • 2002 Coping with Population Ageing in the Netherlands
    by David Carey
  • 2002 The Effect of the State Children's Health Insurance Program on Health Insurance Coverage
    by Anthony T. LoSasso & Thomas C. Buchmueller
  • 2002 Mother's Education and the Intergenerational Transmission of Human Capital: Evidence from College Openings and Longitudinal Data
    by Janet Currie & Enrico Moretti
  • 2002 Why Have Health Expenditures as a Share fo GDP Risen So Much?
    by Charles I. Jones
  • 2002 Health and Retirement: Do Changes in Health Affect Retirement Expectations?
    by Kathleen McGarry
  • 2002 Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State
    by David M. Cutler & Robert S. Huckman
  • 2002 The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
    by Frank R. Lichtenberg & Tomas J. Philipson
  • 2002 Is Health Insurance Affordable for the Uninsured?
    by M. Kate Bundorf & Mark V. Pauly
  • 2002 Does Medicare Benefit the Poor? New Answers to an Old Question
    by Jay Bhattacharya & Darius Lakdawalla
  • 2002 Orphans in Africa
    by Anne Case & Christina Paxson & Joseph Ableidinger
  • 2002 Health Insurance Coverage and the Disability Insurance Application Decision
    by Jonathan Gruber & Jeffrey Kubik
  • 2002 Modeling Health Insurance Expansions: Effects of Alternate Approaches
    by Dahlia K. Remler & Joshua Graff Zivin & Sherry A. Glied
  • 2002 Socioeconomic Status and Health: Why is the Relationship Stronger for Older Children?
    by Janet Currie & Mark Stabile
  • 2002 Drug Treatment as a Crime Fighting Tool
    by Mireia Jofre-Bonet & Jody L. Sindelar
  • 2002 Ownership Form and Trapped Capital in the Hospital Industry
    by Henry Hansmann & Daniel Kessler & Mark McClellan
  • 2002 Estimating Price Elasticities When there is Smuggling: The Sensitivity of Smoking to Price in Canada
    by Jonathan Gruber & Anindya Sen & Mark Stabile
  • 2002 The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
    by Darius Lakdawalla & Tomas Philipson
  • 2002 Medicaid Managed Care and Infant Health: A National Evaluation
    by Robert Kaestner & Lisa Dubay & Genevieve Kenney
  • 2002 HMO Penetration, Ownership Status, and the Rise of Hospital Advertising
    by Jason R. Barro & Michael Chu
  • 2002 Why Did Employee Health Insurance Contributions Rise?
    by Jonathan Gruber & Robin McKnight
  • 2002 Do Cigarette Taxes Make Smokers Happier?
    by Jonathan Gruber & Sendhil Mullainathan
  • 2002 The Health of Nations: The Contribution of Improved Health to Living Standards
    by William D. Nordhaus
  • 2002 A Theory of Government Regulation of Addictive Bads: Optimal Tax Levels and Tax Incidence for Cigarette Excise Taxation
    by Jonathan Gruber & Botond Koszegi
  • 2002 Sources of U.S. Longevity Increase, 1960-1997
    by Frank R. Lichtenberg
  • 2002 Mental Illness and the Demand for Alcohol, Cocaine and Cigarettes
    by Henry Saffer & Dhaval Dave
  • 2002 Is More Information Better? The Effects of 'Report Cards' on Health Care Providers
    by David Dranove & Daniel Kessler & Mark McClellan & Mark Satterthwaite
  • 2002 Dietary Risk Assessment in the WIC Program
    by A report of the Committee on Dietary Risk Assessment in the WIC Program & of which Ronette Briefel was a member
  • 2002 Modeling the Impact of Eliminating SSI Cash-Out in California
    by Karen Cunnyngham
  • 2002 FITS: Feeding Infants and Toddlers Study. A Gerber Initiative
    by Barbara Devaney & Paula Ziegler & Susan Pac & Vatsala Karwe & Susan Barr
  • 2002 Feeding Low-Income Children When School Is Out: The Summer Food Service Program
    by Anne Gordon
  • 2002 An Evaluation of the Seamless Waiver in Five School Districts
    by Tania Tasse & James Ohls
  • 2002 Reaching Those in Need: State Food Stamp Participation Rates in 2000
    by Allen L. Schirm & Laura A. Castner
  • 2002 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates for 1994-1999
    by Allen L. Schirm & Laura A. Castner
  • 2002 The Emergency Food Assistance System: Findings from the Provider Survey. Volume 1
    by James Ohls & Fazana Saleem-Ismail
  • 2002 Promoting Medicaid and Food Stamp Participation: Establishing Eligibility Procedures That Support Participation and Meet Families' Needs
    by LaDonna Pavetti & Kathleen Maloy & Liz Schott
  • 2002 Trends in Food Stamp Program Participation Rates: 1994 to 2000
    by Karen Cunnyngham
  • 2002 Characteristics of Food Stamp Households: Fiscal Year 2001
    by Christina Tuttle
  • 2002 Trends in Food Stamp Program Participation Rates: 1994 to 2000
    by Karen Cunnyngham
  • 2002 Food Stamps in Rural America: Special Issues and Common Themes
    by Sheena McConnell & James Ohls
  • 2002 Reaching Those in Need: State Food Stamp Participation Rates in 1999
    by Allen L. Schirm & Laura A. Castner
  • 2002 Food Stamp Time Limits: A Burdensome Policy that Weakens the Safety Net
    by Sheena McConnell & John L. Czajka & Scott Cody & Nuria Rodriguez
  • 2002 State of Arkansas and Hennepin County, Minnesota: Improving Participation in Food Stamps: Strategies and Challenges
    by Angela Merrill & Megan McHugh & Liz Schott & Julie Darnell
  • 2002 An Assessment of Computer Matching in the Food Stamp Program. Vol. III: Appendix Tables
    by William S. Borden & Robbi L. Ruben-Urm
  • 2002 An Assessment of Computer Matching in the Food Stamp Program. Vol. I: Summary of Survey Results
    by William S. Borden & Robbi L. Ruben-Urm
  • 2002 An Assessment of Computer Matching in the Food Stamp Program. Vol. II: State Profiles
    by William S. Borden & Robbi L. Ruben-Urm
  • 2002 Nutrition, Food Security, and Obesity
    by Harold S. Beebout
  • 2002 Hunger in America 2001: National Report Prepared for America's Second Harvest
    by Myoung Kim & Jim Ohls & Rhoda Cohen
  • 2002 An Assessment of Computer Matching in the Food Stamp Program
    by William S. Borden & Robbi Ruben-Urm
  • 2002 Unofficial Payments for Acute State Hospital Care In Kazakhstan. A Model of Physician Behaviour with Price Discrimination and Vertical Service Differentiation
    by Robin Thompson & Ana Xavier
  • 2002 How Parental Education Affects Child Human Capital: Evidence from Mozambique
    by Rasmus Heltberg & Niels Johannesen
  • 2002 Living Rationally Under the Volcano? An Empirical Analysis of Heavy Drinking and Smoking
    by Arcidiacono, Peter & Sieg, Holger & Sloan, Frank
  • 2002 Disentangling the Age, Period, and Cohort Effects using a Modeling Approach
    by France Portrait & Rob Alessie & Dorly Deeg
  • 2002 The Health of Nations: The Contribution of Improved Health to Living Standards
    by William D. Nordhaus
  • 2002 Density versus quality in health care provision: Using household data to make budgetary choices in Ethiopia
    by Paul Collier & Stefan Dercon & John Mackinnon
  • 2002 Information Asymmetry, Insurance, and the Decision to Hospitalize
    by Åke Blomqvist & Pierre Thomas Léger
  • 2002 Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden
    by Frances B. Garfield & Denis Getsios & J. Jaime Caro & Anders Wimo & Bengt Winblad
  • 2002 Cost Effectiveness of Treatment of Parkinson's Disease with Entacapone in the United States
    by Cynthia S. Palmer & Mark J.C. Nuijten & Jordana K. Schmier & Prasun Subedi & Edward H. Snyder
  • 2002 Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications
    by Judith A. O'Brien & Jaime J. Caro
  • 2002 Cost Effectiveness of Tinzaparin Sodium Versus Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis
    by J. Jaime Caro & Denis Getsios & Ingrid Caro & Judith A. O'Brien
  • 2002 Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes
    by Lisa L. Ioannides-Demos & Joseph E. Ibrahim & John J. McNeil
  • 2002 On-Demand and Intermittent Therapy for Gastro-Oesophageal Reflux Disease: Economic Considerations
    by John M. Inadomi
  • 2002 Economic Benefits of Amlodipine Treatment in Patients with Coronary Artery Disease
    by Roman Casciano & John J. Doyle & John Chen & Steve Arikian & Julian Casciano & Heather Kugel & Raul Arocho
  • 2002 Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care: An Overview and Cost Analysis
    by Craig Anderson & Cliona Ni Mhurchu & Paul M. Brown & Kristie Carter
  • 2002 Ready-to-Use Injection Preparations versus Conventional Reconstituted Admixtures: Economic Evaluation in a Real-Life Setting
    by Phillipe van der Linden & Jacques Douchamps & Claude Schmitt & Dominique Forget
  • 2002 Cost-Effective Approaches to the Treatment of Community-Acquired Pneumonia in the Era of Resistance
    by Joseph L. Kuti & Blair Capitano & David P. Nicolau
  • 2002 Methods for Claims-Based Pharmacoeconomic Studies in Psychosis
    by Frank Gianfrancesco & Ruey-Hua Wang & Ramy Mahmoud & Richard White
  • 2002 Cost Effectiveness of Paclitaxel/Cisplatin Compared with Cyclophosphamide/Cisplatin in the Treatment of Advanced Ovarian Cancer in Belgium
    by Niels Neymark & Thierry Gorlia & Ines Adriaenssen & Benoit Baron & Martine Piccart
  • 2002 A Model to Estimate the Cost Benefit of an Occupational Vaccination Programme for Influenza with Influvac(R) in the UK Use of the tradename is for product identification purposes only and does not imply endorsement
    by Roben Das Gupta & Julian F. Guest
  • 2002 Limitations of the Methods Used for Calculating Quality-Adjusted Life-Year Values
    by Gerard Duru & Jean Paul Auray & Ariel Beresniak & Michel Lamure & Abby Paine & Nicolas Nicoloyannis
  • 2002 Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting
    by Ron L. Akehurst & John E. Brazier & Nigel Mathers & Caroline O'Keefe & Eva Kaltenthaler & Anne Morgan & Maria Platts & Stephen J. Walters
  • 2002 Standardisation of Costs: The Dutch Manual for Costing in Economic Evaluations
    by Jan B. Oostenbrink & Marc A. Koopmanschap & Frans F.H. Rutten
  • 2002 Homocyst(e)ine and Coronary Heart Disease: Pharmacoeconomic Support for Interventions to Lower Hyperhomocyst(e)inaemia
    by Brahmajee K. Nallamothu & A. Mark Fendrick & Gilbert S. Omenn
  • 2002 Use of Healthcare Services by Patients Treated with Risperidone Versus Conventional Antipsychotic Agents
    by Frank Gianfrancesco & Michael B. Durkin & Ramy Mahmoud & Ruey-Hua Wang
  • 2002 Reporting Heterogeneity in the Measurement of Health and Health-Related Quality of Life
    by Amir Shmueli
  • 2002 Estimating the Effect of Changes in Body Mass Index on Health State Preferences
    by Zafar Hakim & Anne Wolf & Louis P. Garrison
  • 2002 A Fair Innings for NICE?
    by Nick Freemantle & Karen Bloor & Joanne Eastaugh
  • 2002 Cost Effectiveness of Treatments for Amyotrophic Lateral Sclerosis: A Review of the Literature
    by Gary Ginsberg & Serena Lowe
  • 2002 Sickle Cell Anaemia: Epidemiology and Cost of Illness
    by Paul J. Nietert & Marc D. Silverstein & Miguel R. Abboud
  • 2002 The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden
    by Lars Agreus & Lars Borgquist
  • 2002 The Practice of Splitting Tablets: Cost and Therapeutic Aspects
    by John Bachynsky & Cheryl Wiens & Krystal Melnychuk
  • 2002 Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer
    by M. Lees & M. Aristides & N. Maniadakis & J. McKendrick & N. Botwood & D. Stephenson
  • 2002 Cost Effectiveness of Oral Terbinafine (Lamisil(R)) Compared with Oral Fluconazole (Diflucan(R)) in the Treatment of Patients with Toenail Onychomycosis
    by Heini Salo & Markku Pekurinen
  • 2002 Economic Considerations Related to Providing Adequate Pain Relief for Women in Labour: Comparison of Epidural and Intravenous Analgesia
    by Cecil Huang & Alex Macario
  • 2002 Quality-of-Life Assessment in Osteoporosis: Health-Status and Preference-Based Measures
    by Anna N.A. Tosteson & Cristina S. Hammond
  • 2002 Cost Effectiveness of Esomeprazole Compared with Omeprazole in the Acute Treatment of Patients with Reflux Oesophagitis in the UK
    by Peter Wahlqvist & Ola Junghard & Andy Higgins & Jonathan Green
  • 2002 Cost Effectiveness of Proton Pump Inhibitors in Gastro-Oesophageal Reflux Disease Without Oesophagitis: Comparison of On-Demand Esomeprazole with Conventional Omeprazole Strategies
    by Peter Wahlqvist & Ola Junghard & Andy Higgins & Jonathan Green
  • 2002 Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma
    by Alan J. Zillich & Karen Blumenschein & Magnus Johannesson & Patricia Freeman
  • 2002 Putting Your Money Where Your Mouth Is: Willingness to Pay for Dental Gel
    by Debora Matthews & Angela Rocchi & Amiram Gafni
  • 2002 Enoxaparin: A Pharmacoeconomic Review of its Use in the Prevention and Treatment of Venous Thromboembolism and in Acute Coronary Syndromes
    by David Bergqvist
  • 2002 A Monte Carlo Simulation for Modelling Outcomes of AIDS Treatment Regimens
    by Anke Richter & Brett Hauber & Kit Simpson & Josephine A. Mauskopf & Dongping Yin
  • 2002 Economic Value of Thrombolysis with Adjunctive Abciximab in Patients with Subacute Peripheral Arterial Occlusion
    by Stephan H. Duda & Gunnar Tepe & Mohan Bala & Oliver Luz & Gerhard Ziemer & Kenneth Ouriel & Benjamin Pusich & Jakub Wiskirchen & Claus D. Claussen & Kurt Banz
  • 2002 Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction
    by Josep Darba & Inaki Izquierdo & Caridad Pontes & Carlos Navas & Joan Rovira
  • 2002 Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies
    by Martin J. Price & Andrew H. Briggs
  • 2002 Intermittent Claudication: Pharmacoeconomic and Quality-of-Life Aspects of Treatment
    by Gregorio Brevetti & Roberta Annecchini & Roxanna Bucur
  • 2002 Acute Exacerbations of Chronic Bronchitis: A Pharmacoeconomic Review of Antibacterial Use
    by Stephen Morris & Pippa Anderson & Debra E. Irwin
  • 2002 Optimising Drug Utilisation in Long Term Care
    by Kate L. Lapane & Carmel M. Hughes
  • 2002 Cost-Effectiveness Analysis of Stratified Versus Stepped Care Strategies for Acute Treatment of Migraine: The Disability in Strategies for Care (DISC) Study
    by Mark Sculpher & David Millson & David Meddis & Lynne Poole
  • 2002 Design, Analysis and Presentation of Multinational Economic Studies: The Need for Guidance
    by Francis Pang
  • 2002 Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer: A Stochastic Economic Evaluation
    by Jonathan Karnon & Jackie Brown
  • 2002 Health-Related Quality of Life in a UK-Based Population of Men with Erectile Dysfunction
    by Julian F. Guest & Roben Das Gupta
  • 2002 Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia
    by Peter Lindgren & Bengt Jonsson & Alberto Redaelli & Davide Radice
  • 2002 Pharmacy Benefit Management: Enhancing the Applicability of Pharmacoeconomics for Optimal Decision Making
    by C. Daniel Mullins & Junling Wang
  • 2002 Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid Arthritis: An Evaluation Based on a 1-Year Randomised Controlled Trial
    by Andreas Maetzel & Vibeke Strand & Peter Tugwell & George Wells & Claire Bombardier
  • 2002 Economic Impact of Low Dose Polyethylene Glycol 3350 Plus Electrolytes Compared with Lactulose in the Management of Idiopathic Constipation in the UK
    by Angela H. Christie & Pearl Culbert & Julian F. Guest
  • 2002 Antihypertensive Treatment with and without Benazepril in Patients with Chronic Renal Insufficiency: A US Economic Evaluation
    by Thomas J. Hogan & William J. Elliott & Arnold H. Seto & George L. Bakris
  • 2002 Onychomycosis: Health-Related Quality of Life Considerations
    by James W. Shaw & Vijay N. Joish & Stephen Joel Coons
  • 2002 Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis
    by Philippe Beutels & W. John Edmunds & Fernando Antonanzas & G. Ardine de Wit & David Evans & Rachel Feilden & A. Mark Fendrick & Gary M. Ginsberg & Henry A. Glick & Eric Mast & Marc Pechevis & Eddy K.A. Van Doorslaer & Ben A. van Hout
  • 2002 Health State Preference Assessment in Diabetic Peripheral Neuropathy
    by Sean D. Sullivan & Doris P. Lew & E. Beth Devine & Zafar Hakim & Gayle E. Reiber & David L. Veenstra
  • 2002 Use of Randomised Controlled Trials for Producing Cost-Effectiveness Evidence: Potential Impact of Design Choices on Sample Size and Study Duration
    by Martin E. Backhouse
  • 2002 Quality of Life in Patients with Epilepsy and Impact of Treatments
    by Patrizia Berto
  • 2002 Developing the Revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors: Opportunity or Threat?
    by Rod S. Taylor & John Hutton & Anthony J. Culyer
  • 2002 Insulin Lispro: A Pharmacoeconomic Review of its Use in Diabetes Mellitus
    by Christopher J. Dunn & Greg L. Plosker
  • 2002 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome
    by Max Brosa & Carlos Rubio-Terres & Ibrahim Farr & Vijay Nadipelli & Jenaro Froufe
  • 2002 Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies
    by Emile Levy & Pierre Levy
  • 2002 Theoretical Arguments for the Discounting of Health Consequences: Where Do We Go from Here?
    by Angelina Lazaro
  • 2002 Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2002 Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma
    by Ketan Sheth & Rohit Borker & Amanda Emmett & Kathleen Rickard & Paul Dorinsky
  • 2002 The Annual Societal Cost of Alcohol Misuse in Scotland
    by Susan J. Varney & Julian F. Guest
  • 2002 The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions
    by Edward C.F. Wilson & Emma S. McKeen & Paul A. Scuffham & Martin C.J. Brown & Kevan Wylie & Geoff Hackett
  • 2002 The Economic Costs of Early Stage Prostate Cancer
    by Christopher S. Saigal & Mark S. Litwin
  • 2002 Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
    by Mark J.C. Nuijten & Frans Rutten
  • 2002 Costs and Effectiveness of Using Coumarins Before, During and After Coronary Angioplasty
    by Jurrien M. ten Berg & Johannas C. Kelder & Thys H.W. Plokker & Ben A. van Hout
  • 2002 UK Department of Health Guidance on Prescribing for Impotence Following the Introduction of Sildenafil: Potential to Contain Costs in the Average Health Authority District
    by Martin Ashton-Key & Michael Sadler & Byron Walmsley & Simon Holmes & Sarah Randall & Michael H. Cummings
  • 2002 Cost-Effectiveness Comparison of Tizanidine and Baclofen in the Management of Spasticity
    by David N. Rushton & Adam C. Lloyd & Pippa M. Anderson
  • 2002 Long Term Cost-of-Illness in Stroke: An International Review
    by Krista A. Payne & Krista F. Huybrechts & Jjaime Caro & Traci J. Craig Green & Wendy S. Klittich
  • 2002 Vision-Specific Instruments for the Assessment of Health-Related Quality of Life and Visual Functioning: A Literature Review
    by Mary Kay Margolis & Karin Coyne & Tessa Kennedy-Martin & Timothy Baker & Oliver Schein & Dennis A. Revicki
  • 2002 Cost Effectiveness of Asthma Management Strategies
    by Mike Thomas & John Haughney & David Price
  • 2002 The Impact of Health Economics on Healthcare Delivery: A Health Economist's Perspective: A Primary Care Response
    by David Kernick
  • 2002 Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer
    by Mike Aristides & Jack Chen & Mark Schulz & Eve Williamson & Stephen Clarke & Kaye Grant
  • 2002 Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia
    by Alexander H. Miners & Caroline A. Sabin & Keith H. Tolley & Christine A. Lee
  • 2002 Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria
    by Xavier Badia & Fermin Mearin & Agustin Balboa & Eva Baro & Ellen Caldwell & Mercedes Cucala & Manuel Diaz-Rubio & Arturo Fueyo & Julio Ponce & Mentse Roset & Nicholas J. Talley
  • 2002 Valuation of Symptomatic Hepatitis A in Adults: Estimates Based on Time Trade-Off and Willingness-To-Pay Measurement
    by R Jake Jacobs & Ronald J. Moleski & Allen S. Meyerhoff
  • 2002 Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death
    by Marian A. Spath & Bernie J. O'Brien
  • 2002 Prospective Study Designs in Outcomes Research: The Case of Migraine
    by Elizabeth A. Rothermich & Meryl I. Brod & Warren H. Schonfeld & Clayton R. Rowland & Baltazar Gomez-Mancilla
  • 2002 Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation
    by Melissa Young & Greg L. Plosker
  • 2002 Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK: A Comparison of Collection Methods of Resource Use Data
    by Bo Standaert & Janet Goldstone & Z. John Lu & Moshe Haim Erder & John Liu Yin
  • 2002 The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma: A Cost Model Based on a 1-Year Pragmatic, Randomised Clinical Study
    by David Price & John Haughney & Martin Duerden & Charles Nicholls & Charlotte Moseley
  • 2002 Cost of Illness of Crohn's Disease
    by Keith Bodger
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Cost-Benefit Analysis of Vaccination Against Influenza of Employees from an Academic Medical Centre
    by Wilma Parlevliet & Corianne de Borgie & Gerard Frijstein & Henk-Jan Guchelaar
  • 2002 An Independent Practice Association-Supported Disease Management Program: Impact on Patients with Coronary Artery Disease
    by Miriam Cannon-Wagner & Diane S. Soule & David R. Walker & Richard P. Vance
  • 2002 The Influence of Socioeconomic and Psychological Factors on Patient Adherence to Self-Management Strategies: Lessons Learned in Asthma
    by John Kolbe
  • 2002 Disease Management and the Application of Privacy Guidelines
    by Marybeth Regan
  • 2002 Pulmonary Rehabilitation Programs: Outcomes in Patients with Chronic Obstructive Pulmonary Disease
    by Nicolino Ambrosino
  • 2002 National Service Framework for Older People: Will Access to Health Services for Elderly Patients Improve?
    by Sumeet Chadha & John Young
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Prevalence and Management of Anemia Among Patients with Chronic Kidney Disease in a Health Maintenance Organization
    by Annamaria T. Kausz & Earl P. Steinberg & Allen R. Nissenson & Brian J.G. Pereira
  • 2002 Methods Aimed at Improving Asthma Care and Outcomes Management: A Case Study
    by Felicia C. Allen-Ramey & Gregory B. Diette & Robert C. McDonald & Elizabeth A. Skinner & Donald M. Steinwachs & Albert W. Wu
  • 2002 Migraine Prophylaxis in Managed Care Organizations: Unclear Role in Disease Management Programs
    by Jennifer H. Lofland & Purna K. Lakhia
  • 2002 Supporting Patient Care by Using Innovative Information Technology: A Case Study from Clinical Psychiatry
    by Elske Ammenwerth & Frauke Ehlers & Ulrike Kutscha & Ansgar Kutscha & Ronald Eichstadter & Franz Resch
  • 2002 Building the Outcomes-Based Formulary
    by Brian T. Sweet & Marcus D. Wilson & William J. Waugh & Andrea D. Hess & Joshua J. Spooner
  • 2002 Managed Drug Use in Assisted Living and Home Care Settings: Who Benefits?
    by Stephen M. Setter & David Alexander Sclar & Brian J. Gates
  • 2002 Disease Management Programs: The Second Generation
    by Paul S. Shelton
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Erectile Dysfunction: Defining the Role of Sildenafil
    by Katherine A. Lyseng-Williamson & Antona J. Wagstaff
  • 2002 The Role of Different Types of Health Insurance on Access and Utilization of Antihypertensive Drugs: An Empirical Study in a US Hypertensive Population
    by Christine Huttin
  • 2002 Community Mental Health Services for Individuals with Intellectual Disabilities: Issues and Approaches to Optimizing Outcomes
    by Angela Hassiotis
  • 2002 Preventing Relapse of Psychotic Illness: Role of Self-Monitoring of Prodromal Symptoms
    by Lisa Hewitt & Max Birchwood
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Type 2 Diabetes Mellitus: Defining the Role of Nateglinide
    by Christopher I. Carswell & Christine R. Culy & Caroline M. Perry
  • 2002 A Formulary Analysis of Angiotensin II Antagonists in a UK Teaching Hospital
    by Andrew P. Moore & Nigel M. Wheeldon & Mike Jennings
  • 2002 Models of Palliative Care Service Delivery: What is Most Cost Effective?
    by Nick Bosanquet
  • 2002 Lymphedema After Surgery for Cancer: The Role of Patient Support Groups in Patient Therapy
    by Stanley G. Rockson
  • 2002 Health Promotion for Individuals with Disabilities: The Need for a Transitional Model in Service Delivery
    by James H. Rimmer
  • 2002 Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
    by Alan Chock & Vera Gong & Christopher J. Destache
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon-beta-1a (Rebif(R)) Use of a tradename is for product identification purposes only, and does not imply endorsement
    by Katherine A. Lyseng-Williamson & Greg L. Plosker
  • 2002 New Trends in Patient Monitoring
    by Senen Barro & Jesus Presedo & Paulo Felix & Daniel Castro & Jose Antonio Vila
  • 2002 Integration of Case and Disease Management: Why and How?
    by Margaret A. Radzwill
  • 2002 Telemedicine, Outcomes and Policy Decisions
    by Arto Ohinmaa & David Hailey
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Spotlight on Paclitaxel in Ovarian Cancer The full text of this article was published in PharmacoEconomics 2001; 19 (12): 1227-1259
    by Melissa Young & Greg L. Plosker
  • 2002 Excess Healthcare Costs Associated with Excess Health Risks in Diseased and Non-Diseased Health Risk Appraisal Participants
    by Shirley Musich & Timothy McDonald & David Hirschland & Dee W. Edington
  • 2002 Standardized Telephonic Case Management in a Hispanic Heart Failure Population: An Effective Intervention
    by Barbara Riegel & Beverly Carlson & Dale Glaser & Zoe Kopp & Tomas E. Romero
  • 2002 The Potential Impact of Measuring Healthcare Quality on Pharmaceutical-Related Costs and Outcomes
    by William L. Roper & R. Tamara Hodlewsky & Hugh Tilson & Kathleen N. Lohr & William H. Campbell
  • 2002 The Emerging Role of the Consumer in Pharmaceutical Pricing Decisions
    by Elinor C. Chumney & Kit N. Simpson
  • 2002 Pharmacy Benefit Managers' Role in Facilitating Medicare Beneficiary Access to Pharmaceutical Care
    by Joshua Cohen & Jennifer Chee
  • 2002 Risks and Benefits of the Use of Capitation Formulae in Primary Care
    by Azeem Majeed
  • 2002 Pharmaceutical Company Websites as Sources of Information for Consumers: How Appropriate and Informative Are They?
    by Kathleen M. Griffiths & Helen Christensen & Kimberley Evans
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Piperacillin/Tazobactam in Moderate to Severe Bacterial Infections The full text of this article was published in PharmacoEconomics 2001; 19 (11): 1135-1175
    by Melissa Young & Greg L. Plosker
  • 2002 Use of the Internet by Patients with Chronic Illness
    by Richard W. Millard & Patricia A. Fintak
  • 2002 Employer Role in Integrative Workplace Health Management: A New Model in Progress
    by Cordia Chu & Sophie Dwyer
  • 2002 Development of a Migraine Disease Management Initiative in a Managed Care Plan
    by Glen D. Solomon & Henry X. Hu & Rick Simmons & Kathleen Conboy & Rob Jeddeloh & Marie Eastburn
  • 2002 The Fifth Vital Sign: Cornerstone of a New Pain Management Strategy
    by Hildegarde J. Berdine
  • 2002 Utilizing an Intranet in Disease Management
    by Marybeth Regan
  • 2002 Role of Family Physicians in Implementing Asthma Self-Management Programs
    by Bart P.A. Thoonen & Chris van Weel
  • 2002 Outcomes Associated with a Disease Management Program for End-Stage Renal Disease
    by Allen R. Nissenson
  • 2002 Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection
    by Alissa Scalera & Ahmed M. Bayoumi & Paul Oh & Nancy Risebrough & Neil Shear & Alice Lin-in Tseng
  • 2002 Integrating Healthcare Standards and Performance Measurement
    by Richard G. Koss & Linda S. Hanold & Jerod M. Loeb
  • 2002 Effective Utilization of Pharmacoeconomics for Decision Makers
    by Judith D. Bentkover & Ron Corey
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Spotlight on Paclitaxel in Non-Small Cell Lung Cancer The full text of this article was published in PharmacoEconomics 2001; 19 (11): 1111-1134
    by Greg L. Plosker & Miriam Hurst
  • 2002 The Development of a Tool to Assess Quality of Cost Estimates
    by Philip Jacobs & Greg Finlayson & Ben Faienza & Murray Brown & Betty Newson & Nadine MacLean
  • 2002 Role of Parent Training in the Effective Management of Attention-Deficit/Hyperactivity Disorder
    by Thomas J. Power & Heather F. Russell & Stephen L. Soffer & Jessica Blom-Hoffman & Suzanne M. Grim
  • 2002 Practical Considerations for the Design and Evaluation of Disease Education and Management Programs in the Workplace
    by Seth Serxner & David Anderson
  • 2002 Worksite Health Promotion: A Critical Investment
    by Bruce Sherman
  • 2002 An HMO-Sponsored Primary Care-Based Disease Management and Case Management Initiative: Economic and Selected Clinical Outcomes
    by Jaan Sidorov & Franz Joseph Fisher & Sabrina Girolami & Otto Wolke
  • 2002 Disease Management Update: From the World Literature
    by Adis International Limited
  • 2002 Management of Acute Bacterial Exacerbations of Chronic Bronchitis: Defining the Role of Moxifloxacin
    by Harinder S. Malhotra & Caroline M. Perry & Douglas Ormrod
  • 2002 Management of Alzheimer's Disease: Defining the Role of Donepezil
    by Tim Ibbotson & Karen L. Goa
  • 2002 Management of Rheumatoid Arthritis: Defining the Role of Etanercept
    by Gillian M. Keating & Blair Jarvis
  • 2002 Improved Diabetes Control Through a Provider-Based Disease Management Program
    by Rose Maljanian & Neil Grey & Ilene Staff & Marisol Cruz-Marino-Aponte
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Spotlight on Mycophenolate Mofetil in Solid Organ Transplantation This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (10): 675-713
    by Melissa Young & Greg L. Plosker
  • 2002 Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs: New Roles in Primary and Collaborative Care
    by Gloria J. Nichols-English & Melanie Provost & Dayin Koompalum & Hua Chen & Masood Athar
  • 2002 Rural Psychiatry: Special Issues and Models of Service Delivery
    by Fiona Judd & Caitlin Fraser & Margaret Grigg & Joseph Scopelliti & Gene Hodgins & Adrian Donoghue & John Humphreys
  • 2002 On the Evaluation of Drug Benefits Policy Changes with Longitudinal Claims Data: Concepts of Income-Based Deductibles and Issues Related to Causal Inference
    by Sebastian Schneeweiss & Malcolm Maclure & Colin Dormuth
  • 2002 Point of Care Testing: Potential for Tracking Disease Management Outcomes
    by Christopher P. Price
  • 2002 Clinical Guidelines in Disease Management
    by Albert I. Wertheimer & Nicole M. Chaney
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 An Empirical Model for the Development of Disease Management Programs in General Practice: A Case Study Using Hypertension
    by Deborah A. Turnbull & Helen Mensforth & Justin J. Beilby & John E. Marley & Farooq Qureshi & Anne L. Tonkin
  • 2002 Patients Diagnosed with Irritable Bowel Syndrome: Medical Record Validation of a Claims-Based Identification Algorithm
    by Antonio P. Legorreta & Jean-Francois Ricci & Mike Markowitz & Priti Jhingran
  • 2002 The Relationship of Diabetes Mellitus Performance Indicators with Self-Reported Health and Patient Satisfaction
    by David P. Nau & Ritesh N. Kumar
  • 2002 Guidelines and Care Management Issues for People with Alzheimer's Disease and Other Dementias
    by Katie Maslow & John Selstad & Susan J. Denman
  • 2002 The Effects of the Internet on Pharmaceutical Consumers and Providers
    by Francois M.H.M. Dupuits
  • 2002 Telemedicine Screening for Diabetic Retinopathy: Improving Patient Access to Care
    by Kanagasingam Yogesan & Ian J. Constable & Ian Chan
  • 2002 Disease Management Update
    by Adis International Limited
  • 2002 Management of Parkinson's Disease: Defining the Role of Entacapone
    by Tim Ibbotson & Karen L. Goa
  • 2002 Improving Patient Outcomes with Tools for Asthma Self-Monitoring: A Review of the Literature
    by Timothy R. Myers
  • 2002 A Complex System Perspective on Medication Compliance: Information for Healthcare Providers
    by Simon Rietveld & Jos M. Koomen
  • 2002 Evaluating Disease Management Programs
    by David R. Walker & Byron K. McKinney & Miriam Cannon-Wagner & Richard P. Vance
  • 2002 The Developing Role of Pharmacists in Patient Access to Emergency Contraception
    by Judith A. Soon & Marc Levine & Mary H.H. Ensom & Jacqueline S. Gardner & Hilary M. Edmondson & David W. Fielding
  • 2002 Opportunities and Barriers in Front of the Coss-Border Cooperation of the Enterprises in South Eastern Europe
    by Mitko Dimitrov
  • 2001 Human Capital Investment In The Presence Of Unemployment: Application To University Enrolment In Spain
    by Fernandez, R.M. & Shioji, E.
  • 2001 Information Asymmetry, Insurance, and the Decision to Hospitalize
    by Åke Blomqvist & Pierre Thomas Léger
  • 2001 The Health of Nations: Infectious Disease, Environmental Change, and Their Effects on National Security and Development
    by Andrew T. Price-Smith
  • 2001 The Impact of HIV/AIDS on Social Safety Nets: What Can the Caribbean Expect?
    by Karl Theodore & Althea Dianne La Foucade
  • 2001 Demand for private health insurance: Is there a quality gap?
    by Joan Costa & Jaume Garcia
  • 2001 Demand for private health insurance: Is there a quality gap?
    by Joan Costa & Jaume Garcia
  • 2001 Income Redistribution and Access to Innovations in Health Care
    by Maria del Carmen García-Alonso & Owen O'Donnell
  • 2001 Human Capital Investment in the Presence of Unemployment: Application to University Enrolment in Spain
    by Rosa M. Fernandez & Etsuro Shioji
  • 2001 Fiscal Implications of Ageing: Projections of Age-Related Spending
    by Thai-Thanh Dang & Pablo Antolín & Howard Oxley
  • 2001 How Should Norway Respond to Ageing?
    by Pablo Antolín & Wim Suyker
  • 2001 How Will Ageing Affect Finland?
    by Pablo Antolín & Howard Oxley & Wim Suyker
  • 2001 The Effect of New Drugs on Mortality from Rare Diseases and HIV
    by Frank R. Lichtenberg
  • 2001 Taxes and Health Insurance
    by Jonathan Gruber
  • 2001 Living Rationally Under the Volcano? An Empirical Analysis of Heavy Drinking and Smoking
    by Peter Arcidiacono & Holger Sieg & Frank Sloan
  • 2001 Changes in the Age Distribution of Mortality Over the 20th Century
    by David Cutler & Ellen Meara
  • 2001 Health and Nutrition in the Preindustrial Era: Insights from a Millennium of Average Heights in Northern Europe
    by Richard H. Steckel
  • 2001 The Effects of Hospital Ownership on Medical Productivity
    by Daniel Kessler & Mark McClellan
  • 2001 Medicare Policy in the 1990s
    by Joseph P. Newhouse
  • 2001 Household Responses to Public Home Care Programs
    by Peter C. Coyte & Mark Stabile
  • 2001 Does Money Protect Health Status? Evidence from South African Pensions
    by Anne Case
  • 2001 Health Policy in the Clinton Era: Once Bitten, Twice Shy
    by David Cutler & Jonathan Gruber
  • 2001 Toward a Framework for Improving Health Care Financing for an Aging Population: The Case of Israel
    by Dov Chernichovsky & Sara Markowitz
  • 2001 The Efficiency of Medicare
    by Jonathan Skinner & Elliott Fisher & John E. Wennberg
  • 2001 Economic Status and Health in Childhood: The Origins of the Gradient
    by Anne Case & Darren Lubotsky & Christina Paxson
  • 2001 The Demand for Nicotine Replacement Therapies
    by John A. Tauras & Frank J. Chaloupka
  • 2001 Effects of Price and Access Laws on Teenage Smoking Initiation: A National Longitudinal Analysis
    by John A. Tauras & Patrick M. O'Malley & Lloyd D. Johnston
  • 2001 Understanding Health Disparities Across Education Groups
    by Dana Goldman & Darius Lakdawalla
  • 2001 Are the Young Becoming More Disabled?
    by Darius Lakdawalla & Dana Goldman & Jay Bhattacharya
  • 2001 Differential Mortality in the UK
    by Orazio P. Attanasio & Carl Emmerson
  • 2001 Union Effects on Health Insurance Provision and Coverage in the United States
    by Thomas C. Buchmueller & John DiNardo
  • 2001 Why is Health Related to Socioeconomic Status?
    by Ellen Meara
  • 2001 The Silent Majority Fallacy of the Elzinga-Hogarty Criteria: A Critique and New Approach to Analyzing Hospital Mergers
    by Cory S. Capps & David Dranove & Shane Greenstein & Mark Satterthwaite
  • 2001 What can the take-up of other programs teach us about how to improve take-up of health insurance programs?
    by Dahlia K. Remler & Jason E. Rachlin & Sherry A. Glied
  • 2001 Medical Care Price Indices: Problems and Opportunities / The Chung-Hua Lectures
    by Joseph P. Newhouse
  • 2001 The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
    by Frank R. Lichtenberg
  • 2001 Are For-Profit Hospitals Really Different? Medicare Upcoding and Market Structure
    by Elaine Silverman & Jonathan Skinner
  • 2001 Relative Deprivation, Inequality, and Mortality
    by Angus Deaton
  • 2001 Effects of Competition under Prospective Payment on Hospital Costs among High and Low Cost Admissions: Evidence from California, 1983 - 1993
    by David Meltzer & Jeanette Chung
  • 2001 The Relation Between Managed Care Market Share and the Treatment of Elderly Fee-For-Service Patients with Myocardial Infarction
    by Paul A. Heidenreich & Mark McClellan & Craig Frances & Laurence C. Baker
  • 2001 The Poor and the Dead: Socioeconomic Status and Mortality in the U.S., 1850-1860
    by Joseph P. Ferrie
  • 2001 Tables Describing the Asset and Vehicle Holdings of Low-Income Households in 1996
    by Lisa Fowler & Daisy Ewell & Nancy Wemmerus
  • 2001 Imposing a Time Limit on Food Stamp Receipt: Implementation of the Provisions and Effects on Food Stamp Program Participation
    by John Czajka & Sheena McConnell & Scott Cody & Nuria Rodriguez
  • 2001 Imposing a Time Limit on Food Stamp Receipt: Implementation of the Provisions and Effects on Food Stamp Program Participation. Volume I
    by John Czajka & Sheena McConnell & Scott Cody & Nuria Rodriguez
  • 2001 Designs for Measuring How the School Breakfast Program Affects Learning
    by Jonathan Jacobson & Ronette Briefel & Philip Gleason & Rachel Sullivan
  • 2001 Final Report of the Project to Analyze 1996 and 1997 Food Security Data
    by James Ohls & Larry Radbill & Allen Schirm
  • 2001 Household Food Security in the United States, 1995-1997: Technical Issues and Statistical Report. Final Report of the Project to Analyze 1996 and 1997 Food Security Data
    by James Ohls & Larry Radbill & Allen Schirm
  • 2001 Empirical Bayes Shrinkage Estimates of State Food Stamp Participation Rates for 1994-1998
    by Allen L. Schirm
  • 2001 The Impact on Clients of a Community-Based Infant Mortality Reduction Program: The National Healthy Start Program Survey of Postpartum Women
    by Marie C. McCormick & Lisa W. Deal & Barbara L. Devaney & Dexter Chu & Lorenzo Moreno & Karen T. Raykovich
  • 2001 Characteristics of Food Stamp Households: Fiscal Year 2000
    by Karen Cunnyngham
  • 2001 Trends in Food Stamp Participation Rates: 1994 to 1999
    by Randy Rosso
  • 2001 The Decline in Food Stamp Participation: A Report to Congress
    by Laura Castner & Sheena McConnell & Carole Trippe conducted the data analyses for Chapter 2 & Appendix C
  • 2001 Characteristics of Food Stamp Households: Fiscal Year 2000. Advance Report
    by Karen Cunnyngham & Lisa Fowler
  • 2001 Food Stamp Program Access
    by James C. Ohls
  • 2001 Final Report of the Project to Analyze 1996 and 1997 Food Security Data
    by James Ohls & Larry Radbill & Allen Schirm
  • 2001 Food Insufficiency, Poverty, and Health: U.S. Pre-School and School-Age Children
    by K. Alaimo & C.M. Olson & E.A. Frongillo & Jr. & R. Briefel
  • 2001 Food for Thought: Children's Diets in the 1990s
    by Philip Gleason & Carol Suitor
  • 2001 Food Stamp Leavers in Illinois: How Are They Doing Two Years Later?
    by Anu Rangarajan & Philip M. Gleason
  • 2001 Energy and Fat Intakes of Children and Adolescents in the United States: Data from the National Health and Nutrition Examination Surveys
    by Richard P. Troiano & Ronette R. Briefel & Margaret D. Carroll & Karil Bialostosky
  • 2001 Reaching Those in Need: State Food Stamp Participation Rates in 1998
    by Allen L. Schirm
  • 2001 The Effects of Welfare Reform on the Characteristics of the Food Stamp Population
    by Phil Gleason & Carole Trippe & Scott Cody & Jacquie Anderson
  • 2001 Changes in Children's Diets: 1989-1991 to 1994-1996
    by Philip Gleason & Carol Suitor
  • 2001 Children's Diets in the Mid-1990s: Dietary Intake and Its Relationship with School Meal Participation
    by Philip Gleason & Carol Suitor
  • 2001 An Econometric Analysis of the Mental-Health Effects of Major Events in the Life of Elderly Individuals
    by Lindeboom, Maarten & Portrait, France & van den Berg, Gerard J.
  • 2001 An Econometric Analysis of the Mental-Health Effects of Major Events in the Life of Elderly Individuals
    by Lindeboom, Maarten & Portrait, France & van den Berg, Gerard J.
  • 2001 Exploring the Economic and Social Determinants of Psychological and Psychosocial Health
    by Shields, Michael A. & Wheatley Price, Stephen
  • 2001 Exploring the Economic and Social Determinants of Psychological and Psychosocial Health
    by Shields, Michael A. & Wheatley Price, Stephen
  • 2001 Delivery complications and determinants of caesarean section rates in India: An analysis of national family health surveys, 1992-93
    by U.S. Mishra & Mala Ramanathan
  • 2001 Differential mortality in the UK
    by Orazio Attanasio & Carl Emmerson
  • 2001 Purchasing Health Care Services from Providers with Unknown Altruism
    by Billy Jack
  • 2001 Consumption expenditure on Health and Education: Econometric models and evolution of OECD countries 1970-96
    by Guisan, M.C. & Arranz, M.
  • 2001 Economie et santé : où en est la Russie ?
    by Peaucelle, Irina
  • 2001 A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy
    by George Dranitsaris & Pauline Leung & Renoto Ciotti & Ana Ortega & Maria Spinthouri & Lycurgus Liaropoulos & Roberto Labianca & Antonello Quadri
  • 2001 The Cost of Palliative Care for Hepatocellular Carcinoma in Hong Kong
    by Anthony T.C. Chan & Philip Jacobs & Winnie Yeo & Maria Lai & Clarke B. Hazlett & Tony S.K. Mok & Thomas W.T. Leung & Wan Y. Lau & Philip J. Johnson
  • 2001 The Economics of HIV Vaccines: Projecting the Impact of HIV Vaccination of Infants in Sub-Saharan Africa
    by Jasper M. Bos & Maarten J. Postma
  • 2001 Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke: A Canadian Healthcare Perspective
    by Shannon E. Sinclair & Luciana Frighetto & Peter S. Loewen & Rubina Sunderji & Philip Teal & Susan C. Fagan & Carlo A. Marra
  • 2001 Different Approaches To Valuing the Lost Productivity of Patients with Migraine
    by Jennifer H. Lofland & Julie C. Locklear & Kevin D. Frick
  • 2001 Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in Sweden: Analysis Using Data from the Cardiac Insufficiency Bisoprolol Study II Trial
    by Mattias Ekman & Niklas Zethraeus & Bengt Jonsson
  • 2001 Impact of Allergic Rhinitis Treatment on Quality of Life
    by Anju Tripathi & Roy Patterson
  • 2001 Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan
    by Takuro Shimbo & Kenji Hira & Manabu Takemura & Tsuguya Fukui
  • 2001 Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma
    by Rogelio Menendez & Richard H. Stanford & Lisa Edwards & Christopher Kalberg & Kathleen Rickard
  • 2001 Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer
    by Sabrina Trippoli & Monica Vaiani & Carlo Lucioni & Andrea Messori
  • 2001 Incremental Cost Analysis of Ambulatory Clinic and Home-Based Intravenous Therapy for Patients with Multiple Myeloma
    by Peter C. Coyte & Mark J. Dobrow & Larry Broadfield
  • 2001 Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC(R)) Use of tradenames is for product identification only and does not imply endorsement. for Helicobacter pylori Eradication
    by Karen Agro & Gordon Blackhouse & Ron Goeree & Andrew R. Willan & Jia-Qing Huang & Richard H. Hunt & Bernie J. O'Brien
  • 2001 The Cost Effectiveness of Stratified Care in the Management of Migraine
    by Paul Williams & Andrew J. Dowson & Alan M. Rapoport & James Sawyer
  • 2001 A Review of the Direct Costs of Rheumatoid Arthritis: Managed Care versus Fee-for-Service Settings
    by Deborah P. Lubeck
  • 2001 The Impact of Health Economics on Healthcare Delivery: The Health Economists' Perspective
    by Ruth McDonald & Alan Haycox & Tom Walley
  • 2001 Pharmacoeconomic Fellowships: The Need for Outcome Measures
    by Vittorio Maio & Tammy K. Girts & Jennifer H. Lofland & David B. Nash
  • 2001 Iatrogenic Cost Factors Incorporating Mild and Moderate Adverse Events in the Economic Comparison of Aceclofenac and Other NSAIDs
    by Francesc Peris & Eduard Martinez & Xavier Badia & Max Brosa
  • 2001 Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
    by Ola Ghatnekar & Ulf Persson & Michael Willis & Knut Odegaard
  • 2001 Emerging Role of Pharmacoeconomics in the Research and Development Decision-Making Process
    by Joseph A. Dimasi & Erol Caglarcan & Maria Wood-Armany
  • 2001 Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson's Disease
    by Linda M. Rubenstein & Andrea DeLeo & Elizabeth A. Chrischilles
  • 2001 A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs
    by Sherine E. Gabriel & Douglas Coyle & Larry W. Moreland
  • 2001 Highly Active Antiretroviral Therapy: Pharmacoeconomic Issues in the Management of HIV Infection
    by Pedram Sendi & Andrew J. Palmer & Amiram Gafni & Manuel Battegay
  • 2001 Torasemide: A Pharmacoeconomic Review of its Use in Chronic Heart Failure
    by Melissa Young & Greg L. Plosker
  • 2001 International Validation of the CLAU-S Quality-of-Life Questionnaire for Use in Patients with Intermittent Claudication
    by Patrick Marquis & Sylvie Comte & Philippe Lehert
  • 2001 An Epidemiological Approach to Assess the Economic Burden of NSAID-Induced Gastrointestinal Events in The Netherlands
    by Ronald M.C. Herings & Olaf H. Klungel
  • 2001 Quality of Life in Irritable Bowel Syndrome
    by Richard Lea & Peter J. Whorwell
  • 2001 An Economic Overview of Chronic Obstructive Pulmonary Disease
    by Hirsch S. Ruchlin & Erik J. Dasbach
  • 2001 Developing Guidance for Budget Impact Analysis
    by Paul Trueman & Michael Drummond & John Hutton
  • 2001 The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis
    by Leona Hakkaart-van Roijen & Paul Verboom & W. Ken Redekop & Karien R. Touw & Frans F.H. Rutten
  • 2001 Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery
    by Lars-Ake Levin & David Bergqvist
  • 2001 Gastrointestinal-Related Healthcare Resource Usage Associated with a Fixed Combination of Diclofenac and Misoprostol versus Other NSAIDs
    by Elham Rahme & Lawrence Joseph & Sheldon X. Kong & Douglas J. Watson & James M. Pellissier & Jacques LeLorier
  • 2001 Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women: Use of Cochrane Collaboration Methods for Meta-Analysis Within Economic Evaluation
    by Douglas Coyle & Ann Cranney & Karen M. Lee & Vivian Welch & Peter Tugwell
  • 2001 Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada
    by Michael Iskedjian & Thomas R. Einarson & Bernie J. O'Brien & J. Gaston De Serres & Ron Gold & Ian M. Gemmill & Natalie Milkovich & Andrew Rosner
  • 2001 Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS
    by Todd A. Lee & Sean D. Sullivan & David L. Veenstra & Scott D. Ramsey & Patrick J.K. Steger & Raffaele Malinverni & Andreas M. Pleil & Todd Williamson
  • 2001 Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients
    by Petra J. van Enckevort & Jan H. Zwaveling & Jan T. Bottema & John K. Maring & Ids J. Klompmaker & Maarten J.H. Slooff & Elisabeth M. Ten Vergert
  • 2001 The Cost of Inadequate Prescriptions for Hypolipidaemic Drugs
    by Luisa Cabello Ballesteros & M. Isabel Fernandez San Martin & Teresa Sanz Cuesta & Esperanza Escortell Mayor & Carmen Lopez Bilbao
  • 2001 Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance
    by Peter K. Schadlich & Josef Georg Brecht & Massimo Brunetti & Eva Pagano & Badrudin Rangoonwala & Eduard Huppertz
  • 2001 The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
    by Charles E. Begley & John F. Annegers & Alan C. Swann & Christopher Lewis & Sharon Coan & William B. Schnapp & Lynda Bryant-Comstock
  • 2001 Cost Considerations in the Use of Anaesthetic Drugs
    by Ian Smith
  • 2001 Hip Fracture Prevention: Cost-Effective Strategies
    by Peter Vestergaard & Lars Rejnmark & Leif Mosekilde
  • 2001 Lifestyle Drugs: Determining Their Value and Who Should Pay
    by Devora Mitrany
  • 2001 Efavirenz: A Pharmacoeconomic Review of its Use in HIV Infection
    by Greg L. Plosker & Caroline M. Perry & Karen L. Goa
  • 2001 Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction: Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial
    by Maria Grazia Franzosi & Massimo Brunetti & Roberto Marchioli & Rosa Maria Marfisi & Gianni Tognoni & Franco Valagussa
  • 2001 Cost Effectiveness of Continuous Terbinafine Compared with Intermittent Itraconazole in the Treatment of Dermatophyte Toenail Onychomycosis: An Analysis Based on Results from the L.I.ON. Study
    by Ronald Jansen & W. Ken Redekop & Frans F.H. Rutten
  • 2001 Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines
    by M. Rhona M.T. Limcangco & Carol L. Armour & Eugene G. Salole & Susan J. Taylor
  • 2001 The Cost of Treatment of Alzheimer's Disease in The Netherlands: A Regression-Based Simulation Model
    by Joseph McDonnell & W. Ken Redekop & Nicole van der Roer & Elles Goes & Annemieke Ruitenberg & Jan J.V. Busschbach & Monique M.B. Breteler & Frans F.H. Rutten
  • 2001 Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements
    by Alan Woodfield
  • 2001 Symptom and Health-Related Quality-of-Life Measures for Use in Selected Gastrointestinal Disease Studies: A Review and Synthesis of the Literature
    by Anne M. Rentz & Carmelina Battista & Elyse Trudeau & Robert Jones & Patricia Robinson & Sheldon Sloan & Sonika Mathur & Lori Frank & Dennis A. Revicki
  • 2001 Pharmacoeconomics of Hypertension Management: The Place of Combination Therapy
    by Ettore Ambrosioni
  • 2001 On Individual Preferences and Aggregation in Economic Evaluation in Healthcare
    by Bengt Liljas & Bjorn Lindgren
  • 2001 Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
    by Harriet M. Lamb & Karen L. Goa
  • 2001 Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
    by Adrian D. Griffin & Andrew S. Perry & Douglas M. Fleming
  • 2001 Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel
    by Gabriel Chodick & Yehuda Lerman & Tamar Peled & Hava Aloni & Shai Ashkenazi
  • 2001 Cost of Treatment for Onychomycosis: Data from a 9-Month Observational Study
    by David M. Stier & Curt Henke & Jeff Schein & Joe Doyle & Warren H. Schonfeld & Jeanette Broering
  • 2001 Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
    by Carlos Gouveia Pinto & Antoine Lafuma & Francis Fagnani & Mark J.C. Nuijten & Gilles Berdeaux
  • 2001 Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options
    by Mitchell Friedman & Daniel E. Hilleman
  • 2001 Workplace Productivity: A Review of the Impact of Migraine and its Treatment
    by Paul Stang & Roger Cady & Alice Batenhorst & Lynn Hoffman
  • 2001 Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies
    by Peter Cram & Susan G. Blitz & Arnold Monto & A. Mark Fendrick
  • 2001 Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands
    by Maarten J. Postma & Marielouise A. Heijnen & Johannes C. Jager
  • 2001 Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making
    by Bernard S. Bloom & Douglas J. Bruno & Daniel Y. Maman & Ravi Jayadevappa
  • 2001 The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
    by William C. Gerth & George W. Carides & Erik J. Dasbach & W. Hester Visser & Nancy C. Santanello
  • 2001 Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval
    by Giovanni Apolone & Gianfranco De Carli & Massimo Brunetti & Silvio Garattini
  • 2001 A Review of Health-Related Quality-of-Life Measures in Stroke
    by Beatrice A. Golomb & Barbara G. Vickrey & Ron D. Hays
  • 2001 Changing Therapeutic Regimens in Benign Prostatic Hyperplasia: Clinical and Economic Considerations
    by Herman J. Stoevelaar & Joseph McDonnell
  • 2001 Quality-of-Life Assessment in Comparative Therapeutic Trials and Causal Structure Considerations in Peripheral Occlusive Arterial Disease
    by Philippe Lehert
  • 2001 Direct-to-Consumer Promotion of Prescription Drugs: Economic Implications for Patients, Payers and Providers
    by Steven D. Findlay
  • 2001 Economic Analysis of Initial HIV Treatment: Efavirenz- versus Indinavir-Containing Triple Therapy
    by J. Jaime Caro & Judith A. O'Brien & Kristen Migliaccio-Walle & Gabriel Raggio
  • 2001 Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection
    by Eva Susanne Dietrich & Bjorn Schubert & Winfried Ebner & Franz Daschner
  • 2001 A General Model of the Effects of Sleep Medications on the Risk and Cost of Motor Vehicle Accidents and its Application to France
    by Joseph Menzin & Kathleen M. Lang & Pierre Levy & Emile Levy
  • 2001 Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis
    by Ermanno Attanasio & Pierluigi Russo & Gabriella Carunchio & Luciano Caprino
  • 2001 Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications
    by William B. Hillegass & Anne R. Newman & Dominic L. Raco
  • 2001 Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies
    by T.V. Parasuraman & Kathleen Frenia & Jose Romero
  • 2001 The Cost of HIV Treatment and Care: A Global Review
    by Eduard J. Beck & Alec H. Miners & Keith Tolley
  • 2001 Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer
    by Melissa Young & Greg L. Plosker
  • 2001 Direct Costs of Schizophrenia in Italian Community Psychiatric Services
    by Livio Garattini & Carlotta Rossi & Fabrizio Tediosi & Cesare Cornaggia & Giampiero Covelli & Corrado Barbui & Fabio Parazzini
  • 2001 Economic Evaluation of Collagenase-Containing Ointment and Hydrocolloid Dressing in the Treatment of Pressure Ulcers
    by Elvira Muller & Martin W.F. van Leen & Rito Bergemann
  • 2001 Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS
    by John H. Kempen & Kevin D. Frick & Douglas A. Jabs
  • 2001 Accounting for Noncompliance in Pharmacoeconomic Evaluations
    by Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley
  • 2001 Piperacillin/Tazobactam: A Pharmacoeconomic Review of its Use in Moderate to Severe Bacterial Infections
    by Melissa Young & Greg L. Plosker
  • 2001 Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer
    by Greg L. Plosker & Miriam Hurst
  • 2001 Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996)
    by Bethan George & Anthony Harris & Andrew Mitchell
  • 2001 Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK
    by Ruth E. Brown & John Hutton & Anita Burrell
  • 2001 Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia: Effects of Various Interventions
    by Jose-Emilio Batista-Miranda & Marta De la Cruz Diez & Pedro Arano Bertran & Humberto Villavicencio
  • 2001 Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?
    by Dyfrig A. Hughes & Tom Walley
  • 2001 Which Antifungal Agent for Onychomycosis?: A Pharmacoeconomic Analysis
    by Vijay N. Joish & Edward P. Armstrong
  • 2001 Formulary Restriction of Selective Serotonin Reuptake Inhibitors for Depression: Potential Pitfalls
    by Paula L. Hensley & H. George Nurnberg
  • 2001 A Cost-Cost Study Comparing Etanercept with Infliximab in Rheumatoid Arthritis
    by Mark J.C. Nuijten & Peter Engelfriet & Klaas Duijn & George Bruijn & David Wierz & Marc Koopmanschap
  • 2001 Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis: Ontario Ministry of Health Perspective
    by John K. Marshall & James M. Pellissier & Cheryl L. Attard & Sheldon X. Kong & Michael A. Marentette
  • 2001 Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson's Disease: Impact of Motor Fluctuations and Dyskinesias
    by Richard C. Dodel & Karin Berger & Wolfgang H. Oertel
  • 2001 Barrett's Oesophagus: A Review of Costs of the Illness
    by Miguel R. Arguedas & Mohamad A. Eloubeidi
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Combining Utility Measurements: Exploring Different Approaches
    by Denise E. Bonds & Kenneth A. Freedberg
  • 2001 Management of Pharmaceutical Resources for the Primary Prevention of Coronary Heart Disease in Catalonia (Spain) Based on Efficiency and Equity
    by Pedro Plans-Rubio
  • 2001 Measuring and Managing Health Outcomes and Quality of Care in End-Stage Renal Disease
    by Kraig S. Kinchen & Neil R. Powe
  • 2001 Improving Quality of Life for Patients with Angina Pectoris: A Team Approach to Disease Management
    by Margaret E. Cupples & Martin Dempster
  • 2001 Improving the Use of Data Sources in Disease Management Programs
    by Jacob Abarca & Edward P. Armstrong
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Healthcare Reform and Disease Management in Italy: Promoting the Effectiveness and Appropriateness of Health Service Use
    by Roberto Grilli & Andrea Donatini & Francesco Taroni
  • 2001 Disease Management Programs for Hepatitis C: A Team Approach to Setting Goals
    by Raymond S. Koff
  • 2001 Effective Employer-Vendor Partnerships: Encouraging Positive Disruptive Innovations in Healthcare
    by Julie A. Meek & Vince Kuraitis
  • 2001 Patient-Centered Healthcare: The Role of the Internet
    by Dixie B. Baker
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Advanced Breast Cancer: Defining the Role of Anastrozole
    by Gillian M. Keating & Karen L. Goa
  • 2001 Hepatitis C Screening and Treatment versus Liver Transplantation: A Financial Option Appraisal and Commissioning Model for Purchasers
    by Nevil Batra
  • 2001 Implementation of Guidelines for Diagnosing and Treating Hypertension
    by Finlay A. McAlister & Raj Padwal
  • 2001 Disability Prevention: New Paradigm for the Management of Occupational Back Pain
    by Patrick Loisel & Marie-Jose Durand & Diane Berthelette & Nicole Vezina & Raymond Baril & Denis Gagnon & Christian Lariviere & Claude Tremblay
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Shared Care Versus Secondary Outpatient Care in The Netherlands
    by Raymond C.W. Hutubessy & Hindrik Vondeling & Jeroen J.J. de Sonnaville & Louisa P. Colly & Jan L..J. Smit & Robert J. Heine
  • 2001 Improved Bone Health Behavior Using Community Pharmacists as Educators: The Geisinger Health System Community Pharmacist Osteoporosis Education Program
    by Eric D. Newman & Philip Hanus
  • 2001 Early Recognition and Intervention: The Key to Success in the Treatment of Schizophrenia?
    by Jan Olav Johannessen
  • 2001 Neonatal Care Management: An Integrated Approach
    by Michael N. Musci & John J. Esslinger & Michael Kornhauser
  • 2001 Sickle Cell Disease Screening Programs: Integration Into Managed Care
    by Sally C. Davies & Lola Oni
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Colorectal Cancer: Defining the Role of Raltitrexed
    by Anna J. Matheson & Stuart Noble
  • 2001 Analysis of Antidepressant Use Through Hierarchical Disease Analysis: Using a Managed Care Administrative Database
    by Edward P. Armstrong
  • 2001 The National Lung Health Education Program and Managed Care: The Importance of Early Identification and Intervention in Chronic Obstructive Pulmonary Disease
    by Thomas L. Petty
  • 2001 The Internet as a Resource for Consumer Healthcare
    by Deborah Lewis & Kimberly Behana
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Chronic Hepatitis B: Defining the Role of Lamivudine
    by Blair Jarvis & Caroline M. Perry
  • 2001 Risperidone, Haloperidol and Clozapine in the South Carolina Medicaid Program: A Comparative Analysis of Utilisation and Expenditure
    by Kenneth M. Shermock & M. Kay Sadik & Chris M. Kozma & Anne-Marie Sesti & C.E. Reeder
  • 2001 The Role of the Patient in Maximizing Efficacy of Drug Therapy in Migraine
    by William Pryse-Phillips
  • 2001 Maximizing Treatment Outcome in Depression: Strategies to Overcome Social Stigma and Noncompliance
    by Glen L. Stimmel
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Analysis of Asthma-Related Costs and Patterns of Resource Utilization in a Managed-Care Population
    by Edward P. Armstrong & Kem Krueger & Paul C. Langley
  • 2001 Assertive Community Treatment for People with Severe Mental Illness: Critical Ingredients and Impact on Patients
    by Gary R. Bond & Robert E. Drake & Kim T. Mueser & Eric Latimer
  • 2001 Utilizing and Integrating the Internet in Disease Management
    by Marybeth Regan
  • 2001 Managing Patients with Diabetes Mellitus and Mental Health Problems: Administrative and Clinical Challenges
    by Barbara H. Warren & Cynthia K. Crews & Martina M. Schulte
  • 2001 Role of the Workplace in Migraine Disease Management
    by Leon J. Warshaw & Wayne N. Burton & William J. Schneider
  • 2001 Behavioral Aspects of Arthritis and Rheumatic Disease Self-Management
    by Julie J. Keysor & Shannon S. Currey & Leigh F. Callahan
  • 2001 Training Issues in the Use of Inhalers
    by Martin Duerden & David Price
  • 2001 Pharmaceutical Restrictions: Possible Effect on Patient/Physician Buy-In of Disease Management Programs
    by C. Daniel Mullins & Simu K. Thomas & David S. Roffman
  • 2001 Community-Acquired Pneumonia and its Management: The Role of Levofloxacin
    by Caroline M. Perry & Karen L. Goa
  • 2001 Trends in the Rate of Self-Report and Diagnosis of Erectile Dysfunction in the United States 1990-1998: Was the Introduction of Sildenafil an Influencing Factor?
    by Tracy L. Skaer & David A. Sclar & Linda M. Robison & Richard S. Galin
  • 2001 Cost Effectiveness of Antibacterial Restriction Strategies in a Tertiary Care University Teaching Hospital
    by Caterina Tsiata & Vassilis Tsekouras & Antonis Karokis & John Starakis & Harry P. Bassaris & Mihalis Maragoudakis & Athanasios T. Skoutelis
  • 2001 Health Utility Attributes for Chronic Conditions
    by Nicole Mittmann & Derek Chan & Kostas Trakas & Nancy Risebrough
  • 2001 Data Warehousing Solutions and Internet Initiatives in the Disease Management Era: Important Issues to Consider
    by Alejandro Jaramillo
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Management of Diabetes Mellitus: Defining the Role of Insulin Lispro Mix75/25 (Humalog(R) Mix75/25(TM))
    by Christine R. Culy & Blair Jarvis
  • 2001 Increased National Cholesterol Education Program (NCEP) Goal Attainment: Outcome Assessment of Department of Defense Conversion to Cerivastatin and Simvastatin
    by Dennis Beaudoin & Emery Spaar & Susan Pitman Lowenthal & Karen C. Chung
  • 2001 Primary Care Clinic-Based Chronic Disease Care: Features of Successful Programs
    by Patrick J. O'Connor & JoAnn M. Sperl-Hillen & Nicolaas P. Pronk & Terry Murray
  • 2001 Optimizing the Delivery of Effective Diabetes Care: An English Perspective
    by Abdu Mohiddin & Martin Gulliford
  • 2001 Health Plans and Disease Management: Threats and Opportunities
    by Karen Ignagni
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Cost and Cost Effectiveness of Venous and Pressure Ulcer Protocols of Care
    by Morris D. Kerstein & Eric Gemmen & Lia van Rijswijk & Courtney H. Lyder & Tania Phillips & George Xakellis & Katharine Golden & Catherine Harrington
  • 2001 Unique Co-Operative Worksite-Based Osteoporosis Project: Employer, Healthcare Plan and Pharmaceutical Company Combine Efforts to Screen and Manage Women at Risk
    by Larry K. Cantley & Cheryl Summers & David E. Rice
  • 2001 Treatment Expectations in Hypertension: Implications for Patients Enrolled in Disease Management Programs
    by Debbie Cohen & Raymond Townsend & Mark Miani & David Bernard
  • 2001 A Fully Integrated Clinical Information System to Support Management of End-Stage Renal Disease: Design and Implementation
    by William D. Mattern & Sue Scott
  • 2001 The Role of Mental Health Patient Organizations in Disease Management: Focus on the US National Depressive and Manic-Depressive Association
    by Lydia Lewis
  • 2001 This Month's News
    by Adis International Limited
  • 2001 Chronic Obstructive Pulmonary Disease in a Managed-Care Setting
    by Steven Kesten
  • 2001 Technology-Based Disease Management: A Low-Cost, High-Value Solution for the Management of Chronic Disease
    by Wally H. Gomaa & Thomas Morrow & Pieter Muntendam
  • 2001 Comparing Smoking Cessation Interventions for Work-Site Disease Management
    by Todd Greenwood
  • 2001 Implementing Change: It's as Hard as it Looks
    by Caren Heller & Ahsan Arozullah
  • 2001 Work Productivity in Psychiatry: Trends in Interventions and Outcomes
    by Pamela L. Moriearty & Eugene Oulvey & Karen Lee
  • 2001 Specialty Pharmacies: Filling a Unique Position in the Disease Management Industry
    by Thomas Morrow
  • 2001 Broad Disease Management Interventions: Reducing Health Care Costs for Plan Members with Congestive Heart Failure
    by Joel C. Hoffman
  • 2001 Testing the descriptive performance of the rank-dependent utility in the domain of health profiles
    by José M. Abellán Perpiñán & José Luis Pinto Prades
  • 2001 The impact of health on wages: Evidence from the British Household Panel Survey
    by (*), Nigel Rice & Paul Contoyannis
  • 2001 Expenditure on healthcare in the UK: a review of the issues
    by Carol Propper
  • 2001 Private insurance subsidies and public health care markets: evidence from Canada
    by Mark Stabile
  • 2001 Do stricter penalties deter drinking and driving? An empirical investigation of Canadian impaired driving laws
    by Anindya Sen
  • 2000 Aids Home and Community-Based Waivers: Effects on Use of Services, Expeditures and Survival
    by Kathryn Anderson & Jean Mitchell
  • 2000 Determinants of Human Resource Development: an empirical analysis
    by Hasan, Zubair
  • 2000 Managed Care and Technology Adoption in Health Care: Evidence from Magnetic Resonance Imaging
    by Laurence C. Baker
  • 2000 Understanding Mid-Life and Older Age Mortality Declines: Evidence from Union Army Veterans
    by Dora L. Costa
  • 2000 Estimating the Effects of Covariates on Health Expenditures
    by Donna B. Gilleskie & Thomas A. Mroz
  • 2000 How Do Doctors Behave When Some (But Not All) of Their Patients are in Managed Care?
    by Sherry Glied & Joshua Zivin
  • 2000 Live Long, Live Well: Quantifying the Health of Heterogenous Populations
    by John Mullahy
  • 2000 Managed Care, Technology Adoption, and Health Care: The Adoption of Neonatal Intensive Care
    by Laurence C. Baker & Ciaran S. Phibbs
  • 2000 Body Weight and Women's Labor Market Outcomes
    by John Cawley
  • 2000 The Behavioral Dynamics of Youth Smoking
    by Donna B. Gilleskie & Koleman S. Strumpf
  • 2000 Enrollee Mix, Treatment Intensity, and Cost in Competing Indemnity and HMO Plans
    by Daniel Altman & David M. Cutler & Richard Zeckhauser
  • 2000 Medicaid
    by Jonathan Gruber
  • 2000 The Economic Impacts of the Tobacco Settlement
    by David M. Cutler & Jonathan Gruber & Raymond S. Hartman & M.B. Landrum, J. Newhouse & Meredith B. Rosenthal
  • 2000 The Boskin Commission Report and its Aftermath
    by Robert J. Gordon
  • 2000 Alcohol Consumption and Alcohol Advertising Bans
    by Henry Saffer
  • 2000 How Good a Deal Was the Tobacco Settlement?: Assessing Payments to Massachusetts
    by David M. Cutler & Arnold M. Epstein & Richard G. Frank & Raymond Hartman & Charles King III & Joseph P. Newhouse & Meredith B. Rosenthal & Elizabeth Richardson Vigdor
  • 2000 Financial Crisis, Health Outcomes and Aging: Mexico in the 1980s and 1990s
    by David M. Cutler & Felicia Knaul & Rafael Lozano & Oscar Mendez & Beatriz Zurita
  • 2000 Mothers and Others: Who Invests in Children's Health?
    by Anne Case & Christina Paxson
  • 2000 The Demand for Medical Care in Urban China
    by H. Naci Mocan & Erdal Tekin & Jeffrey S. Zax
  • 2000 Dietary Reference Intakes: Applications in Dietary Assessment
    by Subcommittee on Interpretation & Uses of Dietary Reference Intakes & of which Barbara Devaney was a member & the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes
  • 2000 Trends in Food Stamp Program Participation Rates: Focus on 1994 to 1998
    by Laura Castner
  • 2000 Study of Direct Certification in the National School Lunch Program
    by Kenneth Jackson & Phil Gleason & John Hall & Rhonda Straus
  • 2000 Characteristics of Food Stamp Households: Fiscal Year 1999
    by Randy Rosso & Lisa Fowler
  • 2000 Summer Feeding Design Study. Vol. III: Survey Instruments
    by Mathematica Policy Research
  • 2000 Summer Feeding Design Study. Volume II: Feasibility, Design, and Cost of a Participant-Nonparticipant Study
    by Anne Gordon & Michael Sinclair & Laura Kalb & Fazana Saleem-Ismail & Thomas Godfrey & Stephen Tordella & Priscilla Foran
  • 2000 Summer Feeding Design Study
    by Anne Gordon & Ronette Briefel
  • 2000 Summer Feeding Design Study. Volume I: Design and Costs for Program Component
    by Ronette Briefel & Michael Sinclair & Laura Kalb & Anne Gordon & Fazana Saleem-Ismail & Martha Kovac
  • 2000 Characteristics of Food Stamp Households: Fiscal Year 1999
    by Randy Rosso & Catherine Palermo
  • 2000 Reaching Those in Need: Food Stamp Participation Rates in the States
    by Allen L. Schirm
  • 2000 Characteristics of Food Stamp Households, Fiscal Year 1998
    by Laura Castner & Randy Rosso
  • 2000 Access to and Participation in Medicaid and the Food Stamp Program: A Review of the Recent Literature
    by M. Robin Dion & LaDonna Pavetti
  • 2000 Dietary Intake and Dietary Attitudes Among Food Stamp Participants and Other Low-Income Individuals
    by Philip Gleason & Anu Rangarajan & Christine Olson
  • 2000 Dépenses des ménages, développement humain et pauvreté au Burkina Faso : substitution ou complémentarité ?
    by Jean-Pierre Lachaud
  • 2000 Quality incentives under a capitation regime: the role of patient expectations
    by Giuliano Masiero & Hugh Gravelle
  • 2000 Chronic Illness and Health Insurance-Related Job Lock
    by Kevin T. Stroupe & Eleanor D. Kinney & Thomas J. Kniesner
  • 2000 Estimer la relation entre invalidité et emploi dans le cas de Madagascar
    by Jean-Christophe Dumont
  • 2000 Estimer la relation entre invalidité et emploi dans le cas de Madagascar
    by Dumont, Jean-Christophe
  • 2000 The anatomy of health insurance
    by Cutler, David M. & Zeckhauser, Richard J.
  • 2000 Equity in health
    by Williams, Alan & Cookson, Richard
  • 2000 Chapter 34 Equity in health care finance and delivery
    by Wagstaff, Adam & van Doorslaer, Eddy
  • 2000 Economic epidemiology and infectious diseases
    by Philipson, Tomas
  • 2000 The measurement of health-related quality of life for use in resource allocation decisions in health care
    by Dolan, Paul
  • 2000 Prevention
    by Kenkel, Donald S.
  • 2000 Alcohol
    by Cook, Philip J. & Moore, Michael J.
  • 2000 The economics of smoking
    by Chaloupka, Frank J. & Warner, Kenneth E.
  • 2000 Regulation of prices and investment in hospitals in the United States
    by Salkever, David S.
  • 2000 Antitrust and competition in health care markets
    by Gaynor, Martin & Vogt, William B.
  • 2000 Liability for medical malpractice
    by Danzon, Patricia M.
  • 2000 The pharmaceutical industry
    by Scherer, F.M.
  • 2000 Economics of dental services
    by Sintonen, Harri & Linnosmaa, Ismo
  • 2000 Waiting lists and medical treatment: Analysis and policies
    by Cullis, John G. & Jones, Philip R. & Propper, Carol
  • 2000 Economics of general practice
    by Scott, Anthony
  • 2000 Not-for-profit ownership and hospital behavior
    by Sloan, Frank A.
  • 2000 The industrial organization of health care markets
    by Dranove, David & Satterthwaite, Mark A.
  • 2000 Child health in developed countries
    by Currie, Janet
  • 2000 The economics of disability and disability policy
    by Haveman, Robert & Wolfe, Barbara
  • 2000 Long-term care
    by Norton, Edward C.
  • 2000 Economics and mental health
    by Frank, Richard G. & McGuire, Thomas G.
  • 2000 Government purchasing of health services
    by Chalkley, Martin & Malcomson, James M.
  • 2000 Risk adjustment in competitive health plan markets
    by Van de ven, Wynand P.M.M. & Ellis, Randall P.
  • 2000 Managed care
    by Glied, Sherry
  • 2000 Health insurance and the labor market
    by Gruber, Jonathan
  • 2000 Insurance reimbursement
    by Pauly, Mark V.
  • 2000 Physician agency
    by McGuire, Thomas G.
  • 2000 Moral hazard and consumer incentives in health care
    by Zweifel, Peter & Manning, Willard G.
  • 2000 The human capital model
    by Grossman, Michael
  • 2000 Health econometrics
    by Jones, Andrew M.
  • 2000 Information diffusion and best practice adoption
    by Phelps, Charles E.
  • 2000 Advances in cost-effectiveness analysis of health interventions
    by Garber, Alan M.
  • 2000 Medical care prices and output
    by Berndt, Ernst R. & Cutler, David M. & Frank, Richard G. & Griliches, Zvi & Newhouse, Joseph P. & Triplett, Jack E.
  • 2000 An overview of the normative economics of the health sector
    by Hurley, Jeremiah
  • 2000 International comparisons of health expenditure: Theory, data and econometric analysis
    by Gerdtham, Ulf-G. & Jonsson, Bengt
  • 2000 Handbook of Health Economics
    by
  • 2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
    by A. Brett Hauber & Josephine A. Mauskopf & Edward H. Snyder
  • 2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
    by Karen W. Linkins & John R. Lloyd & Gregory O. Hjelmstad & Holly J. Strausbaugh
  • 2000 Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
    by Anthony Markham & Julie C. Adkins
  • 2000 Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention: A 2-Stage Econometric Model in a Naturalistic Setting
    by Maureen J. Lage & Beth L. Barber & Mohan Bala & Patrick L. McCollam & Daniel E. Ball
  • 2000 Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia
    by Eric T. Edgell & Scott W. Andersen & Bryan M. Johnstone & Brian Dulisse & Dennis Revicki & Alan Breier
  • 2000 Effectiveness of Eletriptan in Reducing Time Loss Caused by Migraine Attacks
    by Nicholas E.J. Wells & Timothy J. Steiner
  • 2000 Stratified Administration of Serotonin 5-HT3 Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications
    by Lisa A. Sanchez & Mark Holdsworth & Sylvia B. Bartel
  • 2000 The Single Market for Pharmaceuticals in the European Union in Light of European Court of Justice Rulings
    by Panos Kanavos
  • 2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
    by Ceri J. Phillips
  • 2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
    by Pekka Rissanen
  • 2000 Inhaled Fluticasone Propionate: A Pharmacoeconomic Review of its Use in the Management of Asthma
    by Harriet M. Lamb & Christine R. Culy & Diana Faulds
  • 2000 Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy: In the Management of Postmenopausal Women with Climacteric Symptoms in the UK
    by Jonathan M. Plumb & Julian F. Guest
  • 2000 Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol: In the Treatment of Mild to Moderate Plaque Psoriasis
    by Darren M. Ashcroft & Alain Li Wan Po & Hywel C. Williams & Christopher E.M. Griffiths
  • 2000 Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy: A Randomised Trial of the Effect of Education and a Professional Allowance
    by Shalom I. Benrimoj & Jane H. Langford & Geoffrey Berry & David Collins & Roberta Lauchlan & Kay Stewart & Michael Aristides & Matthew Dobson
  • 2000 Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) Programme: A Canadian Teaching Hospital and Ministry of Health Perspective
    by Amy O. Wai & Luciana Frighetto & Carlo A. Marra & Emily Chan & Peter J. Jewesson
  • 2000 Health-Related Quality-of-Life Measurement in Hypertension: A Review of Randomised Controlled Drug Trials
    by Isabelle Cote & Jean-Pierre Gregoire & Jocelyne Moisan
  • 2000 HIV-1 Drug Resistance Genotyping: A Review of Clinical and Economic Issues
    by Carine Chaix-Couturier & Christopher Holtzer & Kathryn A. Phillips & Isabelle Durand-Zaleski & John Stansell
  • 2000 The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research: How Meaningful is it?
    by Ron D. Hays & J. Michael Woolley
  • 2000 Cocaine Medications, Cocaine Consumption and Societal Costs
    by William S. Cartwright
  • 2000 The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS
    by Aslam H. Anis & Daphne Guh & Robert S. Hogg & Xiao-Hua Wang & Benita Yip & Kevin J.P. Craib & Michael V. O'Shaughnessy & Martin T. Schechter & Julio S.G. Montaner
  • 2000 Cost Effectiveness of Acute Imipramine Therapy versus Two Imipramine Maintenance Treatment Regimens for Panic Disorder
    by Matig R. Mavissakalian & Jordana K. Schmier & Jennifer A. Flynn & Dennis A. Revicki
  • 2000 Cost Effectiveness of Cephalosporin Monotherapy and Aminoglycoside/ Ureidopenicillin Combination Therapy: For the Treatment of Febrile Episodes in Neutropenic Patients
    by Joseph A. Paladino & Debra A. Fong & Alan Forrest & Reuben Ramphal
  • 2000 Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers
    by Dewey C. Scheid & Robert M. Hamm & Kevin W. Stevens
  • 2000 Socioeconomic Issues Affecting the Treatment of Obesity in the New Millennium
    by Louis F. Martin & Alex Robinson & Barbara J. Moore
  • 2000 Cost Effectiveness of Therapies for Atrial Fibrillation: A Review
    by Mark P. Teng & Edward Catherwood & Daniel P. Melby
  • 2000 The Impact of Health Economics on Healthcare Delivery: A Primary Care Perspective
    by David P. Kernick
  • 2000 Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus
    by Rachel H. Foster & Greg L. Plosker
  • 2000 The Economic Value of a New Insulin Preparation, Humalog(R) Mix 25(TM): Measured by a Willingness-To-Pay Approach
    by George Dranitsaris & Christopher J. Longo & Loren D. Grossman
  • 2000 Cost Effectiveness of Abciximab During Routine Medical Practice
    by Shelby Ogilvie Reed & C. Daniel Mullins & Laurence S. Magder
  • 2000 Cost Implications for the Use of Inhaled Anti-Inflammatory Medications in the Treatment of Asthma
    by Ronald J. Ozminkowski & Shaohung Wang & William D. Marder & John Azzolini & David Schutt
  • 2000 Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice
    by Josephine A. Mauskopf & Anke Richter & Lieven Annemans & Grant Maclaine
  • 2000 Costs of Deep Foot Infections in Patients with Diabetes Mellitus
    by Gunnel Ragnarson Tennvall & Jan Apelqvist & Magnus Eneroth
  • 2000 The Epidemic of Alzheimer's Disease: How Can We Manage the Costs?
    by Neil Johnson & Tim Davis & Nick Bosanquet
  • 2000 The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs
    by Tracy L. Skaer & David A. Sclar & Linda M. Robison & Richard S. Galin
  • 2000 Antiviral Therapies for Herpes Zoster Infections: Are They Economically Justifiable?
    by Kenneth J. Smith & Mark S. Roberts
  • 2000 Economic Assessment of the Secondary Prevention of Ischaemic Events with Lysine Acetylsalicylate
    by Jean-Pierre Marissal & Bernard Selke & Therese Lebrun
  • 2000 Economic Evaluations of Influenza Vaccination in Healthy Working-Age Adults: Employer and Society Perspective
    by Susan C. Wood & Van Hung Nguyen & Claudia Schmidt
  • 2000 Cost Effectiveness of Epoetin-alpha to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery
    by Douglas Coyle & Karen M. Lee & Dean A. Fergusson & Andreas Laupacis
  • 2000 Differences in Attitudes, Knowledge and Use of Economic Evaluations in Decision-Making in The Netherlands: The Dutch Results from the EUROMET Project
    by Jeannette E.F. Zwart-van Rijkom & Hubertus G.M. Leufkens & Jan J.V. Busschbach & Andre W. Broekmans & Frans F.H. Rutten
  • 2000 Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
    by Hugh Freeman & Steve Arikian & Alan Lenox-Smith
  • 2000 Clinical Trials and the New Good Clinical Practice Guideline in Japan: An Economic Perspective
    by Shunsuke Ono & Yasuo Kodama
  • 2000 Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues
    by Eva Lindstrom & Kerstin Bingefors
  • 2000 Economic Issues in the Prevention of Vertical Transmission of HIV
    by A.E. Ades & Julie Ratcliffe & Diana M. Gibb & Mark J. Sculpher
  • 2000 Economic Evaluation of Enoxaparin Sodium versus Heparin in Unstable Angina: A French Sub-Study of the ESSENCE Trial
    by Bruno Detournay & Xavier Huet & Francois Fagnani & Gilles Montalescot
  • 2000 The Impact of Pituitary Adenoma on Morbidity: Increased Sick Leave and Disability Retirement in a Cross-Sectional Analysis of Swedish National Data
    by Bjorn Jonsson & Bo Nilsson
  • 2000 Health-Related Quality of Life in Asymptomatic Patients with HIV: Evaluation of the SF-36 Health Survey in Italian Patients
    by Fabio Arpinelli & Giovanni Visona & Raffaele Bruno & Gianfranco Decarli & Giovanni Apolone
  • 2000 Using Economic Evaluations to Make Formulary Coverage Decisions: So Much for Guidelines
    by Aslam H. Anis & Yves Gagnon
  • 2000 Long Term Treatment of Multiple Sclerosis with Interferon-beta May Be Cost Effective
    by Malcolm Kendrick & K. Ian Johnson
  • 2000 A Review of Alternative Approaches to Healthcare Resource Allocation
    by Stavros Petrou & Jane Wolstenholme
  • 2000 Social Phobia: Epidemiology and Cost of Illness
    by Joshua D. Lipsitz & Franklin R. Schneier
  • 2000 Introduction to the Pharmacoeconomics of Herbal Medicines
    by Peter A.G.M. De Smet & Gouke Bonsel & Ary Van der Kuy & Yechiel A. Hekster & Marja H. Pronk & Mark J.A. Brorens & Jacques H.M. Lockefeer & Mark J.C. Nuijten
  • 2000 Cost of Illness in Adult Patients with Hypopituitarism
    by Christer Ehrnborg & Leona Hakkaart-Van Roijen & Bjorn Jonsson & Frans F.H. Rutten & Bengt-Ake Bengtsson & Thord Rosen
  • 2000 Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia
    by Josephine A. Mauskopf & Sheryl C. Cates & Adrian D. Griffin & Deirdre M. Neighbors & Sarah C. Lamb & Carolyn Rutherford
  • 2000 Costs for Acute Myocardial Infarction in a Tertiary Care Centre and Nationwide in France
    by Olivier Montagne & Carine Chaix & Alain Harf & Alain Castaigne & Isabelle Durand-Zaleski
  • 2000 Cost-Effectiveness Analysis of Pneumococcal Vaccination of Adults and Elderly Persons in Belgium
    by Diana De Graeve & Geert Lombaert & Herman Goossens
  • 2000 Low-Flow Anaesthesia: Does it have Potential Pharmacoeconomic Consequences?
    by Stefan Suttner & Joachim Boldt
  • 2000 A Critical Review of Published Economic Modelling Studies in Depression
    by Michael T. Jones & Paul C. Cockrum
  • 2000 Expert Judgement in Pharmacoeconomic Studies: Guidance and Future Use
    by Christopher Evans & Bruce Crawford
  • 2000 Disease Management: A Global Cost-Containing Initiative?
    by Karen Bloor & Alan Maynard
  • 2000 Mirtazapine: A Pharmacoeconomic Review of its Use in Depression
    by Kristin J. Holm & Blair Jarvis & Rachel H. Foster
  • 2000 Testing the Validity of Cost-Effectiveness Models
    by Chris McCabe & Simon Dixon
  • 2000 Handling Uncertainty in Cost-Effectiveness Models
    by Andrew H. Briggs
  • 2000 Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application
    by Mark Sculpher & Elisabeth Fenwick & Karl Claxton
  • 2000 Modelling in Health Economic Evaluation: What is its Place? What is its Value?
    by Alan Brennan & Ron Akehurst
  • 2000 Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement
    by Adis International Limited
  • 2000 Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
    by Kevin T. Stroupe & Melissa M. Forthofer & D. Craig Brater & Michael D. Murray
  • 2000 Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
    by Steven J. Crowley & David Tognarini & Paul V. Desmond & Michael Lees
  • 2000 Cost Effectiveness of Competing Strategies to Prevent or Treat GORD-Related Dysphagia
    by Amnon Sonnenberg
  • 2000 Cost Analysis of the Treatment of Schizophrenia in the UK: A Simulation Model Comparing Olanzapine, Risperidone and Haloperidol
    by Stephen Almond & Owen O'Donnell
  • 2000 Initial Treatment Choice in Depression: Impact on Medical Expenditures
    by Eric T. Edgell & Timothy R. Hylan & JoLaine R. Draugalis & Stephen Joel Coons
  • 2000 Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid
    by Mark Sculpher & Michael K. Palmer & Anne Heyes
  • 2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
    by A. Brett Hauber & Ari Gnanasakthy & Edward H. Snyder & Mohan V. Bala & Anke Richter & Josephine A. Mauskopf
  • 2000 Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
    by Anthony O'Hagan & John W. Stevens & Jacques Montmartin
  • 2000 Economic Burden of Irritable Bowel Syndrome: Proposed Strategies to Control Expenditures
    by Michael Camilleri & Donald E. Williams
  • 2000 Cost Effectiveness of Combination HIV Therapy: 3 Years Later
    by Richard D. Moore
  • 2000 The Importance of Achieving Additional Drug Benefits at a Reasonable Cost: A Review of the Fluoxetine Years
    by Nick Freemantle & James Mason
  • 2000 Household Income Losses Associated With Ischaemic Heart Disease For US Employees
    by Jeph Herrin & Charles B. Cangialose & Stephen J. Boccuzzi & William S. Weintraub & David J. Ballard
  • 2000 The Cost Effectiveness of Misoprostol Prophylaxis Alongside Long Term Nonsteroidal Anti-Inflammatory Drugs: Implications of the MUCOSA Trial
    by Peter J. Davey & Eric Meyer
  • 2000 Economics of the Antithymocyte Globulins Thymoglobulin(R) and Atgam(R) in the Treatment of Acute Renal Transplant Rejection
    by Mark A. Schnitzler & Robert S. Woodward & Jeffrey A. Lowell & Leah Amir & Timothy J. Schroeder & Gary G. Singer & Daniel C. Brennan
  • 2000 Assessing Health Utilities in Schizophrenia: A Feasibility Study
    by Lakshmi N. Voruganti & A. George Awad & L. Kola Oyewumi & Leonardo Cortese & Sandra Zirul & Ravinder Dhawan
  • 2000 Evaluating the Potential
    by Eric L. Eisenstein & Eric D. Peterson & James G. Jollis & Barbara E. Tardiff & Robert M. Califf & J. David Knight & Daniel B. Mark
  • 2000 Clinical and Economic Factors Important to Anaesthetic Choice for Day-Case Surgery
    by Edmond I. Eger & Paul F. White & Martin S. Bogetz
  • 2000 ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations
    by Andrew P. Davie
  • 2000 Bridging Decision Analytic Modelling with a Cross-Sectional Study: Application to Parkinson's Disease
    by Mark J.C. Nuijten
  • 2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
    by Ceri J. Phillips
  • 2000 Cost-of-Illness of Epilepsy in Italy: Data from a Multicentre Observational Study (Episcreen)
    by P. Berto & P. Tinuper & S. Viaggi
  • 2000 Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza
    by Fred Y. Aoki & Douglas M. Fleming & Adrian D. Griffin & Loretto A. Lacey & Sally Edmundson
  • 2000 Pharmacoeconomics and Clinical Practice Guidelines: A Survey of Attitudes in Swedish Formulary Committees
    by Anders Anell & Patrick Svarvar
  • 2000 The Costs of Pharmacological Treatment for Major Depression: The Italian Prospective Multicentre Observational Incidence-Based Study
    by Rosanna Tarricone & Giovanni Fattore & Simone Gerzeli & Giulio Serra & Cristina Taddei & Mauro Percudani
  • 2000 Valuing Health-Related Quality of Life: A Review of Health State Valuation Techniques
    by Colin Green & John Brazier & Mark Deverill
  • 2000 Pharmacoeconomic Considerations in Treating Ovarian Cancer
    by Diane Bodurka-Bevers & Charlotte C. Sun & David M. Gershenson
  • 2000 New Generation Aromatase Inhibitors in Breast Cancer: Weighing Out Potential Costs and Benefits
    by Gerald M. Higa
  • 2000 Diagnosis Related Group Costs in a Regulated Environment: A Note About Their Economic Interpretation
    by Claude Le Pen & Gilles Berdeaux
  • 2000 Economic Cost of Male Erectile Dysfunction Using a Decision Analytic Model: For a Hypothetical Managed-Care Plan of 100 000 Members
    by Howard L. Tan
  • 2000 The Cost of Urinary Incontinence in Italian Women: A Cross-Sectional Study
    by Fabrizio Tediosi & Fabio Parazzini & Angela Bortolotti & Livio Garattini
  • 2000 Use and Cost of Hospital and Community Service Provision for Children with HIV Infection at an English HIV Referral Centre
    by Eduard J. Beck & Sundhiya Mandalia & Rebecca Griffith & Jeni Beecham & M. D. Sam Walters & Mary Boulton & David L. Miller
  • 2000 Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in Germany
    by Peter K. Schadlich & Josef G. Brecht
  • 2000 A Comparative Review of Generic Quality-of-Life Instruments
    by Stephen Joel Coons & Sumati Rao & Dorothy L. Keininger & Ron D. Hays
  • 2000 Estimating the Long Term Cost Savings from the Treatment of Alzheimer's Disease: A Modelling Approach
    by Peter J. Neumann
  • 2000 Formulary Management of Low Molecular Weight Heparins
    by William E. Wade & Bradley C. Martin & Jeffrey A. Kotzan & William J. Spruill & Marie A. Chisoholm & Matthew Perri
  • 2000 Management of Acute Repetitive Seizures: Defining the Role of Rectal Diazepam Gel
    by Matthew N. Lowe & Katharine J. Palmer & Michelle I. Wilde
  • 2000 Management of Acute Otitis Media: Defining the Role of Cefuroxime Axetil
    by Harriet M. Lamb & Caroline M. Spencer
  • 2000 Self-Management of Epilepsy: A Review of the Concept and Its Outcomes
    by Janice M. Buelow & Joyce Johnson
  • 2000 The Role of Minimal- and No-Contact Behavioural Treatments in Migraine: A Review of Efficacy and Cost Effectiveness
    by Lisa Scharff & Joseph Etherage
  • 2000 Healthcare Reforms in Germany: Managed Care, An Opportunity?
    by Reinhard Rychlik & Karin Guntertgomann & Anne Kilburg & Jeffrey B. Frazier
  • 2000 Epoetin Alfa Drug Use Evaluation Using A Software System: Lessons Learned
    by Edward P. Armstrong & Ruth E. Cherrick
  • 2000 Economic Evaluations of Influenza Vaccination in the Elderly: Impact on Public Health Policy
    by Susan C. Wood & Van Hung Nguyen & Claudia Schmidt
  • 2000 Recombinant Human Erythropoietin as an Alternative to Blood Transfusion in Cancer-Related Anaemia
    by Andreas Engert
  • 2000 An Integrated Model for the Management of Co-Occurring Psychiatric and Substance Disorders in Managed-Care Systems
    by Kenneth Minkoff
  • 2000 Outcome Measures of Efficacy Associated with a Web-Enabled Asthma Self-Management Programme: Findings from a Quasi-Experiment
    by Martin Atherton
  • 2000 Targeting High Utilisers: Predictive Validity of a Screening Questionnaire
    by Julie A. Meek & Brenda L. Lyon & Frederick E. May & Wendy D. Lynch
  • 2000 Interventions for Families of Individuals with Schizophrenia: Maximising Outcomes for their Relatives
    by Phyllis Solomon
  • 2000 Breast Cancer Epidemiology, Prevention and Costs of Care: Implications for Disease Management Programmes
    by K. Robin Yabroff & Ruth Brown & Michael Halpern
  • 2000 The Role of Community Health Information Networks in Disease Management
    by Francois M.H.M. Dupuits
  • 2000 The Value of Disease Management: Approaching the Industrialisation of Modern Medicine
    by Marc L. Berger & Peter Nebenfuhr & Richard K. Murray
  • 2000 Economic Impact of an Asthma Education Programme on Medical Care Utilisation
    by Dong-Churl Suh & Soungkook Shin & Robert M. Voytovich & Allan Zimmerman
  • 2000 Smoking Cessation: The Contribution of Community Pharmacy
    by James C. McElnay & Terry A. Maguire & Ashlinn Drummond & Carmel M. Hughes
  • 2000 Dynamic Assessment in Disease Management
    by Ira S. Nash
  • 2000 Screening and Brief Intervention in the Management of Early Problem Drinkers: Integration into Healthcare Settings
    by Vania Modestolowe & Ava Boornazian
  • 2000 Disease Management as a Part of Total Health and Productivity Management
    by Ron Z. Goetzel & Ronald J. Ozminkowski
  • 2000 Management of Narcolepsy: Defining the Role of Modafinil
    by Alison M. Comer & Caroline M. Spencer
  • 2000 Recent Developments for Optimal End-Points in Rheumatoid Arthritis Clinical Studies
    by Esmeralda T.H. Molenaar & Maarten Boers & Peter M. Brooks & Lee Simon & Vibeke Strand & Peter Tugwell
  • 2000 Managing Influenza in Primary Care: A Practical Guide to Clinical Diagnosis
    by Rene Snacken
  • 2000 Lipid Clinics as Disease Management Programmes in the United States: Essential Elements and Practical Considerations
    by Ralph L. Laforge
  • 2000 Potential Role of Telecommunication Technologies in the Management of Chronic Health Conditions
    by Joseph Finkelstein & Robert H. Friedman
  • 2000 Medical Savings Account Plans: A Patient-Centred Approach to Medical Insurance
    by David T. Springer
  • 2000 Modification of Albumin Use Pattern After an Educational Intervention
    by Veronica De Miguel & Emilio Vargas & Antonio Portoles & Miguel Puerro & Ana Isabel Terleira & Alfonso Moreno
  • 2000 Cost Estimates for Chronic Diseases
    by Jean Woo & Clive Cockram
  • 2000 Psychosocial Components of Asthma Management in Children
    by Shari L. Wade
  • 2000 Impact of Disease and Health Management Strategies on Formulary Design and Management
    by Michael Toscani & Dong Churl Suh & Brent Benedict
  • 2000 The Economics of Hepatitis B Virus Vaccination: An Analysis of Cost-Effectiveness Results for Switzerland
    by Pascal Zurn & Guy Carrin & Jean-Pierre Danthine & Raoul Kammerlander & Mark Kane
  • 2000 Quality-of-Care Indicators for HIV/AIDS
    by Albert W. Wu & Allen Gifford & Steven Asch & Susan E. Cohn & Samuel A. Bozzette & Robin Yurk
  • 2000 Performance Measurement and Management of Healthcare Professionals: Some Topical Issues
    by Martin N. Marshall & Huw T.O. Davies
  • 2000 Electronic Point-of-Care Prescribing: Writing the `Script'
    by Gordon Schiff & David W. Bates
  • 2000 Management of Hypertension in Patients with Diabetes Mellitus: Defining the Role of Lisinopril
    by Blair Jarvis & Caroline M. Spencer
  • 2000 Formulary Management of Eradication Therapies for Helicobacter pylori: Drug Selection by Means of the SOJA Method
    by Robert Janknegt & Leopold G.J.B. Engels
  • 2000 Computer-Assisted Drug Therapy Problem Notification
    by Ronald A. Lyon & Yvette J. Crockell & Nancy P. England
  • 2000 Developments in Influenza Prevention and Treatment: A Managed Care Perspective
    by Arnold S. Monto & A. Mark Fendrick
  • 2000 Challenging Current Asthma Treatment Guidelines: Improved Control of Asthma Symptoms with Nebulised Budesonide in Patients with Severe Asthma Receiving Continuous Oral Steroids
    by Kevin C. Connolly & Michael D. Peake & David M.G. Halpin & Lynda Golightly & Marlyn L. Turbitt
  • 2000 The Management of Women at High Risk of Experiencing Hereditary Breast and Ovarian Cancer: The Lahey Guidelines
    by Kevin S. Hughes & Constance A. Roche & Timothy Whitney & Robert McLellan
  • 2000 Technology-Based Advances in the Management of Depression: Focus on the COPE(TM) Program
    by John H. Greist & Deborah J. Osgood-Hynes & Lee Baer & Isaac M. Marks
  • 2000 Assessing the Economic Impact of Telemedicine
    by David M. Hailey & Bernard L. Crowe
  • 2000 A Population-Based Approach to Asthma Disease Management
    by Pamela J. Algatt-Bergstrom & Leona E. Markson & Richard K. Murray & Marc L. Berger
  • 2000 Management of Major Depression in the Workplace: Impact on Employee Work Loss
    by Howard G. Birnbaum & Pierre Y. Cremieux & Paul E. Greenberg & Ronald C. Kessler
  • 2000 The Health Hero(R) Online Service: A New Internet-Based Communications Platform for Disease Management, Case Management and Performance Measurement
    by Michael A. O'Connell & Julie Cheitlin Cherry
  • 2000 Designing and Developing Effective Disease Management Programmes: Key Decisions for Programme Success
    by Ann Scheck McAlearney
  • 2000 Performance-Based Contracts and Provider Efficiency: The State of the Art
    by Mingshan Lu & Cam Donaldson
  • 2000 Patients' Views on Healthcare: A Driving Force for Improvement in Disease Management
    by Michel Wensing & Richard Grol
  • 2000 Management of Dyslipidaemias: The Role of Simvastatin
    by Karen M. Hvizdos & Karen L. Goa
  • 2000 The Role of Home Infusion Therapy in Haemophilia: A Disease Management Perspective
    by Erik Berntorp & Stefan Lethagen
  • 2000 Interactive Internet Web Sites: A Potentially Powerful Tool for Disease Management
    by David W. Bulger & Chris Reeves
  • 2000 The Patient's Responsibility for Optimum Healthcare
    by Douglas P. Olsen
  • 2000 The Patient Perspective as an Integral Part of Diabetes Disease Management
    by Kathleen M. Rayman & Geraldine C. Ellison
  • 2000 Monitoring Outcomes of Care in Older People in a UK Community Setting: The North East Fife Outcomes Project
    by Petra Kliempt & Danny Ruta
  • 2000 Health and Disease Management Within an Academic Health System
    by David B. Bernard & Kenneth D. Coburn & Mark A. Miani
  • 2000 Achieving Patient Buy-In and Long Term Compliance with Antihypertensive Treatment
    by Frances B. Garfield & J. Jaime Caro
  • 2000 Medicare Risk Plans and Disease Management Vendors: Present and Future Relationships
    by Sam Forman
  • 2000 Quality adjusted life years as expected utilities
    by José Ma. Abellán Perpiñán & José Luis PintoPrades
  • 1999 Economic Consequences of Health Status: A Review of the Evidence
    by Amar A. Hamoudi & Jeffrey D. Sachs
  • 1999 The Changing Global Distribution of Malaria: A Review
    by Amar Hamoudi & Jeffrey D. Sachs
  • 1999 Radial measures of public services deficit for regional allocation of public funds
    by Jaume Puig
  • 1999 Radial measures of public services deficit for regional allocation of public funds
    by Jaume Puig
  • 1999 Tax Subsidies And The Provision Of Health Insurance In Small Firms
    by Mark Stabile
  • 1999 The Long-Run Growth in Obesity as a Function of Technological Change
    by Tomas J. Philipson & Richard A. Posner
  • 1999 The Technology of Birth: Is it Worth it?
    by David M. Cutler & Ellen Meara
  • 1999 Enter at Your Own Risk: HMO Participation and Enrollment in the MedicareRisk Market
    by Jean Abraham & Ashish Arora & Martin Gaynor & Douglas Wholey
  • 1999 The Impact of Employer-Provided Health Insurance on Dynamic Employment Transitions
    by Donna B. Gilleskie & Byron F. Lutz
  • 1999 Determinants of Smoking Cessation: An Analysis of Young Adult Men and Women
    by John A. Tauras & Frank J. Chaloupka
  • 1999 Managed Care
    by Sherry Glied
  • 1999 The Value of Reductions in Child Injury Mortality in the U.S
    by Sherry Glied
  • 1999 The Anatomy of Health Insurance
    by David M. Cutler & Richard J. Zeckhauser
  • 1999 Inequalities in Income and Inequalities in Health
    by Angus Deaton
  • 1999 Mortality, Education, Income, and Inequality among American Cohorts
    by Angus Deaton & Christina Paxson
  • 1999 The Effect of Alcohol Prohibition on Alcohol Consumption
    by Jeffrey A. Miron
  • 1999 State Drug Control and Illicit Drug Participation
    by Henry Saffer & Frank Chaloupka
  • 1999 Economic Epidemiology and Infectious Diseases
    by Tomas Philipson
  • 1999 Aging and the Growth of Long-Term Care
    by Darius Lakdawalla & Tomas Philipson
  • 1999 Price, Clean Indoor Air, and Cigarette Smoking: Evidence from the Longitudinal Data for Young Adults
    by John A. Tauras & Frank J. Chaloupka
  • 1999 Alcohol
    by Philip J. Cook & Michael J. Moore
  • 1999 Estimating Log Models: To Transform or Not to Transform?
    by Willard G. Manning & John Mullahy
  • 1999 Interaction Effects and Difference-in-Difference Estimation in Loglinear Models
    by John Mullahy
  • 1999 Food Stamp Participants' Access to Food Retailers
    by James C. Ohls & Michael Ponza & Lorenzo Moreno & Amy Zambrowski & Rhoda Cohen
  • 1999 Universal-Free School Breakfast Program Evaluation Design Project. Review of Literature on Breakfast and Learning
    by Michael Ponza & Ronette Briefel & J. Michael Murphy & Susanna Kung & Barbara Devaney
  • 1999 Options for a National Database to Track Participation in Federal Means-Tested Public Assistance Programs
    by Myles Maxfield & James Ohls & William S. Borden
  • 1999 The Reaching the Working Poor and Poor Elderly Study: What We Learned and Recommendations for Future Research
    by Sheena McConnell & Michael Ponza
  • 1999 Household Food Security in the United States, 1995-1998
    by Gary Bickel & Steven Carlson & Mark Nord. From data prepared by James Ohls & Abhijay Prakash & Larry Radbill & Allen Schirm
  • 1999 Characteristics of Food Stamp Households: Fiscal Year 1998
    by Laura Castner & Jacquelyn Anderson
  • 1999 Customer Service in the Food Stamp Program
    by Michael Ponza & James C. Ohls & Lorenzo Moreno & Amy Zambrowski & Rhoda Cohen
  • 1999 Relaxing the FSP Vehicle Asset Test: Findings from the North Carolina Demonstration
    by Nancy Wemmerus & Bruce Gottlieb
  • 1999 Characteristics of Food Stamp Households, Fiscal Year 1997
    by Scott Cody & Laura Castner
  • 1999 Gender and Racial Discrimination in Pay and Promotion for NHS Nurses
    by Pudney, Stephen & Shields, Michael A.
  • 1999 Gender And Racial Discrimination In Pay And Promotion For Nhs Nurses
    by Stephen Pudney & Michael A. Shields
  • 1999 Substitutes or Complements? Alcohol, Cannabis and Tobacco
    by Lisa Cameron & Jenny Williams
  • 1999 Acamprosate: Pharmacoeconomic Implications of Therapy
    by Rachel H. Foster & Karen J. McClellan
  • 1999 Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation
    by Christopher J. Dunn & Rachel H. Foster
  • 1999 Annual Cost of Erectile Dysfunction to UK Society
    by Jonathan M. Plumb & Julian F. Guest
  • 1999 Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis
    by Ron Goeree & Bernie O'Brien & Richard Hunt & Gordon Blackhouse & Andrew Willan & Jan Watson
  • 1999 Health Economics in the Canadian Pharmaceutical Industry
    by Lila Assiff & Michael R. Pollock & Patricia Manzi & Ben Faienza & Devidas Menon
  • 1999 The Effect of Generic Competition on Prescription to Over-the-Counter Switching
    by Christopher S. Hollenbeak
  • 1999 Managing Pharmaceutical Expenditure while Increasing Access: The Pharmaceutical Management Agency (PHARMAC) Experience
    by Richard Braae & Wayne McNee & David Moore
  • 1999 Diagnosis and Management of Osteomyelitis: Decision Analytic and Pharmacoeconomic Considerations
    by Manouche Tavakoli & Peter Davey & Benedict A. Clift & Huw T. O. Davies
  • 1999 Measuring Quality of Life in Paediatric Patients
    by Melinda A. Connolly & Jeffrey A. Johnson
  • 1999 The Doctor-Patient Relationship and Prescribing Patterns: A View from Primary Care
    by Doug T. Steinke & Thomas M. MacDonald & Peter G. Davey
  • 1999 Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole
    by Mike Chambers & John Hutton & John Gladman
  • 1999 Economic Impact of Providing Workplace Influenza Vaccination: A Model and Case Study Application at a Brazilian Pharma-Chemical Company
    by Emmanuel Burckel & Talat Ashraf & Jose P. Galvao de Sousa Filho & Eduardo Forleo Neto & Hubert Guarino & Caio Yauti & Fernando de Barros Barreto & Louis Champion
  • 1999 Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections
    by Daniel J. Walters & Joseph S. Solomkin & Joseph A. Paladino
  • 1999 Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy: Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients in the UK
    by Terry N. Flynn & Stephen M. Kelsey & Dena L. Hazel & Julian F. Guest
  • 1999 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective
    by Robert M. Balen & Carlo A. Marra & Peter J. Zed & Marc Cohen & Luciana Frighetto
  • 1999 Cost Effectiveness of Fluticasone Propionate and Flunisolide in the Treatment of Corticosteroid-Naive Patients with Moderate Asthma
    by Timm Volmer & Adrian Kielhorn & Hans H. Weber & Karl J. Wiessmann
  • 1999 Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year
    by George Torrance & Valery Walker & Ronald Grossman & Jayanti Mukherjee & David Vaughan & Jacques La Forge & Noel Lampron
  • 1999 Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease
    by Nils-Olov Stalhammar & Jonas Carlsson & Robert Peacock & Stefan Mullerlissner & Marcandre Bigard & Gabriele B. Porro & Julio Ponce & James Hosie & Mairi Scott & Donald G. Weir & Claire Fulton & Keith Gillon & Karna D. Bardhan
  • 1999 Linking Health-Related Quality-of-Life Indicators to Large National Data Sets
    by John A. Rizzo & Jody L. Sindelar
  • 1999 Cost Effectiveness, Quality-Adjusted Life-Years and Supportive Care: Recombinant Human Erythropoietin as a Treatment of Cancer-Associated Anaemia
    by Pierre-Yves Cremieux & Stan N. Finkelstein & Ernst R. Berndt & Jeffrey Crawford & Mitchell B. Slavin
  • 1999 Real World Designs in Economic Evaluation: Bridging the Gap Between Clinical Research and Policy-Making
    by Rob Baltussen & Reiner Leidl & Andre Ament
  • 1999 Measuring the Effects of Medication Use on Health-Related Quality of Life in Patients with Rheumatoid Arthritis: A Review
    by Michael B. Nichol & Ann S. M. Harada
  • 1999 Pharmacoeconomics and Health Policy: Current Applications and Prospects for the Future
    by Paul E. Greenberg & Almudena Arcelus & Howard G. Birnbaum & Pierre-Yves Cremieux & Jacques LeLorier & Pierre Ouellette & Mitchell B. Slavin
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects. The Authors Reply
    by Sam S. Salek & Melvyn D. Walker & Anthony J. Bayer
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
    by Stephen P. McKenna & Lynda C. Doward
  • 1999 Costs of Mini Mental State Examination-Related Cognitive Impairment
    by Linus Jonsson & Peter Lindgren & Anders Wimo & Bengt Jonsson & Bengt Winblad
  • 1999 Costs Associated with Symptomatic Systolic Heart Failure
    by Peter G. Davey & Peter B. Clarkson & Alex McMahon & Thomas M. MacDonald
  • 1999 Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK
    by Mark Nuijten & Liebeth Meester & Franz Waibel & Suzanne Wait
  • 1999 Economic Evaluation of the Treatment of Chronic Wounds: Hydroactive Wound Dressings in Combination with Enzymatic Ointment Versus Gauze Dressings in Patients with Pressure Ulcer and Venous Leg Ulcer in Germany
    by Rito Bergemann & Karl W. Lauterbach & Wolfgang Vanscheidt & Klaus-Dieter Neander & Reinhard Engst
  • 1999 Decision Analysis of Histamine H2-Receptor Antagonist Maintenance Therapy Versus Helicobacter pylori Eradication Therapy: A Randomised Controlled Trial in Patients with Continuing Pain After Duodenal Ulcer
    by Manouche Tavakoli & Andrzej T. Prach & Mo Malek & David Hopwood & Bernard W. Senior & Frank E. Murray
  • 1999 Clinical and Economic Considerations of Empirical Antibacterial Therapy of Febrile Neutropenia in Cancer
    by George Dranitsaris
  • 1999 Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations
    by Finn Wisloff & Nina Gulbrandsen & Erik Nord
  • 1999 Herbal Remedies: Issues in Licensing and Economic Evaluation
    by Darren M. Ashcroft & Alain Li Wan Po
  • 1999 Decreased Medical Expenditures for Care of HIV-Seropositive Patients: The Impact of Highly Active Antiretroviral Therapy at a US Veterans Affairs Medical Center
    by Larry Mole & Kimberly Ockrim & Mark Holodniy
  • 1999 Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal Ulcer: An Analysis of Triple Therapy Versus Two Dual Therapy Alternatives
    by Gunnel R. Tennvall & Anna Norinder & Bo Ohlin
  • 1999 Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care Population
    by Scott D. Ramsey & Katherine Newton & David Blough & David K. McCulloch & Nirmala Sandhu & Edward H. Wagner
  • 1999 Pharmacotherapeutic Circles: Results of an 18-Month Peer-Review Prescribing-Improvement Programme for General Practitioners
    by Liselotte von Ferber & Jurgen Bausch & Ingrid Koster & Ingrid Schubert & Peter Ihle
  • 1999 A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure
    by Colin Berry & John McMurray
  • 1999 Formulary Management of Proton Pump Inhibitors
    by Michael F. Byrne & Frank E. Murray
  • 1999 Formulary Submission Guidelines for Blue Cross and Blue Shield of Colorado and Nevada: Structure, Application and Manufacturer Responsibilities
    by Paul C. Langley
  • 1999 Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada
    by Stephen Morris & Ed Godber
  • 1999 Cost Comparison of Antibacterial Therapies for Serious Infections: A New Zealand 3-Hospital Study
    by W. Guy Scott & Helen M. Scott & Seton Henderson & Alison Inder & Joanne Sanders & Ruth Spearing & Colin McArthur & James Judson & Bartrum Baker & Peter Hicks & Philippa Cotterell
  • 1999 The Influence of Hospital-Based Prescribers on Prescribing in General Practice
    by John Feely & Robert Chan & John McManus & Brendan O'Shea
  • 1999 Estimating Long Term Cost Savings from Treatment of Alzheimer's Disease: A Modelling Approach
    by Paul Fenn & Alastair Gray
  • 1999 Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis
    by Andrea Messori & Sabrina Trippoli & Paola Becagli & Gaetano Zaccara
  • 1999 Review of Quality-of-Life Evaluations in Patients with Angina Pectoris
    by Afschin Gandjour & Karl W. Lauterbach
  • 1999 A Review of Quality-of-Life Evaluations in Prostate Cancer
    by Sunshine D. Sommers & Scott D. Ramsey
  • 1999 Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare
    by James Mason
  • 1999 Donepezil: Pharmacoeconomic Implications of Therapy
    by Rachel H. Foster & Greg L. Plosker
  • 1999 The Pharmacoeconomics of Hormone Replacement Therapy
    by David J Torgerson & David M Reid
  • 1999 Diclofenac/Misoprostol: Pharmacoeconomic Implications of Therapy
    by Greg L. Plosker & Harriet M. Lamb
  • 1999 Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS
    by Anita Rachlis & Fiona Smaill & Valery Walker & Lorraine Hotchkies & Amy Jones
  • 1999 Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson's Disease
    by Claude Le Pen & Suzanne Wait & Frederic Moutard-Martin & Max Dujardin & Marc Ziegler
  • 1999 Economic Analysis of Carboplatin Versus Cisplatin in Lung and Ovarian Cancer
    by Zeba M. Khan & Karen L. Rascati & Jim M. Koeller
  • 1999 Measuring Sensitivity in Pharmacoeconomic Studies: Refining Point Sensitivity and Range Sensitivity by Incorporating Probability Distributions
    by Mark J.C. Nuijten
  • 1999 Benefit Valuation in Economic Evaluation of Cancer Therapies: A Systematic Review of the Published Literature
    by Jackie Brown & Mark Sculpher
  • 1999 Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses
    by Howard G. Birnbaum & Pierre Y. Cremieux & Paul E. Greenberg & Jacques LeLorier & JoAnn Ostrander & Laura Venditti
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
    by Sam S. Salek & Melvyn D. Walker & Anthony J. Bayer
  • 1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
    by Marianne Greer & Helma Monteban
  • 1999 Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
    by Rachel H. Foster & Karen L. Goa
  • 1999 Cost of Schizophrenia to UK Society: An Incidence-Based Cost-of-Illness Model for the First 5 Years Following Diagnosis
    by Julian F. Guest & Ron F. Cookson
  • 1999 Costs of Diabetes: A Methodological Analysis of the Literature
    by Eva Pagano & Massimo Brunetti & Fabrizio Tediosi & Livio Garattini
  • 1999 A Model to Compute the Medical Cost of Patients in Intensive Care
    by Carine Chaix & Isabelle Durand-Zaleski & Corinne Alberti & Christian Brun-Buisson
  • 1999 Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference?
    by Ron Goeree & Amiram Gafni & Mary Hannah & Terri Myhr & Gordon Blackhouse
  • 1999 Standard Cost Lists for Healthcare in Canada: Issues in Validity and Inter-Provincial Consolidation
    by Philip Jacobs & Noralou P. Roos
  • 1999 Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure: The Consequences of Underprescribing
    by Fredrik Andersson & Charles Cline & Tina Ryden-Bergsten & Leif Erhardt
  • 1999 Outstanding Regulatory Aspects in the European Pharmaceutical Market
    by Panos Kanavos & Elias Mossialos
  • 1999 Direct Costs of Hip Fractures in Patients Over 60 Years of Age in Belgium
    by Jean-Yves Reginster & Pierre Gillet & Wafa Ben Sedrine & Geoffrey Brands & Olivier Ethgen & Cecile defroidmont & Christiane Gosset
  • 1999 Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression
    by Robert I. Griffiths & Erin M. Sullivan & Richard G. Frank & Michael J. Strauss & Robert J. Herbert & Jon Clouse & Howard H. Goldman
  • 1999 Reconciling Decision Models With the Real World: An Application to Anaemia of Renal Failure
    by Ya-Chen Tina Shih & Teresa L. Kauf
  • 1999 Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia: Results From a Randomised Clinical Trial
    by Susan H. Hamilton & Dennis A. Revicki & Eric T. Edgell & Laura A. Genduso & Gary Tollefson
  • 1999 The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
    by Judith L. Glennie & George W. Torrance & Jean Francois Baladi & Catherine Berka & Eleanor Hubbard & Devidas Menon & Nick Otten & Marc Riviere
  • 1999 Counting the Costs of Drug-Related Adverse Events
    by T. Jeffrey White & Annet Arakelian & Jay P. Rho
  • 1999 Prescribing at the Interface Between Primary and Secondary Care in the UK: Towards Joint Formularies?
    by Martin Duerden & Tom Walley
  • 1999 Pharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies
    by Dennis A. Revicki & Lori Frank
  • 1999 Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review
    by Allan J. Coukell & Stuart Noble & Diana Faulds
  • 1999 Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System
    by M. Postma & Dettie Oenema & Symon Terpstra & Jelte Bouma & Hannah Kuipersupmeijer & Michiel J. Staal & Berry J. Middel
  • 1999 Applying Epidemiology-Based Outcomes Research to Clinical Decision-Making: A Hypothetical Model of Biotechnology Therapy in Gram-Negative Sepsis
    by Edward C.Y. Wang & Thaddeus H. Grasela & Cynthia A. Walawander
  • 1999 Treatment of Locally Advanced Pancreatic Carcinoma in Sweden: A Health Economic Comparison of Palliative Treatment With Best Supportive Care Versus Palliative Treatment With Gemcitabine in Combination With Best Supportive Care
    by Gunnel Ragnarsont Tennvall & Nils Wilking
  • 1999 Utility Scores for Chronic Conditions in a Community-Dwelling Population
    by Nicole Mittmann & Kostas Trakas & Nancy Risebrough & Barbara A. Liu
  • 1999 Recent Advances in the Methods of Cost-Benefit Analysis in Healthcare: Matching the Art to the Science
    by Emma McIntosh & Cam Donaldson & Mandy Ryan
  • 1999 Methodological Hurdles in Conducting Pharmacoeconomic Analyses
    by J. Douglasrizzo & Neil R. Powe
  • 1999 The Clinical and Economic Potential of Cyclosporin Drug Interactions
    by Jill E. Martin & A. Jamal Daoud & Timothy J. Schroeder & M. Royfirst
  • 1999 Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma
    by Carin A. Uyl-de Groot & Gert J. Ossenkoppele & Ivanne Buijt & Peter C. Huijgens
  • 1999 Pharmaceutical Price Regulation: A Study on the Impact of the Rate-of-Return Regulation in the UK
    by Joan-Ramon Borrell
  • 1999 Simvastatin After Orthotopic Heart Transplantation: Costs and Consequences
    by Karl J. Krobot & Klaus Wenke & Bruno Reichart
  • 1999 New Drugs for Osteoporosis: Comparison of the Costs and Required Returns With Those of Other Drugs Intended for Long-Term Use
    by Martin Edwards
  • 1999 Under-Utilisation of beta-Blockers After Acute Myocardial Infarction: Pharmacoeconomic Implications
    by W. David Bradford & Jersey Chen & Harlan M. Krumholz
  • 1999 Patient Self-Reports in Pharmacoeconomic Studies: Their Use and Impact on Study Validity
    by Christopher Evans & Bruce Crawford
  • 1999 The Economics of Multiple Sclerosis: Distribution of Costs and Relationship to Disease Severity
    by Amy Nicole Grudzinski & Zafar Hakim & Emily R. Cox & J. Lyle Bootman
  • 1999 Pharmacoeconomic Consequences of Variable Patient Compliance With Prescribed Drug Regimens
    by John Urquhart
  • 1999 Primary Care Purchasing: Are Integrated Primary Care Provider/Purchasers the Way Forward?
    by Stephen Peckham
  • 1999 Approaches to Missing Data Inference Results from CaPSURE: An Observational Study of Patients with Prostate Cancer
    by Deborah P. Lubeck & David J. Pasta & Scott C. Flanders & James M. Henning
  • 1999 Cost Effectiveness of Recombinant Human Insulin-Like Growth Factor I Therapy in Patients with ALS
    by Stacey J. Ackerman & Erin M. Sullivan & Kathleen M. Beusterien & Howard M. Natter & Deborah F. Gelinas & Donald L. Patrick
  • 1999 Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia
    by Viggo Jonsson & Mogen Mork Hansen & Per Ljungman & Stein Kaasa
  • 1999 Health-Related Quality-of-Life Measurement in Patients with Parkinson's Disease
    by Crispin Jenkinson & Ray Fitzpatrick & Viv Peto
  • 1999 Determining Clinically Important Differences in Health Status Measures: A General Approach with Illustration to the Health Utilities Index Mark II
    by Greg Samsa & David Edelman & Margaret L. Rothman & G. Rhys Williams & Joseph Lipscomb & David Matchar
  • 1999 The Effect of Managed Care on Prescription Drug Costs and Benefits
    by Alan Lyles & Francis B. Palumbo
  • 1999 Valuing Health-Related Quality of Life: Issues and Controversies
    by Paul Dolan
  • 1999 Economic Evaluation of Antibacterials in the Treatment of Acute Sinusitis
    by Claudine Laurier & Jean Lachaine & Murray Ducharme
  • 1999 Willingness to Pay as a Measure of Health Benefits
    by Mohan V. Bala & Josephine A. Mauskopf & Lisa L. Wood
  • 1999 Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia
    by Giampaolo Bucaneve & Francesco Menichetti & Albano Del Favero
  • 1999 Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain
    by F. Javier Jimenez & Pilar Guallar-Castillon & Carlos Rubio Terres & Eliseo Guallar
  • 1999 Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease
    by Joel W. Hay & Winnie M. Yu & Talat Ashraf
  • 1999 Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure: A Review of Recent Randomised Controlled Trials
    by Nancy K. Leidy & Anne M. Rentz & Teresa M. Zyczynski
  • 1999 The Use of Meta-Analysis in Cost-Effectiveness Analysis: Issues and Recommendations
    by Sanjay Saint & David L. Veenstra & Sean D. Sullivan
  • 1999 Behavioural Medicine Group Intervention for High-Utilising Somatising Patients: Evaluation Across 7 Unrelated Healthcare Organisations
    by Steven E. Locke & Pauline P. Chan & Debra S. Morley & Caroline C. McLeod & Matthew A. Budd & Marcia Orlowski
  • 1999 Law and Disorder: Critical Legal Issues in Disease Management
    by James M. Jacobson & James M. Jorling & Neela A. Paykel
  • 1999 Implementing Disease Management Programmes within an Integrated Delivery System
    by Neal Friedman & Linda Skogmo & Pat Aruffo
  • 1999 Integrating Systems of Care: Responding to the Demand
    by Rufus Howe
  • 1999 Playing Disease Management Numbers Games
    by Robert E. Stone
  • 1999 Helping Cure Healthcare Systems: Changing Minds and Behaviour
    by James O. Prochaska & Janice M. Prochaska
  • 1999 Gaining Physician Buy-In for Disease Management Initiatives
    by Harry L. Leider
  • 1999 Episodes of Care: A Tool for Measuring the Impact of Healthcare Services on Cost and Quality
    by Edward Bassin
  • 1999 `Build versus Buy' in Disease Management: Separating Fact from Myth
    by Alfred Lewis
  • 1999 Point-of-Care Testing in Oral Anticoagulant Monitoring: Implications for Patient Management
    by Jennifer Sickels & Jennifer Elston Lafata & Jack E. Ansell
  • 1999 Disease Management by Prevention: The Prospects for Diabetic Retinopathy
    by Emily Y. Chew
  • 1999 Patient Compliance and its Impact on Treatment Outcomes
    by Laura T. Pizzi & Joseph E. Biskupiak
  • 1999 Enhancing Outcomes Research: The Experience of a Community Pharmacist Research Network
    by R. Leon Longe & A. Thomas Taylor & William E. Wade & William J. Spruill
  • 1999 Case Management: Transforming to Meet the Demands of an Evolving Healthcare System
    by Marianne E. Weiss
  • 1999 The Pros and Cons of Covering Lifestyle Drugs
    by Debi Reissman
  • 1999 Management of Community-Acquired Pneumonia: The Role of Clarithromycin
    by Julia A. Barman Balfour & Harriet M. Lamb
  • 1999 Guidelines for Glomerulonephritis: Their Importance in Diagnosis and Designing a Management Strategy
    by Edith Renoult & Luc Frimat & Michele Kessler
  • 1999 Cancer and Disease Management: Indications for Action
    by Marybeth Regan
  • 1999 What is the Role of Stroke Units in Overall Care?
    by Joanne V. Hickey & James C. Grotta
  • 1999 Community-Based Prevention and Chronic Disease Self-Management Programmes: Problems, Praises and Pitfalls
    by Mark Daniel & Lawrence W. Green
  • 1999 Treatment of Pneumonias in a Managed-Care Organisation: The Impact of a Treatment Guideline Promotion on Physician Prescribing Behaviour
    by Edward P. Armstrong & Paul C. Langley
  • 1999 Self-Management Services: Their Role in Disease Management
    by Jessie Gruman & Michael VonKorff
  • 1999 Wellness Programmes: Primary-Care Medicine
    by Sarita Verma & Evelyn Forsyth & Leslie Flynn
  • 1999 Selecting a Vendor for Disease Management Programmes
    by Harry L. Leider
  • 1999 Does Telemedicine Have a Role to Play in Disease Management?
    by John Craig & Maria Loane & Richard Wootton
  • 1999 Management of Patients with Cystic Fibrosis: Defining the Role of Inhaled Tobramycin
    by Harriet M. Lamb & Karen L. Goa
  • 1999 The Burden of Asthma Symptoms and the Positive Role of Patient Management
    by Edward C.Y. Wang & Kathryn A. Gaebel
  • 1999 Principles of Perioperative Antibacterial Prophylaxis: Management of Surgical Site Infections
    by John Bohnen
  • 1999 Carve-Outs: Their Place in Disease Management
    by Marybeth Regan
  • 1999 Guidelines for General Practitioners: Approaches for Managing the Information Influx for Effective Disease Management
    by David Pencheon
  • 1999 Epidemiology of Helicobacter pylori Infection: Disease Management Implications for Peptic Ulcer Disease
    by Hoda M. Malaty & David Y. Graham
  • 1999 Management Strategies for Ensuring Adequate Analgesia in Children
    by Melanie Lux & Chris L. Algren & John T. Algren
  • 1999 Disease State Management Programmes: Approaches and Applications
    by Mark G. Fuller
  • 1999 The Role of the Pharmacist in the Management of HIV/AIDS
    by Anthony J. Zappa
  • 1999 Optimising the Patient's Role: An Essential Component in Disease Management
    by Scott MacStravic
  • 1999 Hospital Length of Stay for Schizophrenia: Is Primary Payer an Influencing Factor?
    by David A. Sclar & Linda M. Robison & Tracy L. Skaer & Richard S. Galin
  • 1999 The Caregiver as Part of the Dementia Management Team
    by Steven M. Albert
  • 1999 Management of Acute Ischaemic Stroke: Recommended Practice Guidelines as a Component of Disease Management
    by Soren Paaske Johnsen & Steen Elkjaer Husted & Anne Thomassen
  • 1999 Patient Education in Asthma: Impact of Nurse Educators
    by Margot F. Underwood & Shirley G. Revitt & Stephen K. Field & Robert L. Cowie
  • 1999 An Inner-City Asthma Disease Management Initiative: Results of an Outcomes Evaluation
    by Rose Maljanian & Scott Wolf & John Goethe & Patricia Hernandez & Sheryl Horowitz
  • 1999 Direct-To-Consumer Advertising: Impact on Patient Expectations Regarding Disease Management
    by Joel Lexchin
  • 1999 Evaluation of Patients with Hypertension: Diagnosis, Screening and Risk Stratification
    by Michael Barenbrock & Martin Hausberg & Claus Spieker
  • 1999 Phased Competency: A New Model to Prepare Nurses for Enhanced Roles In Diabetes Disease Management
    by Linda L. Edwards
  • 1999 Practical Strategies to Increase Patient Education Effectiveness in a Disease State Management Programme
    by Marian Ryan Henry
  • 1999 Actual Costs Versus Diagnostic-Related Group Reimbursements for Unstable Angina: An Important Distinction for Effective Disease Management
    by Claudio Brunelli & Gian Paolo Bezante & Alberto Pasdera & Paolo Spallarossa & Maria Rosalia Merello & Pier Rossettin & Franco Zorzet & Salvatore Caponnetto
  • 1999 The Role of Behavioural Treatment in the Management of Insomnia
    by Chien-Ming Yang & Arthur J. Spielman
  • 1999 Outcomes, Outcomes Research and Disease Management: A View from the UK
    by Tom Walley
  • 1999 Use of Guidelines in the Management of Patients With Glaucoma
    by Paul Lee
  • 1999 Management of Advanced Non-Small Cell Lung Cancer: The Potential Role of Gemcitabine
    by Stuart Noble & Diana Faulds
  • 1999 Costs and Benefits of Prevention and Disease Management
    by Shirley A. Musich & Wayne N. Burton & Dee W. Edington
  • 1999 Design, Development and Implementation of a Multidisciplinary Diabetes Disease Management Programme
    by Robert E. Stone
  • 1999 Baseline Assessment of an Inner City Population Enrolled in an Asthma Disease Management Programme: Data for Continuous Programme Improvement
    by Rose Maljanian & John W. Goethe & Scott A. Wolf & Laura R. Triano & Patricia Hernandez
  • 1999 Message Tailoring: An Essential Component for Disease Management
    by David W. Bulger & Amy B. Smith
  • 1999 The Annual Cost of Chronic Obstructive Pulmonary Disease to the UK's National Health Service
    by Julian F. Guest
  • 1999 A Comparison of a Budesonide-Based and a Beclomethasone/Prednisolone-Based Management Strategy for the Treatment of Severe Asthma in General Practice
    by Govindaraj Mohan & Kevin A. MacLusky & Clifford C. Godley & Pamela L. Todd
  • 1999 Guidelines for the Diagnosis and Treatment of Meningococcal Meningitis
    by Bjorn-Erik Kristiansen & Trond Flaegstad
  • 1999 Diabetes Mellitus: Disease Management in a Multispecialty Group Practice
    by Jeremy M. Gleeson & Michael Foris & Marjorie Cypress & Donna J. Rodriguez & Neal Friedman & Martha Kent
  • 1999 Management of Febrile Episodes in Neutropenic Patients: Defining the Role of Meropenem
    by Harriet M. Lamb & Karen L. Goa
  • 1999 Management of Community-Acquired Pneumonia: Defining the Role of Azithromycin
    by Nishan S. Gunasekara & Julia A. Barman Balfour
  • 1999 Use of Surgical Procedures in the Treatment of Epilepsy: Interventions and Outcomes
    by John T. Langfitt & Kathryn Bronstein
  • 1999 The Burden of Obesity and Its Sequelae
    by Jacob C. Seidell
  • 1999 Measuring Outcomes in Alzheimer's Disease Research: Assessment of the Effectiveness of Interventions
    by Stacey Wood & Jeffrey L. Cummings
  • 1998 Controlling Risk Selction Incentives when Health Insurance Contracts are Endogenous
    by Jack, W.
  • 1998 Equilibrium in Competitive Insurance Markets with Ex Ante Adverse Slection and Ex Post Moral Hazard
    by Jack, W.
  • 1998 Frontiers in Health Policy Research, Volume 1
    by
  • 1998 Distance to Hospitals and Children's Access to Care: Is Being Closer Better, and for Whom?
    by Janet Currie & Patricia Reagan
  • 1998 Price Indexes for Medical Care Goods and Services: An Overview of Measurement Issues
    by Ernst R. Berndt & David M. Cutler & Richard G. Frank & Zvi Griliches & Joseph P. Newhouse
  • 1998 Price Indexes for Acute Phase Treatment of Depression
    by Ernst R. Berndt & Susan H. Busch & Richard G. Frank
  • 1998 The Allocation of Publicly-Funded Biomedical Research
    by Frank R. Lichtenberg
  • 1998 Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
    by Frank R. Lichtenberg
  • 1998 The Rise in Old Age Longevity and the Market for Long-Term Care
    by Darius Lakdawalla & Tomas Philipson
  • 1998 How Much is Enough? Efficiency and Medicare Spending in the Last Six Months of Life
    by Jonathan Skinner & John E. Wennberg
  • 1998 It'll Only Hurt a Second? Microeconomic Determinants of Who Gets Flu Shots
    by John Mullahy
  • 1998 Does Spending on Medical Services Change as HMOs Grow and Mature?
    by Patricia Born & Rosalie Liccardo Pacula
  • 1998 Nonprofit Production and Competition
    by Darius Lakdawalla & Tomas Philipson
  • 1998 Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Economics
    by John Mullahy
  • 1998 Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
    by Aaron A. Stinnett & John Mullahy
  • 1998 Reaching Those in Need: How Effective Is the Food Stamp Program?
    by Allen L. Schirm
  • 1998 Eating Breakfast: Effects of the School Breakfast Program
    by Barbara Devaney & Elizabeth Stuart
  • 1998 Using Bayesian Shrinkage Methods to Derive State Estimates of Poverty, Food Stamp Program Eligibility, and Food Stamp Program Participation
    by Allen L. Schirm & John V. DiCarlo
  • 1998 The Effect of Welfare Reform on Able-Bodied Food Stamp Recipients
    by Michael Stavrianos & Lucia Nixon
  • 1998 The Dynamics of Food Stamp Program Participation in the Early 1990s
    by Philip Gleason & Peter Schochet & Robert Moffitt
  • 1998 Common Errors and Controversies in Pharmacoeconomic Analyses
    by Stephen Palmer & Sarah Byford
  • 1998 Common Errors and Controversies in Pharmacoeconomic Analyses
    by Javier Soto
  • 1998 A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe
    by Sheila Hood & Lieven Annemans & Maureen Rutten-van Molken
  • 1998 A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe
    by Linda D. MacKeigan
  • 1998 Cyclosporin Microemulsion (Neoral(R)) Use of trade name is for product identification, and does not imply endorsement.: A Pharmacoeconomic Review of its Use Compared with Standard Cyclosporin in Renal and Hepatic Transplantation
    by Allan J. Coukell & Greg L. Plosker
  • 1998 Fosphenytoin: Pharmacoeconomic Implications of Therapy
    by Stephen M. Holliday & Paul Benfield & Greg L. Plosker
  • 1998 Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
    by Maureen P.M.H. Rutten-van Molken & Eddy K.A. van Doorslaer & M. Denise Till
  • 1998 Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from the Perspective of Statutory Health Insurance
    by Peter K. Schadlich & Eduard Huppertz & Josef Georg Brecht
  • 1998 The Use and Cost of HIV Service Provision in England in 1996
    by Eduard J. Beck & Keith Tolley & Amanda Power & Sundhiya Mandalia & Philippa Rutter & Junichi Izumi & Jeni Beecham & Alistair Gray & David Barlow & Philippa Easterbrook & Martin Fisher & John Innes & George Kinghorn & Bibhat Mandel & Anton Pozniak & Allan Tang & David Tomlinson & Ian Williams
  • 1998 Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption: A Study of Managed-Care Organisation Enrollees
    by Hind T. Hatoum & Sheldon X. Kong & Christopher M. Kania & Josephine M. Wong & Wallace B. Mendelson
  • 1998 A Review of Quality of Life in Alzheimer's Disease: Part 2: Issues in Assessing Drug Effects
    by Sam S. Salek & Melvyn D. Walker & Antony J. Bayer
  • 1998 Thrombolysis, Stroke Units and Other Strategies for Reducing Acute Stroke Costs
    by Theodore H. Wein & Susan L. Hickenbottom & Andrei V. Alexandrov
  • 1998 Are Mental Health Services Losing Out in the US Under Managed Care?
    by Dale L. Johnson
  • 1998 Economic Evaluation of Nimesulide Versus Diclofenac in the Treatment of Osteoarthritis in Greece
    by Lycurgus Liaropoulos & Maria Spinthouri & Theodore Ignatiades & Georgia Ifandi & Fanis Katostaras & Emmanuel Diamantopoulos
  • 1998 Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis
    by Andrew J. Rosner & Daniel T. Grima & George W. Torrance & Cathy Bradley & Jonathan D. Adachi & Rolf J. Sebaldt & Donald J. Willison
  • 1998 Cost Effectiveness of Pramipexole in Parkinson's Disease in the US
    by Thomas J. Hoerger & Mohan V. Bala & Clayton Rowland & Marianne Greer & Elizabeth A. Chrischilles & Robert G. Holloway
  • 1998 Urge Incontinence: Quality of Life and Patients' Valuation of Symptom Reduction
    by Richard M. O'Conor & Magnus Johannesson & Steven L. Hass & Gisela Kobelt-Nguyen
  • 1998 A Review of Quality of Life in Alzheimer's Disease: Part 1: Issues in Assessing Disease Impact
    by Melvyn D. Walker & Sam S. Salek & Antony J. Bayer
  • 1998 A Review of the Economics of the Prevention and Control of Rabies: Part 2: Rabies in Dogs, Livestock and Wildlife
    by Martin I. Meltzer & Charles E. Rupprecht
  • 1998 Pharmaceutical Reference Prices: How do They Work in Practice?
    by Michael Dickson & Heinz Redwood
  • 1998 Willingness To Pay: What's in a Name?
    by Amiram Gafni
  • 1998 Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer
    by Harriet M. Lamb & Lynda R. Wiseman
  • 1998 Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France
    by Mark Nuijten & Lionel Hadjadjeba & Christopher Evans & John van den Berg
  • 1998 Threshold Analysis of Helicobacter pylori Therapy
    by Amnon Sonnenberg
  • 1998 A Method to Select an Instrument for Measurement of HR-QOL for Cross-Cultural Adaptation Applied to Dermatology
    by Adolfo Ga de Tiedra & Joan Mercadal & Xavier Badia & Jose Ma Mascaro & Rafael Lozano
  • 1998 The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency
    by Leona Hakkaart-van Roijen & Albert Beckers & Achille Stevenaert & Frans F.H. Rutten
  • 1998 Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring
    by Richard L. Slaughter & Diane M. Cappelletty
  • 1998 A Review of the Economics of the Prevention and Control of Rabies: Part 1: Global Impact and Rabies in Humans
    by Martin I. Meltzer & Charles E. Rupprecht
  • 1998 The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis
    by Douglas Coyle & Karen M. Lee
  • 1998 Mega-Mergers in the Pharmaceutical Industry: In Whose Interests?
    by Alain Li Wan Po
  • 1998 Does Managed Care Fuel Pharmaceutical Industry Growth?
    by Michael D. Murray & Frank W. Deardorff
  • 1998 Methodological Quality of Economic Modelling Studies: A Case Study with Hepatitis B Vaccines
    by Michelle Wilde
  • 1998 Costs and Effects Associated with a Community Pharmacy-Based Smoking-Cessation Programme
    by Grainne E. Crealey & James C. McElnay & Terry A. Maguire & Ciaran O'Neill
  • 1998 Cost Effectiveness of Immunoprophylaxis in the Prevention of Recurrent Infectious Rhinitis in Adults
    by Gilles Berdeaux & Antoine Lafuma & Anne-Marie Perruchet & Francis Fagnani
  • 1998 The Economic Impact of Parkinson`s Disease: An Estimation Based on a 3-Month Prospective Analysis
    by Richard C. Dodel & Marikka Singer & Rudolf Kohne-Volland & Thomas Szucs & Bernard Rathay & Erich Scholz & Wolfgang H. Oertel
  • 1998 Cost Analysis of Palliative Care for Terminally Ill Cancer Patients in the UK After Switching from Weak to Strong Opioids
    by Julian F. Guest & Warren M. Hart & Ronald F. Cookson
  • 1998 Outcomes of Pharmacological and Surgical Treatment for Obesity
    by Jennifer Cerulli & Margaret Malone
  • 1998 Reporting Format for Economic Evaluation: Part II: Focus on Modelling Studies
    by C. Nuijten & Marja H. Pronk & Mark J. A. Brorens & Yechiel A. Hekster & Jacques H. M. Lockefeer & Peter A. G. M. de Smet & Gouke Bonsel & Ary van der Kuy
  • 1998 Methodological Quality of Economic Modelling Studies: A Case Study with Hepatitis B Vaccines
    by Tom Jefferson & Vittorio Demicheli
  • 1998 The Need for Pharmacoeconomic Evaluations in the NHS
    by John P. Griffin
  • 1998 Pravastatin: A Pharmacoeconomic Review of its use in Primary and Secondary Prevention of Coronary Heart Disease
    by Allan J. Coukell & Michelle I. Wilde
  • 1998 Cost Effectiveness of Screening for Subclinical Hypothyroidism in the Elderly: A Decision-Analytical Model
    by Massimo Bona & Ferruccio Santini & Giovanni Rivolta & Enzo Grossi & Roberto Grilli
  • 1998 Quality of Life Following a Change in Therapy for Diabetes Mellitus
    by Mirjana Pibernik-Okanovic & Silvija Szabo & Zeljko Melko
  • 1998 Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis: The Impact on Costs and Outcomes in the UK
    by Chris J. McCabe & Ron L. Akehurst & Jeff Kirsch & Malcolm Whitfield & Martin Backhouse & Anthony D. Woolf & David L. Scott & Paul Emery & Ian Haslock
  • 1998 A Review of the Pharmacoeconomics of Pharmaceutical Care
    by Richard J. Plumridge & Richard E. Wojnar-Horton
  • 1998 Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS: An Overview and Methodological Discussion
    by Kenneth A. Freedberg & A. David Paltiel
  • 1998 Reporting Format for Economic Evaluation: Part I: Application to the Dutch Healthcare System
    by Mark J.C. Nuijten & Mark J.A. Brorens & Yechiel A. Hekster & Ary van der Kuy & Jacques H. M. Lockefeer & Per A.G.M. de Smet & Gouke Bonsel & Marja H. Pronk
  • 1998 The Role of Clinical Pathways in Reducing the Economic Burden of Stroke
    by Douglas J. Lanska
  • 1998 Update on Clinical Research Summit in US
    by Jay Moskowitz & James N. Thompson
  • 1998 Cost-of-Illness Studies: Useful for Health Policy?
    by Marc A. Koopmanschap
  • 1998 Risperidone: A Pharmacoeconomic Review of its Use in Schizophrenia
    by Rachel H. Foster & Karen L. Goa
  • 1998 The Use of Decision-Analytical Modelling in Economic Evaluation of Patch Testing in Allergic Contact Dermatitis
    by Rukmini Rajagopalan & Roger T. Anderson & Syam Sarma & Carol Retchin & John Jones
  • 1998 A New Product Pricing Model Using Intracorporate Market Perceptions to Extract the Value of Additional Information
    by Robert S. Woodward & Leah Amir & Mark A. Schnitzler & Daniel C. Brennan
  • 1998 The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients: A Comparison of Atorvastatin, Simvastatin, Lovastatin and Fluvastatin
    by Michael J. Koren & Dean G. Smith & Donald B. Hunninghake & Michael H. Davidson & James M. McKenney & Stuart R. Weiss & Helmut G. Schrott & Robert W. Jr Henley & Perry Tresh & Richard W. McLain & Rebecca G. Bakker-Arkema & Donald M. Black
  • 1998 The Economics of TRACE: A Cost-Effectiveness Analysis of Trandolapril in Postinfarction Patients with Left Ventricular Dysfunction
    by Claude LePen & Herve Lilliu & Thomas Keller & Sylvie Fiessinger
  • 1998 Cost Effectiveness of Coronary Heart Disease Prevention Strategies in Adults
    by Adalsteinn D. Brown & Alan M. Garber
  • 1998 The Impact of Managed Care on Clinical Research
    by Martin McKee & Elias Mossialos
  • 1998 `The Pros and Cons of a Single Euro-Price for Drugs' and `The Economics of Parallel Trade'
    by Patricia Danzon & Adrian Towse
  • 1998 `The Pros and Cons of a Single Euro-Price for Drugs' and `The Economics of Parallel Trade'
    by Joan Rovira
  • 1998 The Role of Pharmacoeconomic Evaluations in Disease Management
    by Kenneth Chang & David Nash
  • 1998 A Reappraisal of Economic Evaluation of Pharmaceuticals: Science or Marketing?
    by Michael F. Drummond
  • 1998 The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in Germany: Economic Evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study
    by Peter K. Schadlich & Josef Georg Brecht
  • 1998 MSQ: Migraine-Specific Quality-of-Life Questionnaire: Further Investigation of the Factor Structure
    by Priti Jhingran & Sonia M. Davis & Lisa M. LaVange & David W. Miller & Ronald W. Helms
  • 1998 Modelling the Potential Economic Impact of Viral Load-Driven Triple Drug Combination Antiretroviral Therapy
    by Aslam H. Anis & Robert S. Hogg & Xiao-hua Wang & Benita Yip & Anita Palepu & Julio S. G. Montaner & Michael V. O'Shaughnessy & Martin T. Schechter
  • 1998 The Influence of Ill-Health Experience on the Valuation of Health
    by Xavier Badia & Michael Herdman & Paul Kind
  • 1998 Socioeconomics of a Global Leprosy Eradication Programme
    by Sharad S. Naik & Ramaswamy Ganapati
  • 1998 The Economic Burden of Migraine to Society
    by Michel D. Ferrari
  • 1998 Common Errors and Controversies in Pharmacoeconomic Analyses
    by Sarah Byford & Stephen Palmer
  • 1998 The Dilemma of New Drugs: Are Costs Rising Faster than Effectiveness?
    by James Mason & Nick Freemantle
  • 1998 Cost Effectiveness of Early Treatment with Oral Aciclovir in Adult Chickenpox Presented in part at the Society of General Internal Medicine 16th Annual Meeting: 1993 Apr; Washington DC
    by Kenneth J. Smith & Mark S. Roberts
  • 1998 Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease: Evaluative Study Carried Out in Spain
    by Pedro Plans-Rubio
  • 1998 Economic Evaluation of Multiple Sclerosis in the UK, Germany and France
    by N. Murphy & C. Confavreux & J. Haas & N. Konig & E. Roullet & M. Sailer & M. Swash & C. Young & J.-L. Merot
  • 1998 The Economic Cost of Multiple Sclerosis in Sweden in 1994
    by Freddie Henriksson & Bengt Jonsson
  • 1998 Assessing the Willingness of Parents to Pay for Reducing Postoperative Emesis in Children
    by Lara Diez
  • 1998 Cost Analysis of the Treatment of Schizophrenia in the UK: A Comparison of Olanzapine and Haloperidol
    by Stephen Almond & Owen O'Donnell
  • 1998 How to Calculate Indirect Costs in Economic Evaluations
    by Bengt Liljas
  • 1998 How to Calculate Indirect Costs in Economic Evaluations
    by Werner B.F. Brouwer & Marc A. Koopmanschap
  • 1998 Fluoxetine: A Pharmacoeconomic Review of its Use in Depression
    by Michelle I. Wilde & Paul Benfield
  • 1998 Linking the Health Utilities Index to National Medical Expenditure Survey Data
    by John A. Rizzo & Steven Pashko & Rebecca Friedkin & John Mullahy & Jody L. Sindelar
  • 1998 Predicting Hospitalisation of Patients with Diabetes Mellitus: An Application of the Bayesian Discriminant Analysis
    by Samir K. Bhattacharyya
  • 1998 Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients
    by George Dranitsaris & Peter Phillips & Coleman Rotstein & Anitasha Puodziunas & Steve Shafran & Gary Garber & Fiona Smaill & Irving Salit & Mark Miller & Kurt Williams & John Conly & Joel Singer & Steve Ioannou
  • 1998 Should Antibacterials Be Deregulated?
    by Joan Rovira & Montserrat Figueras & Josep L. Segu
  • 1998 The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data
    by Alain Desgagne & Anne-Marie Castilloux & Jean-Francois Angers & Jacques LeLorier
  • 1998 Reassessing the Relevance of Pharmacoeconomic Analyses in Formulary Decisions
    by Jeffrey A. Johnson & Erwin Friesen
  • 1998 Pharmacoeconomic Analysis of 3 Treatment Strategies for Cytomegalovirus Retinitis in Patients with AIDS
    by Robert I. Griffiths & Giselle C. Bleecker & Douglas A. Jabs & Douglas T. Dieterich & Laura Coleson & Debbie Winters & Richard Wolitz & Earl P. Steinberg
  • 1998 Evaluation of the Potential Clinical and Economic Effects of Bodyweight Stabilisation with Acarbose in Patients with Type 2 Diabetes Mellitus: A Decision-Analytical Approach
    by Kurt Banz & Rolf Dinkel & Markolf Hanefeld & Uta Schwanebeck
  • 1998 Antidepressant Selection and Use and Healthcare Expenditures: An Empirical Approach
    by William H. Crown & Timothy R. Hylan & Laurie Meneades
  • 1998 Valuation of EuroQOL (EQ-5D) Health States in an Adult US Sample
    by Jeffrey A. Johnson & Stephen Joel Coons & Alex Ergo & George Szava-Kovats
  • 1998 The Use of QALY and Non-QALY Measures of Health-Related Quality of Life: Assessing the State of the Art
    by Mark Deverill & John Brazier & Colin Green & Andrew Booth
  • 1998 An Introduction to Markov Modelling for Economic Evaluation
    by Andrew Briggs & Mark Sculpher
  • 1998 The (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses: Fact or Fallacy?
    by Cam Donaldson
  • 1998 The Role of Government and Private Insurers in Guiding and Implementing Pharmacoeconomic Analyses
    by Deborah A. Freund & Bryan R. Luce
  • 1998 Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections
    by Stephen M. Holliday & Paul Benfield
  • 1998 Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach
    by Peter Davey & David Grainger & Jamie MacMillan & Narayan Rajan & Mike Aristides & Matthew Dobson
  • 1998 Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial
    by Maria Grazia Franzosi & Aldo Pietro Maggioni & Eugenio Santoro & Gianni Tognoni & Emanuele Cavalieri
  • 1998 Average Annual Drug Cost and its Determinants in a Population Based Cohort of HIV-Positive Adult Men and Women
    by Aslam H. Anis & Robert S. Hogg & Benita Yip & Xiao-hua Wang & Julio S. G. Montaner & Michael V. O'Shaughnessy & Martin T. Schechter
  • 1998 A Short Term Cost-Effectiveness Model For Oral Antidiabetic Medicines in Europe
    by Sheila C. Hood & Lieven Annemans & Maureen Rutten -van Molken
  • 1998 The Selection of Data Sources For Use in Modelling Studies
    by Mark J.C. Nuijten
  • 1998 The Economics of Parallel Trade
    by Patricia M. Danzon
  • 1998 Applications of Modelling Studies
    by Mark J.C. Nuijten & John Starzewski
  • 1998 The Role of Cost-Consequence Analysis in Healthcare Decision-Making
    by Josephine A. Mauskopf & John E. Paul & David M. Grant & Andy Stergachis
  • 1998 The Pros and Cons of a Single `Euro-Price' For Drugs
    by Adrian Towse
  • 1998 Cost of an Outbreak of Hepatitis A in Puglia, Italy
    by Carlo Lucioni & Vincenzo Cipriani & Silvio Mazzi & Michele Panunzio
  • 1998 Pharmacoeconomic Analysis of Oral Antifungal Therapies Used to Treat Dermatophyte Onychomycosis of the Toenails: A US Analysis
    by Aditya K. Gupta
  • 1998 Cost-Benefit Analysis of Risperidone and Clozapine in the Treatment of Schizophrenia in Israel
    by Gary Ginsberg & Segev Shani & Boaz Lev
  • 1998 The Effects of Acquisition Cost and Budget-Based Compensation on the Attitudes of Pharmacy Directors Toward the Adoption of a Cost-Effective New Drug
    by Mick Kolassa & Mickey C. Smith & Benjamin F. Banahan III & Dewey D. Garner & William F. Shughart
  • 1998 Chlamydia trachomatis in Adolescents and Adults: Clinical and Economic Implications
    by Carlo A. Marra & David M. Patrick & Robert Reynolds & Fawziah Marra
  • 1998 A Prospective View on European Pharmaceutical Research and Development: Policy Options to Reduce Fragmentation and Increase Competitiveness
    by Panos Kanavos
  • 1998 Pharmacoeconomics in the New Millennium: A Pharmaceutical Industry Perspective
    by Rob Thwaites & Raymond J. Townsend
  • 1998 Measurement of Short Term Health Effects in Economic Evaluations
    by Ann M. Holmes
  • 1998 Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression: A 6-Month Double-Blind Study in a Primary-Care Setting in France
    by P. Boyer & J.M. Danion & J.C. Bisserbe & J.M. Hotton & S. Troy
  • 1998 Economic Evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany
    by Peter K. Schadlich & Britta Paschen & Josef Georg Brecht
  • 1998 Medico-Economic Analysis of Diacerein With or Without Standard Therapy in the Treatment of Osteoarthritis
    by Francis Fagnani & Gilles Bouvenot & Jean-Pierre Valat & Thomas Bardin & Laurent Berdah & Antoine Lafuma & Isabelle Bono & Evelyne Eschwege & Renee- Liliane Dreiser
  • 1998 The Effect of Changes in Treatment Patterns on Drug Expenditure
    by Ulf-G. Gerdtham & Magnus Johannesson & Bo Gunnarsson & Margareta Marcusson & Freddie Henriksson
  • 1998 Using Pharmacoeconomic Analysis to Make Drug Insurance Coverage Decisions
    by Aslam H. Anis & Tuhin Rahman & Martin T. Schechter
  • 1998 Economic Evaluation of Desirudin vs Heparin in Deep Vein Thrombosis Prevention after Hip Replacement Surgery
    by Larse-ke Levin & Manfred Horst & David Bergqvist
  • 1998 Cefotaxime: A Pharmacoeconomic Review of its Use in the Treatment of Infections
    by Greg L. Plosker & Rachel H. Foster & Paul Benfield
  • 1998 Single European Currency and Monetary Union: Macroeconomic Implications for Pharmaceutical Spending
    by Panos Kanavos
  • 1998 Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement
    by Bruno Detournay & Andre Planes & Nicole Vochelle & Francis Fagnani
  • 1998 Price Indices of Drugs and the Switching to New Drugs: Two Empirical Examples
    by Ulf-G Gerdtham & Magnus Johannesson & Bo Gunnarsson & Margareta Marcusson & Freddie Henriksson
  • 1998 Cost Implications of Initial Antidepressant Selection in Primary Care
    by Gregory E. Simon & Paul Fishman
  • 1998 Peripheral Arterial Obliterative Disease: Cost of Illness in France
    by Armelle Montron & Eric Guignard & Alain Pelc & Sylvie Comte
  • 1998 Economic Aspects of Antibacterial Adverse Effects
    by Paul M. Beringer & Annie Wong-Berringer & Jay P. Rho
  • 1998 An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer's Disease
    by Jan J.V. Busschbach & Werner B.F. Brouwer & Adrianus van der Donk & Jan Passchier & Frans F.H. Rutten
  • 1998 How to Calculate Indirect Costs in Economic Evaluations
    by Bengt Liljas
  • 1998 Management of Asthma: The Potential Role of Zafirlukast
    by Blair Jarvis & Julie C. Adkins
  • 1998 Utilisation and Expenditures in the Treatment of Patients with Gastro-Oesophageal Reflux Disease: Prevalence and High Cost Factors
    by Tamra J. Lair & Qinggong Fu & Daniel R. Anderson & Joseph A. Crawley
  • 1998 Rheumatoid Arthritis: Diagnosis and Screening
    by Burkhard F. Leeb & Katharina Weber & Josef S. Smolen
  • 1998 Ensuring Appropriate Care in Epilepsy: An Overview of Epidemiological and Cost of Illness Considerations
    by Dominic C. Heaney & Josemir W.A.S. Sander
  • 1998 Management of HIV Infection: The Potential Role of the Lamivudine/Zidovudine Combination Formulation
    by Caroline M. Perry & Julia A. Barman Balfour
  • 1998 Management of Individuals Who Are Obese: Behaviour Modification and Other Aspects
    by Pertti Mustajoki
  • 1998 Developing Clinical Practice Guidelines: The European Experience
    by Richard Grol & Martin Eccles & Herve Maisonneuve & Steven Woolf
  • 1998 Major Components of an Asthma Disease Management Programme
    by Liza C. O'Dowd & Reynold A. Jr Panettieri
  • 1998 Outpatient Parenteral Antibacterial Therapy of Serious Infections: The Role of Ceftriaxone
    by Julia A. Barman Balfour & Harriet M. Lamb
  • 1998 Guidelines for the Prevention of Coronary Heart Disease: Relating Local Needs to Local Initiatives
    by Ole Faergeman
  • 1998 Management of Tuberculosis: Special Considerations
    by Chester Choi
  • 1998 Cholesterol-Lowering Therapy Interventions: A Pharmacoeconomic Assessment
    by Michael A. Kortt & Edward P. Armstrong
  • 1998 Glaucoma: Screening and Diagnostic Considerations
    by Maurice W. Tuck & Ronald P. Crick
  • 1998 Management of Psychiatric Disorders in Patients with Poor Insight
    by Cedric M. Smith & Cynthia A. Pristach
  • 1998 Cardiac Rehabilitation: Guidelines and Recommendations
    by Catherine Monpere
  • 1998 Depression in the Workplace: Epidemiology, Economics and Effects of Treatment
    by James M. Russell & James Patterson & Andrew M. Baker
  • 1998 Pharmacoeconomic Models in Disease Management: A Guide for the Novice or the Perplexed
    by Richard J. Milne
  • 1998 Clinical Benefits and Cost Reduction Associated with a Comprehensive Asthma Management Programme at a Managed Care Organisation
    by Mark D. Groban & Raeburn M. Evans & Bruce Edgren & Linda T. Butt & Alicia De Stefano & Douglas J. Fernandes & Deborah A. Buchner
  • 1998 Management of HIV-1 Infection in Children: Special Considerations
    by Michael T. Brady
  • 1998 Testicular Cancer: Screening, Diagnostic and Therapeutic Considerations
    by Daan ten Bokkel Huinink & Hendrik Jan Keizer
  • 1998 Management of Primary Open-Angle Glaucoma and Ocular Hypertension: The Potential Role of Latanoprost
    by Julia A. Balfour & Julie C. Adkins
  • 1998 Treatment Expectations in Congestive Heart Failure: Implications for Patients Enrolled in Disease Management Programmes
    by Michael W. Rich
  • 1998 Guidelines for the Implementation of Patient-Controlled Analgesia
    by Lynne Campbell & John Plummer
  • 1998 Selective Digestive Decontamination and its Use in Patients with Liver Disease
    by Janus Ong & Zobair M. Younossi
  • 1998 Interactive Voice Response in Disease Management: Providing Patient Outreach and Improving Outcomes
    by Marnie LaVigne & Kent A. Tapper
  • 1998 Management of Dyslipidaemias: The Potential Role of Atorvastatin
    by Michelle I. Wilde & Caroline M. Spencer
  • 1998 Disease Management Approaches to Asthma: What Does it Mean for the Patient?
    by Maureen George
  • 1998 Current Use of Health Status Instruments in Randomised Controlled Trials on Patients with Rheumatoid Arthritis
    by Jaap Fransen & Gerold Stucki
  • 1998 Disease Management and the Role of Pharmacists
    by David Holdford
  • 1998 Current Guidelines for the Diagnosis and Treatment of Breast Cancer
    by Teresa G. Hayes & Leif E. Peterson & Armin D. Weinberg
  • 1998 Screening, Diagnostic and Outcome Tools for Asthma
    by Anthony M.J. Wever & Jopie Wever-Hess & Mark G. Britton
  • 1998 Hypertension as a Candidate for Disease Management Initiatives: Screening and Diagnosis
    by Lawrence R. Krakoff
  • 1998 Osteoporosis as a Candidate for Disease Management: Epidemiological and Cost-of-Illness Considerations
    by David Torgerson & Cyrus Cooper
  • 1998 Eradication of Helicobacter pylori in the Treatment of Uncomplicated Peptic Ulcer Disease
    by Marie A. Chisholm & Mark W. Jackson & William E. Wade
  • 1998 Interventions and Outcomes Management in Migraine
    by Glen D. Solomon
  • 1998 Dementia Screening and Surveillance: Are There Opportunities for Early Detection?
    by Reinhild Mulligan & Anne-Claude Juillerat & Martial Van del Linden
  • 1998 Screening for Cystic Fibrosis
    by Howard Cuckle & Jenni Murray
  • 1998 Management of Advanced Breast Cancer: Defining the Role of Toremifene
    by Stephen M. Holliday & Diana Faulds
  • 1998 The Use of Guidelines for Managing and Treating Osteoarthritis
    by Geza Balint & Bela Szebenyi & John Kirwan
  • 1998 Economic Considerations and Formulary Management of Oral Antipsychotics
    by Michael W. Jann & Lawrence J. Cohen
  • 1998 Computerised Protocol-Driven Prescribing
    by A. Niklas Holmberg & Rob F. Brenninkmeijer
  • 1998 The Effectiveness of An Interactive Electronic Lung Function Monitoring System in the Total Management of Refractory Asthma
    by Grace Baldwin Doherty & Robert N. Ross & Phyllis E. Ross
  • 1998 Assessing the Cost of Illness of Emphysema
    by Julian F. Guest
  • 1998 Incorporating Diabetes Care Into a Health Maintenance Organisation Setting: A Practical Guide
    by Mayer B. Davidson
  • 1998 Estimating Health-Related Quality of Life in Obese Individuals
    by Kevin R. Fontaine & Susan J. Bartlett
  • 1998 Optimising Outcomes in the Treatment of Obesity: Current Evidence for the Effectiveness of Interventions and Future Prospects
    by Martha L. Elks
  • 1998 Management of Alcohol Dependence after Detoxification: The Potential Role of Acamprosate
    by Michelle I. Wilde & Karen L. Goa
  • 1998 Outsourcing: Disease Management's Magic Bullet
    by Alfred Lewis
  • 1998 Integrated Health Management: The Patient-Centred Future of Demand Management
    by Mark A. Levine & Helen A. Birnbaum
  • 1998 Disease Management: Maximising Treatment Adherence and Self-Management
    by Warren E. Todd & Edward H. Ladon
  • 1997 The Demand for Health Services in a Developing Country : The Role of Prices, Service Quality, and Reporting of Illnesses
    by Deolalikar, A-B
  • 1997 The Demand for Health Services in a Developing Country : The Role of Prices, Service Quality, and Reporting of Illnesses
    by Deolalikar, A-B
  • 1997 The Future of Old-Age Longevity : Competitive Pricing of Mortality Contingent Claims
    by Mullin, C & Philipson, T
  • 1997 Consumption vs. Production of Insurance
    by Tomas Philipson & George Zanjani
  • 1997 The Incidence of Medicare
    by Mark McClellan & Jonathan Skinner
  • 1997 The Effect of Managed Care on Health Care Providers
    by Laurence C. Baker & Martin L. Brown
  • 1997 The Sociology of Groups and the Economics of Incentives: Theory and Evidence on Compensation Systems
    by William E. Encinosa III & Martin Gaynor & James B. Rebitzer
  • 1997 Retiree Health Insurance and the Labor Force Behavior of Older Men in the 1990s
    by David M. Blau & Donna B. Gilleskie
  • 1997 Within Group "Structural" Tests of Labor-Market Discrimination: A Study of Persons with Serious Disabilities
    by David S. Salkever & Marisa E. Domino
  • 1997 Nutritional Status and Agricultural Surpluses in the Antebellum United States
    by Lee A. Craig & Thomas Weiss
  • 1997 Trends in FSP Participation Rates: Focus on August 1995
    by Scott Cody & Carole Trippe
  • 1997 Food Stamp Program Participation Rates: January 1994
    by Michael Stavrianos.
  • 1997 Characteristics of Childless Unemployed Adults and Legal Immigrant Food Stamp Participants: Fiscal Year 1995
    by Mike Stavrianos & Scott Cody & Kimball Lewis
  • 1996 Mortality Contingent Claims, Health Care, and Social Insurance
    by Philipson, T & Becker, G-S
  • 1996 Products Liability and Prescription Drug Prices in Canada and the United States
    by Manning, R-L
  • 1996 Can We Afford to Grow Older?
    by Richard Disney
  • 1996 The Duration of Medicaid Spells: An Analysis Using Flow and Stock Samples
    by Mark C. Berger & Dan A. Black
  • 1996 Option value and quality in the measurement of equity in the delivery of health services
    by Guido Citoni
  • 1996 Choices, Beliefs, and Infectious Disease Dynamics
    by M. Christopher Auld
  • 1996 Alternate Insurance Arrangements and the Treatment of Depression: What Are the Facts?
    by Ernst R. Berndt & Richard G. Frank & Thomas G. McGuire